data_2jyy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jyy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--O 1.235 0.331 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -136.24 118.49 15.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.848 0.356 . . . . 0.0 110.412 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 47' ' ' TYR . 13.1 pt -63.67 150.7 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.878 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.0 t -86.49 77.32 9.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.573 0.702 . . . . 0.0 109.661 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 p -141.51 -173.28 3.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.815 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.796 ' HA ' HD11 ' A' ' 45' ' ' ILE . 19.4 p30 -171.69 -172.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.7 m -60.27 -45.1 94.48 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -76.76 -39.87 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.26 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.06 -30.78 69.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.88 140.01 37.49 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.381 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.9 m -67.85 135.75 53.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.733 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 5.9 tmtm? -59.27 126.1 26.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.47 ' N ' ' HD3' ' A' ' 12' ' ' LYS . . . 112.71 -28.62 8.8 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 29.8 m -87.85 128.28 35.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.086 0.469 . . . . 0.0 110.283 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 31.2 mmtt -93.21 119.33 32.27 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.787 ' HB3' HG22 ' A' ' 45' ' ' ILE . 15.1 m-85 -95.53 128.28 42.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.254 0.549 . . . . 0.0 111.596 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.606 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 8.6 m-85 -120.8 162.02 20.5 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.495 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.452 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 69.3 m -83.28 176.99 8.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.548 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -72.43 -29.8 64.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.564 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 44.1 p-10 -69.08 -38.37 78.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.968 0.413 . . . . 0.0 110.742 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.22 -13.25 4.35 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 m -66.69 134.38 52.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.095 0.474 . . . . 0.0 111.537 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.0 123.75 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.947 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.6 t -86.29 -65.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 111.243 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.0 p -176.56 152.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.664 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -84.88 139.27 31.99 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -67.35 144.58 44.56 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.144 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.733 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 7.6 tt0 -146.26 46.07 1.23 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.682 0.753 . . . . 0.0 110.399 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 95.1 p -79.13 133.83 36.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.395 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.81 129.66 94.48 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 123.481 0.488 . . . . 0.0 110.272 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -90.0 39.35 0.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.186 2.591 . . . . 0.0 113.132 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -127.81 -47.24 1.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.026 0.441 . . . . 0.0 110.006 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 5.7 p30 -81.08 143.88 53.69 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.387 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 20.1 Cg_exo -65.63 106.26 0.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.403 2.069 . . . . 0.0 111.223 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -62.91 107.61 1.03 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.364 0.602 . . . . 0.0 111.192 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.38 -50.8 0.17 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.46 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.97 -53.49 48.33 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.306 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.65 71.47 5.39 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.297 1.998 . . . . 0.0 111.191 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -139.62 36.4 2.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.354 0.597 . . . . 0.0 110.419 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -83.54 135.55 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.7 m -70.89 123.82 22.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.387 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 66.8 t0 -97.49 110.81 56.44 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.98 43.98 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.747 2.965 . . . . 0.0 112.28 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.44 ' HB3' ' HE ' ' A' ' 44' ' ' ARG . 27.5 ttp180 -144.37 -33.21 0.4 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.748 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.796 HD11 ' HA ' ' A' ' 6' ' ' ASN . 39.1 mt -88.82 134.59 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.796 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.441 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -111.15 -44.53 3.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.021 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.533 ' HA ' HD12 ' A' ' 3' ' ' ILE . 10.5 p90 -151.47 150.43 30.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.608 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -122.84 127.89 6.87 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.918 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.501 HG23 ' HD2' ' A' ' 51' ' ' PRO . 43.1 mm -98.09 119.78 46.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 74.1 m -88.09 -46.67 0.46 Allowed Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.501 ' HD2' HG23 ' A' ' 49' ' ' ILE . 8.6 Cg_exo . . . . . 0 C--N 1.358 1.077 0 C-N-CA 122.332 2.021 . . . . 0.0 112.297 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 121.489 0.662 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.861 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -71.45 140.75 50.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.809 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 46' ' ' ALA . 12.5 pt -60.74 135.91 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.351 0.596 . . . . 0.0 111.822 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.3 t -88.99 60.77 5.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.597 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 24.0 p -123.62 -148.54 0.4 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.949 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.718 ' HA ' HD11 ' A' ' 45' ' ' ILE . 2.8 p-10 -170.09 176.76 4.51 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 m -51.09 -45.97 61.65 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.483 0.489 . . . . 0.0 111.8 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.568 ' HB3' HD22 ' A' ' 6' ' ' ASN . . . -64.24 -46.64 82.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.844 0.354 . . . . 0.0 111.297 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.1 56.45 2.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.106 0.479 . . . . 0.0 110.767 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.09 133.79 3.52 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -59.45 136.71 58.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.268 0.227 . . . . 0.0 111.426 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' CYS . 17.7 tppt? -56.19 -36.49 68.44 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 110.604 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.85 27.39 1.95 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.129 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 59.1 m -147.32 138.23 23.63 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.623 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 29.0 mttt -114.78 127.48 55.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.836 0.35 . . . . 0.0 110.216 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.503 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 3.3 m-85 -81.22 129.45 34.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.02 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.436 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 26.0 m-85 -123.11 158.99 29.47 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.407 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.523 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 50.9 m -86.32 164.82 16.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.34 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.403 ' CG ' HH21 ' A' ' 2' ' ' ARG . 1.0 OUTLIER -68.98 -25.44 64.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.914 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 3.5 p-10 -70.84 -34.46 71.7 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.78 -17.21 5.25 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.439 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.61 HG22 HH22 ' A' ' 44' ' ' ARG . 83.1 m -71.68 135.13 46.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.231 0.538 . . . . 0.0 111.912 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.623 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 26.9 t80 -65.69 130.63 43.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.675 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.535 HG12 ' CG1' ' A' ' 45' ' ' ILE . 46.2 t -90.96 -68.34 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 p -169.03 159.02 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.178 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -80.34 162.7 24.39 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.05 98.19 0.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.513 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -90.11 51.27 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.932 0.396 . . . . 0.0 110.952 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -80.16 47.14 0.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.155 0.503 . . . . 0.0 111.635 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 38.7 t70 -74.09 135.44 76.75 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.927 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.431 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 57.2 Cg_endo -71.29 45.31 0.63 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.922 2.414 . . . . 0.0 113.938 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -134.46 34.19 3.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.448 ' N ' ' HD3' ' A' ' 34' ' ' PRO . 14.8 p30 39.19 58.19 6.08 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 33' ' ' ASN . 12.8 Cg_exo -69.33 87.7 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.619 2.212 . . . . 0.0 112.261 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 12.8 mmmt -63.74 134.8 55.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.997 0.903 . . . . 0.0 113.221 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.416 ' HB1' HD21 ' A' ' 6' ' ' ASN . . . -161.08 -172.56 3.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.74 -1.573 . . . . 0.0 107.295 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.77 149.17 0.12 Allowed Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.922 0.764 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 39' ' ' ARG . 64.8 Cg_endo -72.54 -141.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.896 2.397 . . . . 0.0 112.866 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.453 ' H ' ' HB2' ' A' ' 38' ' ' PRO . 13.8 tpt180 -61.01 -40.8 94.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.379 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -176.22 144.31 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.631 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 m 62.54 116.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 O-C-N 124.03 0.831 . . . . 0.0 111.971 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.675 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . 9.3 t70 -71.37 122.16 86.33 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.05 -32.67 59.56 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.643 2.896 . . . . 0.0 114.762 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.61 HH22 HG22 ' A' ' 22' ' ' THR . 5.7 ptm180 -104.61 -3.21 24.07 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.718 HD11 ' HA ' ' A' ' 6' ' ' ASN . 23.4 mt -89.0 132.65 33.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.007 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.861 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -125.02 -49.51 1.72 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.134 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -154.65 148.65 25.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 0.0 111.9 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.54 125.4 7.8 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.615 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.0 mm -101.82 120.33 51.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 39.0 m -89.87 110.79 42.3 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.606 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--N 1.345 0.347 0 C-N-CA 123.4 2.733 . . . . 0.0 111.904 179.76 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.84 0.353 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.434 ' HG3' ' HB2' ' A' ' 46' ' ' ALA . 1.6 mpp_? -140.05 123.88 17.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 46' ' ' ALA . 13.7 pt -60.54 139.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.26 0.552 . . . . 0.0 111.68 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 40.4 t -85.93 83.93 7.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.517 0.675 . . . . 0.0 109.211 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.437 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 23.6 p -139.86 -159.39 0.95 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.989 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.54 HD22 ' HB1' ' A' ' 8' ' ' ALA . 4.4 p-10 -170.47 171.96 6.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.6 m -51.87 -40.85 61.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.54 ' HB1' HD22 ' A' ' 6' ' ' ASN . . . -65.59 -46.0 81.05 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 110.915 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.88 40.53 0.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.179 0.514 . . . . 0.0 110.659 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -110.51 129.49 9.34 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.854 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.433 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 10.7 m -63.69 131.87 49.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.543 0.211 . . . . 0.0 110.646 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -57.91 132.29 52.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.362 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.47 -26.2 16.96 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.218 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.433 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 38.1 m -88.26 129.56 35.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 50.6 mttm -99.23 120.74 40.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.949 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.715 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.5 m-85 -88.57 127.13 35.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.042 0.449 . . . . 0.0 110.984 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.499 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 26.9 m-85 -120.69 161.06 22.05 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.86 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -83.89 165.27 18.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.97 -34.07 76.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.466 0.175 . . . . 0.0 111.005 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.08 -37.59 84.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.83 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.33 -23.68 2.84 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.053 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 m -59.8 136.92 58.15 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.453 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.8 t80 -74.12 123.87 25.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.947 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 44' ' ' ARG . 13.9 t -85.76 -64.5 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.609 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 p -178.31 157.68 1.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.699 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 4.6 tt0 -86.26 -159.99 0.52 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.463 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -83.14 89.57 1.52 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.457 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -88.18 39.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.365 0.603 . . . . 0.0 110.596 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 p -85.45 56.41 3.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.162 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.2 t70 -126.38 135.87 27.81 Favored Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.357 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 23.3 Cg_exo -65.03 -179.12 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.879 2.386 . . . . 0.0 112.439 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.9 mtm-85 78.84 -32.11 0.15 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.972 0.909 . . . . 0.0 110.705 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 31' ' ' PRO . 3.3 p-10 -141.41 54.57 4.36 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.414 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 56.2 Cg_endo -70.04 137.54 34.88 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.79 1.66 . . . . 0.0 110.946 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 34' ' ' PRO . 67.9 mmtt -126.4 127.06 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.77 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.16 136.57 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.167 0.917 . . . . 0.0 111.888 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -69.92 136.96 87.41 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.154 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 7.8 Cg_exo -72.11 68.71 3.23 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.318 2.679 . . . . 0.0 111.933 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.1 ttp85 -155.38 -42.29 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.075 0.465 . . . . 0.0 110.606 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.18 121.52 28.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.216 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 2.3 m -69.86 128.34 36.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.739 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 67.2 t0 -79.6 114.97 50.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 19.6 Cg_endo -61.05 -17.25 50.81 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.041 2.494 . . . . 0.0 112.483 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.528 ' O ' HG21 ' A' ' 24' ' ' VAL . 28.1 mtp-105 -73.09 -35.38 66.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.504 HD11 ' HA ' ' A' ' 6' ' ' ASN . 43.4 mt -88.48 134.37 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.434 ' HB2' ' HG3' ' A' ' 2' ' ' ARG . . . -118.12 -47.98 2.56 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.986 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -154.14 145.72 23.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.209 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.13 128.4 8.84 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.553 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.6 mm -93.82 121.01 44.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 94.6 m -97.77 152.61 38.21 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.992 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo . . . . . 0 N--CA 1.463 -0.313 0 C-N-CA 122.404 2.069 . . . . 0.0 111.525 179.926 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 2' ' ' ARG . 1.2 p30 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.402 0.62 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 1' ' ' ASP . 13.0 mtt-85 -151.96 131.74 13.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.085 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -76.06 141.29 15.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.801 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 47.6 t -87.23 59.62 5.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.717 0.77 . . . . 0.0 109.532 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 p -135.28 125.9 27.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.431 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.632 HD22 ' HB1' ' A' ' 8' ' ' ALA . 3.4 p-10 -90.28 176.52 6.71 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.0 m -51.2 -44.74 61.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.958 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . . . -61.05 -47.53 85.97 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.15 67.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.998 0.427 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.34 138.13 48.42 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.539 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -67.71 124.42 23.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.689 0.281 . . . . 0.0 110.936 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -60.02 131.3 50.42 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.432 ' O ' ' HE2' ' A' ' 15' ' ' LYS . . . 112.35 -33.91 5.44 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.8 m -88.63 131.47 34.96 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.515 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -97.93 119.05 35.86 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.727 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 3.9 m-85 -89.62 125.07 35.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.157 0.503 . . . . 0.0 110.872 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.98 163.55 15.42 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.95 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.4 t -86.49 168.56 13.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.921 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -66.8 -32.77 74.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.83 0.348 . . . . 0.0 110.336 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.53 -32.56 73.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.647 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.23 -23.75 4.29 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.191 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.8 m -62.92 135.45 57.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.141 0.496 . . . . 0.0 111.992 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.3 t80 -71.17 124.29 24.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.787 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.676 HG23 ' HG2' ' A' ' 44' ' ' ARG . 46.8 t -87.91 -64.96 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.515 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 p -172.89 153.95 2.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 111.58 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.456 ' CD ' ' HZ2' ' A' ' 15' ' ' LYS . 37.0 tt0 -90.99 157.61 17.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.334 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.78 130.02 45.71 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.429 -0.415 . . . . 0.0 113.849 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.958 ' HB3' ' HA ' ' A' ' 8' ' ' ALA . 6.6 tt0 -96.82 0.26 49.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.145 0.498 . . . . 0.0 110.734 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.3 p -77.75 -168.92 1.34 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.48 . . . . 0.0 111.632 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.518 ' HB3' HD22 ' A' ' 33' ' ' ASN . 38.7 t0 -163.86 124.31 1.4 Allowed Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 17.3 Cg_exo -68.7 38.25 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.175 2.583 . . . . 0.0 113.983 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.12 17.8 1.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.518 HD22 ' HB3' ' A' ' 30' ' ' ASP . 8.3 p30 -165.21 142.03 4.76 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.033 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.54 57.88 5.66 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.805 2.337 . . . . 0.0 113.861 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -80.25 105.84 11.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.946 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -163.97 29.45 0.08 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.52 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -74.78 -56.64 2.13 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.849 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD3' ' HB1' ' A' ' 37' ' ' ALA . 8.2 Cg_exo -71.33 134.35 24.55 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.894 1.729 . . . . 0.0 110.82 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -157.09 48.87 0.44 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.233 0.539 . . . . 0.0 110.9 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -80.39 138.56 36.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.018 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.6 m -75.78 70.68 2.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.384 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.578 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 33.2 t70 -66.14 115.57 24.76 Favored Pre-proline 0 C--N 1.332 -0.179 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.39 -24.83 78.87 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.302 2.668 . . . . 0.0 112.979 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.676 ' HG2' HG23 ' A' ' 24' ' ' VAL . 19.7 ttm105 -66.8 -33.53 75.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.628 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.5 mt -88.2 108.98 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.084 0.469 . . . . 0.0 110.053 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.07 -48.17 5.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.497 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -153.39 145.13 23.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.727 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.12 128.18 8.89 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.34 119.45 47.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.764 0.316 . . . . 0.0 110.964 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.5 m -98.0 122.16 55.32 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo . . . . . 0 N--CA 1.465 -0.174 0 C-N-CA 123.082 2.521 . . . . 0.0 112.687 -179.552 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.459 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . 44.5 t0 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -169.31 62.88 0.05 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 46' ' ' ALA . 6.9 pt -55.3 142.88 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.934 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 t -87.22 66.86 9.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.553 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.457 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 38.7 p -133.91 -149.41 0.36 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.723 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.708 ' HA ' HD13 ' A' ' 45' ' ' ILE . 24.4 p30 -174.12 -159.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.8 m -66.25 -63.73 1.01 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.064 0.227 . . . . 0.0 111.135 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.948 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . . . -57.5 -38.39 74.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.029 0.443 . . . . 0.0 112.081 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.88 -19.43 60.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.082 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.94 147.9 31.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.681 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.422 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 20.2 m -63.39 124.19 20.64 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.585 0.231 . . . . 0.0 111.359 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -57.4 132.1 52.08 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.528 ' N ' ' HD2' ' A' ' 12' ' ' LYS . . . 106.6 -36.37 4.44 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.729 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 76.2 m -88.35 132.98 34.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.675 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.839 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 25.0 mmtp -82.92 111.33 18.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.74 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.688 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 6.1 m-85 -86.97 124.15 32.85 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.233 0.54 . . . . 0.0 109.894 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.944 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -147.49 178.5 8.39 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.395 0.617 . . . . 0.0 111.834 -178.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.509 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 14.7 m -76.14 168.49 19.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.543 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -66.89 -35.35 79.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.1 p-10 -63.49 -41.4 98.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.999 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.7 -11.92 2.92 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.074 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.7 m -62.61 111.04 1.9 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.86 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.944 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 25.1 t80 -68.08 122.72 18.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.113 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 17' ' ' PHE . 45.8 t -91.55 -61.84 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.549 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.9 p -174.58 152.69 1.71 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.96 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.839 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 10.2 tt0 -80.06 158.29 26.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -65.09 133.92 36.79 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.029 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.948 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 45.2 mt-10 -105.71 16.13 25.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.694 0.247 . . . . 0.0 111.629 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.611 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 26.5 p -80.3 46.78 0.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.402 0.62 . . . . 0.0 110.823 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' ARG . 12.3 t0 -66.15 -50.77 49.05 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.518 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 4.2 Cg_exo -76.23 27.05 0.41 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.236 1.957 . . . . 0.0 112.657 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 30' ' ' ASP . 76.7 mtp180 52.28 40.89 29.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.308 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.611 ' OD1' ' HA ' ' A' ' 29' ' ' SER . 8.8 p-10 -74.49 132.76 78.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.402 . . . . 0.0 110.739 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.33 67.67 3.5 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.144 2.563 . . . . 0.0 112.023 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 68.31 -134.08 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.048 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.505 ' HB1' ' H ' ' A' ' 37' ' ' ALA . . . -160.15 -144.27 0.11 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.568 0.223 . . . . 0.0 110.998 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.505 ' H ' ' HB1' ' A' ' 36' ' ' ALA . . . -67.06 138.11 94.78 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.483 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.12 45.7 1.42 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.847 2.365 . . . . 0.0 112.604 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -174.17 47.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.249 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.96 41.53 1.54 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.331 0.586 . . . . 0.0 111.367 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.1 m -80.93 124.21 28.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.356 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.515 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 33.4 t70 -75.02 114.82 38.75 Favored Pre-proline 0 C--O 1.239 0.531 0 O-C-N 123.233 0.333 . . . . 0.0 110.387 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.41 46.93 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.298 2.665 . . . . 0.0 111.896 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.515 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 13.9 ttp180 -154.94 -23.53 0.12 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.907 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.708 HD13 ' HA ' ' A' ' 6' ' ' ASN . 63.3 mt -85.64 120.89 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.029 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -95.61 -51.9 4.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.449 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.463 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 13.7 p90 -159.92 154.25 23.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.034 0.445 . . . . 0.0 111.59 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.688 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.08 131.56 10.51 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.902 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.563 HG21 ' HD2' ' A' ' 51' ' ' PRO . 34.4 mm -122.02 132.93 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.756 0.312 . . . . 0.0 111.18 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.4 m -88.49 -54.21 0.34 Allowed Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.563 ' HD2' HG21 ' A' ' 49' ' ' ILE . 72.3 Cg_endo . . . . . 0 C--N 1.353 0.795 0 C-N-CA 121.768 1.646 . . . . 0.0 113.4 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.654 0.74 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.402 ' NE ' ' HA ' ' A' ' 46' ' ' ALA . 39.1 ttt180 -73.9 124.49 26.25 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.938 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -65.32 124.84 21.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.452 0.644 . . . . 0.0 111.771 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 t -93.42 51.17 1.57 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.592 0.71 . . . . 0.0 109.724 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 9.1 p -110.04 -145.47 0.4 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.356 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.515 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 16.1 p30 -173.16 176.92 2.84 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.8 m -53.19 -47.77 68.61 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.566 ' HB1' ' HG2' ' A' ' 31' ' ' PRO . . . -68.72 -44.54 73.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.226 0.536 . . . . 0.0 110.44 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.18 49.16 1.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.285 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.677 ' HA2' ' HH ' ' A' ' 16' ' ' TYR . . . -104.2 -141.1 10.89 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.125 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.715 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 87.2 m -157.4 131.58 8.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -55.19 131.54 45.53 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.306 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.87 21.6 71.02 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.524 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 57.9 m -137.63 127.61 25.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 25.9 mtmm -107.26 131.54 54.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.102 0.477 . . . . 0.0 111.763 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.677 ' HH ' ' HA2' ' A' ' 10' ' ' GLY . 6.4 m-30 -85.24 126.85 34.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.369 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -121.63 155.95 34.01 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.451 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.479 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 19.9 m -78.4 175.68 10.06 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.071 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.44 -38.14 86.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.207 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.479 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 43.1 p-10 -66.52 -40.24 89.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.948 0.404 . . . . 0.0 111.069 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.15 -7.97 3.78 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.5 m -65.33 134.35 53.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.13 0.49 . . . . 0.0 111.477 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -73.35 122.08 21.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.619 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.56 -63.02 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.72 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 p -174.5 147.67 1.13 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.373 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 19.2 tt0 -77.78 151.8 33.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.715 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -68.3 94.57 0.33 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.683 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 13.3 tp10 -88.82 69.89 8.65 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 11.4 p -77.51 41.92 0.34 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.528 -1.214 . . . . 0.0 113.266 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 22.6 t70 -89.7 -51.26 0.36 Allowed Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 119.421 -0.323 . . . . 0.0 111.011 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.566 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 42.9 Cg_endo -67.7 58.66 0.79 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 122.87 2.38 . . . . 0.0 112.497 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -65.64 -26.99 68.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.871 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -73.09 135.87 79.73 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.822 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -45.4 128.94 10.58 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 123.581 2.854 . . . . 0.0 114.248 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 35.9 mmtm -149.09 158.13 43.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.493 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.05 -24.94 58.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.621 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -61.93 -54.34 51.56 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.621 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 11.9 Cg_exo -70.51 122.22 8.71 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.918 1.745 . . . . 0.0 111.597 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -114.15 -124.64 0.28 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -171.04 152.85 3.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.048 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.7 m 56.32 52.99 9.32 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.759 0.662 . . . . 0.0 111.907 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.3 127.92 93.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.87 -36.15 62.29 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.764 2.976 . . . . 0.0 114.605 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.09 -23.87 35.52 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.888 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 6' ' ' ASN . 91.8 mt -87.36 127.62 40.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.232 0.539 . . . . 0.0 111.927 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . . . -120.91 -50.61 2.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.858 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -149.75 148.35 29.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.979 0.418 . . . . 0.0 111.802 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.94 134.03 11.92 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 49' ' ' ILE . 42.5 mm -112.89 129.16 69.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.615 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 39.2 m -101.96 -55.63 0.12 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.253 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 74.2 Cg_endo . . . . . 0 C--N 1.355 0.884 0 C-N-CA 121.651 1.567 . . . . 0.0 112.701 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 2' ' ' ARG . 4.2 p-10 . . . . . 0 C--O 1.233 0.193 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.93 ' HD2' ' HA ' ' A' ' 46' ' ' ALA . 26.8 ptt-85 47.7 -164.42 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.192 0.932 . . . . 0.0 112.664 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -82.54 120.8 34.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.122 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.2 t -89.11 58.36 4.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.547 0.689 . . . . 0.0 109.994 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.694 ' HG1' ' HE2' ' A' ' 16' ' ' TYR . 23.5 p -117.29 -152.03 0.49 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.678 ' HA ' HD12 ' A' ' 45' ' ' ILE . 14.6 p30 -175.45 172.26 2.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 59.2 m -58.05 -43.09 86.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.02 -44.17 82.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 111.579 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.06 26.08 6.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.591 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.19 129.11 11.24 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.707 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 m -67.22 124.4 23.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.737 0.303 . . . . 0.0 110.785 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.887 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 54.3 mtmt -55.96 136.06 52.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.415 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.89 -30.96 7.33 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.922 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 39.7 m -88.98 125.03 34.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.0 110.642 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.685 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 2.2 tppt? -85.86 119.42 26.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.205 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.694 ' HE2' ' HG1' ' A' ' 5' ' ' THR . 2.4 m-85 -89.41 124.73 34.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.272 0.558 . . . . 0.0 111.423 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 87.4 m-85 -122.56 158.18 30.47 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.088 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 19' ' ' ASP . 1.3 p -78.11 -161.51 0.27 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.13 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.402 ' H ' ' HB2' ' A' ' 18' ' ' SER . 0.8 OUTLIER -74.75 -44.97 47.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.55 0.214 . . . . 0.0 111.253 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -63.36 -39.81 95.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.601 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.61 0.9 5.24 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -67.47 135.98 53.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.033 0.444 . . . . 0.0 111.033 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -67.26 112.52 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.925 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.545 HG11 HG12 ' A' ' 45' ' ' ILE . 83.6 t -87.83 -55.72 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.28 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.421 ' SG ' HG13 ' A' ' 24' ' ' VAL . 7.7 p -174.38 -170.18 0.5 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.946 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.833 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 13.9 tt0 -134.27 -158.81 0.91 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.742 0.305 . . . . 0.0 110.645 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.833 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -79.78 85.78 1.27 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.251 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -88.26 15.39 7.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.87 0.367 . . . . 0.0 110.985 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 p -79.67 55.31 1.98 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.887 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 24.4 t0 -173.94 -57.73 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 7.3 Cg_exo -72.86 65.68 4.02 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.421 2.081 . . . . 0.0 112.657 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 64.07 55.01 1.59 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -48.63 134.61 13.55 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.106 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.82 178.55 3.89 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.681 2.254 . . . . 0.0 110.678 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.71 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -92.95 129.95 38.7 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.213 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 73.7 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.727 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.52 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -67.24 -48.91 46.4 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.313 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 11.7 Cg_exo -70.97 66.28 2.49 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.648 2.232 . . . . 0.0 111.859 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -68.65 -34.49 75.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.82 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -80.34 45.49 0.76 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.425 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.9 m 67.37 118.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.413 0.685 . . . . 0.0 110.933 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.563 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 10.5 t70 -58.06 111.67 3.84 Favored Pre-proline 0 C--O 1.24 0.566 0 CA-C-O 120.75 0.31 . . . . 0.0 111.0 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.8 52.1 2.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.653 2.902 . . . . 0.0 112.042 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.563 ' HB3' ' OD1' ' A' ' 42' ' ' ASP . 12.8 ttp180 -166.27 -34.31 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.313 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 6' ' ' ASN . 62.7 mt -89.39 129.76 39.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.2 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.93 ' HA ' ' HD2' ' A' ' 2' ' ' ARG . . . -115.16 -44.19 3.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -152.77 152.89 32.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 112.009 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.4 128.69 7.26 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.937 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mm -97.24 116.06 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 49.9 m -89.19 -52.03 0.36 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.672 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 60.5 Cg_endo . . . . . 0 C--N 1.354 0.84 0 C-N-CA 121.56 1.507 . . . . 0.0 112.365 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.593 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 13.0 mtm105 62.76 58.25 1.61 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.549 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.3 pt -58.08 150.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.518 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 40.9 t -85.2 78.69 9.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.6 0.714 . . . . 0.0 109.575 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 39.2 p -138.71 -156.62 0.7 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.04 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.752 ' HA ' HD13 ' A' ' 45' ' ' ILE . 17.1 p30 -178.3 178.59 0.87 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 m -54.12 -55.45 27.54 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.803 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . . . -62.2 -35.76 79.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.81 -30.17 62.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.882 0.373 . . . . 0.0 111.366 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.93 147.13 48.81 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.206 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.438 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 23.1 m -69.31 128.29 36.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.562 0.22 . . . . 0.0 111.122 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 43.8 mtmt -57.05 136.22 56.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.344 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.75 -32.27 7.42 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.658 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.5 m -87.91 134.27 33.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.974 0.416 . . . . 0.0 109.958 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 38.3 mmtt -93.1 122.47 35.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.488 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.64 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.3 m-85 -95.17 129.73 42.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.966 0.412 . . . . 0.0 110.823 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.483 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 38.3 m-85 -121.04 165.22 15.61 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.885 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.2 m -79.1 -156.65 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.748 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -84.75 -42.17 15.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.746 0.308 . . . . 0.0 110.622 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -63.98 -42.46 97.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.633 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.89 -5.25 3.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.1 m -64.34 131.2 46.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.005 0.431 . . . . 0.0 110.779 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.9 t80 -70.3 117.74 12.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.942 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.567 HG23 ' HG2' ' A' ' 44' ' ' ARG . 86.0 t -81.66 -63.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.986 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.6 p -178.1 167.79 1.99 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.502 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -95.57 156.25 16.4 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -68.81 133.39 27.12 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.874 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.803 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 29.9 mt-10 -116.09 32.78 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.977 0.418 . . . . 0.0 110.243 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.438 ' OG ' ' HA ' ' A' ' 11' ' ' THR . 14.5 p -78.41 55.0 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 0.0 111.76 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.572 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 13.0 t0 -68.12 -56.79 10.3 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.006 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 1.2 Cg_endo -82.21 12.89 2.69 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.264 1.976 . . . . 0.0 111.254 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 60.66 33.66 20.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.549 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -169.85 137.14 1.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.18 0.514 . . . . 0.0 110.964 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.474 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 91.5 Cg_endo -82.32 60.14 7.24 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.803 2.335 . . . . 0.0 111.501 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.636 ' HB2' ' NZ ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER 67.76 116.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.499 -178.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.5 ' HB3' ' H ' ' A' ' 37' ' ' ALA . . . 57.57 -135.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.812 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.5 ' H ' ' HB3' ' A' ' 36' ' ' ALA . . . -96.79 134.57 22.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.52 0.2 . . . . 0.0 110.684 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 22.6 Cg_exo -64.22 130.84 28.26 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.717 2.278 . . . . 0.0 111.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -164.04 45.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.887 0.375 . . . . 0.0 110.999 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -160.32 125.84 3.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.124 0.487 . . . . 0.0 110.475 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 3.3 m -107.98 125.9 52.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.07 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -90.35 110.75 42.96 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.28 -21.71 73.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.414 2.742 . . . . 0.0 112.306 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.567 ' HG2' HG23 ' A' ' 24' ' ' VAL . 26.5 ttp180 -66.06 -30.87 71.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.688 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.752 HD13 ' HA ' ' A' ' 6' ' ' ASN . 50.9 mt -89.53 126.5 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.935 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -110.65 -42.98 3.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.7 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -156.37 145.41 20.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.274 0.559 . . . . 0.0 112.0 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.24 131.54 10.64 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.488 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.99 121.69 55.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.057 0.456 . . . . 0.0 111.023 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 76.7 m -97.92 137.95 20.95 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.7 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.6 Cg_exo . . . . . 0 CA--C 1.53 0.317 0 C-N-CA 122.884 2.39 . . . . 0.0 112.445 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 121.423 0.63 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -151.68 60.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.859 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.747 HD11 ' HA ' ' A' ' 47' ' ' TYR . 21.2 pt -64.62 140.64 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.336 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.72 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 52.2 t -87.15 69.11 10.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.554 0.693 . . . . 0.0 110.268 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 29.9 p -120.49 -164.15 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.86 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HA ' HD11 ' A' ' 45' ' ' ILE . 23.0 p30 -175.04 161.09 2.86 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.4 m -60.06 -35.31 74.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.49 -23.55 64.59 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.198 0.523 . . . . 0.0 110.938 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.41 -109.56 0.36 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.177 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.92 -136.45 50.83 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.186 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.5 m -152.17 127.53 9.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 42.0 tptt -60.07 133.11 55.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.783 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.08 -26.16 23.88 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.893 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HB2' ' HE1' ' A' ' 16' ' ' TYR . 33.9 m -88.05 129.76 35.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.125 0.488 . . . . 0.0 110.458 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -90.3 114.92 27.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.047 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.674 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.1 m-85 -96.2 128.68 43.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.855 0.36 . . . . 0.0 110.359 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.978 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 0.6 OUTLIER -148.91 178.27 8.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.028 0.442 . . . . 0.0 111.502 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.541 ' HA ' ' HB2' ' A' ' 46' ' ' ALA . 13.1 p -78.72 174.7 11.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.887 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -68.6 -35.6 77.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.27 -36.59 84.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.041 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.32 -18.84 4.13 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.238 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.3 m -58.56 115.35 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.059 0.457 . . . . 0.0 111.262 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.978 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 23.8 t80 -65.04 118.14 8.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.569 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.8 t -84.81 -58.91 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.353 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 26.0 p -178.26 151.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.775 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.2 147.06 28.25 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.19 124.41 29.95 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.746 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' ASP . 7.5 tp10 -128.4 65.49 1.4 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.58 43.18 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.627 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -70.02 130.02 90.24 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.148 178.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 4.4 Cg_exo -81.99 39.05 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.399 2.733 . . . . 0.0 112.973 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.454 ' HG3' HH11 ' A' ' 32' ' ' ARG . 17.2 mmt85 -131.22 -46.7 1.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 18.0 p30 -62.86 136.19 96.34 Favored Pre-proline 0 C--O 1.237 0.445 0 CA-C-O 121.201 0.524 . . . . 0.0 110.624 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 32.0 Cg_exo -60.22 139.22 86.0 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.609 2.873 . . . . 0.0 113.736 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -132.95 128.62 36.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.098 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.7 -37.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.256 0.347 . . . . 0.0 110.823 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -59.0 136.28 87.7 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.989 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 16.7 Cg_exo -68.38 59.29 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.716 2.944 . . . . 0.0 113.122 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.533 ' HD2' ' OD2' ' A' ' 42' ' ' ASP . 12.6 tpp180 -94.99 43.94 1.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.933 0.873 . . . . 0.0 109.704 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -90.65 139.58 30.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.797 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.72 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 65.3 m 60.49 52.62 4.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.672 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.533 ' OD2' ' HD2' ' A' ' 39' ' ' ARG . 8.4 t0 -58.5 113.23 6.21 Favored Pre-proline 0 N--CA 1.464 0.269 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.39 -30.61 91.83 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.575 2.85 . . . . 0.0 113.915 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.506 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 34.5 ptt180 -70.64 -26.25 63.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.375 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.552 HG22 ' HB3' ' A' ' 16' ' ' TYR . 59.9 mt -89.13 111.31 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.977 0.417 . . . . 0.0 110.761 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 18' ' ' SER . . . -89.91 -49.99 6.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.245 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.747 ' HA ' HD11 ' A' ' 3' ' ' ILE . 14.8 p90 -161.77 147.49 13.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.253 0.549 . . . . 0.0 111.678 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.38 129.4 9.56 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.296 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.415 ' HA ' HD13 ' A' ' 49' ' ' ILE . 49.8 mm -99.11 124.8 52.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.025 0.44 . . . . 0.0 111.194 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.4 m -100.13 139.33 20.64 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.98 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--N 1.342 0.194 0 C-N-CA 122.588 2.192 . . . . 0.0 112.103 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.1 t0 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.605 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -64.97 144.93 56.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.205 0.526 . . . . 0.0 111.311 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 pt -68.06 135.01 29.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.238 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 41.8 t -87.66 57.87 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.692 0.758 . . . . 0.0 110.254 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 9' ' ' ALA . 34.1 p -124.5 -143.35 0.31 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.765 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.607 ' HA ' HD12 ' A' ' 45' ' ' ILE . 9.4 p-10 -177.46 -171.15 0.31 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.469 ' C ' ' HG2' ' A' ' 28' ' ' GLU . 4.3 m -60.33 -41.86 94.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.589 0.233 . . . . 0.0 110.453 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.604 ' HB3' HD22 ' A' ' 6' ' ' ASN . . . -60.11 -44.47 94.83 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.715 0.293 . . . . 0.0 111.584 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 5' ' ' THR . . . -82.52 21.75 0.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.099 0.476 . . . . 0.0 110.521 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.532 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -91.46 131.45 10.79 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.188 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.618 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 5.3 m -69.22 148.96 49.1 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.647 0.26 . . . . 0.0 110.591 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -58.34 131.89 52.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.439 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.76 -11.03 54.98 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.13 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.794 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 61.3 m -89.52 128.83 36.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.422 0.629 . . . . 0.0 110.624 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.525 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 15.2 mmtp -98.81 121.34 40.63 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.715 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.578 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.5 m-85 -92.05 125.76 36.87 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.768 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.26 162.84 16.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.734 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.467 ' HB2' ' H ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -78.51 -154.14 0.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.997 178.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.467 ' H ' ' HB2' ' A' ' 18' ' ' SER . 14.4 p-10 -82.76 -42.15 18.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.681 0.276 . . . . 0.0 110.488 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -64.41 -41.26 96.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.665 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.96 -0.04 4.38 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -68.27 134.5 50.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 110.754 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.9 t80 -68.78 111.88 5.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.614 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.7 t -83.26 -57.11 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.778 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.9 p -175.53 158.28 2.22 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.981 0.42 . . . . 0.0 111.923 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 38.0 tt0 -92.44 173.21 7.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -69.91 108.48 2.49 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.572 -0.823 . . . . 0.0 114.062 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.56 ' HG2' ' N ' ' A' ' 8' ' ' ALA . 21.8 pt-20 -89.16 36.43 0.82 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.201 1.0 . . . . 0.0 108.392 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 3.5 p -78.08 56.24 1.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.359 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -63.46 128.97 93.28 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.532 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 33' ' ' ASN . 73.9 Cg_endo -75.63 -136.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.784 2.323 . . . . 0.0 111.237 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.503 ' H ' ' HB2' ' A' ' 31' ' ' PRO . 38.2 mtp85 73.21 -31.96 0.23 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.388 0.675 . . . . 0.0 111.122 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 31' ' ' PRO . 5.8 p30 -169.37 141.7 2.06 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.055 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 14.0 Cg_exo -70.35 71.8 1.79 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.602 2.868 . . . . 0.0 113.004 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -68.23 112.81 5.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.728 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.6 122.07 28.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.321 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.72 114.43 50.06 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.898 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.42 46.51 2.23 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.838 2.359 . . . . 0.0 112.254 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.401 ' HE ' ' ND2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -160.87 52.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.216 0.531 . . . . 0.0 111.322 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.99 161.48 29.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.399 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 65.62 48.6 1.94 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.365 0.416 . . . . 0.0 110.436 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.656 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 4.4 t0 -60.5 113.59 7.94 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 12.1 Cg_endo -56.58 -33.72 93.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.646 2.898 . . . . 0.0 114.313 -177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.656 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 23.2 ptt180 -71.07 -27.01 63.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.789 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 6' ' ' ASN . 67.7 mt -91.72 127.31 44.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 111.703 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.08 -45.34 3.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.55 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -152.5 145.82 24.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.209 0.528 . . . . 0.0 111.616 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -111.84 129.19 8.97 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.31 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.41 HG22 ' HD2' ' A' ' 51' ' ' PRO . 40.1 mm -110.69 125.05 67.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.794 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 19.2 m -87.68 -51.69 0.41 Allowed Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.646 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 2.8 Cg_exo . . . . . 0 C--N 1.353 0.791 0 C-N-CA 122.373 2.049 . . . . 0.0 112.469 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 110.432 -0.211 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.759 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 61.6 mtt85 54.27 60.52 3.52 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.863 0.727 . . . . 0.0 111.931 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 pt -57.28 147.44 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.323 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.542 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 43.6 t -85.33 75.24 10.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.758 0.79 . . . . 0.0 109.937 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.3 p -140.9 -163.94 1.64 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.205 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.972 ' HA ' HD13 ' A' ' 45' ' ' ILE . 15.4 p30 -173.24 -158.62 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 m -69.71 -54.5 13.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.267 0.485 . . . . 0.0 110.467 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -65.91 -44.03 86.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.307 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.82 -4.65 47.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.089 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.26 141.04 23.59 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.053 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.688 HG21 ' HB3' ' A' ' 31' ' ' PRO . 72.7 m -68.26 127.19 32.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.727 0.298 . . . . 0.0 110.497 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.714 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 82.2 tttt -57.66 131.31 49.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.907 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.27 -29.59 12.17 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.532 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.5 m -88.42 128.44 35.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.124 0.488 . . . . 0.0 109.943 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.612 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 10.9 mtpp -90.67 114.42 26.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.364 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.705 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.5 m-85 -86.37 126.01 34.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.302 0.572 . . . . 0.0 111.637 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 14.4 m-85 -119.89 163.07 18.09 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.653 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.7 t -84.32 169.22 14.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -69.1 -32.25 71.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 0.0 110.127 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -66.27 -33.94 76.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.591 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.73 -23.9 3.72 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.195 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -60.97 133.18 55.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.095 0.474 . . . . 0.0 112.097 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -73.49 122.86 22.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.466 HG11 ' CG1' ' A' ' 45' ' ' ILE . 48.9 t -86.93 -65.13 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.403 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.0 p -175.69 152.29 1.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.577 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -85.71 145.72 27.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.714 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -66.37 144.41 45.86 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.659 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.401 ' CG ' ' HA ' ' A' ' 8' ' ' ALA . 14.2 pt-20 -117.32 -18.12 9.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 82.5 p -78.56 139.9 38.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.372 0.606 . . . . 0.0 112.445 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.405 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -63.52 138.14 97.28 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.606 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.688 ' HB3' HG21 ' A' ' 11' ' ' THR . 90.5 Cg_endo -82.36 29.49 0.54 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.663 2.242 . . . . 0.0 113.68 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.406 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.7 mmp_? -129.04 29.07 5.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.926 0.393 . . . . 0.0 110.348 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -154.07 146.4 17.34 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.77 143.75 46.79 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.829 2.353 . . . . 0.0 111.631 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -70.19 140.76 52.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.719 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -43.64 -51.27 7.11 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -166.96 125.53 1.05 Allowed Pre-proline 0 C--N 1.328 -0.342 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.571 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 3.0 Cg_exo -75.61 63.21 6.48 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.538 2.825 . . . . 0.0 111.665 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -148.76 -23.11 0.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.011 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -86.37 48.78 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.49 0.662 . . . . 0.0 110.101 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m -67.34 125.52 26.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.058 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.504 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 66.0 t0 -78.32 116.98 63.41 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.18 -24.77 75.43 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.334 2.689 . . . . 0.0 113.97 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 28.6 ptt-85 -93.78 -1.53 54.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.413 -0.515 . . . . 0.0 112.326 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.972 HD13 ' HA ' ' A' ' 6' ' ' ASN . 15.7 mt -102.79 124.02 56.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.984 0.421 . . . . 0.0 110.7 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.759 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -108.67 -46.13 3.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.29 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -153.25 147.48 25.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.262 0.553 . . . . 0.0 112.431 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.705 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.66 125.68 7.53 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.6 mm -89.74 113.61 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.826 0.346 . . . . 0.0 110.785 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.0 m -95.72 134.14 24.53 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.065 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 C--O 1.231 0.167 0 C-N-CA 122.496 2.131 . . . . 0.0 112.32 -179.843 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.3 t70 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.8 ptt85 -162.26 108.05 1.25 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.23 0.538 . . . . 0.0 110.34 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 pt -65.04 145.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.766 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -87.24 78.76 8.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.481 0.658 . . . . 0.0 109.676 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.2 p -138.35 -168.32 2.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.854 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.481 ' HA ' HD13 ' A' ' 45' ' ' ILE . 17.7 p30 -168.9 -179.53 3.73 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -55.99 -46.01 78.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.37 -49.28 17.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.67 60.47 6.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.515 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.53 -143.16 5.03 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.097 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 m -132.19 131.13 41.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.589 ' HG2' ' OE1' ' A' ' 28' ' ' GLU . 29.8 mtpp -56.96 130.09 44.47 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.45 0.469 . . . . 0.0 111.379 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.31 -21.24 25.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.384 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.7 m -88.21 128.98 35.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.285 0.564 . . . . 0.0 110.208 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.549 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 46.1 mttm -96.25 123.67 39.96 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.298 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.625 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 11.6 m-85 -92.39 127.46 37.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.204 0.526 . . . . 0.0 111.31 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.485 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 12.2 m-85 -118.38 164.61 14.98 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.4 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.9 m -77.29 -158.98 0.12 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.797 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -84.58 -40.38 17.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.776 0.322 . . . . 0.0 110.311 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -65.35 -43.81 89.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.529 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.92 -3.79 2.31 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -65.43 130.13 42.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 110.989 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.1 t80 -72.87 115.71 12.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.732 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.67 -62.43 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 28.7 p -175.21 150.31 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.698 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 23.0 tt0 -83.12 141.23 32.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.562 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.66 132.97 12.07 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.697 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.589 ' OE1' ' HG2' ' A' ' 12' ' ' LYS . 4.5 tp10 -141.09 69.99 1.34 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.961 0.886 . . . . 0.0 109.741 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -85.39 43.56 1.03 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.692 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.572 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.5 t70 -64.47 -51.42 60.08 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.707 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 32.6 Cg_exo -61.55 133.91 48.26 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.741 1.627 . . . . 0.0 111.743 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 1.4 mmt85 -81.75 36.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.347 0.594 . . . . 0.0 109.903 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.453 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.5 p30 -167.32 63.09 0.66 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.85 132.49 52.27 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.785 2.323 . . . . 0.0 111.634 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -107.97 115.99 31.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.04 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -174.34 176.49 2.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.576 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.27 137.93 95.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 123.058 0.224 . . . . 0.0 110.482 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.62 125.32 15.28 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.355 2.036 . . . . 0.0 112.283 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 16.0 tpp85 60.56 44.97 11.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.081 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -96.04 135.96 37.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.935 0.398 . . . . 0.0 110.096 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.9 m -115.55 123.28 48.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -71.91 115.75 41.31 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.39 -22.36 74.34 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.168 2.578 . . . . 0.0 112.84 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -82.73 -27.51 31.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 6' ' ' ASN . 68.1 mt -87.86 124.92 41.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.399 0.619 . . . . 0.0 112.332 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.07 -46.78 3.07 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.573 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -149.75 142.93 25.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.346 0.593 . . . . 0.0 111.91 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -103.01 132.3 10.96 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.746 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.1 mm -101.05 122.6 53.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.83 0.348 . . . . 0.0 110.542 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 83.2 m -105.15 124.39 36.68 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.201 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 C-N-CA 122.69 2.26 . . . . 0.0 112.237 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -168.16 121.97 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 45' ' ' ILE . 9.7 pt -65.42 129.67 29.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 110.693 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.01 62.49 6.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.493 0.663 . . . . 0.0 109.406 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 21.9 p -128.73 -154.43 0.64 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.991 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.463 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 15.6 p30 -176.84 -166.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 m -61.39 -53.91 50.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.32 0.388 . . . . 0.0 111.083 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . . . -61.69 -40.57 95.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 0.0 111.007 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.12 57.44 4.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.61 141.5 7.12 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.212 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -61.51 135.69 57.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.479 0.18 . . . . 0.0 110.723 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER -57.89 -32.33 67.6 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.515 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.1 27.16 3.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.074 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.6 m -147.51 132.02 17.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.564 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 59.2 mttp -105.67 126.87 52.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.643 ' HB3' HG21 ' A' ' 45' ' ' ILE . 3.1 m-30 -82.99 124.48 30.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.144 0.497 . . . . 0.0 111.249 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -121.47 161.32 22.45 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.799 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.5 t -87.38 163.86 16.54 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 15.8 p-10 -66.58 -33.04 74.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.662 0.268 . . . . 0.0 110.54 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.49 -31.12 72.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.502 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.28 -21.72 4.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.305 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 m -63.84 133.34 53.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.238 0.542 . . . . 0.0 112.335 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 19.2 t80 -74.56 122.02 22.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.508 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.8 t -86.72 -62.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.396 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.5 p -174.8 150.95 1.34 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.208 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.564 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 37.1 tt0 -80.38 149.64 30.13 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.42 137.99 40.44 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.251 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 8' ' ' ALA . 16.3 pt-20 -137.21 61.05 1.63 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.787 0.803 . . . . 0.0 110.099 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.15 65.66 3.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.89 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.7 t70 -58.33 128.93 83.15 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.998 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.504 ' C ' ' H ' ' A' ' 33' ' ' ASN . 2.3 Cg_endo -81.77 -147.83 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.072 2.515 . . . . 0.0 111.158 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 70.88 -30.75 0.21 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.399 0.68 . . . . 0.0 112.098 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.504 ' H ' ' C ' ' A' ' 31' ' ' PRO . 10.6 p30 -132.12 133.26 23.68 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 121.202 0.525 . . . . 0.0 110.772 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 20.2 Cg_exo -66.81 137.6 45.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.369 2.713 . . . . 0.0 112.956 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -95.04 130.83 41.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.465 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -155.04 148.37 25.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.969 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.405 ' N ' ' HD3' ' A' ' 38' ' ' PRO . . . 56.92 64.73 4.31 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.943 0.777 . . . . 0.0 112.045 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 37' ' ' ALA . 9.5 Cg_exo -72.19 52.62 1.92 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.319 2.679 . . . . 0.0 112.337 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -76.61 49.45 0.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.311 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -153.8 43.99 0.58 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.608 0.718 . . . . 0.0 109.857 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.3 m -65.07 131.99 48.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.498 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.449 ' HB3' HD13 ' A' ' 45' ' ' ILE . 65.6 t0 -91.46 112.21 53.06 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.919 0.39 . . . . 0.0 110.298 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 29.6 Cg_endo -63.46 -22.89 71.28 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.122 2.548 . . . . 0.0 112.546 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -67.86 -21.95 65.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.782 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.643 HG21 ' HB3' ' A' ' 16' ' ' TYR . 67.3 mt -87.3 133.82 29.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.189 0.518 . . . . 0.0 111.432 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.17 -41.72 2.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.466 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 19' ' ' ASP . 4.5 p90 -155.24 149.18 25.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.051 0.453 . . . . 0.0 111.857 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -106.84 126.66 8.54 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.2 mm -92.27 117.39 35.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.859 0.361 . . . . 0.0 110.612 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 51' ' ' PRO . 76.8 m -99.68 -46.19 0.22 Allowed Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.173 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HD2' ' H ' ' A' ' 50' ' ' CYS . 52.1 Cg_endo . . . . . 0 C--N 1.363 1.296 0 C-N-CA 122.2 1.933 . . . . 0.0 113.025 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.627 0.251 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.05 138.03 1.65 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.099 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 pt -64.49 133.9 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.3 0.571 . . . . 0.0 111.933 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t -89.79 69.1 7.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.984 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -135.17 -169.73 2.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.802 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.673 ' HA ' HD11 ' A' ' 45' ' ' ILE . 16.9 p30 -165.15 -173.86 3.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 m -59.68 -48.93 79.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.57 -48.95 23.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.11 0.481 . . . . 0.0 110.462 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.87 63.04 7.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.737 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.23 -135.21 2.83 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.734 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.5 m -161.0 125.58 3.56 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 12.8 ttmm -60.91 133.48 56.14 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.178 0.514 . . . . 0.0 109.944 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.19 -39.58 2.55 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 40.0 m -92.49 125.69 37.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.772 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -96.23 125.18 40.56 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.68 ' HB3' HG23 ' A' ' 45' ' ' ILE . 53.2 m-85 -91.78 126.06 36.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.162 0.506 . . . . 0.0 111.52 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -117.56 163.92 15.7 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.838 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -76.21 -155.21 0.05 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.966 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -91.19 -40.24 11.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.824 0.345 . . . . 0.0 110.129 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.17 -41.83 96.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.772 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.61 -13.55 2.7 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.748 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -60.84 132.0 52.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.285 0.564 . . . . 0.0 111.542 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.592 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.0 t80 -74.0 120.89 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.718 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.0 t -88.3 -62.68 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.308 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.3 p -171.8 149.59 2.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 0.0 111.116 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.772 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 23.1 tt0 -85.38 151.88 23.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -59.83 122.26 29.41 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.467 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -105.27 58.69 0.68 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.577 0.703 . . . . 0.0 110.088 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 p -156.03 141.19 17.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.429 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 10.0 t70 -63.0 134.1 95.67 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.19 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 18.8 Cg_exo -68.36 41.35 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.982 3.122 . . . . 0.0 114.176 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -71.06 -32.83 69.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.416 . . . . 0.0 110.405 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -173.2 149.77 1.79 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.648 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.89 128.61 26.02 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.363 2.042 . . . . 0.0 111.148 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -89.61 140.51 29.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -161.75 145.0 12.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.39 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.47 149.5 21.48 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.095 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.86 116.13 2.91 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.751 2.301 . . . . 0.0 113.248 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 59.37 33.29 22.35 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.642 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.11 26.02 3.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.746 0.784 . . . . 0.0 110.236 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.42 120.52 17.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.07 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.469 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 10.0 t70 -78.61 121.3 83.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.24 -27.87 68.47 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.24 2.626 . . . . 0.0 113.524 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 -30.24 26.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.634 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.68 HG23 ' HB3' ' A' ' 16' ' ' TYR . 84.6 mt -88.72 123.98 41.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.11 -44.69 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.551 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -146.58 145.34 30.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.445 . . . . 0.0 111.427 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -116.04 136.13 12.68 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.785 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.1 mm -101.52 119.6 49.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 85.9 m -88.22 -41.32 0.48 Allowed Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 50' ' ' CYS . 9.9 Cg_endo . . . . . 0 C--N 1.362 1.274 0 C-N-CA 121.907 1.738 . . . . 0.0 112.052 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 49.2 t0 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 59.21 54.83 4.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.528 0.731 . . . . 0.0 110.518 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.551 HD11 ' HA ' ' A' ' 47' ' ' TYR . 9.5 pt -60.11 138.62 20.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.429 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.6 t -86.03 84.93 7.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.8 p -138.48 -168.05 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.832 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -165.6 159.9 17.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.6 m -57.15 -38.1 73.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.68 95.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.983 0.42 . . . . 0.0 110.931 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.86 -96.89 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.062 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.91 -131.82 47.95 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.674 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.3 m -155.02 115.56 3.88 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 18.4 tptm -61.15 121.59 12.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.52 -33.88 4.91 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.422 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 86.3 m -95.56 131.93 41.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.107 0.48 . . . . 0.0 110.159 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 0.8 OUTLIER -92.03 122.11 34.23 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.767 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.4 m-85 -87.04 131.73 34.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.759 0.314 . . . . 0.0 110.743 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -125.41 163.93 21.54 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.767 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.451 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 44.2 m -85.78 -179.99 6.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.119 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -69.5 -37.36 77.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.64 0.257 . . . . 0.0 111.434 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 43.9 p-10 -66.24 -40.41 90.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.14 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.67 -9.64 3.99 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -62.88 132.53 52.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.111 0.481 . . . . 0.0 111.155 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CE1' ' HG3' ' A' ' 15' ' ' LYS . 20.6 t80 -71.94 120.15 17.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.696 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.913 HG13 HG12 ' A' ' 45' ' ' ILE . 82.9 t -83.7 -68.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 27.2 p 177.72 158.39 0.42 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -91.7 146.56 23.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -75.23 119.0 5.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.434 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -89.62 50.59 1.93 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 117.452 0.626 . . . . 0.0 111.99 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 40.94 1.03 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.771 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.672 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 1.6 t70 -65.62 -58.31 12.01 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.15 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.672 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 9.8 Cg_endo -90.73 -148.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.883 2.389 . . . . 0.0 111.685 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -117.91 41.82 2.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.366 0.603 . . . . 0.0 110.637 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.569 ' CG ' ' HD3' ' A' ' 34' ' ' PRO . 10.1 p-10 -79.56 -40.91 1.47 Allowed Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.569 ' HD3' ' CG ' ' A' ' 33' ' ' ASN . 2.8 Cg_exo -75.83 146.88 30.26 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.074 1.849 . . . . 0.0 112.718 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HD2' ' C ' ' A' ' 34' ' ' PRO . 13.4 mptt -124.99 133.95 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB2' ' H ' ' A' ' 37' ' ' ALA . . . 62.61 -134.22 0.48 Allowed 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.761 0.663 . . . . 0.0 110.471 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.514 ' H ' ' HD2' ' A' ' 38' ' ' PRO . . . -166.81 -52.38 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.514 ' HD2' ' H ' ' A' ' 37' ' ' ALA . 74.4 Cg_endo -74.06 45.02 1.08 Allowed 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.226 1.951 . . . . 0.0 113.336 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -83.64 -40.28 19.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.621 0.724 . . . . 0.0 109.485 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -174.2 135.38 0.46 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.904 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.2 m -123.21 137.17 54.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.824 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 8.0 t0 -86.7 120.18 71.68 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.091 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.11 -24.27 78.97 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.351 2.701 . . . . 0.0 112.55 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.474 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 21.1 ttp180 -68.13 -19.47 64.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.263 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.913 HG12 HG13 ' A' ' 24' ' ' VAL . 57.5 mt -85.94 129.27 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.923 0.392 . . . . 0.0 110.875 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.02 -51.2 2.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.459 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.551 ' HA ' HD11 ' A' ' 3' ' ' ILE . 11.9 p90 -155.97 144.95 20.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.237 0.542 . . . . 0.0 112.082 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -104.24 128.3 9.42 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.5 mm -122.58 129.0 75.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 117.183 0.492 . . . . 0.0 112.069 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.3 m -89.57 113.47 56.8 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 177.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.456 -0.679 0 C-N-CA 122.648 2.232 . . . . 0.0 111.793 179.866 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 121.578 0.704 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 -121.5 131.96 54.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.939 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -79.11 129.94 36.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.759 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.39 62.34 5.99 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.449 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 17.2 p -128.84 -151.95 0.5 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.868 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.449 ' H ' ' HB ' ' A' ' 5' ' ' THR . 21.4 p30 -163.83 -176.79 4.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.764 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.3 m -56.94 -44.39 82.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.151 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 -50.5 72.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.016 0.436 . . . . 0.0 110.61 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.53 37.48 0.64 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.596 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.475 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -97.26 -27.37 9.34 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.772 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 10' ' ' GLY . 31.5 m 76.41 126.36 0.04 OUTLIER 'General case' 0 C--O 1.237 0.426 0 C-N-CA 122.878 0.471 . . . . 0.0 111.055 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.59 ' HD2' ' O ' ' A' ' 27' ' ' GLY . 25.2 mmmt -54.85 133.35 47.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.42 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.71 -42.93 1.79 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.727 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.3 m -87.68 136.65 32.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.208 0.527 . . . . 0.0 110.579 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 59.4 mttp -112.02 127.44 55.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.536 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.475 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 5.3 m-30 -82.51 129.03 34.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -125.88 160.29 30.31 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.812 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.404 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 39.3 m -83.96 178.87 7.7 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -76.37 -33.28 58.92 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.022 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.404 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.5 p-10 -65.87 -39.54 90.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.378 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.27 -14.46 3.49 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.987 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.5 m -62.52 134.06 55.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.272 0.558 . . . . 0.0 111.787 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.547 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 20.0 t80 -75.44 120.78 21.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.196 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.515 HG13 ' HG3' ' A' ' 44' ' ' ARG . 57.7 t -84.46 -63.35 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.722 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.2 p -176.61 147.09 0.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.999 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 36.4 tt0 -79.19 150.56 31.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.59 ' O ' ' HD2' ' A' ' 12' ' ' LYS . . . -63.64 122.91 27.73 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.047 -1.073 . . . . 0.0 111.084 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 4.6 tp10 -109.39 63.08 0.6 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.291 0.567 . . . . 0.0 110.278 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.7 p -79.52 112.64 16.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.421 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -69.47 130.37 90.77 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.079 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.26 42.13 1.08 Allowed 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.793 2.329 . . . . 0.0 113.335 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -135.22 52.26 2.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.715 0.293 . . . . 0.0 111.061 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 38.28 69.7 1.45 Allowed Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -70.63 65.97 2.3 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.189 2.593 . . . . 0.0 112.296 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -70.48 137.68 50.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.446 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.67 35.11 7.16 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.867 0.729 . . . . 0.0 111.196 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.0 145.58 96.48 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.796 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.79 114.98 2.14 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.626 2.217 . . . . 0.0 112.009 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.5 ptt-85 -92.59 41.56 1.08 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.263 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.54 115.76 19.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 5' ' ' THR . 7.9 m -77.6 126.85 31.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.761 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.727 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 12.1 t0 -90.42 123.74 64.66 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 47.9 Cg_exo -58.15 -30.65 91.19 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 123.556 2.838 . . . . 0.0 114.273 -178.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.727 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 15.5 ptt180 -74.87 -14.62 60.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.494 HD12 ' HB3' ' A' ' 42' ' ' ASP . 75.8 mt -88.17 128.88 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.977 0.418 . . . . 0.0 111.231 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.22 -52.91 2.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.818 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -153.7 150.19 28.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.08 0.467 . . . . 0.0 111.576 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.9 131.62 10.63 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.704 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -105.86 119.31 54.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.781 0.324 . . . . 0.0 110.414 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 35.5 m -104.56 127.29 29.29 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 1.1 Cg_endo . . . . . 0 N--CA 1.457 -0.652 0 C-N-CA 123.469 2.779 . . . . 0.0 112.05 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 2' ' ' ARG . 34.6 t0 . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.862 ' HG3' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -60.67 127.68 32.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.862 0.363 . . . . 0.0 110.707 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -66.88 142.25 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.221 0.534 . . . . 0.0 111.723 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.7 t -87.44 84.0 7.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.493 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 p -140.74 -166.57 2.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.751 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.631 ' HA ' HD12 ' A' ' 45' ' ' ILE . 21.6 p30 -171.99 165.63 6.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -50.18 -47.05 54.67 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.77 92.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.978 0.418 . . . . 0.0 112.008 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.422 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . . . -75.92 -37.34 58.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.847 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.33 144.29 36.79 Favored Glycine 0 N--CA 1.453 -0.219 0 O-C-N 123.847 0.717 . . . . 0.0 114.01 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -77.42 136.37 38.39 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.747 0.419 . . . . 0.0 111.339 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.491 ' HB2' ' HE3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -58.03 147.57 29.04 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.67 -35.14 4.17 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 77.6 m -89.05 125.49 35.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 72.6 mttt -106.0 119.28 38.78 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.6 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.642 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 6.1 m-85 -87.89 132.2 34.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.671 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -120.86 157.97 28.63 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.481 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.0 t -86.26 161.84 18.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.573 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -65.38 -29.98 70.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.432 0.158 . . . . 0.0 111.387 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.35 -33.89 75.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.973 0.416 . . . . 0.0 110.001 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.69 -14.75 5.51 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.259 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -69.53 130.69 43.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.143 0.497 . . . . 0.0 111.576 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.507 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 23.1 t80 -68.83 129.78 40.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.82 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.557 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 18.3 t -90.74 -69.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.468 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.0 p -178.84 157.44 0.9 Allowed 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.371 0.419 . . . . 0.0 111.154 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 69.8 tt0 -88.42 157.52 18.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.88 115.06 7.52 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.497 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -89.42 27.78 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.802 0.334 . . . . 0.0 111.55 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 p -90.99 21.42 4.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.563 0.697 . . . . 0.0 110.737 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.534 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.0 t0 -86.86 -51.99 0.43 Allowed Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.109 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 10.5 Cg_exo -71.26 22.0 0.23 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.29 1.994 . . . . 0.0 112.482 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 30' ' ' ASP . 58.2 mmt-85 52.54 51.18 16.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.042 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 8.5 p30 -64.38 134.92 96.14 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 15.2 Cg_exo -69.08 119.87 6.81 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.821 2.347 . . . . 0.0 111.773 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.422 ' NZ ' ' HA ' ' A' ' 9' ' ' ALA . 4.7 mmmm -83.24 96.93 8.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.409 0.623 . . . . 0.0 110.629 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.41 -40.11 9.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.161 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . . . -124.12 59.17 17.61 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.96 58.69 6.62 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.349 2.032 . . . . 0.0 110.869 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.511 ' NH1' ' HA ' ' A' ' 37' ' ' ALA . 7.2 ptp85 -155.34 53.0 0.61 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.542 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -149.2 144.61 26.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.662 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.8 m -111.88 121.07 44.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.946 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' A' ' 44' ' ' ARG . 9.9 t70 -83.81 120.02 74.45 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.05 -23.29 72.73 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.236 2.624 . . . . 0.0 112.782 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.568 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 42.7 mtp85 -71.8 -32.0 67.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.639 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 6' ' ' ASN . 43.6 mt -86.85 120.59 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.566 0.698 . . . . 0.0 112.222 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.862 ' HA ' ' HG3' ' A' ' 2' ' ' ARG . . . -106.74 -48.45 3.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.415 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -150.53 143.13 24.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.061 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -103.97 122.82 7.53 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.695 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.675 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.2 mm -101.43 128.19 54.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 35.8 m -106.41 89.0 3.64 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.743 0.306 . . . . 0.0 110.281 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.675 ' HD3' ' O ' ' A' ' 49' ' ' ILE . 19.2 Cg_endo . . . . . 0 N--CA 1.45 -1.039 0 C-N-CA 123.321 2.68 . . . . 0.0 112.155 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.747 0.308 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.596 ' HG2' ' HA ' ' A' ' 46' ' ' ALA . 7.5 tmm_? -152.66 102.5 2.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 pt -60.13 138.23 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.286 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.5 t -88.31 69.59 9.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.547 0.689 . . . . 0.0 109.715 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.9 p -133.78 153.71 51.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.276 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 39' ' ' ARG . 17.5 p-10 -131.1 160.32 35.05 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -48.66 -46.55 40.31 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.98 -38.33 88.16 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.94 56.91 0.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.809 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.77 -148.77 0.5 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.115 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 78.5 m -155.3 124.53 6.28 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.565 -0.374 . . . . 0.0 111.258 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 56.97 -88.73 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 O-C-N 124.052 0.845 . . . . 0.0 111.341 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.56 41.55 0.18 Allowed Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 108.811 -1.715 . . . . 0.0 108.811 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.1 m -88.09 133.9 33.88 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.657 -0.771 . . . . 0.0 110.52 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.55 ' HZ2' ' CD ' ' A' ' 26' ' ' GLU . 42.2 mttp -83.03 115.9 22.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.175 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.59 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 92.0 m-85 -84.03 128.56 34.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.88 0.372 . . . . 0.0 111.11 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -122.47 158.72 29.15 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.344 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.475 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 50.0 m -84.65 176.28 8.68 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -68.07 -35.6 78.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.628 0.252 . . . . 0.0 110.896 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.1 p-10 -65.36 -40.03 93.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.787 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.7 -16.88 3.99 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.201 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.407 HG22 ' NH2' ' A' ' 44' ' ' ARG . 97.7 m -64.49 134.1 53.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.165 0.507 . . . . 0.0 111.503 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -69.88 123.58 21.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.445 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.518 HG13 ' HD2' ' A' ' 44' ' ' ARG . 21.6 t -84.25 -65.18 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.877 0.37 . . . . 0.0 111.141 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 p -175.33 154.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.624 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.55 ' CD ' ' HZ2' ' A' ' 15' ' ' LYS . 15.8 tt0 -85.08 144.93 27.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.57 102.63 0.57 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.944 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.21 61.87 5.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.136 0.97 . . . . 0.0 109.139 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 p -92.75 36.83 1.01 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.457 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.545 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 45.1 t0 -92.4 124.96 57.84 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.545 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 43.9 Cg_endo -68.31 54.7 0.75 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.261 2.641 . . . . 0.0 114.374 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -69.59 -43.52 72.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -167.5 153.97 7.66 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.284 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.31 123.51 13.27 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.18 1.92 . . . . 0.0 111.928 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.97 128.16 33.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.419 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.0 -30.73 61.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.022 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.92 121.03 81.48 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.08 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.22 153.44 74.56 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.006 2.47 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.554 ' HA ' ' OD1' ' A' ' 6' ' ' ASN . 14.0 ttm180 -77.45 56.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.571 0.7 . . . . 0.0 110.421 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.19 154.82 41.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.111 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.9 m -66.17 93.89 0.23 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 9.6 t0 -62.94 117.84 36.53 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.177 0.513 . . . . 0.0 110.919 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 26.0 Cg_exo -62.68 -25.54 75.16 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 123.276 2.651 . . . . 0.0 112.907 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.552 ' HD3' ' O ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -82.26 -26.16 33.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.519 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.564 HG21 ' HB3' ' A' ' 16' ' ' TYR . 54.5 mt -88.4 125.3 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.596 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . . . -109.47 -51.52 2.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.564 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -149.08 147.5 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.81 127.39 8.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.318 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 49' ' ' ILE . 47.3 mm -91.56 112.24 25.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.9 m -89.68 128.91 48.74 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.531 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 CA--C 1.53 0.28 0 C-N-CA 122.82 2.347 . . . . 0.0 112.363 179.95 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 C--O 1.234 0.264 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.512 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -74.86 170.27 16.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 pt -57.81 128.93 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.472 0.653 . . . . 0.0 112.093 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.9 t -88.03 71.3 9.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.257 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 19.8 p -137.16 -158.66 0.88 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.478 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.553 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 18.2 p30 -171.21 -177.17 2.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -60.85 -43.79 97.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.01 66.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.039 0.447 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.95 44.52 1.2 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.981 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.88 142.22 14.45 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.927 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.0 m -58.38 122.36 13.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.577 0.227 . . . . 0.0 110.969 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -59.76 136.73 58.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.668 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.86 -29.7 10.14 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.222 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.7 m -89.46 130.01 35.87 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.652 ' HG3' ' HE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -99.86 122.08 42.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.978 179.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.766 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.0 m-85 -81.23 128.09 33.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.137 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.652 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 5.7 m-85 -118.57 162.09 18.95 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.674 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.442 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 12.4 t -80.3 -170.26 2.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.245 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -74.21 -44.33 53.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.722 0.296 . . . . 0.0 110.961 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.442 ' OD1' ' HB3' ' A' ' 18' ' ' SER . 42.9 p-10 -62.01 -42.59 99.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.682 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.4 -1.89 3.06 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -69.64 131.14 44.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.008 0.433 . . . . 0.0 110.842 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -69.45 119.73 14.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.774 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.659 HG12 ' HG3' ' A' ' 44' ' ' ARG . 90.3 t -86.75 -63.95 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.346 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.0 p -174.67 148.48 1.14 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.771 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 14.7 tt0 -82.44 142.51 31.86 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -80.02 145.76 27.4 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.234 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -145.09 67.62 1.24 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-O 122.163 0.982 . . . . 0.0 110.129 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 p -78.76 132.07 36.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.895 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 32' ' ' ARG . 2.2 t70 -63.38 137.2 97.01 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.546 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 10.4 Cg_exo -71.3 33.0 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.267 2.645 . . . . 0.0 112.884 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 31' ' ' PRO . 28.4 mmm180 -140.29 -36.39 0.49 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.088 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -171.65 151.88 3.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.043 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.53 128.31 23.2 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 121.94 1.76 . . . . 0.0 111.052 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -62.8 135.91 57.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.411 ' HB1' ' H ' ' A' ' 37' ' ' ALA . . . 66.9 -120.16 0.26 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.948 0.78 . . . . 0.0 110.235 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.411 ' H ' ' HB1' ' A' ' 36' ' ' ALA . . . -164.44 140.97 5.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 7.6 Cg_exo -73.04 46.83 1.17 Allowed 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.097 2.532 . . . . 0.0 112.127 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -110.51 -40.5 4.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.033 0.444 . . . . 0.0 110.105 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -82.11 56.48 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.605 0.717 . . . . 0.0 109.712 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.4 m -61.56 124.31 20.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.07 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.736 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 12.0 t0 -79.27 124.44 84.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.01 -32.13 94.5 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.349 2.699 . . . . 0.0 113.715 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.736 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 16.8 ptt180 -74.27 -10.24 59.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.563 HG23 ' HD2' ' A' ' 16' ' ' TYR . 55.5 mt -88.34 106.94 17.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -97.55 -45.99 6.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.292 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -156.79 142.99 18.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.211 0.529 . . . . 0.0 112.254 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.766 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -97.44 128.9 9.71 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.652 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.82 120.13 43.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.2 m -102.02 107.94 54.55 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.26 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 C-N-CA 123.453 2.769 . . . . 0.0 112.215 -179.841 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 48.7 t0 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 2' ' ' ARG . 20.6 mmm180 59.53 50.66 7.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.711 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.5 pt -64.16 129.72 28.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.375 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 8.9 t -88.88 52.8 2.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.478 0.656 . . . . 0.0 110.8 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.449 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 13.7 p -112.28 -144.1 0.39 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.19 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.449 ' H ' ' HB ' ' A' ' 5' ' ' THR . 25.4 p30 -169.91 171.24 7.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.9 m -51.32 -48.22 62.43 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.535 0.522 . . . . 0.0 112.293 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.715 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . . . -58.02 -49.09 78.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.983 0.421 . . . . 0.0 111.0 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.34 31.49 0.51 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.266 0.555 . . . . 0.0 110.822 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.571 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -88.27 -19.32 53.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.925 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m 74.72 118.09 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.095 0.558 . . . . 0.0 110.502 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -53.27 127.85 26.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.544 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.0 -38.09 3.5 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.864 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 70.6 m -90.82 131.7 36.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.222 0.534 . . . . 0.0 109.602 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 17.0 mtmm -104.54 127.94 52.39 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.136 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.571 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 4.7 m-30 -82.68 121.27 26.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.78 0.324 . . . . 0.0 110.303 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -108.3 158.17 17.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.326 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.583 ' OG ' ' HD3' ' A' ' 44' ' ' ARG . 6.0 t -82.64 -158.05 0.25 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.091 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -84.25 -46.53 11.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.166 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -63.98 -37.9 89.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.278 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.07 -6.22 5.07 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.5 m -66.61 132.65 48.64 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.176 0.512 . . . . 0.0 111.151 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.2 t80 -68.5 120.53 14.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.198 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.61 -60.14 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.534 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 16.8 p -171.33 140.12 1.4 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.792 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 29.8 tt0 -81.45 160.23 24.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.95 112.7 2.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.363 -0.446 . . . . 0.0 113.307 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.715 ' HB3' ' HA ' ' A' ' 8' ' ' ALA . 79.4 tt0 -88.79 52.4 2.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.639 0.733 . . . . 0.0 110.138 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 92.0 p -105.28 53.87 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.103 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 8.7 t70 -140.42 131.19 13.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 32.4 Cg_exo -58.59 159.68 19.54 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.041 2.494 . . . . 0.0 112.889 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 48.0 mtm180 78.87 33.34 0.25 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.562 0.745 . . . . 0.0 110.276 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -116.86 148.03 41.25 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.049 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.08 117.24 4.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.371 2.047 . . . . 0.0 110.651 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -59.89 111.81 1.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 111.093 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.76 -128.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.539 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 69.44 153.85 0.14 Allowed Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 123.737 0.648 . . . . 0.0 111.784 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.72 147.25 88.92 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.786 2.324 . . . . 0.0 111.868 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -64.62 -57.4 9.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 111.225 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -174.82 155.25 2.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.363 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 7.8 m 59.81 42.59 16.39 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.662 0.601 . . . . 0.0 111.817 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.71 124.02 77.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.017 0.437 . . . . 0.0 110.224 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.08 -30.61 90.84 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.474 2.783 . . . . 0.0 113.839 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.583 ' HD3' ' OG ' ' A' ' 18' ' ' SER . 10.9 tpp180 -82.39 -24.0 34.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.037 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' A' ' 16' ' ' TYR . 75.9 mt -87.69 123.14 40.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.211 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.29 -58.18 2.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.764 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -140.58 139.85 35.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.329 0.585 . . . . 0.0 111.707 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.28 135.92 12.43 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.974 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.478 HG21 ' HD2' ' A' ' 51' ' ' PRO . 50.0 mm -120.15 127.01 75.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.864 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 57.9 m -85.61 -50.12 0.53 Allowed Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.053 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 6.2 Cg_exo . . . . . 0 C--N 1.354 0.817 0 C-N-CA 121.811 1.674 . . . . 0.0 111.838 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--O 1.235 0.331 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -136.24 118.49 15.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.848 0.356 . . . . 0.0 110.412 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 47' ' ' TYR . 13.1 pt -63.67 150.7 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.878 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.0 t -86.49 77.32 9.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.573 0.702 . . . . 0.0 109.661 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 p -141.51 -173.28 3.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.815 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.796 ' HA ' HD11 ' A' ' 45' ' ' ILE . 19.4 p30 -171.69 -172.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.7 m -60.27 -45.1 94.48 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -76.76 -39.87 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.26 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.06 -30.78 69.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.88 140.01 37.49 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.381 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.9 m -67.85 135.75 53.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.733 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 5.9 tmtm? -59.27 126.1 26.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.47 ' N ' ' HD3' ' A' ' 12' ' ' LYS . . . 112.71 -28.62 8.8 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 29.8 m -87.85 128.28 35.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.086 0.469 . . . . 0.0 110.283 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.606 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 31.2 mmtt -93.21 119.33 32.27 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.787 ' HB3' HG22 ' A' ' 45' ' ' ILE . 15.1 m-85 -95.53 128.28 42.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.254 0.549 . . . . 0.0 111.596 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.606 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 8.6 m-85 -120.8 162.02 20.5 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.495 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.452 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 69.3 m -83.28 176.99 8.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.548 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -72.43 -29.8 64.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.564 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 44.1 p-10 -69.08 -38.37 78.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.968 0.413 . . . . 0.0 110.742 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.22 -13.25 4.35 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 m -66.69 134.38 52.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.095 0.474 . . . . 0.0 111.537 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.0 123.75 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.947 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.6 t -86.29 -65.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 111.243 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.0 p -176.56 152.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.664 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -84.88 139.27 31.99 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.713 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -67.35 144.58 44.56 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.144 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.733 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 7.6 tt0 -146.26 46.07 1.23 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.682 0.753 . . . . 0.0 110.399 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 95.1 p -79.13 133.83 36.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.395 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.81 129.66 94.48 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 123.481 0.488 . . . . 0.0 110.272 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -90.0 39.35 0.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.186 2.591 . . . . 0.0 113.132 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -127.81 -47.24 1.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.026 0.441 . . . . 0.0 110.006 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 5.7 p30 -81.08 143.88 53.69 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.387 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 20.1 Cg_exo -65.63 106.26 0.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.403 2.069 . . . . 0.0 111.223 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -62.91 107.61 1.03 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.364 0.602 . . . . 0.0 111.192 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.38 -50.8 0.17 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.46 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.97 -53.49 48.33 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.306 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.65 71.47 5.39 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.297 1.998 . . . . 0.0 111.191 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -139.62 36.4 2.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.354 0.597 . . . . 0.0 110.419 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -83.54 135.55 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.7 m -70.89 123.82 22.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.387 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 66.8 t0 -97.49 110.81 56.44 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.98 43.98 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.747 2.965 . . . . 0.0 112.28 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.44 ' HB3' ' HE ' ' A' ' 44' ' ' ARG . 27.5 ttp180 -144.37 -33.21 0.4 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.748 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.796 HD11 ' HA ' ' A' ' 6' ' ' ASN . 39.1 mt -88.82 134.59 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.796 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.441 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -111.15 -44.53 3.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.021 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.533 ' HA ' HD12 ' A' ' 3' ' ' ILE . 10.5 p90 -151.47 150.43 30.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.608 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -122.84 127.89 6.87 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.918 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.501 HG23 ' HD2' ' A' ' 51' ' ' PRO . 43.1 mm -98.09 119.78 46.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 74.1 m -88.09 -46.67 0.46 Allowed Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.501 ' HD2' HG23 ' A' ' 49' ' ' ILE . 8.6 Cg_exo -72.7 59.06 3.34 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.332 2.021 . . . . 0.0 112.297 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -156.65 132.65 9.7 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.975 -179.353 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 121.489 0.662 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.861 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -71.45 140.75 50.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.809 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 46' ' ' ALA . 12.5 pt -60.74 135.91 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.351 0.596 . . . . 0.0 111.822 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.3 t -88.99 60.77 5.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.597 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 24.0 p -123.62 -148.54 0.4 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.949 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.718 ' HA ' HD11 ' A' ' 45' ' ' ILE . 2.8 p-10 -170.09 176.76 4.51 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 m -51.09 -45.97 61.65 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.483 0.489 . . . . 0.0 111.8 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.568 ' HB3' HD22 ' A' ' 6' ' ' ASN . . . -64.24 -46.64 82.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.844 0.354 . . . . 0.0 111.297 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.1 56.45 2.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.106 0.479 . . . . 0.0 110.767 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.09 133.79 3.52 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -59.45 136.71 58.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.268 0.227 . . . . 0.0 111.426 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 14' ' ' CYS . 17.7 tppt? -56.19 -36.49 68.44 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 110.604 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.85 27.39 1.95 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.129 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 59.1 m -147.32 138.23 23.63 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.623 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 29.0 mttt -114.78 127.48 55.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.836 0.35 . . . . 0.0 110.216 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.503 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 3.3 m-85 -81.22 129.45 34.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.02 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.436 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 26.0 m-85 -123.11 158.99 29.47 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.407 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.523 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 50.9 m -86.32 164.82 16.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.34 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.403 ' CG ' HH21 ' A' ' 2' ' ' ARG . 1.0 OUTLIER -68.98 -25.44 64.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.914 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 3.5 p-10 -70.84 -34.46 71.7 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.78 -17.21 5.25 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.439 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.61 HG22 HH22 ' A' ' 44' ' ' ARG . 83.1 m -71.68 135.13 46.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.231 0.538 . . . . 0.0 111.912 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.623 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 26.9 t80 -65.69 130.63 43.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.675 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG12 ' CG1' ' A' ' 45' ' ' ILE . 46.2 t -90.96 -68.34 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 p -169.03 159.02 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.178 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -80.34 162.7 24.39 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.05 98.19 0.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.513 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -90.11 51.27 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.932 0.396 . . . . 0.0 110.952 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -80.16 47.14 0.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.155 0.503 . . . . 0.0 111.635 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 38.7 t70 -74.09 135.44 76.75 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.927 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.431 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 57.2 Cg_endo -71.29 45.31 0.63 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.922 2.414 . . . . 0.0 113.938 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -134.46 34.19 3.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.448 ' N ' ' HD3' ' A' ' 34' ' ' PRO . 14.8 p30 39.19 58.19 6.08 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 33' ' ' ASN . 12.8 Cg_exo -69.33 87.7 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.619 2.212 . . . . 0.0 112.261 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 12.8 mmmt -63.74 134.8 55.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.997 0.903 . . . . 0.0 113.221 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.416 ' HB1' HD21 ' A' ' 6' ' ' ASN . . . -161.08 -172.56 3.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.74 -1.573 . . . . 0.0 107.295 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.77 149.17 0.12 Allowed Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.922 0.764 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 39' ' ' ARG . 64.8 Cg_endo -72.54 -141.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.896 2.397 . . . . 0.0 112.866 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.453 ' H ' ' HB2' ' A' ' 38' ' ' PRO . 13.8 tpt180 -61.01 -40.8 94.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.379 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -176.22 144.31 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.631 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 m 62.54 116.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 O-C-N 124.03 0.831 . . . . 0.0 111.971 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.675 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . 9.3 t70 -71.37 122.16 86.33 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -53.05 -32.67 59.56 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.643 2.896 . . . . 0.0 114.762 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.61 HH22 HG22 ' A' ' 22' ' ' THR . 5.7 ptm180 -104.61 -3.21 24.07 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.718 HD11 ' HA ' ' A' ' 6' ' ' ASN . 23.4 mt -89.0 132.65 33.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.007 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.861 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -125.02 -49.51 1.72 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.134 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -154.65 148.65 25.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 0.0 111.9 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.54 125.4 7.8 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.615 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.0 mm -101.82 120.33 51.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.708 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 39.0 m -89.87 110.79 42.3 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.606 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.19 55.26 5.28 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.4 2.733 . . . . 0.0 111.904 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -100.51 38.51 1.5 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.458 -1.258 . . . . 0.0 109.092 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.84 0.353 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.434 ' HG3' ' HB2' ' A' ' 46' ' ' ALA . 1.6 mpp_? -140.05 123.88 17.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 46' ' ' ALA . 13.7 pt -60.54 139.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.26 0.552 . . . . 0.0 111.68 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 40.4 t -85.93 83.93 7.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.517 0.675 . . . . 0.0 109.211 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.437 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 23.6 p -139.86 -159.39 0.95 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.989 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.54 HD22 ' HB1' ' A' ' 8' ' ' ALA . 4.4 p-10 -170.47 171.96 6.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.6 m -51.87 -40.85 61.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.54 ' HB1' HD22 ' A' ' 6' ' ' ASN . . . -65.59 -46.0 81.05 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 110.915 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.88 40.53 0.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.179 0.514 . . . . 0.0 110.659 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -110.51 129.49 9.34 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.854 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.433 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 10.7 m -63.69 131.87 49.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.543 0.211 . . . . 0.0 110.646 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -57.91 132.29 52.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.362 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.47 -26.2 16.96 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.218 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.433 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 38.1 m -88.26 129.56 35.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 50.6 mttm -99.23 120.74 40.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.949 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.715 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.5 m-85 -88.57 127.13 35.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.042 0.449 . . . . 0.0 110.984 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.499 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 26.9 m-85 -120.69 161.06 22.05 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.86 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -83.89 165.27 18.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.97 -34.07 76.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.466 0.175 . . . . 0.0 111.005 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.08 -37.59 84.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.83 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.33 -23.68 2.84 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.053 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 m -59.8 136.92 58.15 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.453 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.8 t80 -74.12 123.87 25.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.947 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 44' ' ' ARG . 13.9 t -85.76 -64.5 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.609 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 p -178.31 157.68 1.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.699 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 4.6 tt0 -86.26 -159.99 0.52 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.463 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.439 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -83.14 89.57 1.52 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.457 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -88.18 39.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.365 0.603 . . . . 0.0 110.596 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 p -85.45 56.41 3.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.162 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.423 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.2 t70 -126.38 135.87 27.81 Favored Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.357 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 23.3 Cg_exo -65.03 -179.12 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.879 2.386 . . . . 0.0 112.439 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.9 mtm-85 78.84 -32.11 0.15 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.972 0.909 . . . . 0.0 110.705 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.413 ' H ' ' C ' ' A' ' 31' ' ' PRO . 3.3 p-10 -141.41 54.57 4.36 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.414 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 56.2 Cg_endo -70.04 137.54 34.88 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.79 1.66 . . . . 0.0 110.946 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HD3' ' O ' ' A' ' 34' ' ' PRO . 67.9 mmtt -126.4 127.06 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.77 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.16 136.57 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.167 0.917 . . . . 0.0 111.888 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -69.92 136.96 87.41 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.154 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 7.8 Cg_exo -72.11 68.71 3.23 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.318 2.679 . . . . 0.0 111.933 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.1 ttp85 -155.38 -42.29 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.075 0.465 . . . . 0.0 110.606 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.18 121.52 28.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.216 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.443 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 2.3 m -69.86 128.34 36.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.739 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 67.2 t0 -79.6 114.97 50.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 19.6 Cg_endo -61.05 -17.25 50.81 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.041 2.494 . . . . 0.0 112.483 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.528 ' O ' HG21 ' A' ' 24' ' ' VAL . 28.1 mtp-105 -73.09 -35.38 66.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.504 HD11 ' HA ' ' A' ' 6' ' ' ASN . 43.4 mt -88.48 134.37 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.434 ' HB2' ' HG3' ' A' ' 2' ' ' ARG . . . -118.12 -47.98 2.56 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.986 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -154.14 145.72 23.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.209 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.13 128.4 8.84 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.553 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.6 mm -93.82 121.01 44.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 94.6 m -97.77 152.61 38.21 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.992 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.01 96.81 0.27 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.404 2.069 . . . . 0.0 111.525 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.9 mt 66.23 42.51 3.07 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.634 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.235 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.878 179.634 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 2' ' ' ARG . 1.2 p30 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.402 0.62 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 1' ' ' ASP . 13.0 mtt-85 -151.96 131.74 13.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.085 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -76.06 141.29 15.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.801 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 47.6 t -87.23 59.62 5.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.717 0.77 . . . . 0.0 109.532 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 p -135.28 125.9 27.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.431 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.632 HD22 ' HB1' ' A' ' 8' ' ' ALA . 3.4 p-10 -90.28 176.52 6.71 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.0 m -51.2 -44.74 61.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.958 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . . . -61.05 -47.53 85.97 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.15 67.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.998 0.427 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.34 138.13 48.42 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.539 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -67.71 124.42 23.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.689 0.281 . . . . 0.0 110.936 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -60.02 131.3 50.42 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.432 ' O ' ' HE2' ' A' ' 15' ' ' LYS . . . 112.35 -33.91 5.44 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.8 m -88.63 131.47 34.96 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.515 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -97.93 119.05 35.86 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.727 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 3.9 m-85 -89.62 125.07 35.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.157 0.503 . . . . 0.0 110.872 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.98 163.55 15.42 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.95 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.4 t -86.49 168.56 13.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.921 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -66.8 -32.77 74.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.83 0.348 . . . . 0.0 110.336 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.53 -32.56 73.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.647 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.23 -23.75 4.29 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.191 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.8 m -62.92 135.45 57.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.141 0.496 . . . . 0.0 111.992 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.515 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.3 t80 -71.17 124.29 24.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.787 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.676 HG23 ' HG2' ' A' ' 44' ' ' ARG . 46.8 t -87.91 -64.96 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.515 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 p -172.89 153.95 2.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 111.58 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.456 ' CD ' ' HZ2' ' A' ' 15' ' ' LYS . 37.0 tt0 -90.99 157.61 17.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.334 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.78 130.02 45.71 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.429 -0.415 . . . . 0.0 113.849 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.958 ' HB3' ' HA ' ' A' ' 8' ' ' ALA . 6.6 tt0 -96.82 0.26 49.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.145 0.498 . . . . 0.0 110.734 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.3 p -77.75 -168.92 1.34 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.48 . . . . 0.0 111.632 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.518 ' HB3' HD22 ' A' ' 33' ' ' ASN . 38.7 t0 -163.86 124.31 1.4 Allowed Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 17.3 Cg_exo -68.7 38.25 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.175 2.583 . . . . 0.0 113.983 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -147.12 17.8 1.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.518 HD22 ' HB3' ' A' ' 30' ' ' ASP . 8.3 p30 -165.21 142.03 4.76 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.033 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.54 57.88 5.66 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.805 2.337 . . . . 0.0 113.861 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -80.25 105.84 11.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.946 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -163.97 29.45 0.08 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.52 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.579 ' HB1' ' HD3' ' A' ' 38' ' ' PRO . . . -74.78 -56.64 2.13 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.849 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD3' ' HB1' ' A' ' 37' ' ' ALA . 8.2 Cg_exo -71.33 134.35 24.55 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.894 1.729 . . . . 0.0 110.82 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -157.09 48.87 0.44 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.233 0.539 . . . . 0.0 110.9 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -80.39 138.56 36.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.018 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 38.6 m -75.78 70.68 2.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.384 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.578 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 33.2 t70 -66.14 115.57 24.76 Favored Pre-proline 0 C--N 1.332 -0.179 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.39 -24.83 78.87 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.302 2.668 . . . . 0.0 112.979 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.676 ' HG2' HG23 ' A' ' 24' ' ' VAL . 19.7 ttm105 -66.8 -33.53 75.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.628 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.5 mt -88.2 108.98 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.084 0.469 . . . . 0.0 110.053 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.07 -48.17 5.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.497 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -153.39 145.13 23.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.727 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.12 128.18 8.89 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.34 119.45 47.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.764 0.316 . . . . 0.0 110.964 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.5 m -98.0 122.16 55.32 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.74 54.32 5.14 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 123.082 2.521 . . . . 0.0 112.687 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 62.51 44.79 6.76 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.383 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.111 -1.423 . . . . 0.0 108.471 179.68 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.459 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . 44.5 t0 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -169.31 62.88 0.05 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 46' ' ' ALA . 6.9 pt -55.3 142.88 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.934 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 t -87.22 66.86 9.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.553 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.457 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 38.7 p -133.91 -149.41 0.36 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.723 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.708 ' HA ' HD13 ' A' ' 45' ' ' ILE . 24.4 p30 -174.12 -159.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.8 m -66.25 -63.73 1.01 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.064 0.227 . . . . 0.0 111.135 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.948 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . . . -57.5 -38.39 74.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.029 0.443 . . . . 0.0 112.081 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.88 -19.43 60.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.082 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.94 147.9 31.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.681 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.422 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 20.2 m -63.39 124.19 20.64 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.585 0.231 . . . . 0.0 111.359 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -57.4 132.1 52.08 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.528 ' N ' ' HD2' ' A' ' 12' ' ' LYS . . . 106.6 -36.37 4.44 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.729 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 76.2 m -88.35 132.98 34.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.675 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.839 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 25.0 mmtp -82.92 111.33 18.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.74 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.688 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 6.1 m-85 -86.97 124.15 32.85 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.233 0.54 . . . . 0.0 109.894 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.944 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -147.49 178.5 8.39 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.395 0.617 . . . . 0.0 111.834 -178.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.509 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 14.7 m -76.14 168.49 19.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.543 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -66.89 -35.35 79.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.509 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.1 p-10 -63.49 -41.4 98.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.999 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.7 -11.92 2.92 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.074 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.7 m -62.61 111.04 1.9 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.86 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.944 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 25.1 t80 -68.08 122.72 18.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.113 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 17' ' ' PHE . 45.8 t -91.55 -61.84 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.549 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.9 p -174.58 152.69 1.71 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.96 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.839 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 10.2 tt0 -80.06 158.29 26.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -65.09 133.92 36.79 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.029 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.948 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 45.2 mt-10 -105.71 16.13 25.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.694 0.247 . . . . 0.0 111.629 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.611 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 26.5 p -80.3 46.78 0.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.402 0.62 . . . . 0.0 110.823 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' ARG . 12.3 t0 -66.15 -50.77 49.05 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.518 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.409 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 4.2 Cg_exo -76.23 27.05 0.41 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.236 1.957 . . . . 0.0 112.657 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 30' ' ' ASP . 76.7 mtp180 52.28 40.89 29.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.308 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.611 ' OD1' ' HA ' ' A' ' 29' ' ' SER . 8.8 p-10 -74.49 132.76 78.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.402 . . . . 0.0 110.739 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.33 67.67 3.5 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.144 2.563 . . . . 0.0 112.023 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 68.31 -134.08 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.048 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.505 ' HB1' ' H ' ' A' ' 37' ' ' ALA . . . -160.15 -144.27 0.11 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.568 0.223 . . . . 0.0 110.998 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.505 ' H ' ' HB1' ' A' ' 36' ' ' ALA . . . -67.06 138.11 94.78 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.483 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.12 45.7 1.42 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.847 2.365 . . . . 0.0 112.604 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -174.17 47.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.249 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.96 41.53 1.54 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.331 0.586 . . . . 0.0 111.367 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.1 m -80.93 124.21 28.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.356 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.515 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 33.4 t70 -75.02 114.82 38.75 Favored Pre-proline 0 C--O 1.239 0.531 0 O-C-N 123.233 0.333 . . . . 0.0 110.387 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.41 46.93 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.298 2.665 . . . . 0.0 111.896 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.515 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 13.9 ttp180 -154.94 -23.53 0.12 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.907 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.708 HD13 ' HA ' ' A' ' 6' ' ' ASN . 63.3 mt -85.64 120.89 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.029 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -95.61 -51.9 4.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.449 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.463 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 13.7 p90 -159.92 154.25 23.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.034 0.445 . . . . 0.0 111.59 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.688 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.08 131.56 10.51 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.902 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.563 HG21 ' HD2' ' A' ' 51' ' ' PRO . 34.4 mm -122.02 132.93 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.756 0.312 . . . . 0.0 111.18 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.4 m -88.49 -54.21 0.34 Allowed Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.563 ' HD2' HG21 ' A' ' 49' ' ' ILE . 72.3 Cg_endo -77.34 139.1 18.31 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.768 1.646 . . . . 0.0 113.4 -179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 52' ' ' LEU . 98.8 mt 62.97 45.98 5.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.87 179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.448 ' O ' ' HG3' ' A' ' 15' ' ' LYS . . . . . . . . 0 C--O 1.251 1.132 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.654 0.74 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.402 ' NE ' ' HA ' ' A' ' 46' ' ' ALA . 39.1 ttt180 -73.9 124.49 26.25 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.938 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -65.32 124.84 21.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.452 0.644 . . . . 0.0 111.771 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 t -93.42 51.17 1.57 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.592 0.71 . . . . 0.0 109.724 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 9.1 p -110.04 -145.47 0.4 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.356 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.515 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 16.1 p30 -173.16 176.92 2.84 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.8 m -53.19 -47.77 68.61 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.566 ' HB1' ' HG2' ' A' ' 31' ' ' PRO . . . -68.72 -44.54 73.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.226 0.536 . . . . 0.0 110.44 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.18 49.16 1.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.285 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.677 ' HA2' ' HH ' ' A' ' 16' ' ' TYR . . . -104.2 -141.1 10.89 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.125 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.715 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 87.2 m -157.4 131.58 8.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -55.19 131.54 45.53 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.306 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.87 21.6 71.02 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.524 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 57.9 m -137.63 127.61 25.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 25.9 mtmm -107.26 131.54 54.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.102 0.477 . . . . 0.0 111.763 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.677 ' HH ' ' HA2' ' A' ' 10' ' ' GLY . 6.4 m-30 -85.24 126.85 34.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.369 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -121.63 155.95 34.01 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.451 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.479 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 19.9 m -78.4 175.68 10.06 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.071 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.44 -38.14 86.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.207 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.479 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 43.1 p-10 -66.52 -40.24 89.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.948 0.404 . . . . 0.0 111.069 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.15 -7.97 3.78 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.5 m -65.33 134.35 53.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.13 0.49 . . . . 0.0 111.477 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -73.35 122.08 21.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.619 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.56 -63.02 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.72 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 p -174.5 147.67 1.13 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.373 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 19.2 tt0 -77.78 151.8 33.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.715 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -68.3 94.57 0.33 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.683 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 13.3 tp10 -88.82 69.89 8.65 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 11.4 p -77.51 41.92 0.34 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.528 -1.214 . . . . 0.0 113.266 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' N ' ' HD2' ' A' ' 31' ' ' PRO . 22.6 t70 -89.7 -51.26 0.36 Allowed Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 119.421 -0.323 . . . . 0.0 111.011 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.566 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 42.9 Cg_endo -67.7 58.66 0.79 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 122.87 2.38 . . . . 0.0 112.497 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -65.64 -26.99 68.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.871 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -73.09 135.87 79.73 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.822 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -45.4 128.94 10.58 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 123.581 2.854 . . . . 0.0 114.248 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 35.9 mmtm -149.09 158.13 43.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.493 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.05 -24.94 58.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.621 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . . . -61.93 -54.34 51.56 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.621 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 11.9 Cg_exo -70.51 122.22 8.71 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.918 1.745 . . . . 0.0 111.597 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -114.15 -124.64 0.28 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -171.04 152.85 3.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.048 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.7 m 56.32 52.99 9.32 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.759 0.662 . . . . 0.0 111.907 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -66.3 127.92 93.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.87 -36.15 62.29 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.764 2.976 . . . . 0.0 114.605 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.09 -23.87 35.52 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.888 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 6' ' ' ASN . 91.8 mt -87.36 127.62 40.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.232 0.539 . . . . 0.0 111.927 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.402 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . . . -120.91 -50.61 2.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.858 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -149.75 148.35 29.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.979 0.418 . . . . 0.0 111.802 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -110.94 134.03 11.92 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 49' ' ' ILE . 42.5 mm -112.89 129.16 69.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.615 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 39.2 m -101.96 -55.63 0.12 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.253 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 74.2 Cg_endo -78.71 135.16 12.65 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.651 1.567 . . . . 0.0 112.701 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.485 ' N ' HD13 ' A' ' 52' ' ' LEU . 8.8 mp 62.87 46.28 5.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.331 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.332 179.504 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.565 ' O ' ' HG2' ' A' ' 2' ' ' ARG . 4.2 p-10 . . . . . 0 C--O 1.233 0.193 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.93 ' HD2' ' HA ' ' A' ' 46' ' ' ALA . 26.8 ptt-85 47.7 -164.42 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.192 0.932 . . . . 0.0 112.664 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -82.54 120.8 34.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.122 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.2 t -89.11 58.36 4.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.547 0.689 . . . . 0.0 109.994 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.694 ' HG1' ' HE2' ' A' ' 16' ' ' TYR . 23.5 p -117.29 -152.03 0.49 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.678 ' HA ' HD12 ' A' ' 45' ' ' ILE . 14.6 p30 -175.45 172.26 2.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 59.2 m -58.05 -43.09 86.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.02 -44.17 82.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 111.579 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.06 26.08 6.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.591 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.19 129.11 11.24 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.707 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 m -67.22 124.4 23.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.737 0.303 . . . . 0.0 110.785 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.887 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 54.3 mtmt -55.96 136.06 52.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.415 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.89 -30.96 7.33 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.922 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 39.7 m -88.98 125.03 34.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.0 110.642 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.685 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 2.2 tppt? -85.86 119.42 26.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.205 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.694 ' HE2' ' HG1' ' A' ' 5' ' ' THR . 2.4 m-85 -89.41 124.73 34.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.272 0.558 . . . . 0.0 111.423 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 87.4 m-85 -122.56 158.18 30.47 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.088 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 19' ' ' ASP . 1.3 p -78.11 -161.51 0.27 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.13 178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.402 ' H ' ' HB2' ' A' ' 18' ' ' SER . 0.8 OUTLIER -74.75 -44.97 47.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.55 0.214 . . . . 0.0 111.253 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -63.36 -39.81 95.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.601 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.61 0.9 5.24 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -67.47 135.98 53.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.033 0.444 . . . . 0.0 111.033 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -67.26 112.52 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.925 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.545 HG11 HG12 ' A' ' 45' ' ' ILE . 83.6 t -87.83 -55.72 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.28 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.421 ' SG ' HG13 ' A' ' 24' ' ' VAL . 7.7 p -174.38 -170.18 0.5 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.946 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.833 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 13.9 tt0 -134.27 -158.81 0.91 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.742 0.305 . . . . 0.0 110.645 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.833 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -79.78 85.78 1.27 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.251 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -88.26 15.39 7.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.87 0.367 . . . . 0.0 110.985 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 p -79.67 55.31 1.98 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.887 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 24.4 t0 -173.94 -57.73 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.774 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 7.3 Cg_exo -72.86 65.68 4.02 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.421 2.081 . . . . 0.0 112.657 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 64.07 55.01 1.59 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -48.63 134.61 13.55 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.106 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.82 178.55 3.89 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.681 2.254 . . . . 0.0 110.678 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.71 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -92.95 129.95 38.7 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.213 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 73.7 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.727 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.52 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -67.24 -48.91 46.4 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.313 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 11.7 Cg_exo -70.97 66.28 2.49 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.648 2.232 . . . . 0.0 111.859 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -68.65 -34.49 75.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.82 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -80.34 45.49 0.76 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.425 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.9 m 67.37 118.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.413 0.685 . . . . 0.0 110.933 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.563 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 10.5 t70 -58.06 111.67 3.84 Favored Pre-proline 0 C--O 1.24 0.566 0 CA-C-O 120.75 0.31 . . . . 0.0 111.0 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.8 52.1 2.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.653 2.902 . . . . 0.0 112.042 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.563 ' HB3' ' OD1' ' A' ' 42' ' ' ASP . 12.8 ttp180 -166.27 -34.31 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.313 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' A' ' 6' ' ' ASN . 62.7 mt -89.39 129.76 39.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.2 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.93 ' HA ' ' HD2' ' A' ' 2' ' ' ARG . . . -115.16 -44.19 3.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -152.77 152.89 32.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 112.009 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.4 128.69 7.26 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.937 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mm -97.24 116.06 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 49.9 m -89.19 -52.03 0.36 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.672 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 60.5 Cg_endo -73.65 138.32 26.4 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.56 1.507 . . . . 0.0 112.365 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.443 ' N ' HD21 ' A' ' 52' ' ' LEU . 3.9 mm? 63.92 60.39 1.03 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.563 0.539 . . . . 0.0 111.046 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.698 -0.668 . . . . 0.0 109.626 179.765 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.593 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 13.0 mtm105 62.76 58.25 1.61 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.549 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.3 pt -58.08 150.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.518 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.53 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 40.9 t -85.2 78.69 9.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.6 0.714 . . . . 0.0 109.575 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.431 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 39.2 p -138.71 -156.62 0.7 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.04 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.752 ' HA ' HD13 ' A' ' 45' ' ' ILE . 17.1 p30 -178.3 178.59 0.87 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 m -54.12 -55.45 27.54 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.803 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . . . -62.2 -35.76 79.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.81 -30.17 62.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.882 0.373 . . . . 0.0 111.366 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.93 147.13 48.81 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.206 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.438 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 23.1 m -69.31 128.29 36.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.562 0.22 . . . . 0.0 111.122 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 43.8 mtmt -57.05 136.22 56.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.344 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.75 -32.27 7.42 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.658 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.5 m -87.91 134.27 33.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.974 0.416 . . . . 0.0 109.958 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.508 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 38.3 mmtt -93.1 122.47 35.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.488 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.64 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.3 m-85 -95.17 129.73 42.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.966 0.412 . . . . 0.0 110.823 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.483 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 38.3 m-85 -121.04 165.22 15.61 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.885 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.2 m -79.1 -156.65 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.748 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -84.75 -42.17 15.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.746 0.308 . . . . 0.0 110.622 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -63.98 -42.46 97.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.633 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.89 -5.25 3.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.1 m -64.34 131.2 46.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.005 0.431 . . . . 0.0 110.779 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.9 t80 -70.3 117.74 12.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.942 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.567 HG23 ' HG2' ' A' ' 44' ' ' ARG . 86.0 t -81.66 -63.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.986 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.6 p -178.1 167.79 1.99 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.502 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -95.57 156.25 16.4 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -68.81 133.39 27.12 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.874 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.803 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 29.9 mt-10 -116.09 32.78 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.977 0.418 . . . . 0.0 110.243 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.438 ' OG ' ' HA ' ' A' ' 11' ' ' THR . 14.5 p -78.41 55.0 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 0.0 111.76 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.572 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 13.0 t0 -68.12 -56.79 10.3 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.006 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 1.2 Cg_endo -82.21 12.89 2.69 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.264 1.976 . . . . 0.0 111.254 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 60.66 33.66 20.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.549 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -169.85 137.14 1.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.18 0.514 . . . . 0.0 110.964 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.474 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 91.5 Cg_endo -82.32 60.14 7.24 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.803 2.335 . . . . 0.0 111.501 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.636 ' HB2' ' NZ ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER 67.76 116.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.499 -178.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.5 ' HB3' ' H ' ' A' ' 37' ' ' ALA . . . 57.57 -135.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.812 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.5 ' H ' ' HB3' ' A' ' 36' ' ' ALA . . . -96.79 134.57 22.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.52 0.2 . . . . 0.0 110.684 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 22.6 Cg_exo -64.22 130.84 28.26 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.717 2.278 . . . . 0.0 111.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -164.04 45.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.887 0.375 . . . . 0.0 110.999 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -160.32 125.84 3.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.124 0.487 . . . . 0.0 110.475 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.53 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 3.3 m -107.98 125.9 52.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.07 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -90.35 110.75 42.96 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.28 -21.71 73.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.414 2.742 . . . . 0.0 112.306 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.567 ' HG2' HG23 ' A' ' 24' ' ' VAL . 26.5 ttp180 -66.06 -30.87 71.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.688 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.752 HD13 ' HA ' ' A' ' 6' ' ' ASN . 50.9 mt -89.53 126.5 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.935 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -110.65 -42.98 3.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.7 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -156.37 145.41 20.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.274 0.559 . . . . 0.0 112.0 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.24 131.54 10.64 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.488 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.99 121.69 55.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.057 0.456 . . . . 0.0 111.023 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 76.7 m -97.92 137.95 20.95 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.7 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.6 Cg_exo -76.83 -143.79 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.884 2.39 . . . . 0.0 112.445 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.405 ' HA ' HD22 ' A' ' 52' ' ' LEU . 97.2 mt 63.92 41.75 6.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.778 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.269 0 CA-C-O 117.331 -1.319 . . . . 0.0 108.658 179.611 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 121.423 0.63 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -151.68 60.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.859 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.747 HD11 ' HA ' ' A' ' 47' ' ' TYR . 21.2 pt -64.62 140.64 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.336 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.72 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 52.2 t -87.15 69.11 10.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.554 0.693 . . . . 0.0 110.268 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 29.9 p -120.49 -164.15 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.86 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.414 ' HA ' HD11 ' A' ' 45' ' ' ILE . 23.0 p30 -175.04 161.09 2.86 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.4 m -60.06 -35.31 74.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.49 -23.55 64.59 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.198 0.523 . . . . 0.0 110.938 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.41 -109.56 0.36 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.177 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.92 -136.45 50.83 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.186 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.5 m -152.17 127.53 9.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 42.0 tptt -60.07 133.11 55.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.783 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.08 -26.16 23.88 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.893 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.432 ' HB2' ' HE1' ' A' ' 16' ' ' TYR . 33.9 m -88.05 129.76 35.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.125 0.488 . . . . 0.0 110.458 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -90.3 114.92 27.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.047 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.674 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.1 m-85 -96.2 128.68 43.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.855 0.36 . . . . 0.0 110.359 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.978 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 0.6 OUTLIER -148.91 178.27 8.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.028 0.442 . . . . 0.0 111.502 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.541 ' HA ' ' HB2' ' A' ' 46' ' ' ALA . 13.1 p -78.72 174.7 11.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.887 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -68.6 -35.6 77.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.27 -36.59 84.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.041 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.32 -18.84 4.13 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.238 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.3 m -58.56 115.35 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.059 0.457 . . . . 0.0 111.262 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.978 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 23.8 t80 -65.04 118.14 8.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.569 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.8 t -84.81 -58.91 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.353 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.433 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 26.0 p -178.26 151.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.775 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.2 147.06 28.25 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.19 124.41 29.95 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.746 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' ASP . 7.5 tp10 -128.4 65.49 1.4 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.58 43.18 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.627 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.427 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -70.02 130.02 90.24 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.148 178.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 4.4 Cg_exo -81.99 39.05 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.399 2.733 . . . . 0.0 112.973 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.454 ' HG3' HH11 ' A' ' 32' ' ' ARG . 17.2 mmt85 -131.22 -46.7 1.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.464 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 18.0 p30 -62.86 136.19 96.34 Favored Pre-proline 0 C--O 1.237 0.445 0 CA-C-O 121.201 0.524 . . . . 0.0 110.624 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 32.0 Cg_exo -60.22 139.22 86.0 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.609 2.873 . . . . 0.0 113.736 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -132.95 128.62 36.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.098 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.7 -37.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.256 0.347 . . . . 0.0 110.823 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -59.0 136.28 87.7 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.989 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 16.7 Cg_exo -68.38 59.29 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.716 2.944 . . . . 0.0 113.122 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.533 ' HD2' ' OD2' ' A' ' 42' ' ' ASP . 12.6 tpp180 -94.99 43.94 1.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.933 0.873 . . . . 0.0 109.704 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -90.65 139.58 30.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.797 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.72 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 65.3 m 60.49 52.62 4.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.672 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.533 ' OD2' ' HD2' ' A' ' 39' ' ' ARG . 8.4 t0 -58.5 113.23 6.21 Favored Pre-proline 0 N--CA 1.464 0.269 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.39 -30.61 91.83 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.575 2.85 . . . . 0.0 113.915 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.506 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 34.5 ptt180 -70.64 -26.25 63.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.375 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.552 HG22 ' HB3' ' A' ' 16' ' ' TYR . 59.9 mt -89.13 111.31 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.977 0.417 . . . . 0.0 110.761 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.541 ' HB2' ' HA ' ' A' ' 18' ' ' SER . . . -89.91 -49.99 6.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.245 179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.747 ' HA ' HD11 ' A' ' 3' ' ' ILE . 14.8 p90 -161.77 147.49 13.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.253 0.549 . . . . 0.0 111.678 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.38 129.4 9.56 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.296 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.415 ' HA ' HD13 ' A' ' 49' ' ' ILE . 49.8 mm -99.11 124.8 52.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.025 0.44 . . . . 0.0 111.194 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.4 m -100.13 139.33 20.64 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.98 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.07 126.77 17.85 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.588 2.192 . . . . 0.0 112.103 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.0 tp -88.74 138.1 31.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.378 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.832 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.1 t0 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.605 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -64.97 144.93 56.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.205 0.526 . . . . 0.0 111.311 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 pt -68.06 135.01 29.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.238 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 41.8 t -87.66 57.87 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.692 0.758 . . . . 0.0 110.254 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 9' ' ' ALA . 34.1 p -124.5 -143.35 0.31 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.765 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.607 ' HA ' HD12 ' A' ' 45' ' ' ILE . 9.4 p-10 -177.46 -171.15 0.31 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.469 ' C ' ' HG2' ' A' ' 28' ' ' GLU . 4.3 m -60.33 -41.86 94.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.589 0.233 . . . . 0.0 110.453 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.604 ' HB3' HD22 ' A' ' 6' ' ' ASN . . . -60.11 -44.47 94.83 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.715 0.293 . . . . 0.0 111.584 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' A' ' 5' ' ' THR . . . -82.52 21.75 0.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.099 0.476 . . . . 0.0 110.521 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.532 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -91.46 131.45 10.79 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.188 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.618 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 5.3 m -69.22 148.96 49.1 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.647 0.26 . . . . 0.0 110.591 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -58.34 131.89 52.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.439 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.76 -11.03 54.98 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.13 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.794 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 61.3 m -89.52 128.83 36.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.422 0.629 . . . . 0.0 110.624 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.525 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 15.2 mmtp -98.81 121.34 40.63 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.715 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.578 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.5 m-85 -92.05 125.76 36.87 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.768 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.26 162.84 16.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.734 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.467 ' HB2' ' H ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -78.51 -154.14 0.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.997 178.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.467 ' H ' ' HB2' ' A' ' 18' ' ' SER . 14.4 p-10 -82.76 -42.15 18.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.681 0.276 . . . . 0.0 110.488 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -64.41 -41.26 96.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.665 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.96 -0.04 4.38 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -68.27 134.5 50.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 110.754 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.525 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.9 t80 -68.78 111.88 5.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.614 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.7 t -83.26 -57.11 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.778 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.9 p -175.53 158.28 2.22 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.981 0.42 . . . . 0.0 111.923 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 38.0 tt0 -92.44 173.21 7.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -69.91 108.48 2.49 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.572 -0.823 . . . . 0.0 114.062 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.56 ' HG2' ' N ' ' A' ' 8' ' ' ALA . 21.8 pt-20 -89.16 36.43 0.82 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.201 1.0 . . . . 0.0 108.392 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 3.5 p -78.08 56.24 1.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.359 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -63.46 128.97 93.28 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.532 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.538 ' C ' ' H ' ' A' ' 33' ' ' ASN . 73.9 Cg_endo -75.63 -136.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.784 2.323 . . . . 0.0 111.237 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.503 ' H ' ' HB2' ' A' ' 31' ' ' PRO . 38.2 mtp85 73.21 -31.96 0.23 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.388 0.675 . . . . 0.0 111.122 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.538 ' H ' ' C ' ' A' ' 31' ' ' PRO . 5.8 p30 -169.37 141.7 2.06 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.055 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 14.0 Cg_exo -70.35 71.8 1.79 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.602 2.868 . . . . 0.0 113.004 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -68.23 112.81 5.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.728 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.6 122.07 28.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.321 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.72 114.43 50.06 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.898 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.42 46.51 2.23 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.838 2.359 . . . . 0.0 112.254 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.401 ' HE ' ' ND2' ' A' ' 6' ' ' ASN . 0.0 OUTLIER -160.87 52.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.216 0.531 . . . . 0.0 111.322 -179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.99 161.48 29.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.399 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 65.62 48.6 1.94 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.365 0.416 . . . . 0.0 110.436 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.656 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 4.4 t0 -60.5 113.59 7.94 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 12.1 Cg_endo -56.58 -33.72 93.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.646 2.898 . . . . 0.0 114.313 -177.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.656 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 23.2 ptt180 -71.07 -27.01 63.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.789 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 6' ' ' ASN . 67.7 mt -91.72 127.31 44.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 111.703 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.08 -45.34 3.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.55 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -152.5 145.82 24.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.209 0.528 . . . . 0.0 111.616 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.578 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -111.84 129.19 8.97 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.31 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.566 HG23 ' HB2' ' A' ' 52' ' ' LEU . 40.1 mm -110.69 125.05 67.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.794 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 19.2 m -87.68 -51.69 0.41 Allowed Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.646 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 2.8 Cg_exo -75.74 61.64 6.27 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.373 2.049 . . . . 0.0 112.469 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.566 ' HB2' HG23 ' A' ' 49' ' ' ILE . 5.9 tt -154.83 116.55 4.13 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.492 ' HB2' HD21 ' A' ' 52' ' ' LEU . . . . . . . . 0 C--O 1.247 0.921 0 O-C-N 124.078 0.861 . . . . 0.0 111.397 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 110.432 -0.211 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.759 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 61.6 mtt85 54.27 60.52 3.52 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.863 0.727 . . . . 0.0 111.931 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 pt -57.28 147.44 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.323 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.542 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 43.6 t -85.33 75.24 10.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.758 0.79 . . . . 0.0 109.937 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.3 p -140.9 -163.94 1.64 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.205 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.972 ' HA ' HD13 ' A' ' 45' ' ' ILE . 15.4 p30 -173.24 -158.62 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 m -69.71 -54.5 13.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.267 0.485 . . . . 0.0 110.467 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.566 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -65.91 -44.03 86.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.307 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.82 -4.65 47.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.089 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.26 141.04 23.59 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.053 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.688 HG21 ' HB3' ' A' ' 31' ' ' PRO . 72.7 m -68.26 127.19 32.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.727 0.298 . . . . 0.0 110.497 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.714 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 82.2 tttt -57.66 131.31 49.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.907 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.27 -29.59 12.17 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.532 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.5 m -88.42 128.44 35.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.124 0.488 . . . . 0.0 109.943 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.612 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 10.9 mtpp -90.67 114.42 26.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.364 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.705 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.5 m-85 -86.37 126.01 34.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.302 0.572 . . . . 0.0 111.637 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.612 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 14.4 m-85 -119.89 163.07 18.09 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.653 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.7 t -84.32 169.22 14.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -69.1 -32.25 71.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 0.0 110.127 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -66.27 -33.94 76.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.591 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.73 -23.9 3.72 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.195 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -60.97 133.18 55.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.095 0.474 . . . . 0.0 112.097 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -73.49 122.86 22.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.466 HG11 ' CG1' ' A' ' 45' ' ' ILE . 48.9 t -86.93 -65.13 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.403 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.0 p -175.69 152.29 1.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.577 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -85.71 145.72 27.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.714 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -66.37 144.41 45.86 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.659 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.401 ' CG ' ' HA ' ' A' ' 8' ' ' ALA . 14.2 pt-20 -117.32 -18.12 9.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 82.5 p -78.56 139.9 38.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.372 0.606 . . . . 0.0 112.445 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.405 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 0.6 OUTLIER -63.52 138.14 97.28 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.606 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.688 ' HB3' HG21 ' A' ' 11' ' ' THR . 90.5 Cg_endo -82.36 29.49 0.54 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.663 2.242 . . . . 0.0 113.68 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.406 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.7 mmp_? -129.04 29.07 5.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.926 0.393 . . . . 0.0 110.348 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -154.07 146.4 17.34 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.77 143.75 46.79 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.829 2.353 . . . . 0.0 111.631 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -70.19 140.76 52.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.719 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -43.64 -51.27 7.11 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.466 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -166.96 125.53 1.05 Allowed Pre-proline 0 C--N 1.328 -0.342 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.571 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 3.0 Cg_exo -75.61 63.21 6.48 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.538 2.825 . . . . 0.0 111.665 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -148.76 -23.11 0.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.011 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -86.37 48.78 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.49 0.662 . . . . 0.0 110.101 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.542 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m -67.34 125.52 26.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.058 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.504 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 66.0 t0 -78.32 116.98 63.41 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.18 -24.77 75.43 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.334 2.689 . . . . 0.0 113.97 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.472 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 28.6 ptt-85 -93.78 -1.53 54.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.413 -0.515 . . . . 0.0 112.326 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.972 HD13 ' HA ' ' A' ' 6' ' ' ASN . 15.7 mt -102.79 124.02 56.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.984 0.421 . . . . 0.0 110.7 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.759 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -108.67 -46.13 3.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.29 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -153.25 147.48 25.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.262 0.553 . . . . 0.0 112.431 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.705 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.66 125.68 7.53 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.6 mm -89.74 113.61 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.826 0.346 . . . . 0.0 110.785 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.0 m -95.72 134.14 24.53 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.065 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.69 131.92 25.57 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.496 2.131 . . . . 0.0 112.32 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.6 tp -83.78 137.35 33.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.826 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.3 t70 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.8 ptt85 -162.26 108.05 1.25 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.23 0.538 . . . . 0.0 110.34 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 pt -65.04 145.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.766 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -87.24 78.76 8.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.481 0.658 . . . . 0.0 109.676 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.2 p -138.35 -168.32 2.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.854 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.481 ' HA ' HD13 ' A' ' 45' ' ' ILE . 17.7 p30 -168.9 -179.53 3.73 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -55.99 -46.01 78.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.37 -49.28 17.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.67 60.47 6.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.515 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.53 -143.16 5.03 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.097 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 m -132.19 131.13 41.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.589 ' HG2' ' OE1' ' A' ' 28' ' ' GLU . 29.8 mtpp -56.96 130.09 44.47 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.45 0.469 . . . . 0.0 111.379 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.31 -21.24 25.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.384 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.7 m -88.21 128.98 35.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.285 0.564 . . . . 0.0 110.208 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.549 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 46.1 mttm -96.25 123.67 39.96 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.298 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.625 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 11.6 m-85 -92.39 127.46 37.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.204 0.526 . . . . 0.0 111.31 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.485 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 12.2 m-85 -118.38 164.61 14.98 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.4 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.9 m -77.29 -158.98 0.12 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.797 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -84.58 -40.38 17.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.776 0.322 . . . . 0.0 110.311 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -65.35 -43.81 89.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.529 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.92 -3.79 2.31 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -65.43 130.13 42.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 110.989 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.1 t80 -72.87 115.71 12.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.732 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.67 -62.43 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 28.7 p -175.21 150.31 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.698 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 23.0 tt0 -83.12 141.23 32.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.562 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.66 132.97 12.07 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.697 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.589 ' OE1' ' HG2' ' A' ' 12' ' ' LYS . 4.5 tp10 -141.09 69.99 1.34 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.961 0.886 . . . . 0.0 109.741 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -85.39 43.56 1.03 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.692 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.572 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.5 t70 -64.47 -51.42 60.08 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.707 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 32.6 Cg_exo -61.55 133.91 48.26 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.741 1.627 . . . . 0.0 111.743 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 1.4 mmt85 -81.75 36.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.347 0.594 . . . . 0.0 109.903 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.453 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.5 p30 -167.32 63.09 0.66 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.85 132.49 52.27 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.785 2.323 . . . . 0.0 111.634 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -107.97 115.99 31.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.04 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -174.34 176.49 2.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.576 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.27 137.93 95.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 123.058 0.224 . . . . 0.0 110.482 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.62 125.32 15.28 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.355 2.036 . . . . 0.0 112.283 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 39' ' ' ARG . 16.0 tpp85 60.56 44.97 11.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.081 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -96.04 135.96 37.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.935 0.398 . . . . 0.0 110.096 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.9 m -115.55 123.28 48.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -71.91 115.75 41.31 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.39 -22.36 74.34 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.168 2.578 . . . . 0.0 112.84 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -82.73 -27.51 31.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.481 HD13 ' HA ' ' A' ' 6' ' ' ASN . 68.1 mt -87.86 124.92 41.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.399 0.619 . . . . 0.0 112.332 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.07 -46.78 3.07 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.573 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -149.75 142.93 25.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.346 0.593 . . . . 0.0 111.91 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -103.01 132.3 10.96 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.746 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.1 mm -101.05 122.6 53.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.83 0.348 . . . . 0.0 110.542 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 83.2 m -105.15 124.39 36.68 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.201 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.59 135.66 18.3 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.69 2.26 . . . . 0.0 112.237 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.816 HD21 ' H ' ' A' ' 52' ' ' LEU . 2.3 pt? -80.1 140.68 36.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.328 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.99 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -168.16 121.97 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 45' ' ' ILE . 9.7 pt -65.42 129.67 29.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 110.693 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.01 62.49 6.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.493 0.663 . . . . 0.0 109.406 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.417 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 21.9 p -128.73 -154.43 0.64 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.991 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.463 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 15.6 p30 -176.84 -166.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 m -61.39 -53.91 50.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.32 0.388 . . . . 0.0 111.083 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . . . -61.69 -40.57 95.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 0.0 111.007 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.12 57.44 4.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.61 141.5 7.12 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.212 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -61.51 135.69 57.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.479 0.18 . . . . 0.0 110.723 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER -57.89 -32.33 67.6 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.515 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.1 27.16 3.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.074 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.6 m -147.51 132.02 17.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.564 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 59.2 mttp -105.67 126.87 52.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.643 ' HB3' HG21 ' A' ' 45' ' ' ILE . 3.1 m-30 -82.99 124.48 30.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.144 0.497 . . . . 0.0 111.249 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -121.47 161.32 22.45 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.799 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.5 t -87.38 163.86 16.54 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.408 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 15.8 p-10 -66.58 -33.04 74.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.662 0.268 . . . . 0.0 110.54 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.49 -31.12 72.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.502 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.28 -21.72 4.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.305 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 m -63.84 133.34 53.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.238 0.542 . . . . 0.0 112.335 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 19.2 t80 -74.56 122.02 22.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.508 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.8 t -86.72 -62.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.396 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.5 p -174.8 150.95 1.34 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.208 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.564 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 37.1 tt0 -80.38 149.64 30.13 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.42 137.99 40.44 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.251 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG3' ' HA ' ' A' ' 8' ' ' ALA . 16.3 pt-20 -137.21 61.05 1.63 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.787 0.803 . . . . 0.0 110.099 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.15 65.66 3.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.89 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.7 t70 -58.33 128.93 83.15 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.998 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.504 ' C ' ' H ' ' A' ' 33' ' ' ASN . 2.3 Cg_endo -81.77 -147.83 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.072 2.515 . . . . 0.0 111.158 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 70.88 -30.75 0.21 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.399 0.68 . . . . 0.0 112.098 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.504 ' H ' ' C ' ' A' ' 31' ' ' PRO . 10.6 p30 -132.12 133.26 23.68 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 121.202 0.525 . . . . 0.0 110.772 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 20.2 Cg_exo -66.81 137.6 45.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.369 2.713 . . . . 0.0 112.956 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -95.04 130.83 41.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.465 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -155.04 148.37 25.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.969 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.405 ' N ' ' HD3' ' A' ' 38' ' ' PRO . . . 56.92 64.73 4.31 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.943 0.777 . . . . 0.0 112.045 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 37' ' ' ALA . 9.5 Cg_exo -72.19 52.62 1.92 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.319 2.679 . . . . 0.0 112.337 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -76.61 49.45 0.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.311 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -153.8 43.99 0.58 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.608 0.718 . . . . 0.0 109.857 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.3 m -65.07 131.99 48.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.498 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.449 ' HB3' HD13 ' A' ' 45' ' ' ILE . 65.6 t0 -91.46 112.21 53.06 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.919 0.39 . . . . 0.0 110.298 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 29.6 Cg_endo -63.46 -22.89 71.28 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.122 2.548 . . . . 0.0 112.546 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -67.86 -21.95 65.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.782 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.643 HG21 ' HB3' ' A' ' 16' ' ' TYR . 67.3 mt -87.3 133.82 29.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.189 0.518 . . . . 0.0 111.432 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.17 -41.72 2.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.466 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.408 ' CE2' ' HA ' ' A' ' 19' ' ' ASP . 4.5 p90 -155.24 149.18 25.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.051 0.453 . . . . 0.0 111.857 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -106.84 126.66 8.54 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.2 mm -92.27 117.39 35.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.859 0.361 . . . . 0.0 110.612 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.537 ' H ' ' HD2' ' A' ' 51' ' ' PRO . 76.8 m -99.68 -46.19 0.22 Allowed Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.173 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HD2' ' H ' ' A' ' 50' ' ' CYS . 52.1 Cg_endo -68.53 73.36 0.89 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.2 1.933 . . . . 0.0 113.025 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.403 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 57.2 tp 74.05 116.29 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.747 0.819 . . . . 0.0 111.476 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.442 ' O ' ' HD2' ' A' ' 15' ' ' LYS . . . . . . . . 0 C--O 1.244 0.776 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.17 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.627 0.251 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.05 138.03 1.65 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.099 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 pt -64.49 133.9 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.3 0.571 . . . . 0.0 111.933 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t -89.79 69.1 7.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.984 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -135.17 -169.73 2.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.802 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.673 ' HA ' HD11 ' A' ' 45' ' ' ILE . 16.9 p30 -165.15 -173.86 3.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 m -59.68 -48.93 79.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.57 -48.95 23.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.11 0.481 . . . . 0.0 110.462 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.87 63.04 7.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.737 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.23 -135.21 2.83 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.734 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.5 m -161.0 125.58 3.56 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 12.8 ttmm -60.91 133.48 56.14 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.178 0.514 . . . . 0.0 109.944 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.19 -39.58 2.55 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 40.0 m -92.49 125.69 37.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.772 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -96.23 125.18 40.56 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.68 ' HB3' HG23 ' A' ' 45' ' ' ILE . 53.2 m-85 -91.78 126.06 36.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.162 0.506 . . . . 0.0 111.52 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -117.56 163.92 15.7 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.838 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -76.21 -155.21 0.05 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.966 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -91.19 -40.24 11.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.824 0.345 . . . . 0.0 110.129 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.17 -41.83 96.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.772 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.61 -13.55 2.7 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.748 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -60.84 132.0 52.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.285 0.564 . . . . 0.0 111.542 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.592 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.0 t80 -74.0 120.89 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.718 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.0 t -88.3 -62.68 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.308 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.3 p -171.8 149.59 2.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 0.0 111.116 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.772 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 23.1 tt0 -85.38 151.88 23.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -59.83 122.26 29.41 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.467 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -105.27 58.69 0.68 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.577 0.703 . . . . 0.0 110.088 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 p -156.03 141.19 17.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.429 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 10.0 t70 -63.0 134.1 95.67 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.19 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 18.8 Cg_exo -68.36 41.35 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.982 3.122 . . . . 0.0 114.176 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -71.06 -32.83 69.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.416 . . . . 0.0 110.405 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -173.2 149.77 1.79 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.648 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.89 128.61 26.02 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.363 2.042 . . . . 0.0 111.148 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -89.61 140.51 29.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -161.75 145.0 12.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.39 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.47 149.5 21.48 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.095 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.86 116.13 2.91 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.751 2.301 . . . . 0.0 113.248 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 59.37 33.29 22.35 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.642 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.11 26.02 3.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.746 0.784 . . . . 0.0 110.236 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.42 120.52 17.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.07 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.469 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 10.0 t70 -78.61 121.3 83.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.24 -27.87 68.47 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.24 2.626 . . . . 0.0 113.524 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 -30.24 26.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.634 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.68 HG23 ' HB3' ' A' ' 16' ' ' TYR . 84.6 mt -88.72 123.98 41.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.11 -44.69 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.551 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -146.58 145.34 30.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.445 . . . . 0.0 111.427 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -116.04 136.13 12.68 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.785 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.1 mm -101.52 119.6 49.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.623 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 85.9 m -88.22 -41.32 0.48 Allowed Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.623 ' HD2' ' N ' ' A' ' 50' ' ' CYS . 9.9 Cg_endo -51.79 148.92 20.84 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 121.907 1.738 . . . . 0.0 112.052 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.686 HD22 ' H ' ' A' ' 52' ' ' LEU . 3.8 mm? -46.38 124.19 5.53 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.696 0.623 . . . . 0.0 112.217 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.827 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.532 179.905 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 49.2 t0 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 59.21 54.83 4.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.528 0.731 . . . . 0.0 110.518 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.551 HD11 ' HA ' ' A' ' 47' ' ' TYR . 9.5 pt -60.11 138.62 20.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.429 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.6 t -86.03 84.93 7.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.8 p -138.48 -168.05 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.832 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -165.6 159.9 17.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.6 m -57.15 -38.1 73.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.68 95.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.983 0.42 . . . . 0.0 110.931 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.86 -96.89 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.062 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.91 -131.82 47.95 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.674 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.3 m -155.02 115.56 3.88 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 18.4 tptm -61.15 121.59 12.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.52 -33.88 4.91 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.422 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 86.3 m -95.56 131.93 41.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.107 0.48 . . . . 0.0 110.159 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.419 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 0.8 OUTLIER -92.03 122.11 34.23 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.376 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.767 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.4 m-85 -87.04 131.73 34.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.759 0.314 . . . . 0.0 110.743 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -125.41 163.93 21.54 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.767 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.451 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 44.2 m -85.78 -179.99 6.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.119 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -69.5 -37.36 77.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.64 0.257 . . . . 0.0 111.434 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 43.9 p-10 -66.24 -40.41 90.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.14 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.67 -9.64 3.99 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -62.88 132.53 52.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.111 0.481 . . . . 0.0 111.155 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CE1' ' HG3' ' A' ' 15' ' ' LYS . 20.6 t80 -71.94 120.15 17.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.696 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.913 HG13 HG12 ' A' ' 45' ' ' ILE . 82.9 t -83.7 -68.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 27.2 p 177.72 158.39 0.42 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -91.7 146.56 23.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -75.23 119.0 5.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.434 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -89.62 50.59 1.93 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 117.452 0.626 . . . . 0.0 111.99 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 40.94 1.03 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.771 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.672 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 1.6 t70 -65.62 -58.31 12.01 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.15 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.672 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 9.8 Cg_endo -90.73 -148.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.883 2.389 . . . . 0.0 111.685 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -117.91 41.82 2.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.366 0.603 . . . . 0.0 110.637 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.569 ' CG ' ' HD3' ' A' ' 34' ' ' PRO . 10.1 p-10 -79.56 -40.91 1.47 Allowed Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.569 ' HD3' ' CG ' ' A' ' 33' ' ' ASN . 2.8 Cg_exo -75.83 146.88 30.26 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.074 1.849 . . . . 0.0 112.718 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.487 ' HD2' ' C ' ' A' ' 34' ' ' PRO . 13.4 mptt -124.99 133.95 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB2' ' H ' ' A' ' 37' ' ' ALA . . . 62.61 -134.22 0.48 Allowed 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.761 0.663 . . . . 0.0 110.471 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.514 ' H ' ' HD2' ' A' ' 38' ' ' PRO . . . -166.81 -52.38 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.514 ' HD2' ' H ' ' A' ' 37' ' ' ALA . 74.4 Cg_endo -74.06 45.02 1.08 Allowed 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.226 1.951 . . . . 0.0 113.336 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -83.64 -40.28 19.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.621 0.724 . . . . 0.0 109.485 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -174.2 135.38 0.46 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.904 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.2 m -123.21 137.17 54.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.824 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 8.0 t0 -86.7 120.18 71.68 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.091 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.11 -24.27 78.97 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.351 2.701 . . . . 0.0 112.55 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.474 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 21.1 ttp180 -68.13 -19.47 64.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.263 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.913 HG12 HG13 ' A' ' 24' ' ' VAL . 57.5 mt -85.94 129.27 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.923 0.392 . . . . 0.0 110.875 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.02 -51.2 2.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.459 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.551 ' HA ' HD11 ' A' ' 3' ' ' ILE . 11.9 p90 -155.97 144.95 20.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.237 0.542 . . . . 0.0 112.082 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -104.24 128.3 9.42 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.5 mm -122.58 129.0 75.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 117.183 0.492 . . . . 0.0 112.069 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.3 m -89.57 113.47 56.8 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 177.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.438 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 72.5 Cg_endo -81.06 163.53 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.648 2.232 . . . . 0.0 111.793 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.3 mt -85.25 38.6 0.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.403 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.438 ' O ' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 C--O 1.254 1.302 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.144 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 121.578 0.704 . . . . 0.0 110.11 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 19.6 mmt85 -121.5 131.96 54.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.939 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -79.11 129.94 36.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.759 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.39 62.34 5.99 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.449 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 17.2 p -128.84 -151.95 0.5 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.868 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.449 ' H ' ' HB ' ' A' ' 5' ' ' THR . 21.4 p30 -163.83 -176.79 4.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.764 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.3 m -56.94 -44.39 82.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.151 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 -50.5 72.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.016 0.436 . . . . 0.0 110.61 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.53 37.48 0.64 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.596 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -97.26 -27.37 9.34 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.772 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 10' ' ' GLY . 31.5 m 76.41 126.36 0.04 OUTLIER 'General case' 0 C--O 1.237 0.426 0 C-N-CA 122.878 0.471 . . . . 0.0 111.055 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.59 ' HD2' ' O ' ' A' ' 27' ' ' GLY . 25.2 mmmt -54.85 133.35 47.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.42 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.71 -42.93 1.79 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.727 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.3 m -87.68 136.65 32.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.208 0.527 . . . . 0.0 110.579 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 59.4 mttp -112.02 127.44 55.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.536 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.475 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 5.3 m-30 -82.51 129.03 34.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -125.88 160.29 30.31 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.812 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.404 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 39.3 m -83.96 178.87 7.7 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -76.37 -33.28 58.92 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.022 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.404 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.5 p-10 -65.87 -39.54 90.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.378 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.27 -14.46 3.49 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.987 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.5 m -62.52 134.06 55.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.272 0.558 . . . . 0.0 111.787 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.547 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 20.0 t80 -75.44 120.78 21.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.196 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.515 HG13 ' HG3' ' A' ' 44' ' ' ARG . 57.7 t -84.46 -63.35 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.722 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.2 p -176.61 147.09 0.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.999 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.589 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 36.4 tt0 -79.19 150.56 31.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.59 ' O ' ' HD2' ' A' ' 12' ' ' LYS . . . -63.64 122.91 27.73 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.047 -1.073 . . . . 0.0 111.084 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.403 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 4.6 tp10 -109.39 63.08 0.6 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.291 0.567 . . . . 0.0 110.278 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.7 p -79.52 112.64 16.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.421 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -69.47 130.37 90.77 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.079 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.26 42.13 1.08 Allowed 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.793 2.329 . . . . 0.0 113.335 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -135.22 52.26 2.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.715 0.293 . . . . 0.0 111.061 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 38.28 69.7 1.45 Allowed Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -70.63 65.97 2.3 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.189 2.593 . . . . 0.0 112.296 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -70.48 137.68 50.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.446 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.67 35.11 7.16 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.867 0.729 . . . . 0.0 111.196 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.0 145.58 96.48 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.796 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.79 114.98 2.14 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.626 2.217 . . . . 0.0 112.009 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.5 ptt-85 -92.59 41.56 1.08 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.263 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.54 115.76 19.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 5' ' ' THR . 7.9 m -77.6 126.85 31.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.761 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.727 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 12.1 t0 -90.42 123.74 64.66 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 47.9 Cg_exo -58.15 -30.65 91.19 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 123.556 2.838 . . . . 0.0 114.273 -178.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.727 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 15.5 ptt180 -74.87 -14.62 60.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.494 HD12 ' HB3' ' A' ' 42' ' ' ASP . 75.8 mt -88.17 128.88 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.977 0.418 . . . . 0.0 111.231 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.22 -52.91 2.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.818 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -153.7 150.19 28.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.08 0.467 . . . . 0.0 111.576 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.9 131.62 10.63 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.704 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -105.86 119.31 54.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.781 0.324 . . . . 0.0 110.414 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 35.5 m -104.56 127.29 29.29 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.428 ' HD2' ' O ' ' A' ' 53' ' ' ALA . 1.1 Cg_endo -84.08 -134.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.469 2.779 . . . . 0.0 112.05 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.661 HD21 ' H ' ' A' ' 52' ' ' LEU . 2.1 pt? -90.61 33.26 0.92 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.182 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.428 ' O ' ' HD2' ' A' ' 51' ' ' PRO . . . . . . . . 0 C--O 1.253 1.238 0 CA-C-O 117.311 -1.328 . . . . 0.0 108.767 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.434 ' CG ' ' H ' ' A' ' 2' ' ' ARG . 34.6 t0 . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.862 ' HG3' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -60.67 127.68 32.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.862 0.363 . . . . 0.0 110.707 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -66.88 142.25 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.221 0.534 . . . . 0.0 111.723 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.7 t -87.44 84.0 7.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.493 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 p -140.74 -166.57 2.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.751 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.631 ' HA ' HD12 ' A' ' 45' ' ' ILE . 21.6 p30 -171.99 165.63 6.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -50.18 -47.05 54.67 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.77 92.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.978 0.418 . . . . 0.0 112.008 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.422 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . . . -75.92 -37.34 58.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.847 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.33 144.29 36.79 Favored Glycine 0 N--CA 1.453 -0.219 0 O-C-N 123.847 0.717 . . . . 0.0 114.01 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -77.42 136.37 38.39 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.747 0.419 . . . . 0.0 111.339 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.491 ' HB2' ' HE3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -58.03 147.57 29.04 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.67 -35.14 4.17 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 77.6 m -89.05 125.49 35.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 72.6 mttt -106.0 119.28 38.78 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.6 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.642 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 6.1 m-85 -87.89 132.2 34.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.671 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -120.86 157.97 28.63 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.481 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.0 t -86.26 161.84 18.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.573 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -65.38 -29.98 70.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.432 0.158 . . . . 0.0 111.387 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.35 -33.89 75.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.973 0.416 . . . . 0.0 110.001 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.69 -14.75 5.51 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.259 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -69.53 130.69 43.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.143 0.497 . . . . 0.0 111.576 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.507 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 23.1 t80 -68.83 129.78 40.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.82 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.557 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 18.3 t -90.74 -69.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.468 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.0 p -178.84 157.44 0.9 Allowed 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.371 0.419 . . . . 0.0 111.154 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 69.8 tt0 -88.42 157.52 18.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.88 115.06 7.52 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.497 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -89.42 27.78 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.802 0.334 . . . . 0.0 111.55 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 p -90.99 21.42 4.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.563 0.697 . . . . 0.0 110.737 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.534 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.0 t0 -86.86 -51.99 0.43 Allowed Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.109 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 10.5 Cg_exo -71.26 22.0 0.23 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.29 1.994 . . . . 0.0 112.482 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 30' ' ' ASP . 58.2 mmt-85 52.54 51.18 16.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.042 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 8.5 p30 -64.38 134.92 96.14 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 15.2 Cg_exo -69.08 119.87 6.81 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.821 2.347 . . . . 0.0 111.773 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' NZ ' ' HA ' ' A' ' 9' ' ' ALA . 4.7 mmmm -83.24 96.93 8.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.409 0.623 . . . . 0.0 110.629 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.41 -40.11 9.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.161 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . . . -124.12 59.17 17.61 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.96 58.69 6.62 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.349 2.032 . . . . 0.0 110.869 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.511 ' NH1' ' HA ' ' A' ' 37' ' ' ALA . 7.2 ptp85 -155.34 53.0 0.61 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.542 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -149.2 144.61 26.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.662 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.8 m -111.88 121.07 44.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.946 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.568 ' OD2' ' HB2' ' A' ' 44' ' ' ARG . 9.9 t70 -83.81 120.02 74.45 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.05 -23.29 72.73 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.236 2.624 . . . . 0.0 112.782 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.568 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 42.7 mtp85 -71.8 -32.0 67.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.639 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.631 HD12 ' HA ' ' A' ' 6' ' ' ASN . 43.6 mt -86.85 120.59 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.566 0.698 . . . . 0.0 112.222 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.862 ' HA ' ' HG3' ' A' ' 2' ' ' ARG . . . -106.74 -48.45 3.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.415 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -150.53 143.13 24.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.061 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -103.97 122.82 7.53 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.695 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.675 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.2 mm -101.43 128.19 54.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 35.8 m -106.41 89.0 3.64 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.743 0.306 . . . . 0.0 110.281 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.675 ' HD3' ' O ' ' A' ' 49' ' ' ILE . 19.2 Cg_endo -92.27 154.27 3.12 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.321 2.68 . . . . 0.0 112.155 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 52' ' ' LEU . 93.4 mt -84.51 37.64 0.64 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.85 0.357 . . . . 0.0 110.232 179.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.442 -0.799 . . . . 0.0 108.917 -179.866 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.747 0.308 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.596 ' HG2' ' HA ' ' A' ' 46' ' ' ALA . 7.5 tmm_? -152.66 102.5 2.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 pt -60.13 138.23 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.286 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.5 t -88.31 69.59 9.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.547 0.689 . . . . 0.0 109.715 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.9 p -133.78 153.71 51.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.276 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 39' ' ' ARG . 17.5 p-10 -131.1 160.32 35.05 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -48.66 -46.55 40.31 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.98 -38.33 88.16 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -114.94 56.91 0.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.809 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.77 -148.77 0.5 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.115 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 78.5 m -155.3 124.53 6.28 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.565 -0.374 . . . . 0.0 111.258 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 56.97 -88.73 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 O-C-N 124.052 0.845 . . . . 0.0 111.341 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.56 41.55 0.18 Allowed Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 108.811 -1.715 . . . . 0.0 108.811 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.1 m -88.09 133.9 33.88 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.657 -0.771 . . . . 0.0 110.52 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.55 ' HZ2' ' CD ' ' A' ' 26' ' ' GLU . 42.2 mttp -83.03 115.9 22.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.175 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.59 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 92.0 m-85 -84.03 128.56 34.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.88 0.372 . . . . 0.0 111.11 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -122.47 158.72 29.15 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.344 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.475 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 50.0 m -84.65 176.28 8.68 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -68.07 -35.6 78.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.628 0.252 . . . . 0.0 110.896 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.475 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.1 p-10 -65.36 -40.03 93.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.787 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.7 -16.88 3.99 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.201 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.407 HG22 ' NH2' ' A' ' 44' ' ' ARG . 97.7 m -64.49 134.1 53.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.165 0.507 . . . . 0.0 111.503 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -69.88 123.58 21.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.445 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.518 HG13 ' HD2' ' A' ' 44' ' ' ARG . 21.6 t -84.25 -65.18 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.877 0.37 . . . . 0.0 111.141 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 p -175.33 154.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.624 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.55 ' CD ' ' HZ2' ' A' ' 15' ' ' LYS . 15.8 tt0 -85.08 144.93 27.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.57 102.63 0.57 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.944 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.21 61.87 5.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.136 0.97 . . . . 0.0 109.139 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 p -92.75 36.83 1.01 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.457 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.545 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 45.1 t0 -92.4 124.96 57.84 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.545 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 43.9 Cg_endo -68.31 54.7 0.75 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.261 2.641 . . . . 0.0 114.374 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -69.59 -43.52 72.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -167.5 153.97 7.66 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.284 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.31 123.51 13.27 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.18 1.92 . . . . 0.0 111.928 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.97 128.16 33.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.419 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.0 -30.73 61.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.022 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.92 121.03 81.48 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.08 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.22 153.44 74.56 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.006 2.47 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.554 ' HA ' ' OD1' ' A' ' 6' ' ' ASN . 14.0 ttm180 -77.45 56.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.571 0.7 . . . . 0.0 110.421 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.19 154.82 41.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.111 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.9 m -66.17 93.89 0.23 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 9.6 t0 -62.94 117.84 36.53 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.177 0.513 . . . . 0.0 110.919 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 26.0 Cg_exo -62.68 -25.54 75.16 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 123.276 2.651 . . . . 0.0 112.907 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.552 ' HD3' ' O ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -82.26 -26.16 33.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.519 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.564 HG21 ' HB3' ' A' ' 16' ' ' TYR . 54.5 mt -88.4 125.3 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.596 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . . . -109.47 -51.52 2.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.564 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -149.08 147.5 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.59 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.81 127.39 8.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.318 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 49' ' ' ILE . 47.3 mm -91.56 112.24 25.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.9 m -89.68 128.91 48.74 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.531 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.76 46.06 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.82 2.347 . . . . 0.0 112.363 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.2 tp -171.11 133.28 0.86 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.858 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.918 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 C--O 1.234 0.264 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.512 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -74.86 170.27 16.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 179.447 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 pt -57.81 128.93 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.472 0.653 . . . . 0.0 112.093 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.9 t -88.03 71.3 9.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.257 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 19.8 p -137.16 -158.66 0.88 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.478 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.553 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 18.2 p30 -171.21 -177.17 2.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -60.85 -43.79 97.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.01 66.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.039 0.447 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.95 44.52 1.2 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.981 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.88 142.22 14.45 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.927 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.0 m -58.38 122.36 13.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.577 0.227 . . . . 0.0 110.969 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.677 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -59.76 136.73 58.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.668 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.86 -29.7 10.14 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.222 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.7 m -89.46 130.01 35.87 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.652 ' HG3' ' HE1' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -99.86 122.08 42.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.978 179.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.766 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.0 m-85 -81.23 128.09 33.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.137 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.652 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 5.7 m-85 -118.57 162.09 18.95 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.674 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.442 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 12.4 t -80.3 -170.26 2.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.245 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -74.21 -44.33 53.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.722 0.296 . . . . 0.0 110.961 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.442 ' OD1' ' HB3' ' A' ' 18' ' ' SER . 42.9 p-10 -62.01 -42.59 99.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.682 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.4 -1.89 3.06 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -69.64 131.14 44.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.008 0.433 . . . . 0.0 110.842 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -69.45 119.73 14.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.774 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.659 HG12 ' HG3' ' A' ' 44' ' ' ARG . 90.3 t -86.75 -63.95 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.346 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.0 p -174.67 148.48 1.14 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.771 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 14.7 tt0 -82.44 142.51 31.86 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.677 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -80.02 145.76 27.4 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.234 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -145.09 67.62 1.24 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-O 122.163 0.982 . . . . 0.0 110.129 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 p -78.76 132.07 36.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.895 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 32' ' ' ARG . 2.2 t70 -63.38 137.2 97.01 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.546 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 10.4 Cg_exo -71.3 33.0 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.267 2.645 . . . . 0.0 112.884 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.546 ' HD2' ' O ' ' A' ' 31' ' ' PRO . 28.4 mmm180 -140.29 -36.39 0.49 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.088 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -171.65 151.88 3.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.043 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.53 128.31 23.2 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 121.94 1.76 . . . . 0.0 111.052 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -62.8 135.91 57.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.411 ' HB1' ' H ' ' A' ' 37' ' ' ALA . . . 66.9 -120.16 0.26 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.948 0.78 . . . . 0.0 110.235 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.411 ' H ' ' HB1' ' A' ' 36' ' ' ALA . . . -164.44 140.97 5.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 7.6 Cg_exo -73.04 46.83 1.17 Allowed 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.097 2.532 . . . . 0.0 112.127 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -110.51 -40.5 4.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.033 0.444 . . . . 0.0 110.105 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -82.11 56.48 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.605 0.717 . . . . 0.0 109.712 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 12.4 m -61.56 124.31 20.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.07 -179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.736 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 12.0 t0 -79.27 124.44 84.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.01 -32.13 94.5 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.349 2.699 . . . . 0.0 113.715 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.736 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 16.8 ptt180 -74.27 -10.24 59.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.563 HG23 ' HD2' ' A' ' 16' ' ' TYR . 55.5 mt -88.34 106.94 17.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -97.55 -45.99 6.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.292 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -156.79 142.99 18.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.211 0.529 . . . . 0.0 112.254 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.766 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -97.44 128.9 9.71 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.652 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.82 120.13 43.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.2 m -102.02 107.94 54.55 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.26 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -87.64 51.73 2.16 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.453 2.769 . . . . 0.0 112.215 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.687 HD12 ' H ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -81.53 146.57 30.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.64 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 48.7 t0 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.412 ' HA ' ' HD2' ' A' ' 2' ' ' ARG . 20.6 mmm180 59.53 50.66 7.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.711 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.5 pt -64.16 129.72 28.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.375 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 8.9 t -88.88 52.8 2.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.478 0.656 . . . . 0.0 110.8 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.449 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 13.7 p -112.28 -144.1 0.39 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.19 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.449 ' H ' ' HB ' ' A' ' 5' ' ' THR . 25.4 p30 -169.91 171.24 7.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.9 m -51.32 -48.22 62.43 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.535 0.522 . . . . 0.0 112.293 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.715 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . . . -58.02 -49.09 78.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.983 0.421 . . . . 0.0 111.0 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.34 31.49 0.51 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.266 0.555 . . . . 0.0 110.822 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.571 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -88.27 -19.32 53.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.925 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m 74.72 118.09 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.095 0.558 . . . . 0.0 110.502 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -53.27 127.85 26.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.544 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.0 -38.09 3.5 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.864 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 70.6 m -90.82 131.7 36.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.222 0.534 . . . . 0.0 109.602 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 17.0 mtmm -104.54 127.94 52.39 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.136 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.571 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 4.7 m-30 -82.68 121.27 26.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.78 0.324 . . . . 0.0 110.303 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -108.3 158.17 17.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.326 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.583 ' OG ' ' HD3' ' A' ' 44' ' ' ARG . 6.0 t -82.64 -158.05 0.25 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.091 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -84.25 -46.53 11.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.166 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -63.98 -37.9 89.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.278 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.07 -6.22 5.07 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.5 m -66.61 132.65 48.64 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.176 0.512 . . . . 0.0 111.151 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.415 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.2 t80 -68.5 120.53 14.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.198 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.61 -60.14 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.534 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 16.8 p -171.33 140.12 1.4 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.792 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 29.8 tt0 -81.45 160.23 24.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.95 112.7 2.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.363 -0.446 . . . . 0.0 113.307 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.715 ' HB3' ' HA ' ' A' ' 8' ' ' ALA . 79.4 tt0 -88.79 52.4 2.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.639 0.733 . . . . 0.0 110.138 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 92.0 p -105.28 53.87 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.103 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 8.7 t70 -140.42 131.19 13.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 32.4 Cg_exo -58.59 159.68 19.54 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.041 2.494 . . . . 0.0 112.889 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.415 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 48.0 mtm180 78.87 33.34 0.25 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.562 0.745 . . . . 0.0 110.276 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -116.86 148.03 41.25 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.049 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.08 117.24 4.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.371 2.047 . . . . 0.0 110.651 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -59.89 111.81 1.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 111.093 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.76 -128.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.539 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 69.44 153.85 0.14 Allowed Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 123.737 0.648 . . . . 0.0 111.784 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.72 147.25 88.92 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.786 2.324 . . . . 0.0 111.868 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -64.62 -57.4 9.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 111.225 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -174.82 155.25 2.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.363 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 7.8 m 59.81 42.59 16.39 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.662 0.601 . . . . 0.0 111.817 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.71 124.02 77.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.017 0.437 . . . . 0.0 110.224 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.08 -30.61 90.84 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.474 2.783 . . . . 0.0 113.839 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.583 ' HD3' ' OG ' ' A' ' 18' ' ' SER . 10.9 tpp180 -82.39 -24.0 34.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.037 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.565 HD11 ' HD2' ' A' ' 16' ' ' TYR . 75.9 mt -87.69 123.14 40.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.211 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.29 -58.18 2.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.764 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -140.58 139.85 35.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.329 0.585 . . . . 0.0 111.707 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.28 135.92 12.43 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.974 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.478 HG21 ' HD2' ' A' ' 51' ' ' PRO . 50.0 mm -120.15 127.01 75.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.864 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 57.9 m -85.61 -50.12 0.53 Allowed Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.053 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 6.2 Cg_exo -73.67 -145.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.811 1.674 . . . . 0.0 111.838 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.4 tp 61.71 38.68 14.95 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.355 0.598 . . . . 0.0 110.4 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.603 ' HB2' ' HE3' ' A' ' 15' ' ' LYS . . . . . . . . 0 C--O 1.245 0.86 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.647 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--O 1.235 0.331 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -136.24 118.49 15.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.848 0.356 . . . . 0.0 110.412 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 46' ' ' ALA . 13.1 pt -63.67 150.7 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.878 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.0 t -86.49 77.32 9.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.573 0.702 . . . . 0.0 109.661 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 p -141.51 -173.28 3.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.815 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.894 ' HA ' HD12 ' A' ' 45' ' ' ILE . 19.4 p30 -171.69 -172.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.7 m -60.27 -45.1 94.48 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -76.76 -39.87 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.26 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.06 -30.78 69.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.88 140.01 37.49 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.381 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.9 m -67.85 135.75 53.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.759 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 5.9 tmtm? -59.27 126.1 26.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.476 ' N ' ' HD3' ' A' ' 12' ' ' LYS . . . 112.71 -28.62 8.8 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 29.8 m -87.85 128.28 35.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.086 0.469 . . . . 0.0 110.283 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.623 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 31.2 mmtt -93.21 119.33 32.27 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.602 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 15.1 m-85 -95.53 128.28 42.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.254 0.549 . . . . 0.0 111.596 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.623 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 8.6 m-85 -120.8 162.02 20.5 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.495 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.476 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 69.3 m -83.28 176.99 8.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.548 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -72.43 -29.8 64.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.564 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 44.1 p-10 -69.08 -38.37 78.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.968 0.413 . . . . 0.0 110.742 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.22 -13.25 4.35 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 m -66.69 134.38 52.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.095 0.474 . . . . 0.0 111.537 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.0 123.75 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.947 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.448 HG11 HG12 ' A' ' 45' ' ' ILE . 53.6 t -86.29 -65.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 111.243 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.0 p -176.56 152.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.664 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -84.88 139.27 31.99 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -67.35 144.58 44.56 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.144 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.759 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 7.6 tt0 -146.26 46.07 1.23 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.682 0.753 . . . . 0.0 110.399 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 95.1 p -79.13 133.83 36.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.395 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.81 129.66 94.48 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 123.481 0.488 . . . . 0.0 110.272 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -90.0 39.35 0.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.186 2.591 . . . . 0.0 113.132 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -127.81 -47.24 1.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.026 0.441 . . . . 0.0 110.006 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 5.7 p30 -81.08 143.88 53.69 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.387 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 20.1 Cg_exo -65.63 106.26 0.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.403 2.069 . . . . 0.0 111.223 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -62.91 107.61 1.03 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.364 0.602 . . . . 0.0 111.192 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.38 -50.8 0.17 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.46 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -63.97 -53.49 48.33 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.306 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 2.8 Cg_exo -75.65 71.47 5.39 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.297 1.998 . . . . 0.0 111.191 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -139.62 36.4 2.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.354 0.597 . . . . 0.0 110.419 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -83.54 135.55 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.7 m -70.89 123.82 22.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.387 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 66.8 t0 -97.49 110.81 56.44 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 13.0 Cg_exo -69.98 43.98 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.747 2.965 . . . . 0.0 112.28 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HE ' ' HB3' ' A' ' 44' ' ' ARG . 27.5 ttp180 -144.37 -33.21 0.4 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.748 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.894 HD12 ' HA ' ' A' ' 6' ' ' ASN . 39.1 mt -88.82 134.59 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.796 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -111.15 -44.53 3.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.021 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -151.47 150.43 30.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.608 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -122.84 127.89 6.87 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.918 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.1 mm -98.09 119.78 46.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 74.1 m -88.09 -46.67 0.46 Allowed Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 8.6 Cg_exo . . . . . 0 C--N 1.358 1.077 0 C-N-CA 122.332 2.021 . . . . 0.0 112.297 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 121.489 0.662 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.875 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -71.45 140.75 50.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.809 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 46' ' ' ALA . 12.5 pt -60.74 135.91 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.351 0.596 . . . . 0.0 111.822 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.3 t -88.99 60.77 5.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.597 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.449 ' HG1' ' HE2' ' A' ' 16' ' ' TYR . 24.0 p -123.62 -148.54 0.4 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.949 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.668 ' HA ' HD12 ' A' ' 45' ' ' ILE . 2.8 p-10 -170.09 176.76 4.51 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 m -51.09 -45.97 61.65 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.483 0.489 . . . . 0.0 111.8 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.64 82.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.844 0.354 . . . . 0.0 111.297 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.1 56.45 2.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.106 0.479 . . . . 0.0 110.767 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.09 133.79 3.52 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -59.45 136.71 58.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.268 0.227 . . . . 0.0 111.426 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 14' ' ' CYS . 17.7 tppt? -56.19 -36.49 68.44 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 110.604 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.85 27.39 1.95 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.129 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.727 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 59.1 m -147.32 138.23 23.63 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.638 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 29.0 mttt -114.78 127.48 55.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.836 0.35 . . . . 0.0 110.216 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.532 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 3.3 m-85 -81.22 129.45 34.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.02 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.455 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 26.0 m-85 -123.11 158.99 29.47 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.407 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.544 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 50.9 m -86.32 164.82 16.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.34 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.406 ' CG ' HH21 ' A' ' 2' ' ' ARG . 1.0 OUTLIER -68.98 -25.44 64.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.914 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.544 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 3.5 p-10 -70.84 -34.46 71.7 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.78 -17.21 5.25 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.439 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.496 HG22 HH22 ' A' ' 44' ' ' ARG . 83.1 m -71.68 135.13 46.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.231 0.538 . . . . 0.0 111.912 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.638 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 26.9 t80 -65.69 130.63 43.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.675 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.547 HG11 ' CG1' ' A' ' 45' ' ' ILE . 46.2 t -90.96 -68.34 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 p -169.03 159.02 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.178 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -80.34 162.7 24.39 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.05 98.19 0.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.513 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -90.11 51.27 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.932 0.396 . . . . 0.0 110.952 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -80.16 47.14 0.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.155 0.503 . . . . 0.0 111.635 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 38.7 t70 -74.09 135.44 76.75 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.927 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 57.2 Cg_endo -71.29 45.31 0.63 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.922 2.414 . . . . 0.0 113.938 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -134.46 34.19 3.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 34' ' ' PRO . 0.8 OUTLIER 39.19 58.19 6.08 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 33' ' ' ASN . 12.8 Cg_exo -69.33 87.7 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.619 2.212 . . . . 0.0 112.261 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 12.8 mmmt -63.74 134.8 55.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.997 0.903 . . . . 0.0 113.221 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 6' ' ' ASN . . . -161.08 -172.56 3.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.74 -1.573 . . . . 0.0 107.295 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.77 149.17 0.12 Allowed Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.922 0.764 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HB2' ' H ' ' A' ' 39' ' ' ARG . 64.8 Cg_endo -72.54 -141.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.896 2.397 . . . . 0.0 112.866 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.445 ' H ' ' HB2' ' A' ' 38' ' ' PRO . 13.8 tpt180 -61.01 -40.8 94.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.379 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -176.22 144.31 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.631 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 m 62.54 116.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 O-C-N 124.03 0.831 . . . . 0.0 111.971 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.682 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . 9.3 t70 -71.37 122.16 86.33 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 64.3 Cg_exo -53.05 -32.67 59.56 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.643 2.896 . . . . 0.0 114.762 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.496 HH22 HG22 ' A' ' 22' ' ' THR . 5.7 ptm180 -104.61 -3.21 24.07 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.682 ' HB ' ' HB3' ' A' ' 42' ' ' ASP . 23.4 mt -89.0 132.65 33.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.007 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.875 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -125.02 -49.51 1.72 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.134 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -154.65 148.65 25.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 0.0 111.9 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.54 125.4 7.8 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.615 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.0 mm -101.82 120.33 51.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.727 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 39.0 m -89.87 110.79 42.3 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.606 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 5.8 Cg_exo . . . . . 0 C--N 1.345 0.347 0 C-N-CA 123.4 2.733 . . . . 0.0 111.904 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.84 0.353 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -140.05 123.88 17.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 46' ' ' ALA . 13.7 pt -60.54 139.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.26 0.552 . . . . 0.0 111.68 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 40.4 t -85.93 83.93 7.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.517 0.675 . . . . 0.0 109.211 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -139.86 -159.39 0.95 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.989 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.511 ' HA ' HD12 ' A' ' 45' ' ' ILE . 4.4 p-10 -170.47 171.96 6.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.6 m -51.87 -40.85 61.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.59 -46.0 81.05 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 110.915 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.88 40.53 0.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.179 0.514 . . . . 0.0 110.659 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.479 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -110.51 129.49 9.34 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.854 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.443 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 10.7 m -63.69 131.87 49.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.543 0.211 . . . . 0.0 110.646 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -57.91 132.29 52.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.362 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.47 -26.2 16.96 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.218 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 38.1 m -88.26 129.56 35.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 50.6 mttm -99.23 120.74 40.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.949 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.737 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.5 m-85 -88.57 127.13 35.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.042 0.449 . . . . 0.0 110.984 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.521 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 26.9 m-85 -120.69 161.06 22.05 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.86 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -83.89 165.27 18.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.97 -34.07 76.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.466 0.175 . . . . 0.0 111.005 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.08 -37.59 84.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.83 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.33 -23.68 2.84 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.053 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 m -59.8 136.92 58.15 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.8 t80 -74.12 123.87 25.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.947 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.598 HG11 ' CG1' ' A' ' 45' ' ' ILE . 13.9 t -85.76 -64.5 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.609 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 p -178.31 157.68 1.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.699 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.456 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 4.6 tt0 -86.26 -159.99 0.52 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.463 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.456 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -83.14 89.57 1.52 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.457 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -88.18 39.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.365 0.603 . . . . 0.0 110.596 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 p -85.45 56.41 3.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.162 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.2 t70 -126.38 135.87 27.81 Favored Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.357 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 23.3 Cg_exo -65.03 -179.12 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.879 2.386 . . . . 0.0 112.439 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.9 mtm-85 78.84 -32.11 0.15 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.972 0.909 . . . . 0.0 110.705 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -141.41 54.57 4.36 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.409 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 56.2 Cg_endo -70.04 137.54 34.88 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.79 1.66 . . . . 0.0 110.946 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 34' ' ' PRO . 67.9 mmtt -126.4 127.06 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.77 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.16 136.57 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.167 0.917 . . . . 0.0 111.888 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -69.92 136.96 87.41 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.154 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 7.8 Cg_exo -72.11 68.71 3.23 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.318 2.679 . . . . 0.0 111.933 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.1 ttp85 -155.38 -42.29 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.075 0.465 . . . . 0.0 110.606 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.18 121.52 28.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.216 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 2.3 m -69.86 128.34 36.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.739 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.429 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 67.2 t0 -79.6 114.97 50.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 19.6 Cg_endo -61.05 -17.25 50.81 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.041 2.494 . . . . 0.0 112.483 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.1 mtp-105 -73.09 -35.38 66.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.598 ' CG1' HG11 ' A' ' 24' ' ' VAL . 43.4 mt -88.48 134.37 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.422 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -118.12 -47.98 2.56 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.986 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -154.14 145.72 23.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.209 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.13 128.4 8.84 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.553 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.6 mm -93.82 121.01 44.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 94.6 m -97.77 152.61 38.21 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.992 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo . . . . . 0 N--CA 1.463 -0.313 0 C-N-CA 122.404 2.069 . . . . 0.0 111.525 179.926 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 2' ' ' ARG . 1.2 p30 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.402 0.62 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 1' ' ' ASP . 13.0 mtt-85 -151.96 131.74 13.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.085 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -76.06 141.29 15.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.801 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 47.6 t -87.23 59.62 5.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.717 0.77 . . . . 0.0 109.532 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 p -135.28 125.9 27.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.431 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.441 ' HA ' HD12 ' A' ' 45' ' ' ILE . 3.4 p-10 -90.28 176.52 6.71 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.0 m -51.2 -44.74 61.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.971 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . . . -61.05 -47.53 85.97 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.15 67.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.998 0.427 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.34 138.13 48.42 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.539 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -67.71 124.42 23.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.689 0.281 . . . . 0.0 110.936 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -60.02 131.3 50.42 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.449 ' O ' ' HE2' ' A' ' 15' ' ' LYS . . . 112.35 -33.91 5.44 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.8 m -88.63 131.47 34.96 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.514 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -97.93 119.05 35.86 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.747 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 3.9 m-85 -89.62 125.07 35.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.157 0.503 . . . . 0.0 110.872 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.98 163.55 15.42 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.95 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.4 t -86.49 168.56 13.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.921 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -66.8 -32.77 74.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.83 0.348 . . . . 0.0 110.336 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.53 -32.56 73.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.647 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.23 -23.75 4.29 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.191 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.8 m -62.92 135.45 57.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.141 0.496 . . . . 0.0 111.992 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.3 t80 -71.17 124.29 24.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.787 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.584 HG11 HG12 ' A' ' 45' ' ' ILE . 46.8 t -87.91 -64.96 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.515 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 p -172.89 153.95 2.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 111.58 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.99 157.61 17.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.334 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.78 130.02 45.71 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.429 -0.415 . . . . 0.0 113.849 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.971 ' HB3' ' HA ' ' A' ' 8' ' ' ALA . 6.6 tt0 -96.82 0.26 49.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.145 0.498 . . . . 0.0 110.734 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.3 p -77.75 -168.92 1.34 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.48 . . . . 0.0 111.632 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.517 ' HB3' HD21 ' A' ' 33' ' ' ASN . 38.7 t0 -163.86 124.31 1.4 Allowed Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 17.3 Cg_exo -68.7 38.25 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.175 2.583 . . . . 0.0 113.983 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HE ' ' CG ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -147.12 17.8 1.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.517 HD21 ' HB3' ' A' ' 30' ' ' ASP . 8.3 p30 -165.21 142.03 4.76 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.033 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.54 57.88 5.66 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.805 2.337 . . . . 0.0 113.861 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -80.25 105.84 11.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.946 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -163.97 29.45 0.08 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.52 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.719 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -74.78 -56.64 2.13 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.849 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.719 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 8.2 Cg_exo -71.33 134.35 24.55 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.894 1.729 . . . . 0.0 110.82 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -157.09 48.87 0.44 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.233 0.539 . . . . 0.0 110.9 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -80.39 138.56 36.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.018 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 38.6 m -75.78 70.68 2.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.384 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.592 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 33.2 t70 -66.14 115.57 24.76 Favored Pre-proline 0 C--N 1.332 -0.179 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.39 -24.83 78.87 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.302 2.668 . . . . 0.0 112.979 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.592 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 19.7 ttm105 -66.8 -33.53 75.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.628 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.584 HG12 HG11 ' A' ' 24' ' ' VAL . 62.5 mt -88.2 108.98 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.084 0.469 . . . . 0.0 110.053 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.07 -48.17 5.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.497 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -153.39 145.13 23.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.12 128.18 8.89 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.34 119.45 47.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.764 0.316 . . . . 0.0 110.964 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.5 m -98.0 122.16 55.32 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo . . . . . 0 N--CA 1.465 -0.174 0 C-N-CA 123.082 2.521 . . . . 0.0 112.687 -179.552 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.477 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . 44.5 t0 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.602 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -169.31 62.88 0.05 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 46' ' ' ALA . 6.9 pt -55.3 142.88 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.934 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 t -87.22 66.86 9.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.553 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.7 p -133.91 -149.41 0.36 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.723 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.798 ' HA ' HD12 ' A' ' 45' ' ' ILE . 24.4 p30 -174.12 -159.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.8 m -66.25 -63.73 1.01 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.064 0.227 . . . . 0.0 111.135 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.961 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . . . -57.5 -38.39 74.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.029 0.443 . . . . 0.0 112.081 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.88 -19.43 60.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.082 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.94 147.9 31.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.681 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.441 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 20.2 m -63.39 124.19 20.64 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.585 0.231 . . . . 0.0 111.359 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -57.4 132.1 52.08 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.531 ' N ' ' HD2' ' A' ' 12' ' ' LYS . . . 106.6 -36.37 4.44 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.729 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 76.2 m -88.35 132.98 34.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.675 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.857 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 25.0 mmtp -82.92 111.33 18.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.74 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.698 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 6.1 m-85 -86.97 124.15 32.85 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.233 0.54 . . . . 0.0 109.894 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.968 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -147.49 178.5 8.39 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.395 0.617 . . . . 0.0 111.834 -178.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.532 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 14.7 m -76.14 168.49 19.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.543 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -66.89 -35.35 79.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.1 p-10 -63.49 -41.4 98.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.999 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.7 -11.92 2.92 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.074 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.7 m -62.61 111.04 1.9 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.86 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.968 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 25.1 t80 -68.08 122.72 18.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.113 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.631 HG23 ' HA ' ' A' ' 17' ' ' PHE . 45.8 t -91.55 -61.84 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.549 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.9 p -174.58 152.69 1.71 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.96 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.857 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 10.2 tt0 -80.06 158.29 26.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -65.09 133.92 36.79 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.029 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.961 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 45.2 mt-10 -105.71 16.13 25.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.694 0.247 . . . . 0.0 111.629 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.626 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 26.5 p -80.3 46.78 0.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.402 0.62 . . . . 0.0 110.823 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.408 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 12.3 t0 -66.15 -50.77 49.05 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.518 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 4.2 Cg_exo -76.23 27.05 0.41 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.236 1.957 . . . . 0.0 112.657 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 52.28 40.89 29.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.308 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.626 ' OD1' ' HA ' ' A' ' 29' ' ' SER . 8.8 p-10 -74.49 132.76 78.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.402 . . . . 0.0 110.739 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.33 67.67 3.5 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.144 2.563 . . . . 0.0 112.023 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 68.31 -134.08 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.048 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.15 -144.27 0.11 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.568 0.223 . . . . 0.0 110.998 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.06 138.11 94.78 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.483 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.12 45.7 1.42 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.847 2.365 . . . . 0.0 112.604 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -174.17 47.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.249 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.96 41.53 1.54 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.331 0.586 . . . . 0.0 111.367 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.1 m -80.93 124.21 28.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.356 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.515 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 33.4 t70 -75.02 114.82 38.75 Favored Pre-proline 0 C--O 1.239 0.531 0 O-C-N 123.233 0.333 . . . . 0.0 110.387 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.41 46.93 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.298 2.665 . . . . 0.0 111.896 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.515 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 13.9 ttp180 -154.94 -23.53 0.12 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.907 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 6' ' ' ASN . 63.3 mt -85.64 120.89 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.029 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -95.61 -51.9 4.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.449 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.477 ' HD2' ' HB3' ' A' ' 1' ' ' ASP . 13.7 p90 -159.92 154.25 23.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.034 0.445 . . . . 0.0 111.59 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.08 131.56 10.51 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.902 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.4 mm -122.02 132.93 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.756 0.312 . . . . 0.0 111.18 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.4 m -88.49 -54.21 0.34 Allowed Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 C--N 1.353 0.795 0 C-N-CA 121.768 1.646 . . . . 0.0 113.4 -179.185 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.654 0.74 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.406 ' NE ' ' HA ' ' A' ' 46' ' ' ALA . 39.1 ttt180 -73.9 124.49 26.25 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.938 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -65.32 124.84 21.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.452 0.644 . . . . 0.0 111.771 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 t -93.42 51.17 1.57 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.592 0.71 . . . . 0.0 109.724 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.424 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 9.1 p -110.04 -145.47 0.4 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.356 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.519 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 16.1 p30 -173.16 176.92 2.84 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.8 m -53.19 -47.77 68.61 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.514 ' HB1' ' HG2' ' A' ' 31' ' ' PRO . . . -68.72 -44.54 73.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.226 0.536 . . . . 0.0 110.44 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.18 49.16 1.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.285 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA2' ' OH ' ' A' ' 16' ' ' TYR . . . -104.2 -141.1 10.89 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.125 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.75 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 87.2 m -157.4 131.58 8.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HD3' ' H ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -55.19 131.54 45.53 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.306 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.87 21.6 71.02 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.524 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 57.9 m -137.63 127.61 25.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 25.9 mtmm -107.26 131.54 54.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.102 0.477 . . . . 0.0 111.763 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.719 ' HD2' HD13 ' A' ' 45' ' ' ILE . 6.4 m-30 -85.24 126.85 34.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.369 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -121.63 155.95 34.01 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.451 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.502 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 19.9 m -78.4 175.68 10.06 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.071 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.44 -38.14 86.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.207 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 43.1 p-10 -66.52 -40.24 89.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.948 0.404 . . . . 0.0 111.069 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.15 -7.97 3.78 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.5 m -65.33 134.35 53.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.13 0.49 . . . . 0.0 111.477 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -73.35 122.08 21.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.619 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.56 -63.02 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.72 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 p -174.5 147.67 1.13 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.373 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 19.2 tt0 -77.78 151.8 33.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.75 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -68.3 94.57 0.33 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.683 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 13.3 tp10 -88.82 69.89 8.65 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 11.4 p -77.51 41.92 0.34 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.528 -1.214 . . . . 0.0 113.266 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.511 ' H ' ' HD2' ' A' ' 31' ' ' PRO . 22.6 t70 -89.7 -51.26 0.36 Allowed Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 119.421 -0.323 . . . . 0.0 111.011 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.514 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 42.9 Cg_endo -67.7 58.66 0.79 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 122.87 2.38 . . . . 0.0 112.497 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -65.64 -26.99 68.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.871 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -73.09 135.87 79.73 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.822 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -45.4 128.94 10.58 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 123.581 2.854 . . . . 0.0 114.248 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 35.9 mmtm -149.09 158.13 43.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.493 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.05 -24.94 58.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.66 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -61.93 -54.34 51.56 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 11.9 Cg_exo -70.51 122.22 8.71 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.918 1.745 . . . . 0.0 111.597 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -114.15 -124.64 0.28 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -171.04 152.85 3.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.048 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.7 m 56.32 52.99 9.32 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.759 0.662 . . . . 0.0 111.907 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 37.0 t70 -66.3 127.92 93.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 9.9 Cg_endo -51.87 -36.15 62.29 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.764 2.976 . . . . 0.0 114.605 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.09 -23.87 35.52 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.888 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.719 HD13 ' HD2' ' A' ' 16' ' ' TYR . 91.8 mt -87.36 127.62 40.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.232 0.539 . . . . 0.0 111.927 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . . . -120.91 -50.61 2.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.858 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -149.75 148.35 29.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.979 0.418 . . . . 0.0 111.802 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.94 134.03 11.92 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.5 mm -112.89 129.16 69.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.646 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 39.2 m -101.96 -55.63 0.12 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.253 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 74.2 Cg_endo . . . . . 0 C--N 1.355 0.884 0 C-N-CA 121.651 1.567 . . . . 0.0 112.701 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 2' ' ' ARG . 4.2 p-10 . . . . . 0 C--O 1.233 0.193 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.92 ' HD2' ' HA ' ' A' ' 46' ' ' ALA . 26.8 ptt-85 47.7 -164.42 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.192 0.932 . . . . 0.0 112.664 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -82.54 120.8 34.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.122 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.2 t -89.11 58.36 4.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.547 0.689 . . . . 0.0 109.994 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 23.5 p -117.29 -152.03 0.49 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.742 ' HA ' HD12 ' A' ' 45' ' ' ILE . 14.6 p30 -175.45 172.26 2.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 59.2 m -58.05 -43.09 86.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.02 -44.17 82.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 111.579 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.06 26.08 6.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.591 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.19 129.11 11.24 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.707 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 m -67.22 124.4 23.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.737 0.303 . . . . 0.0 110.785 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.915 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 54.3 mtmt -55.96 136.06 52.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.415 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.89 -30.96 7.33 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.922 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 39.7 m -88.98 125.03 34.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.0 110.642 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.677 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 2.2 tppt? -85.86 119.42 26.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.205 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.485 ' HD2' HG21 ' A' ' 45' ' ' ILE . 2.4 m-85 -89.41 124.73 34.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.272 0.558 . . . . 0.0 111.423 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 87.4 m-85 -122.56 158.18 30.47 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.088 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 p -78.11 -161.51 0.27 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.13 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -44.97 47.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.55 0.214 . . . . 0.0 111.253 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -63.36 -39.81 95.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.601 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.61 0.9 5.24 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -67.47 135.98 53.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.033 0.444 . . . . 0.0 111.033 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -67.26 112.52 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.925 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.596 HG11 HG12 ' A' ' 45' ' ' ILE . 83.6 t -87.83 -55.72 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.28 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.411 ' SG ' HG12 ' A' ' 24' ' ' VAL . 7.7 p -174.38 -170.18 0.5 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.946 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.818 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 13.9 tt0 -134.27 -158.81 0.91 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.742 0.305 . . . . 0.0 110.645 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.818 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -79.78 85.78 1.27 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.251 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -88.26 15.39 7.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.87 0.367 . . . . 0.0 110.985 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 p -79.67 55.31 1.98 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.915 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 24.4 t0 -173.94 -57.73 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 7.3 Cg_exo -72.86 65.68 4.02 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.421 2.081 . . . . 0.0 112.657 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 64.07 55.01 1.59 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -48.63 134.61 13.55 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.106 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.82 178.55 3.89 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.681 2.254 . . . . 0.0 110.678 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.716 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -92.95 129.95 38.7 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.213 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 73.7 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.727 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -67.24 -48.91 46.4 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.313 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 11.7 Cg_exo -70.97 66.28 2.49 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.648 2.232 . . . . 0.0 111.859 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -68.65 -34.49 75.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.82 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -80.34 45.49 0.76 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.425 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.9 m 67.37 118.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.413 0.685 . . . . 0.0 110.933 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.567 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 10.5 t70 -58.06 111.67 3.84 Favored Pre-proline 0 C--O 1.24 0.566 0 CA-C-O 120.75 0.31 . . . . 0.0 111.0 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.8 52.1 2.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.653 2.902 . . . . 0.0 112.042 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.567 ' HB3' ' OD1' ' A' ' 42' ' ' ASP . 12.8 ttp180 -166.27 -34.31 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.313 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.742 HD12 ' HA ' ' A' ' 6' ' ' ASN . 62.7 mt -89.39 129.76 39.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.2 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.92 ' HA ' ' HD2' ' A' ' 2' ' ' ARG . . . -115.16 -44.19 3.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -152.77 152.89 32.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 112.009 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.4 128.69 7.26 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.937 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mm -97.24 116.06 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 49.9 m -89.19 -52.03 0.36 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.672 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 60.5 Cg_endo . . . . . 0 C--N 1.354 0.84 0 C-N-CA 121.56 1.507 . . . . 0.0 112.365 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 13.0 mtm105 62.76 58.25 1.61 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.549 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.3 pt -58.08 150.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.518 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 40.9 t -85.2 78.69 9.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.6 0.714 . . . . 0.0 109.575 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.2 p -138.71 -156.62 0.7 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.04 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.562 ' HA ' HD12 ' A' ' 45' ' ' ILE . 17.1 p30 -178.3 178.59 0.87 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 m -54.12 -55.45 27.54 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.806 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . . . -62.2 -35.76 79.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.81 -30.17 62.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.882 0.373 . . . . 0.0 111.366 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.93 147.13 48.81 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.206 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.453 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 23.1 m -69.31 128.29 36.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.562 0.22 . . . . 0.0 111.122 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 43.8 mtmt -57.05 136.22 56.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.344 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.75 -32.27 7.42 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.658 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.5 m -87.91 134.27 33.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.974 0.416 . . . . 0.0 109.958 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.52 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 38.3 mmtt -93.1 122.47 35.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.488 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.67 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.3 m-85 -95.17 129.73 42.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.966 0.412 . . . . 0.0 110.823 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 38.3 m-85 -121.04 165.22 15.61 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.885 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.2 m -79.1 -156.65 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.748 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -84.75 -42.17 15.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.746 0.308 . . . . 0.0 110.622 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -63.98 -42.46 97.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.633 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.89 -5.25 3.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.1 m -64.34 131.2 46.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.005 0.431 . . . . 0.0 110.779 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.9 t80 -70.3 117.74 12.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.942 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.653 HG11 HG12 ' A' ' 45' ' ' ILE . 86.0 t -81.66 -63.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.986 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.455 ' SG ' HG12 ' A' ' 24' ' ' VAL . 16.6 p -178.1 167.79 1.99 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.502 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -95.57 156.25 16.4 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -68.81 133.39 27.12 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.874 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.806 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 29.9 mt-10 -116.09 32.78 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.977 0.418 . . . . 0.0 110.243 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 11' ' ' THR . 14.5 p -78.41 55.0 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 0.0 111.76 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.577 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 13.0 t0 -68.12 -56.79 10.3 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.006 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 1.2 Cg_endo -82.21 12.89 2.69 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.264 1.976 . . . . 0.0 111.254 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 60.66 33.66 20.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.549 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -169.85 137.14 1.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.18 0.514 . . . . 0.0 110.964 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.32 60.14 7.24 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.803 2.335 . . . . 0.0 111.501 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.635 ' NZ ' ' HB2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER 67.76 116.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.499 -178.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 57.57 -135.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.812 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -96.79 134.57 22.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.52 0.2 . . . . 0.0 110.684 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 22.6 Cg_exo -64.22 130.84 28.26 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.717 2.278 . . . . 0.0 111.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -164.04 45.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.887 0.375 . . . . 0.0 110.999 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -160.32 125.84 3.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.124 0.487 . . . . 0.0 110.475 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 3.3 m -107.98 125.9 52.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.07 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 17.2 t0 -90.35 110.75 42.96 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 27.5 Cg_endo -62.28 -21.71 73.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.414 2.742 . . . . 0.0 112.306 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.485 ' HE ' ' HB3' ' A' ' 44' ' ' ARG . 26.5 ttp180 -66.06 -30.87 71.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.688 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.653 HG12 HG11 ' A' ' 24' ' ' VAL . 50.9 mt -89.53 126.5 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.935 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -110.65 -42.98 3.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.7 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -156.37 145.41 20.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.274 0.559 . . . . 0.0 112.0 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.67 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.24 131.54 10.64 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.488 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.99 121.69 55.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.057 0.456 . . . . 0.0 111.023 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 76.7 m -97.92 137.95 20.95 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.7 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.6 Cg_exo . . . . . 0 CA--C 1.53 0.317 0 C-N-CA 122.884 2.39 . . . . 0.0 112.445 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 121.423 0.63 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -151.68 60.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.859 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.2 pt -64.62 140.64 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.336 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 52.2 t -87.15 69.11 10.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.554 0.693 . . . . 0.0 110.268 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.9 p -120.49 -164.15 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.86 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -175.04 161.09 2.86 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.4 m -60.06 -35.31 74.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.49 -23.55 64.59 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.198 0.523 . . . . 0.0 110.938 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.41 -109.56 0.36 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.177 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.92 -136.45 50.83 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.186 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.5 m -152.17 127.53 9.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 42.0 tptt -60.07 133.11 55.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.783 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.08 -26.16 23.88 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.893 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.451 ' HB2' ' HE1' ' A' ' 16' ' ' TYR . 33.9 m -88.05 129.76 35.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.125 0.488 . . . . 0.0 110.458 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -90.3 114.92 27.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.047 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.703 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.1 m-85 -96.2 128.68 43.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.855 0.36 . . . . 0.0 110.359 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.995 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 0.6 OUTLIER -148.91 178.27 8.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.028 0.442 . . . . 0.0 111.502 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.1 p -78.72 174.7 11.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.887 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -68.6 -35.6 77.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.27 -36.59 84.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.041 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.32 -18.84 4.13 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.238 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.3 m -58.56 115.35 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.059 0.457 . . . . 0.0 111.262 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.995 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 23.8 t80 -65.04 118.14 8.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.569 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.535 HG23 ' HA ' ' A' ' 17' ' ' PHE . 87.8 t -84.81 -58.91 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.353 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 26.0 p -178.26 151.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.775 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.2 147.06 28.25 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.19 124.41 29.95 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.746 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -128.4 65.49 1.4 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.58 43.18 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.627 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -70.02 130.02 90.24 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.148 178.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 4.4 Cg_exo -81.99 39.05 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.399 2.733 . . . . 0.0 112.973 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.461 ' HG3' HH11 ' A' ' 32' ' ' ARG . 17.2 mmt85 -131.22 -46.7 1.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.479 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 18.0 p30 -62.86 136.19 96.34 Favored Pre-proline 0 C--O 1.237 0.445 0 CA-C-O 121.201 0.524 . . . . 0.0 110.624 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 32.0 Cg_exo -60.22 139.22 86.0 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.609 2.873 . . . . 0.0 113.736 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -132.95 128.62 36.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.098 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.7 -37.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.256 0.347 . . . . 0.0 110.823 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -59.0 136.28 87.7 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.989 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 16.7 Cg_exo -68.38 59.29 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.716 2.944 . . . . 0.0 113.122 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.546 ' HD2' ' OD2' ' A' ' 42' ' ' ASP . 12.6 tpp180 -94.99 43.94 1.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.933 0.873 . . . . 0.0 109.704 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -90.65 139.58 30.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.797 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 65.3 m 60.49 52.62 4.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.672 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.546 ' OD2' ' HD2' ' A' ' 39' ' ' ARG . 8.4 t0 -58.5 113.23 6.21 Favored Pre-proline 0 N--CA 1.464 0.269 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.39 -30.61 91.83 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.575 2.85 . . . . 0.0 113.915 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.522 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 34.5 ptt180 -70.64 -26.25 63.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.375 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.9 mt -89.13 111.31 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.977 0.417 . . . . 0.0 110.761 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.91 -49.99 6.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.245 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.468 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 14.8 p90 -161.77 147.49 13.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.253 0.549 . . . . 0.0 111.678 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.703 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.38 129.4 9.56 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.296 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.11 124.8 52.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.025 0.44 . . . . 0.0 111.194 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.4 m -100.13 139.33 20.64 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.98 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--N 1.342 0.194 0 C-N-CA 122.588 2.192 . . . . 0.0 112.103 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.1 t0 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.604 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -64.97 144.93 56.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.205 0.526 . . . . 0.0 111.311 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 pt -68.06 135.01 29.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.238 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 41.8 t -87.66 57.87 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.692 0.758 . . . . 0.0 110.254 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 9' ' ' ALA . 34.1 p -124.5 -143.35 0.31 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.765 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.754 ' HA ' HD12 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -177.46 -171.15 0.31 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.474 ' C ' ' HG2' ' A' ' 28' ' ' GLU . 4.3 m -60.33 -41.86 94.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.589 0.233 . . . . 0.0 110.453 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.571 ' N ' ' HG2' ' A' ' 28' ' ' GLU . . . -60.11 -44.47 94.83 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.715 0.293 . . . . 0.0 111.584 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' A' ' 5' ' ' THR . . . -82.52 21.75 0.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.099 0.476 . . . . 0.0 110.521 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -91.46 131.45 10.79 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.188 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.631 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 5.3 m -69.22 148.96 49.1 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.647 0.26 . . . . 0.0 110.591 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -58.34 131.89 52.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.439 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.76 -11.03 54.98 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.13 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 61.3 m -89.52 128.83 36.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.422 0.629 . . . . 0.0 110.624 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 15.2 mmtp -98.81 121.34 40.63 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.715 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.603 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.5 m-85 -92.05 125.76 36.87 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.768 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.26 162.84 16.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.734 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.416 ' HB2' ' H ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -78.51 -154.14 0.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.997 178.353 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.416 ' H ' ' HB2' ' A' ' 18' ' ' SER . 14.4 p-10 -82.76 -42.15 18.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.681 0.276 . . . . 0.0 110.488 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -64.41 -41.26 96.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.665 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.96 -0.04 4.38 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -68.27 134.5 50.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 110.754 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.9 t80 -68.78 111.88 5.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.614 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.466 HG13 ' HD2' ' A' ' 44' ' ' ARG . 94.7 t -83.26 -57.11 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.778 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.9 p -175.53 158.28 2.22 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.981 0.42 . . . . 0.0 111.923 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 38.0 tt0 -92.44 173.21 7.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -69.91 108.48 2.49 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.572 -0.823 . . . . 0.0 114.062 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.571 ' HG2' ' N ' ' A' ' 8' ' ' ALA . 21.8 pt-20 -89.16 36.43 0.82 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.201 1.0 . . . . 0.0 108.392 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 3.5 p -78.08 56.24 1.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.359 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -63.46 128.97 93.28 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.532 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 33' ' ' ASN . 73.9 Cg_endo -75.63 -136.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.784 2.323 . . . . 0.0 111.237 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.437 ' H ' ' HB2' ' A' ' 31' ' ' PRO . 38.2 mtp85 73.21 -31.96 0.23 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.388 0.675 . . . . 0.0 111.122 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.494 ' H ' ' C ' ' A' ' 31' ' ' PRO . 5.8 p30 -169.37 141.7 2.06 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.055 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 14.0 Cg_exo -70.35 71.8 1.79 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.602 2.868 . . . . 0.0 113.004 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 33' ' ' ASN . 35.5 mtmm -68.23 112.81 5.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.728 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.6 122.07 28.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.321 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.72 114.43 50.06 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.898 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.42 46.51 2.23 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.838 2.359 . . . . 0.0 112.254 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.87 52.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.216 0.531 . . . . 0.0 111.322 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -69.99 161.48 29.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.399 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 65.62 48.6 1.94 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.365 0.416 . . . . 0.0 110.436 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.666 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 4.4 t0 -60.5 113.59 7.94 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 12.1 Cg_endo -56.58 -33.72 93.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.646 2.898 . . . . 0.0 114.313 -177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.666 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 23.2 ptt180 -71.07 -27.01 63.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.789 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 6' ' ' ASN . 67.7 mt -91.72 127.31 44.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 111.703 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.08 -45.34 3.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.55 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -152.5 145.82 24.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.209 0.528 . . . . 0.0 111.616 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -111.84 129.19 8.97 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.31 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.1 mm -110.69 125.05 67.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 19.2 m -87.68 -51.69 0.41 Allowed Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.646 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 2.8 Cg_exo . . . . . 0 C--N 1.353 0.791 0 C-N-CA 122.373 2.049 . . . . 0.0 112.469 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 110.432 -0.211 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.762 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 61.6 mtt85 54.27 60.52 3.52 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.863 0.727 . . . . 0.0 111.931 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 pt -57.28 147.44 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.323 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 43.6 t -85.33 75.24 10.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.758 0.79 . . . . 0.0 109.937 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.3 p -140.9 -163.94 1.64 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.205 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.957 ' HA ' HD12 ' A' ' 45' ' ' ILE . 15.4 p30 -173.24 -158.62 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 m -69.71 -54.5 13.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.267 0.485 . . . . 0.0 110.467 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -65.91 -44.03 86.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.307 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.82 -4.65 47.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.089 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.26 141.04 23.59 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.053 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 31' ' ' PRO . 72.7 m -68.26 127.19 32.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.727 0.298 . . . . 0.0 110.497 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.721 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 82.2 tttt -57.66 131.31 49.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.907 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.27 -29.59 12.17 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.532 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.5 m -88.42 128.44 35.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.124 0.488 . . . . 0.0 109.943 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.632 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 10.9 mtpp -90.67 114.42 26.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.364 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.723 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.5 m-85 -86.37 126.01 34.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.302 0.572 . . . . 0.0 111.637 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.632 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 14.4 m-85 -119.89 163.07 18.09 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.653 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.7 t -84.32 169.22 14.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -69.1 -32.25 71.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 0.0 110.127 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -66.27 -33.94 76.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.591 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.73 -23.9 3.72 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.195 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -60.97 133.18 55.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.095 0.474 . . . . 0.0 112.097 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -73.49 122.86 22.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.454 HG11 ' CG1' ' A' ' 45' ' ' ILE . 48.9 t -86.93 -65.13 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.403 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.0 p -175.69 152.29 1.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.577 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -85.71 145.72 27.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -66.37 144.41 45.86 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.659 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 8' ' ' ALA . 14.2 pt-20 -117.32 -18.12 9.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.567 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 82.5 p -78.56 139.9 38.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.372 0.606 . . . . 0.0 112.445 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.408 ' OD2' ' HB2' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -63.52 138.14 97.28 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.606 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.562 ' HB3' HG23 ' A' ' 11' ' ' THR . 90.5 Cg_endo -82.36 29.49 0.54 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.663 2.242 . . . . 0.0 113.68 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.7 mmp_? -129.04 29.07 5.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.926 0.393 . . . . 0.0 110.348 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -154.07 146.4 17.34 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.77 143.75 46.79 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.829 2.353 . . . . 0.0 111.631 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -70.19 140.76 52.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.719 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -43.64 -51.27 7.11 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -166.96 125.53 1.05 Allowed Pre-proline 0 C--N 1.328 -0.342 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.571 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 3.0 Cg_exo -75.61 63.21 6.48 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.538 2.825 . . . . 0.0 111.665 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -148.76 -23.11 0.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.011 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -86.37 48.78 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.49 0.662 . . . . 0.0 110.101 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m -67.34 125.52 26.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.058 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 66.0 t0 -78.32 116.98 63.41 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.18 -24.77 75.43 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.334 2.689 . . . . 0.0 113.97 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.489 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 28.6 ptt-85 -93.78 -1.53 54.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.413 -0.515 . . . . 0.0 112.326 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.957 HD12 ' HA ' ' A' ' 6' ' ' ASN . 15.7 mt -102.79 124.02 56.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.984 0.421 . . . . 0.0 110.7 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -108.67 -46.13 3.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.29 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -153.25 147.48 25.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.262 0.553 . . . . 0.0 112.431 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.66 125.68 7.53 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.6 mm -89.74 113.61 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.826 0.346 . . . . 0.0 110.785 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.0 m -95.72 134.14 24.53 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.065 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 C--O 1.231 0.167 0 C-N-CA 122.496 2.131 . . . . 0.0 112.32 -179.843 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.3 t70 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.8 ptt85 -162.26 108.05 1.25 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.23 0.538 . . . . 0.0 110.34 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 pt -65.04 145.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.766 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -87.24 78.76 8.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.481 0.658 . . . . 0.0 109.676 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.2 p -138.35 -168.32 2.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.854 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.758 ' HA ' HD12 ' A' ' 45' ' ' ILE . 17.7 p30 -168.9 -179.53 3.73 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -55.99 -46.01 78.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.37 -49.28 17.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.67 60.47 6.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.515 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.53 -143.16 5.03 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.097 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 m -132.19 131.13 41.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.59 ' HG2' ' OE1' ' A' ' 28' ' ' GLU . 29.8 mtpp -56.96 130.09 44.47 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.45 0.469 . . . . 0.0 111.379 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.31 -21.24 25.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.384 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.7 m -88.21 128.98 35.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.285 0.564 . . . . 0.0 110.208 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 46.1 mttm -96.25 123.67 39.96 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.298 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.646 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 11.6 m-85 -92.39 127.46 37.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.204 0.526 . . . . 0.0 111.31 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 12.2 m-85 -118.38 164.61 14.98 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.4 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.9 m -77.29 -158.98 0.12 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.797 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -84.58 -40.38 17.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.776 0.322 . . . . 0.0 110.311 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -65.35 -43.81 89.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.529 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.92 -3.79 2.31 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -65.43 130.13 42.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 110.989 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.1 t80 -72.87 115.71 12.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.732 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.435 HG11 HG13 ' A' ' 45' ' ' ILE . 38.5 t -82.67 -62.43 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 28.7 p -175.21 150.31 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.698 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 23.0 tt0 -83.12 141.23 32.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.562 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.66 132.97 12.07 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.697 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.59 ' OE1' ' HG2' ' A' ' 12' ' ' LYS . 4.5 tp10 -141.09 69.99 1.34 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.961 0.886 . . . . 0.0 109.741 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -85.39 43.56 1.03 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.692 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.578 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.5 t70 -64.47 -51.42 60.08 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.707 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 32.6 Cg_exo -61.55 133.91 48.26 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.741 1.627 . . . . 0.0 111.743 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -81.75 36.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.347 0.594 . . . . 0.0 109.903 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.5 p30 -167.32 63.09 0.66 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.85 132.49 52.27 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.785 2.323 . . . . 0.0 111.634 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -107.97 115.99 31.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.04 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -174.34 176.49 2.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.576 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.27 137.93 95.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 123.058 0.224 . . . . 0.0 110.482 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.62 125.32 15.28 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.355 2.036 . . . . 0.0 112.283 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.0 tpp85 60.56 44.97 11.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -96.04 135.96 37.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.935 0.398 . . . . 0.0 110.096 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.9 m -115.55 123.28 48.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -71.91 115.75 41.31 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.39 -22.36 74.34 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.168 2.578 . . . . 0.0 112.84 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -82.73 -27.51 31.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.758 HD12 ' HA ' ' A' ' 6' ' ' ASN . 68.1 mt -87.86 124.92 41.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.399 0.619 . . . . 0.0 112.332 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.07 -46.78 3.07 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.573 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -149.75 142.93 25.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.346 0.593 . . . . 0.0 111.91 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -103.01 132.3 10.96 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.746 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.1 mm -101.05 122.6 53.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.83 0.348 . . . . 0.0 110.542 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 83.2 m -105.15 124.39 36.68 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.201 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 C-N-CA 122.69 2.26 . . . . 0.0 112.237 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -168.16 121.97 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 45' ' ' ILE . 9.7 pt -65.42 129.67 29.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 110.693 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.01 62.49 6.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.493 0.663 . . . . 0.0 109.406 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -128.73 -154.43 0.64 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.991 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.569 ' HA ' HD12 ' A' ' 45' ' ' ILE . 15.6 p30 -176.84 -166.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 m -61.39 -53.91 50.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.32 0.388 . . . . 0.0 111.083 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.463 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . . . -61.69 -40.57 95.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 0.0 111.007 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.12 57.44 4.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.61 141.5 7.12 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.212 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -61.51 135.69 57.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.479 0.18 . . . . 0.0 110.723 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER -57.89 -32.33 67.6 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.515 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.1 27.16 3.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.074 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.6 m -147.51 132.02 17.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 59.2 mttp -105.67 126.87 52.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.698 ' HD2' HD13 ' A' ' 45' ' ' ILE . 3.1 m-30 -82.99 124.48 30.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.144 0.497 . . . . 0.0 111.249 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -121.47 161.32 22.45 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.799 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.5 t -87.38 163.86 16.54 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.417 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 15.8 p-10 -66.58 -33.04 74.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.662 0.268 . . . . 0.0 110.54 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.49 -31.12 72.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.502 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.28 -21.72 4.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.305 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 m -63.84 133.34 53.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.238 0.542 . . . . 0.0 112.335 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 19.2 t80 -74.56 122.02 22.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.508 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.8 t -86.72 -62.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.396 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.5 p -174.8 150.95 1.34 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.208 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.578 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 37.1 tt0 -80.38 149.64 30.13 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.42 137.99 40.44 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.251 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 8' ' ' ALA . 16.3 pt-20 -137.21 61.05 1.63 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.787 0.803 . . . . 0.0 110.099 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.15 65.66 3.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.89 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.474 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.7 t70 -58.33 128.93 83.15 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.998 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 2.3 Cg_endo -81.77 -147.83 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.072 2.515 . . . . 0.0 111.158 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 70.88 -30.75 0.21 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.399 0.68 . . . . 0.0 112.098 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 31' ' ' PRO . 10.6 p30 -132.12 133.26 23.68 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 121.202 0.525 . . . . 0.0 110.772 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 20.2 Cg_exo -66.81 137.6 45.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.369 2.713 . . . . 0.0 112.956 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -95.04 130.83 41.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.465 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -155.04 148.37 25.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.969 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.407 ' N ' ' HD3' ' A' ' 38' ' ' PRO . . . 56.92 64.73 4.31 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.943 0.777 . . . . 0.0 112.045 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 37' ' ' ALA . 9.5 Cg_exo -72.19 52.62 1.92 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.319 2.679 . . . . 0.0 112.337 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -76.61 49.45 0.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.311 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -153.8 43.99 0.58 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.608 0.718 . . . . 0.0 109.857 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.3 m -65.07 131.99 48.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.498 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.449 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 65.6 t0 -91.46 112.21 53.06 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.919 0.39 . . . . 0.0 110.298 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 29.6 Cg_endo -63.46 -22.89 71.28 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.122 2.548 . . . . 0.0 112.546 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -67.86 -21.95 65.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.782 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.698 HD13 ' HD2' ' A' ' 16' ' ' TYR . 67.3 mt -87.3 133.82 29.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.189 0.518 . . . . 0.0 111.432 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.17 -41.72 2.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.466 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 19' ' ' ASP . 4.5 p90 -155.24 149.18 25.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.051 0.453 . . . . 0.0 111.857 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -106.84 126.66 8.54 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.2 mm -92.27 117.39 35.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.859 0.361 . . . . 0.0 110.612 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.608 ' H ' ' HD2' ' A' ' 51' ' ' PRO . 76.8 m -99.68 -46.19 0.22 Allowed Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.173 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' ' H ' ' A' ' 50' ' ' CYS . 52.1 Cg_endo . . . . . 0 C--N 1.363 1.296 0 C-N-CA 122.2 1.933 . . . . 0.0 113.025 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.627 0.251 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.05 138.03 1.65 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.099 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 pt -64.49 133.9 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.3 0.571 . . . . 0.0 111.933 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t -89.79 69.1 7.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.984 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -135.17 -169.73 2.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.802 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.846 ' HA ' HD12 ' A' ' 45' ' ' ILE . 16.9 p30 -165.15 -173.86 3.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 m -59.68 -48.93 79.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.57 -48.95 23.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.11 0.481 . . . . 0.0 110.462 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.87 63.04 7.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.737 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.23 -135.21 2.83 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.734 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.5 m -161.0 125.58 3.56 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 12.8 ttmm -60.91 133.48 56.14 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.178 0.514 . . . . 0.0 109.944 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.19 -39.58 2.55 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 40.0 m -92.49 125.69 37.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.77 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -96.23 125.18 40.56 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.454 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 53.2 m-85 -91.78 126.06 36.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.162 0.506 . . . . 0.0 111.52 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -117.56 163.92 15.7 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.838 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -76.21 -155.21 0.05 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.966 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -91.19 -40.24 11.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.824 0.345 . . . . 0.0 110.129 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.17 -41.83 96.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.772 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.61 -13.55 2.7 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.748 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -60.84 132.0 52.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.285 0.564 . . . . 0.0 111.542 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.593 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.0 t80 -74.0 120.89 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.718 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.0 t -88.3 -62.68 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.308 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.3 p -171.8 149.59 2.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 0.0 111.116 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.77 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 23.1 tt0 -85.38 151.88 23.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -59.83 122.26 29.41 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.467 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -105.27 58.69 0.68 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.577 0.703 . . . . 0.0 110.088 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 p -156.03 141.19 17.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.429 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 10.0 t70 -63.0 134.1 95.67 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.19 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 18.8 Cg_exo -68.36 41.35 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.982 3.122 . . . . 0.0 114.176 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -71.06 -32.83 69.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.416 . . . . 0.0 110.405 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -173.2 149.77 1.79 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.648 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.89 128.61 26.02 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.363 2.042 . . . . 0.0 111.148 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -89.61 140.51 29.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -161.75 145.0 12.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.39 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.47 149.5 21.48 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.095 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.86 116.13 2.91 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.751 2.301 . . . . 0.0 113.248 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 59.37 33.29 22.35 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.642 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -93.11 26.02 3.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.746 0.784 . . . . 0.0 110.236 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.42 120.52 17.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.07 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 10.0 t70 -78.61 121.3 83.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.24 -27.87 68.47 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.24 2.626 . . . . 0.0 113.524 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 -30.24 26.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.634 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 6' ' ' ASN . 84.6 mt -88.72 123.98 41.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.11 -44.69 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.551 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -146.58 145.34 30.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.445 . . . . 0.0 111.427 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -116.04 136.13 12.68 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.785 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.1 mm -101.52 119.6 49.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 85.9 m -88.22 -41.32 0.48 Allowed Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 50' ' ' CYS . 9.9 Cg_endo . . . . . 0 C--N 1.362 1.274 0 C-N-CA 121.907 1.738 . . . . 0.0 112.052 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 49.2 t0 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 59.21 54.83 4.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.528 0.731 . . . . 0.0 110.518 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -60.11 138.62 20.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.429 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.6 t -86.03 84.93 7.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.8 p -138.48 -168.05 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.832 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -165.6 159.9 17.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.6 m -57.15 -38.1 73.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.68 95.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.983 0.42 . . . . 0.0 110.931 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.86 -96.89 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.062 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.91 -131.82 47.95 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.674 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.3 m -155.02 115.56 3.88 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 18.4 tptm -61.15 121.59 12.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.52 -33.88 4.91 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.422 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 86.3 m -95.56 131.93 41.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.107 0.48 . . . . 0.0 110.159 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 0.8 OUTLIER -92.03 122.11 34.23 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.376 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.795 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.4 m-85 -87.04 131.73 34.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.759 0.314 . . . . 0.0 110.743 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -125.41 163.93 21.54 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.767 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.473 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 44.2 m -85.78 -179.99 6.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.119 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -69.5 -37.36 77.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.64 0.257 . . . . 0.0 111.434 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 43.9 p-10 -66.24 -40.41 90.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.14 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.67 -9.64 3.99 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -62.88 132.53 52.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.111 0.481 . . . . 0.0 111.155 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 15' ' ' LYS . 20.6 t80 -71.94 120.15 17.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.696 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.965 HG11 HG12 ' A' ' 45' ' ' ILE . 82.9 t -83.7 -68.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 27.2 p 177.72 158.39 0.42 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -91.7 146.56 23.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -75.23 119.0 5.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.434 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -89.62 50.59 1.93 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 117.452 0.626 . . . . 0.0 111.99 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 40.94 1.03 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.771 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.67 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 1.6 t70 -65.62 -58.31 12.01 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.15 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 9.8 Cg_endo -90.73 -148.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.883 2.389 . . . . 0.0 111.685 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -117.91 41.82 2.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.366 0.603 . . . . 0.0 110.637 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.565 ' OD1' ' HD3' ' A' ' 34' ' ' PRO . 10.1 p-10 -79.56 -40.91 1.47 Allowed Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.565 ' HD3' ' OD1' ' A' ' 33' ' ' ASN . 2.8 Cg_exo -75.83 146.88 30.26 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.074 1.849 . . . . 0.0 112.718 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.497 ' HD2' ' C ' ' A' ' 34' ' ' PRO . 13.4 mptt -124.99 133.95 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.61 -134.22 0.48 Allowed 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.761 0.663 . . . . 0.0 110.471 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.575 ' H ' ' HD2' ' A' ' 38' ' ' PRO . . . -166.81 -52.38 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.575 ' HD2' ' H ' ' A' ' 37' ' ' ALA . 74.4 Cg_endo -74.06 45.02 1.08 Allowed 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.226 1.951 . . . . 0.0 113.336 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -83.64 -40.28 19.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.621 0.724 . . . . 0.0 109.485 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -174.2 135.38 0.46 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.904 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.2 m -123.21 137.17 54.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.824 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 8.0 t0 -86.7 120.18 71.68 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.091 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.11 -24.27 78.97 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.351 2.701 . . . . 0.0 112.55 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.481 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 21.1 ttp180 -68.13 -19.47 64.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.263 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.965 HG12 HG11 ' A' ' 24' ' ' VAL . 57.5 mt -85.94 129.27 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.923 0.392 . . . . 0.0 110.875 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.02 -51.2 2.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.459 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -155.97 144.95 20.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.237 0.542 . . . . 0.0 112.082 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.795 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -104.24 128.3 9.42 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.5 mm -122.58 129.0 75.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 117.183 0.492 . . . . 0.0 112.069 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.3 m -89.57 113.47 56.8 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 177.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.456 -0.679 0 C-N-CA 122.648 2.232 . . . . 0.0 111.793 179.866 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 2' ' ' ARG . 12.4 p-10 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 121.578 0.704 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 1' ' ' ASP . 19.6 mmt85 -121.5 131.96 54.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.939 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -79.11 129.94 36.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.759 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.39 62.34 5.99 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 17.2 p -128.84 -151.95 0.5 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.868 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 21.4 p30 -163.83 -176.79 4.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.764 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.3 m -56.94 -44.39 82.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.151 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 -50.5 72.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.016 0.436 . . . . 0.0 110.61 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.53 37.48 0.64 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.596 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -97.26 -27.37 9.34 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.772 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 10' ' ' GLY . 31.5 m 76.41 126.36 0.04 OUTLIER 'General case' 0 C--O 1.237 0.426 0 C-N-CA 122.878 0.471 . . . . 0.0 111.055 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.596 ' HD2' ' O ' ' A' ' 27' ' ' GLY . 25.2 mmmt -54.85 133.35 47.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.42 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.71 -42.93 1.79 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.727 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.3 m -87.68 136.65 32.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.208 0.527 . . . . 0.0 110.579 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 59.4 mttp -112.02 127.44 55.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.536 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.799 ' HD2' HD13 ' A' ' 45' ' ' ILE . 5.3 m-30 -82.51 129.03 34.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -125.88 160.29 30.31 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.812 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.427 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 39.3 m -83.96 178.87 7.7 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -76.37 -33.28 58.92 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.022 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.5 p-10 -65.87 -39.54 90.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.378 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.27 -14.46 3.49 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.987 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.5 m -62.52 134.06 55.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.272 0.558 . . . . 0.0 111.787 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.543 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 20.0 t80 -75.44 120.78 21.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.196 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 45' ' ' ILE . 57.7 t -84.46 -63.35 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.722 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.2 p -176.61 147.09 0.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.999 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 36.4 tt0 -79.19 150.56 31.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.596 ' O ' ' HD2' ' A' ' 12' ' ' LYS . . . -63.64 122.91 27.73 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.047 -1.073 . . . . 0.0 111.084 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 4.6 tp10 -109.39 63.08 0.6 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.291 0.567 . . . . 0.0 110.278 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.7 p -79.52 112.64 16.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.421 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -69.47 130.37 90.77 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.079 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.26 42.13 1.08 Allowed 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.793 2.329 . . . . 0.0 113.335 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -135.22 52.26 2.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.715 0.293 . . . . 0.0 111.061 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 38.28 69.7 1.45 Allowed Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -70.63 65.97 2.3 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.189 2.593 . . . . 0.0 112.296 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -70.48 137.68 50.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.446 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.67 35.11 7.16 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.867 0.729 . . . . 0.0 111.196 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.0 145.58 96.48 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.796 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.79 114.98 2.14 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.626 2.217 . . . . 0.0 112.009 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.5 ptt-85 -92.59 41.56 1.08 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.263 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.54 115.76 19.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 5' ' ' THR . 7.9 m -77.6 126.85 31.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.761 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.733 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 12.1 t0 -90.42 123.74 64.66 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 47.9 Cg_exo -58.15 -30.65 91.19 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 123.556 2.838 . . . . 0.0 114.273 -178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.733 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 15.5 ptt180 -74.87 -14.62 60.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.799 HD13 ' HD2' ' A' ' 16' ' ' TYR . 75.8 mt -88.17 128.88 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.977 0.418 . . . . 0.0 111.231 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.22 -52.91 2.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.818 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -153.7 150.19 28.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.08 0.467 . . . . 0.0 111.576 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.9 131.62 10.63 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.704 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -105.86 119.31 54.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.781 0.324 . . . . 0.0 110.414 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 35.5 m -104.56 127.29 29.29 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 1.1 Cg_endo . . . . . 0 N--CA 1.457 -0.652 0 C-N-CA 123.469 2.779 . . . . 0.0 112.05 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.874 ' HG3' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -60.67 127.68 32.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.862 0.363 . . . . 0.0 110.707 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -66.88 142.25 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.221 0.534 . . . . 0.0 111.723 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.7 t -87.44 84.0 7.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.493 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 p -140.74 -166.57 2.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.751 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.504 ' HA ' HD12 ' A' ' 45' ' ' ILE . 21.6 p30 -171.99 165.63 6.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -50.18 -47.05 54.67 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.77 92.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.978 0.418 . . . . 0.0 112.008 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.443 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . . . -75.92 -37.34 58.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.847 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.33 144.29 36.79 Favored Glycine 0 N--CA 1.453 -0.219 0 O-C-N 123.847 0.717 . . . . 0.0 114.01 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -77.42 136.37 38.39 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.747 0.419 . . . . 0.0 111.339 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HB2' ' HE3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -58.03 147.57 29.04 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.257 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.67 -35.14 4.17 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 77.6 m -89.05 125.49 35.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 72.6 mttt -106.0 119.28 38.78 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.6 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.663 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 6.1 m-85 -87.89 132.2 34.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.671 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -120.86 157.97 28.63 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.481 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.0 t -86.26 161.84 18.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.573 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -65.38 -29.98 70.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.432 0.158 . . . . 0.0 111.387 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.35 -33.89 75.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.973 0.416 . . . . 0.0 110.001 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.69 -14.75 5.51 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.259 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -69.53 130.69 43.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.143 0.497 . . . . 0.0 111.576 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.506 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 23.1 t80 -68.83 129.78 40.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.82 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 18.3 t -90.74 -69.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.468 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.0 p -178.84 157.44 0.9 Allowed 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.371 0.419 . . . . 0.0 111.154 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 69.8 tt0 -88.42 157.52 18.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.88 115.06 7.52 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.497 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -89.42 27.78 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.802 0.334 . . . . 0.0 111.55 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 p -90.99 21.42 4.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.563 0.697 . . . . 0.0 110.737 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.532 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.0 t0 -86.86 -51.99 0.43 Allowed Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.109 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 10.5 Cg_exo -71.26 22.0 0.23 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.29 1.994 . . . . 0.0 112.482 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 30' ' ' ASP . 58.2 mmt-85 52.54 51.18 16.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.042 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 8.5 p30 -64.38 134.92 96.14 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 15.2 Cg_exo -69.08 119.87 6.81 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.821 2.347 . . . . 0.0 111.773 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' NZ ' ' HA ' ' A' ' 9' ' ' ALA . 4.7 mmmm -83.24 96.93 8.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.409 0.623 . . . . 0.0 110.629 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.41 -40.11 9.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.161 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . . . -124.12 59.17 17.61 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.96 58.69 6.62 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.349 2.032 . . . . 0.0 110.869 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.523 ' NH1' ' HA ' ' A' ' 37' ' ' ALA . 7.2 ptp85 -155.34 53.0 0.61 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.542 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -149.2 144.61 26.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.662 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.8 m -111.88 121.07 44.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.946 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.582 ' OD2' ' HB2' ' A' ' 44' ' ' ARG . 9.9 t70 -83.81 120.02 74.45 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.05 -23.29 72.73 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.236 2.624 . . . . 0.0 112.782 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 42.7 mtp85 -71.8 -32.0 67.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.639 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 6' ' ' ASN . 43.6 mt -86.85 120.59 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.566 0.698 . . . . 0.0 112.222 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.874 ' HA ' ' HG3' ' A' ' 2' ' ' ARG . . . -106.74 -48.45 3.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.415 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -150.53 143.13 24.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.061 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -103.97 122.82 7.53 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.695 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.683 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.2 mm -101.43 128.19 54.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 35.8 m -106.41 89.0 3.64 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.743 0.306 . . . . 0.0 110.281 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.683 ' HD3' ' O ' ' A' ' 49' ' ' ILE . 19.2 Cg_endo . . . . . 0 N--CA 1.45 -1.039 0 C-N-CA 123.321 2.68 . . . . 0.0 112.155 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.747 0.308 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.617 ' HG2' ' HA ' ' A' ' 46' ' ' ALA . 7.5 tmm_? -152.66 102.5 2.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 3' ' ' ILE . 5.0 pt -60.13 138.23 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.286 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.5 t -88.31 69.59 9.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.547 0.689 . . . . 0.0 109.715 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.9 p -133.78 153.71 51.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.276 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.565 ' OD1' ' HA ' ' A' ' 39' ' ' ARG . 17.5 p-10 -131.1 160.32 35.05 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -48.66 -46.55 40.31 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.98 -38.33 88.16 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.401 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -114.94 56.91 0.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.809 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.77 -148.77 0.5 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.115 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 78.5 m -155.3 124.53 6.28 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.565 -0.374 . . . . 0.0 111.258 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 56.97 -88.73 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 O-C-N 124.052 0.845 . . . . 0.0 111.341 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.56 41.55 0.18 Allowed Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 108.811 -1.715 . . . . 0.0 108.811 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.1 m -88.09 133.9 33.88 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.657 -0.771 . . . . 0.0 110.52 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 42.2 mttp -83.03 115.9 22.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.175 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 92.0 m-85 -84.03 128.56 34.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.88 0.372 . . . . 0.0 111.11 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -122.47 158.72 29.15 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.344 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.498 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 50.0 m -84.65 176.28 8.68 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -68.07 -35.6 78.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.628 0.252 . . . . 0.0 110.896 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.1 p-10 -65.36 -40.03 93.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.787 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.7 -16.88 3.99 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.201 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.7 m -64.49 134.1 53.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.165 0.507 . . . . 0.0 111.503 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -69.88 123.58 21.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.445 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.656 HG13 ' HD2' ' A' ' 44' ' ' ARG . 21.6 t -84.25 -65.18 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.877 0.37 . . . . 0.0 111.141 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 p -175.33 154.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.624 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.8 tt0 -85.08 144.93 27.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.57 102.63 0.57 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.944 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.21 61.87 5.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.136 0.97 . . . . 0.0 109.139 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 p -92.75 36.83 1.01 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.457 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 45.1 t0 -92.4 124.96 57.84 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.538 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 43.9 Cg_endo -68.31 54.7 0.75 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.261 2.641 . . . . 0.0 114.374 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.405 ' HD3' ' OD2' ' A' ' 30' ' ' ASP . 14.8 mmm180 -69.59 -43.52 72.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -167.5 153.97 7.66 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.284 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.31 123.51 13.27 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.18 1.92 . . . . 0.0 111.928 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.97 128.16 33.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.419 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.0 -30.73 61.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.022 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.92 121.03 81.48 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.08 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.22 153.44 74.56 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.006 2.47 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.565 ' HA ' ' OD1' ' A' ' 6' ' ' ASN . 14.0 ttm180 -77.45 56.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.571 0.7 . . . . 0.0 110.421 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -71.19 154.82 41.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.111 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.9 m -66.17 93.89 0.23 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 9.6 t0 -62.94 117.84 36.53 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.177 0.513 . . . . 0.0 110.919 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 26.0 Cg_exo -62.68 -25.54 75.16 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 123.276 2.651 . . . . 0.0 112.907 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.656 ' HD2' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -82.26 -26.16 33.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.519 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.442 ' CG1' HG11 ' A' ' 24' ' ' VAL . 54.5 mt -88.4 125.3 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.617 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . . . -109.47 -51.52 2.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.564 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -149.08 147.5 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.81 127.39 8.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.318 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.3 mm -91.56 112.24 25.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.9 m -89.68 128.91 48.74 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.531 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 CA--C 1.53 0.28 0 C-N-CA 122.82 2.347 . . . . 0.0 112.363 179.95 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 C--O 1.234 0.264 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -74.86 170.27 16.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 pt -57.81 128.93 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.472 0.653 . . . . 0.0 112.093 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.9 t -88.03 71.3 9.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.257 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 19.8 p -137.16 -158.66 0.88 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.478 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.555 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 18.2 p30 -171.21 -177.17 2.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -60.85 -43.79 97.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.01 66.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.039 0.447 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.95 44.52 1.2 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.981 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.88 142.22 14.45 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.927 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.0 m -58.38 122.36 13.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.577 0.227 . . . . 0.0 110.969 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -59.76 136.73 58.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.668 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.86 -29.7 10.14 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.222 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.7 m -89.46 130.01 35.87 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -99.86 122.08 42.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.978 179.396 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.789 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.0 m-85 -81.23 128.09 33.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.137 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.652 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 5.7 m-85 -118.57 162.09 18.95 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.674 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.447 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 12.4 t -80.3 -170.26 2.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.245 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -74.21 -44.33 53.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.722 0.296 . . . . 0.0 110.961 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 18' ' ' SER . 42.9 p-10 -62.01 -42.59 99.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.682 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.4 -1.89 3.06 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -69.64 131.14 44.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.008 0.433 . . . . 0.0 110.842 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -69.45 119.73 14.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.774 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.535 HG11 HG12 ' A' ' 45' ' ' ILE . 90.3 t -86.75 -63.95 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.346 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.0 p -174.67 148.48 1.14 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.771 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 14.7 tt0 -82.44 142.51 31.86 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -80.02 145.76 27.4 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.234 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -145.09 67.62 1.24 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-O 122.163 0.982 . . . . 0.0 110.129 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 p -78.76 132.07 36.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.895 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.483 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.2 t70 -63.38 137.2 97.01 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 10.4 Cg_exo -71.3 33.0 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.267 2.645 . . . . 0.0 112.884 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 31' ' ' PRO . 28.4 mmm180 -140.29 -36.39 0.49 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.088 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -171.65 151.88 3.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.043 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.53 128.31 23.2 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 121.94 1.76 . . . . 0.0 111.052 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -62.8 135.91 57.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 66.9 -120.16 0.26 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.948 0.78 . . . . 0.0 110.235 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -164.44 140.97 5.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 7.6 Cg_exo -73.04 46.83 1.17 Allowed 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.097 2.532 . . . . 0.0 112.127 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -110.51 -40.5 4.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.033 0.444 . . . . 0.0 110.105 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -82.11 56.48 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.605 0.717 . . . . 0.0 109.712 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' THR . 12.4 m -61.56 124.31 20.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.07 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.737 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 12.0 t0 -79.27 124.44 84.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.01 -32.13 94.5 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.349 2.699 . . . . 0.0 113.715 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.737 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 16.8 ptt180 -74.27 -10.24 59.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 6' ' ' ASN . 55.5 mt -88.34 106.94 17.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -97.55 -45.99 6.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.292 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -156.79 142.99 18.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.211 0.529 . . . . 0.0 112.254 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -97.44 128.9 9.71 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.652 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.82 120.13 43.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.2 m -102.02 107.94 54.55 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.26 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 C-N-CA 123.453 2.769 . . . . 0.0 112.215 -179.841 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 48.7 t0 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 2' ' ' ARG . 20.6 mmm180 59.53 50.66 7.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.711 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.5 pt -64.16 129.72 28.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.375 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 8.9 t -88.88 52.8 2.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.478 0.656 . . . . 0.0 110.8 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.409 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 13.7 p -112.28 -144.1 0.39 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.19 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.409 ' H ' ' HB ' ' A' ' 5' ' ' THR . 25.4 p30 -169.91 171.24 7.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.9 m -51.32 -48.22 62.43 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.535 0.522 . . . . 0.0 112.293 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.717 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . . . -58.02 -49.09 78.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.983 0.421 . . . . 0.0 111.0 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.34 31.49 0.51 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.266 0.555 . . . . 0.0 110.822 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.588 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -88.27 -19.32 53.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.925 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m 74.72 118.09 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.095 0.558 . . . . 0.0 110.502 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -53.27 127.85 26.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.544 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.0 -38.09 3.5 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.868 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 70.6 m -90.82 131.7 36.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.222 0.534 . . . . 0.0 109.602 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 17.0 mtmm -104.54 127.94 52.39 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.136 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.588 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 4.7 m-30 -82.68 121.27 26.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.78 0.324 . . . . 0.0 110.303 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -108.3 158.17 17.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.326 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.603 ' OG ' ' HD3' ' A' ' 44' ' ' ARG . 6.0 t -82.64 -158.05 0.25 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.091 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -84.25 -46.53 11.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.166 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -63.98 -37.9 89.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.278 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.07 -6.22 5.07 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.5 m -66.61 132.65 48.64 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.176 0.512 . . . . 0.0 111.151 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.2 t80 -68.5 120.53 14.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.198 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.61 -60.14 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.534 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 16.8 p -171.33 140.12 1.4 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.792 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 29.8 tt0 -81.45 160.23 24.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.95 112.7 2.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.363 -0.446 . . . . 0.0 113.307 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 8' ' ' ALA . 79.4 tt0 -88.79 52.4 2.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.639 0.733 . . . . 0.0 110.138 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 92.0 p -105.28 53.87 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.103 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 8.7 t70 -140.42 131.19 13.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 32.4 Cg_exo -58.59 159.68 19.54 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.041 2.494 . . . . 0.0 112.889 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 48.0 mtm180 78.87 33.34 0.25 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.562 0.745 . . . . 0.0 110.276 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 11.8 p-10 -116.86 148.03 41.25 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.049 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 11.5 Cg_exo -70.08 117.24 4.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.371 2.047 . . . . 0.0 110.651 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -59.89 111.81 1.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 111.093 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.76 -128.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.539 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 69.44 153.85 0.14 Allowed Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 123.737 0.648 . . . . 0.0 111.784 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.72 147.25 88.92 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.786 2.324 . . . . 0.0 111.868 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -64.62 -57.4 9.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 111.225 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -174.82 155.25 2.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.363 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 7.8 m 59.81 42.59 16.39 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.662 0.601 . . . . 0.0 111.817 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.71 124.02 77.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.017 0.437 . . . . 0.0 110.224 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.08 -30.61 90.84 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.474 2.783 . . . . 0.0 113.839 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.603 ' HD3' ' OG ' ' A' ' 18' ' ' SER . 10.9 tpp180 -82.39 -24.0 34.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.037 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.586 HD13 ' HD2' ' A' ' 16' ' ' TYR . 75.9 mt -87.69 123.14 40.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.211 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.29 -58.18 2.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.764 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -140.58 139.85 35.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.329 0.585 . . . . 0.0 111.707 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.28 135.92 12.43 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.974 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.0 mm -120.15 127.01 75.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.868 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 57.9 m -85.61 -50.12 0.53 Allowed Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.053 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 6.2 Cg_exo . . . . . 0 C--N 1.354 0.817 0 C-N-CA 121.811 1.674 . . . . 0.0 111.838 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--O 1.235 0.331 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -136.24 118.49 15.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.848 0.356 . . . . 0.0 110.412 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 46' ' ' ALA . 13.1 pt -63.67 150.7 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.878 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.0 t -86.49 77.32 9.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.573 0.702 . . . . 0.0 109.661 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 p -141.51 -173.28 3.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.815 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.894 ' HA ' HD12 ' A' ' 45' ' ' ILE . 19.4 p30 -171.69 -172.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.7 m -60.27 -45.1 94.48 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -76.76 -39.87 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.26 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.06 -30.78 69.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.88 140.01 37.49 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.381 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.9 m -67.85 135.75 53.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.759 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 5.9 tmtm? -59.27 126.1 26.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.476 ' N ' ' HD3' ' A' ' 12' ' ' LYS . . . 112.71 -28.62 8.8 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 29.8 m -87.85 128.28 35.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.086 0.469 . . . . 0.0 110.283 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.623 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 31.2 mmtt -93.21 119.33 32.27 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.602 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 15.1 m-85 -95.53 128.28 42.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.254 0.549 . . . . 0.0 111.596 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.623 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 8.6 m-85 -120.8 162.02 20.5 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.495 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.476 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 69.3 m -83.28 176.99 8.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.548 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -72.43 -29.8 64.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.564 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 44.1 p-10 -69.08 -38.37 78.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.968 0.413 . . . . 0.0 110.742 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.22 -13.25 4.35 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 m -66.69 134.38 52.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.095 0.474 . . . . 0.0 111.537 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.0 123.75 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.947 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.448 HG11 HG12 ' A' ' 45' ' ' ILE . 53.6 t -86.29 -65.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 111.243 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.0 p -176.56 152.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.664 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -84.88 139.27 31.99 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -67.35 144.58 44.56 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.144 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.759 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 7.6 tt0 -146.26 46.07 1.23 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.682 0.753 . . . . 0.0 110.399 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 95.1 p -79.13 133.83 36.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.395 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.81 129.66 94.48 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 123.481 0.488 . . . . 0.0 110.272 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -90.0 39.35 0.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.186 2.591 . . . . 0.0 113.132 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -127.81 -47.24 1.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.026 0.441 . . . . 0.0 110.006 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 5.7 p30 -81.08 143.88 53.69 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.387 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 20.1 Cg_exo -65.63 106.26 0.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.403 2.069 . . . . 0.0 111.223 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -62.91 107.61 1.03 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.364 0.602 . . . . 0.0 111.192 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.38 -50.8 0.17 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.46 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -63.97 -53.49 48.33 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.306 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 2.8 Cg_exo -75.65 71.47 5.39 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.297 1.998 . . . . 0.0 111.191 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -139.62 36.4 2.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.354 0.597 . . . . 0.0 110.419 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -83.54 135.55 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.7 m -70.89 123.82 22.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.387 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 66.8 t0 -97.49 110.81 56.44 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 13.0 Cg_exo -69.98 43.98 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.747 2.965 . . . . 0.0 112.28 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HE ' ' HB3' ' A' ' 44' ' ' ARG . 27.5 ttp180 -144.37 -33.21 0.4 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.748 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.894 HD12 ' HA ' ' A' ' 6' ' ' ASN . 39.1 mt -88.82 134.59 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.796 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -111.15 -44.53 3.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.021 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -151.47 150.43 30.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.608 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -122.84 127.89 6.87 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.918 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.1 mm -98.09 119.78 46.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 74.1 m -88.09 -46.67 0.46 Allowed Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 8.6 Cg_exo -72.7 59.06 3.34 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.332 2.021 . . . . 0.0 112.297 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -156.65 132.65 9.7 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.975 -179.353 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 121.489 0.662 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.875 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -71.45 140.75 50.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.809 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 46' ' ' ALA . 12.5 pt -60.74 135.91 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.351 0.596 . . . . 0.0 111.822 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.3 t -88.99 60.77 5.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.597 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.449 ' HG1' ' HE2' ' A' ' 16' ' ' TYR . 24.0 p -123.62 -148.54 0.4 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.949 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.668 ' HA ' HD12 ' A' ' 45' ' ' ILE . 2.8 p-10 -170.09 176.76 4.51 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 m -51.09 -45.97 61.65 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.483 0.489 . . . . 0.0 111.8 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.64 82.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.844 0.354 . . . . 0.0 111.297 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.1 56.45 2.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.106 0.479 . . . . 0.0 110.767 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.09 133.79 3.52 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -59.45 136.71 58.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.268 0.227 . . . . 0.0 111.426 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 14' ' ' CYS . 17.7 tppt? -56.19 -36.49 68.44 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 110.604 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.85 27.39 1.95 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.129 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.727 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 59.1 m -147.32 138.23 23.63 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.638 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 29.0 mttt -114.78 127.48 55.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.836 0.35 . . . . 0.0 110.216 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.532 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 3.3 m-85 -81.22 129.45 34.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.02 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.455 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 26.0 m-85 -123.11 158.99 29.47 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.407 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.544 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 50.9 m -86.32 164.82 16.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.34 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.406 ' CG ' HH21 ' A' ' 2' ' ' ARG . 1.0 OUTLIER -68.98 -25.44 64.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.914 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.544 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 3.5 p-10 -70.84 -34.46 71.7 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.78 -17.21 5.25 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.439 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.496 HG22 HH22 ' A' ' 44' ' ' ARG . 83.1 m -71.68 135.13 46.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.231 0.538 . . . . 0.0 111.912 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.638 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 26.9 t80 -65.69 130.63 43.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.675 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.547 HG11 ' CG1' ' A' ' 45' ' ' ILE . 46.2 t -90.96 -68.34 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 p -169.03 159.02 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.178 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -80.34 162.7 24.39 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.05 98.19 0.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.513 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -90.11 51.27 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.932 0.396 . . . . 0.0 110.952 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -80.16 47.14 0.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.155 0.503 . . . . 0.0 111.635 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 38.7 t70 -74.09 135.44 76.75 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.927 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 57.2 Cg_endo -71.29 45.31 0.63 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.922 2.414 . . . . 0.0 113.938 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -134.46 34.19 3.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 34' ' ' PRO . 0.8 OUTLIER 39.19 58.19 6.08 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.674 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 33' ' ' ASN . 12.8 Cg_exo -69.33 87.7 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.619 2.212 . . . . 0.0 112.261 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 12.8 mmmt -63.74 134.8 55.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.997 0.903 . . . . 0.0 113.221 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 6' ' ' ASN . . . -161.08 -172.56 3.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.74 -1.573 . . . . 0.0 107.295 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.77 149.17 0.12 Allowed Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.922 0.764 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HB2' ' H ' ' A' ' 39' ' ' ARG . 64.8 Cg_endo -72.54 -141.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.896 2.397 . . . . 0.0 112.866 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.445 ' H ' ' HB2' ' A' ' 38' ' ' PRO . 13.8 tpt180 -61.01 -40.8 94.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.379 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -176.22 144.31 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.631 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 m 62.54 116.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 O-C-N 124.03 0.831 . . . . 0.0 111.971 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.682 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . 9.3 t70 -71.37 122.16 86.33 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 64.3 Cg_exo -53.05 -32.67 59.56 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.643 2.896 . . . . 0.0 114.762 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.496 HH22 HG22 ' A' ' 22' ' ' THR . 5.7 ptm180 -104.61 -3.21 24.07 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.682 ' HB ' ' HB3' ' A' ' 42' ' ' ASP . 23.4 mt -89.0 132.65 33.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.007 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.875 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -125.02 -49.51 1.72 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.134 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -154.65 148.65 25.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 0.0 111.9 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.54 125.4 7.8 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.615 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.0 mm -101.82 120.33 51.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.727 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 39.0 m -89.87 110.79 42.3 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.606 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 5.8 Cg_exo -78.19 55.26 5.28 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.4 2.733 . . . . 0.0 111.904 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -100.51 38.51 1.5 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.458 -1.258 . . . . 0.0 109.092 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.84 0.353 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -140.05 123.88 17.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 46' ' ' ALA . 13.7 pt -60.54 139.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.26 0.552 . . . . 0.0 111.68 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 40.4 t -85.93 83.93 7.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.517 0.675 . . . . 0.0 109.211 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -139.86 -159.39 0.95 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.989 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.511 ' HA ' HD12 ' A' ' 45' ' ' ILE . 4.4 p-10 -170.47 171.96 6.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.6 m -51.87 -40.85 61.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.59 -46.0 81.05 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 110.915 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.88 40.53 0.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.179 0.514 . . . . 0.0 110.659 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.479 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -110.51 129.49 9.34 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.854 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.443 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 10.7 m -63.69 131.87 49.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.543 0.211 . . . . 0.0 110.646 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -57.91 132.29 52.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.362 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.47 -26.2 16.96 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.218 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 38.1 m -88.26 129.56 35.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 50.6 mttm -99.23 120.74 40.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.949 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.737 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.5 m-85 -88.57 127.13 35.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.042 0.449 . . . . 0.0 110.984 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.521 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 26.9 m-85 -120.69 161.06 22.05 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.86 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -83.89 165.27 18.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.97 -34.07 76.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.466 0.175 . . . . 0.0 111.005 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.08 -37.59 84.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.83 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.33 -23.68 2.84 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.053 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 m -59.8 136.92 58.15 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.8 t80 -74.12 123.87 25.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.947 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.598 HG11 ' CG1' ' A' ' 45' ' ' ILE . 13.9 t -85.76 -64.5 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.609 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 p -178.31 157.68 1.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.699 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.456 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 4.6 tt0 -86.26 -159.99 0.52 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.463 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.456 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -83.14 89.57 1.52 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.457 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -88.18 39.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.365 0.603 . . . . 0.0 110.596 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 p -85.45 56.41 3.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.162 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.2 t70 -126.38 135.87 27.81 Favored Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.357 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 23.3 Cg_exo -65.03 -179.12 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.879 2.386 . . . . 0.0 112.439 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.9 mtm-85 78.84 -32.11 0.15 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.972 0.909 . . . . 0.0 110.705 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -141.41 54.57 4.36 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 56.2 Cg_endo -70.04 137.54 34.88 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.79 1.66 . . . . 0.0 110.946 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 34' ' ' PRO . 67.9 mmtt -126.4 127.06 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.77 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.16 136.57 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.167 0.917 . . . . 0.0 111.888 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -69.92 136.96 87.41 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.154 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 7.8 Cg_exo -72.11 68.71 3.23 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.318 2.679 . . . . 0.0 111.933 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.1 ttp85 -155.38 -42.29 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.075 0.465 . . . . 0.0 110.606 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.18 121.52 28.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.216 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 2.3 m -69.86 128.34 36.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.739 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.429 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 67.2 t0 -79.6 114.97 50.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 19.6 Cg_endo -61.05 -17.25 50.81 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.041 2.494 . . . . 0.0 112.483 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.1 mtp-105 -73.09 -35.38 66.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.598 ' CG1' HG11 ' A' ' 24' ' ' VAL . 43.4 mt -88.48 134.37 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -118.12 -47.98 2.56 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.986 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -154.14 145.72 23.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.209 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.13 128.4 8.84 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.553 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.6 mm -93.82 121.01 44.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 94.6 m -97.77 152.61 38.21 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.992 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.01 96.81 0.27 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.404 2.069 . . . . 0.0 111.525 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.9 mt 66.23 42.51 3.07 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.634 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.235 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.878 179.634 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 2' ' ' ARG . 1.2 p30 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.402 0.62 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 1' ' ' ASP . 13.0 mtt-85 -151.96 131.74 13.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.085 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -76.06 141.29 15.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.801 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 47.6 t -87.23 59.62 5.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.717 0.77 . . . . 0.0 109.532 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 p -135.28 125.9 27.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.431 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.441 ' HA ' HD12 ' A' ' 45' ' ' ILE . 3.4 p-10 -90.28 176.52 6.71 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.0 m -51.2 -44.74 61.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.971 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . . . -61.05 -47.53 85.97 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.15 67.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.998 0.427 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.34 138.13 48.42 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.539 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -67.71 124.42 23.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.689 0.281 . . . . 0.0 110.936 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -60.02 131.3 50.42 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.449 ' O ' ' HE2' ' A' ' 15' ' ' LYS . . . 112.35 -33.91 5.44 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.8 m -88.63 131.47 34.96 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.514 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -97.93 119.05 35.86 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.747 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 3.9 m-85 -89.62 125.07 35.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.157 0.503 . . . . 0.0 110.872 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.98 163.55 15.42 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.95 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.4 t -86.49 168.56 13.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.921 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -66.8 -32.77 74.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.83 0.348 . . . . 0.0 110.336 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.53 -32.56 73.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.647 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.23 -23.75 4.29 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.191 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.8 m -62.92 135.45 57.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.141 0.496 . . . . 0.0 111.992 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.3 t80 -71.17 124.29 24.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.787 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.584 HG11 HG12 ' A' ' 45' ' ' ILE . 46.8 t -87.91 -64.96 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.515 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 p -172.89 153.95 2.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 111.58 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.99 157.61 17.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.334 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.78 130.02 45.71 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.429 -0.415 . . . . 0.0 113.849 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.971 ' HB3' ' HA ' ' A' ' 8' ' ' ALA . 6.6 tt0 -96.82 0.26 49.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.145 0.498 . . . . 0.0 110.734 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.3 p -77.75 -168.92 1.34 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.48 . . . . 0.0 111.632 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.517 ' HB3' HD21 ' A' ' 33' ' ' ASN . 38.7 t0 -163.86 124.31 1.4 Allowed Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 17.3 Cg_exo -68.7 38.25 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.175 2.583 . . . . 0.0 113.983 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HE ' ' CG ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -147.12 17.8 1.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.517 HD21 ' HB3' ' A' ' 30' ' ' ASP . 8.3 p30 -165.21 142.03 4.76 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.033 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.54 57.88 5.66 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.805 2.337 . . . . 0.0 113.861 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -80.25 105.84 11.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.946 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -163.97 29.45 0.08 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.52 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.719 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -74.78 -56.64 2.13 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.849 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.719 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 8.2 Cg_exo -71.33 134.35 24.55 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.894 1.729 . . . . 0.0 110.82 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -157.09 48.87 0.44 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.233 0.539 . . . . 0.0 110.9 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -80.39 138.56 36.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.018 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 38.6 m -75.78 70.68 2.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.384 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.592 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 33.2 t70 -66.14 115.57 24.76 Favored Pre-proline 0 C--N 1.332 -0.179 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.39 -24.83 78.87 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.302 2.668 . . . . 0.0 112.979 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.592 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 19.7 ttm105 -66.8 -33.53 75.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.628 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.584 HG12 HG11 ' A' ' 24' ' ' VAL . 62.5 mt -88.2 108.98 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.084 0.469 . . . . 0.0 110.053 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.07 -48.17 5.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.497 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -153.39 145.13 23.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.12 128.18 8.89 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.34 119.45 47.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.764 0.316 . . . . 0.0 110.964 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.5 m -98.0 122.16 55.32 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.74 54.32 5.14 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 123.082 2.521 . . . . 0.0 112.687 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 52' ' ' LEU . 4.0 mm? 62.51 44.79 6.76 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.383 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.111 -1.423 . . . . 0.0 108.471 179.68 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.477 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . 44.5 t0 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.602 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -169.31 62.88 0.05 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 46' ' ' ALA . 6.9 pt -55.3 142.88 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.934 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 t -87.22 66.86 9.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.553 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.7 p -133.91 -149.41 0.36 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.723 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.798 ' HA ' HD12 ' A' ' 45' ' ' ILE . 24.4 p30 -174.12 -159.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.8 m -66.25 -63.73 1.01 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.064 0.227 . . . . 0.0 111.135 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.961 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . . . -57.5 -38.39 74.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.029 0.443 . . . . 0.0 112.081 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.88 -19.43 60.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.082 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.94 147.9 31.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.681 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.441 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 20.2 m -63.39 124.19 20.64 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.585 0.231 . . . . 0.0 111.359 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -57.4 132.1 52.08 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.531 ' N ' ' HD2' ' A' ' 12' ' ' LYS . . . 106.6 -36.37 4.44 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.729 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 76.2 m -88.35 132.98 34.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.675 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.857 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 25.0 mmtp -82.92 111.33 18.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.74 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.698 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 6.1 m-85 -86.97 124.15 32.85 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.233 0.54 . . . . 0.0 109.894 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.968 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -147.49 178.5 8.39 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.395 0.617 . . . . 0.0 111.834 -178.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.532 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 14.7 m -76.14 168.49 19.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.543 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -66.89 -35.35 79.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.1 p-10 -63.49 -41.4 98.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.999 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.7 -11.92 2.92 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.074 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.7 m -62.61 111.04 1.9 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.86 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.968 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 25.1 t80 -68.08 122.72 18.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.113 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.631 HG23 ' HA ' ' A' ' 17' ' ' PHE . 45.8 t -91.55 -61.84 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.549 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.9 p -174.58 152.69 1.71 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.96 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.857 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 10.2 tt0 -80.06 158.29 26.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -65.09 133.92 36.79 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.029 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.961 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 45.2 mt-10 -105.71 16.13 25.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.694 0.247 . . . . 0.0 111.629 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.626 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 26.5 p -80.3 46.78 0.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.402 0.62 . . . . 0.0 110.823 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.408 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 12.3 t0 -66.15 -50.77 49.05 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.518 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 4.2 Cg_exo -76.23 27.05 0.41 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.236 1.957 . . . . 0.0 112.657 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 52.28 40.89 29.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.308 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.626 ' OD1' ' HA ' ' A' ' 29' ' ' SER . 8.8 p-10 -74.49 132.76 78.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.402 . . . . 0.0 110.739 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.33 67.67 3.5 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.144 2.563 . . . . 0.0 112.023 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 68.31 -134.08 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.048 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.15 -144.27 0.11 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.568 0.223 . . . . 0.0 110.998 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.06 138.11 94.78 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.483 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.12 45.7 1.42 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.847 2.365 . . . . 0.0 112.604 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -174.17 47.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.249 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.96 41.53 1.54 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.331 0.586 . . . . 0.0 111.367 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.1 m -80.93 124.21 28.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.356 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.515 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 33.4 t70 -75.02 114.82 38.75 Favored Pre-proline 0 C--O 1.239 0.531 0 O-C-N 123.233 0.333 . . . . 0.0 110.387 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.41 46.93 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.298 2.665 . . . . 0.0 111.896 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.515 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 13.9 ttp180 -154.94 -23.53 0.12 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.907 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 6' ' ' ASN . 63.3 mt -85.64 120.89 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.029 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -95.61 -51.9 4.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.449 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.477 ' HD2' ' HB3' ' A' ' 1' ' ' ASP . 13.7 p90 -159.92 154.25 23.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.034 0.445 . . . . 0.0 111.59 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.08 131.56 10.51 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.902 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.4 mm -122.02 132.93 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.756 0.312 . . . . 0.0 111.18 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.4 m -88.49 -54.21 0.34 Allowed Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.34 139.1 18.31 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.768 1.646 . . . . 0.0 113.4 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.8 mt 62.97 45.98 5.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.87 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 15' ' ' LYS . . . . . . . . 0 C--O 1.251 1.132 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.654 0.74 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.406 ' NE ' ' HA ' ' A' ' 46' ' ' ALA . 39.1 ttt180 -73.9 124.49 26.25 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.938 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -65.32 124.84 21.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.452 0.644 . . . . 0.0 111.771 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 t -93.42 51.17 1.57 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.592 0.71 . . . . 0.0 109.724 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.424 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 9.1 p -110.04 -145.47 0.4 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.356 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.519 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 16.1 p30 -173.16 176.92 2.84 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.8 m -53.19 -47.77 68.61 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.514 ' HB1' ' HG2' ' A' ' 31' ' ' PRO . . . -68.72 -44.54 73.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.226 0.536 . . . . 0.0 110.44 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.18 49.16 1.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.285 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA2' ' OH ' ' A' ' 16' ' ' TYR . . . -104.2 -141.1 10.89 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.125 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.75 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 87.2 m -157.4 131.58 8.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HD3' ' H ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -55.19 131.54 45.53 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.306 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.87 21.6 71.02 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.524 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 57.9 m -137.63 127.61 25.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 25.9 mtmm -107.26 131.54 54.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.102 0.477 . . . . 0.0 111.763 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.719 ' HD2' HD13 ' A' ' 45' ' ' ILE . 6.4 m-30 -85.24 126.85 34.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.369 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -121.63 155.95 34.01 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.451 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.502 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 19.9 m -78.4 175.68 10.06 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.071 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.44 -38.14 86.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.207 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 43.1 p-10 -66.52 -40.24 89.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.948 0.404 . . . . 0.0 111.069 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.15 -7.97 3.78 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.5 m -65.33 134.35 53.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.13 0.49 . . . . 0.0 111.477 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -73.35 122.08 21.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.619 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.56 -63.02 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.72 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 p -174.5 147.67 1.13 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.373 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 19.2 tt0 -77.78 151.8 33.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.75 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -68.3 94.57 0.33 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.683 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 13.3 tp10 -88.82 69.89 8.65 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 11.4 p -77.51 41.92 0.34 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.528 -1.214 . . . . 0.0 113.266 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.511 ' H ' ' HD2' ' A' ' 31' ' ' PRO . 22.6 t70 -89.7 -51.26 0.36 Allowed Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 119.421 -0.323 . . . . 0.0 111.011 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.514 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 42.9 Cg_endo -67.7 58.66 0.79 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 122.87 2.38 . . . . 0.0 112.497 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -65.64 -26.99 68.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.871 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -73.09 135.87 79.73 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.822 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -45.4 128.94 10.58 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 123.581 2.854 . . . . 0.0 114.248 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 35.9 mmtm -149.09 158.13 43.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.493 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.05 -24.94 58.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.66 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -61.93 -54.34 51.56 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 11.9 Cg_exo -70.51 122.22 8.71 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.918 1.745 . . . . 0.0 111.597 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -114.15 -124.64 0.28 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -171.04 152.85 3.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.048 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.7 m 56.32 52.99 9.32 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.759 0.662 . . . . 0.0 111.907 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 37.0 t70 -66.3 127.92 93.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 9.9 Cg_endo -51.87 -36.15 62.29 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.764 2.976 . . . . 0.0 114.605 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.09 -23.87 35.52 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.888 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.719 HD13 ' HD2' ' A' ' 16' ' ' TYR . 91.8 mt -87.36 127.62 40.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.232 0.539 . . . . 0.0 111.927 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . . . -120.91 -50.61 2.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.858 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -149.75 148.35 29.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.979 0.418 . . . . 0.0 111.802 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.94 134.03 11.92 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.5 mm -112.89 129.16 69.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.646 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 39.2 m -101.96 -55.63 0.12 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.253 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 74.2 Cg_endo -78.71 135.16 12.65 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.651 1.567 . . . . 0.0 112.701 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 mp 62.87 46.28 5.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.331 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.332 179.504 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 2' ' ' ARG . 4.2 p-10 . . . . . 0 C--O 1.233 0.193 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.92 ' HD2' ' HA ' ' A' ' 46' ' ' ALA . 26.8 ptt-85 47.7 -164.42 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.192 0.932 . . . . 0.0 112.664 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -82.54 120.8 34.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.122 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.2 t -89.11 58.36 4.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.547 0.689 . . . . 0.0 109.994 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 23.5 p -117.29 -152.03 0.49 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.742 ' HA ' HD12 ' A' ' 45' ' ' ILE . 14.6 p30 -175.45 172.26 2.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 59.2 m -58.05 -43.09 86.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.02 -44.17 82.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 111.579 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.06 26.08 6.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.591 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.19 129.11 11.24 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.707 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 m -67.22 124.4 23.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.737 0.303 . . . . 0.0 110.785 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.915 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 54.3 mtmt -55.96 136.06 52.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.415 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.89 -30.96 7.33 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.922 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 39.7 m -88.98 125.03 34.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.0 110.642 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.82 ' HE2' ' HB1' ' A' ' 53' ' ' ALA . 2.2 tppt? -85.86 119.42 26.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.205 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.485 ' HD2' HG21 ' A' ' 45' ' ' ILE . 2.4 m-85 -89.41 124.73 34.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.272 0.558 . . . . 0.0 111.423 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 87.4 m-85 -122.56 158.18 30.47 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.088 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 p -78.11 -161.51 0.27 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.13 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -44.97 47.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.55 0.214 . . . . 0.0 111.253 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -63.36 -39.81 95.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.601 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.61 0.9 5.24 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -67.47 135.98 53.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.033 0.444 . . . . 0.0 111.033 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -67.26 112.52 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.925 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.596 HG11 HG12 ' A' ' 45' ' ' ILE . 83.6 t -87.83 -55.72 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.28 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.411 ' SG ' HG12 ' A' ' 24' ' ' VAL . 7.7 p -174.38 -170.18 0.5 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.946 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.818 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 13.9 tt0 -134.27 -158.81 0.91 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.742 0.305 . . . . 0.0 110.645 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.818 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -79.78 85.78 1.27 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.251 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -88.26 15.39 7.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.87 0.367 . . . . 0.0 110.985 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 p -79.67 55.31 1.98 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.915 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 24.4 t0 -173.94 -57.73 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 7.3 Cg_exo -72.86 65.68 4.02 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.421 2.081 . . . . 0.0 112.657 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 64.07 55.01 1.59 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -48.63 134.61 13.55 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.106 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.82 178.55 3.89 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.681 2.254 . . . . 0.0 110.678 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.716 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -92.95 129.95 38.7 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.213 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 73.7 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.727 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -67.24 -48.91 46.4 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.313 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 11.7 Cg_exo -70.97 66.28 2.49 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.648 2.232 . . . . 0.0 111.859 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -68.65 -34.49 75.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.82 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -80.34 45.49 0.76 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.425 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.9 m 67.37 118.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.413 0.685 . . . . 0.0 110.933 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.567 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 10.5 t70 -58.06 111.67 3.84 Favored Pre-proline 0 C--O 1.24 0.566 0 CA-C-O 120.75 0.31 . . . . 0.0 111.0 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.8 52.1 2.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.653 2.902 . . . . 0.0 112.042 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.567 ' HB3' ' OD1' ' A' ' 42' ' ' ASP . 12.8 ttp180 -166.27 -34.31 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.313 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.742 HD12 ' HA ' ' A' ' 6' ' ' ASN . 62.7 mt -89.39 129.76 39.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.2 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.92 ' HA ' ' HD2' ' A' ' 2' ' ' ARG . . . -115.16 -44.19 3.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -152.77 152.89 32.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 112.009 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.4 128.69 7.26 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.937 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mm -97.24 116.06 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 49.9 m -89.19 -52.03 0.36 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.672 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 60.5 Cg_endo -73.65 138.32 26.4 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.56 1.507 . . . . 0.0 112.365 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 63.92 60.39 1.03 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.563 0.539 . . . . 0.0 111.046 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.82 ' HB1' ' HE2' ' A' ' 15' ' ' LYS . . . . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.698 -0.668 . . . . 0.0 109.626 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 13.0 mtm105 62.76 58.25 1.61 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.549 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.3 pt -58.08 150.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.518 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 40.9 t -85.2 78.69 9.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.6 0.714 . . . . 0.0 109.575 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.2 p -138.71 -156.62 0.7 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.04 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.562 ' HA ' HD12 ' A' ' 45' ' ' ILE . 17.1 p30 -178.3 178.59 0.87 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 m -54.12 -55.45 27.54 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.806 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . . . -62.2 -35.76 79.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.81 -30.17 62.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.882 0.373 . . . . 0.0 111.366 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.93 147.13 48.81 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.206 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.453 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 23.1 m -69.31 128.29 36.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.562 0.22 . . . . 0.0 111.122 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 43.8 mtmt -57.05 136.22 56.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.344 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.75 -32.27 7.42 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.658 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.5 m -87.91 134.27 33.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.974 0.416 . . . . 0.0 109.958 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.52 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 38.3 mmtt -93.1 122.47 35.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.488 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.67 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.3 m-85 -95.17 129.73 42.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.966 0.412 . . . . 0.0 110.823 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 38.3 m-85 -121.04 165.22 15.61 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.885 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.2 m -79.1 -156.65 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.748 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -84.75 -42.17 15.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.746 0.308 . . . . 0.0 110.622 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -63.98 -42.46 97.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.633 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.89 -5.25 3.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.1 m -64.34 131.2 46.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.005 0.431 . . . . 0.0 110.779 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.9 t80 -70.3 117.74 12.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.942 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.653 HG11 HG12 ' A' ' 45' ' ' ILE . 86.0 t -81.66 -63.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.986 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.455 ' SG ' HG12 ' A' ' 24' ' ' VAL . 16.6 p -178.1 167.79 1.99 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.502 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -95.57 156.25 16.4 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -68.81 133.39 27.12 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.874 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.806 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 29.9 mt-10 -116.09 32.78 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.977 0.418 . . . . 0.0 110.243 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 11' ' ' THR . 14.5 p -78.41 55.0 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 0.0 111.76 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.577 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 13.0 t0 -68.12 -56.79 10.3 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.006 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 1.2 Cg_endo -82.21 12.89 2.69 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.264 1.976 . . . . 0.0 111.254 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 60.66 33.66 20.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.549 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -169.85 137.14 1.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.18 0.514 . . . . 0.0 110.964 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.32 60.14 7.24 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.803 2.335 . . . . 0.0 111.501 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.635 ' NZ ' ' HB2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER 67.76 116.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.499 -178.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 57.57 -135.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.812 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -96.79 134.57 22.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.52 0.2 . . . . 0.0 110.684 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 22.6 Cg_exo -64.22 130.84 28.26 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.717 2.278 . . . . 0.0 111.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -164.04 45.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.887 0.375 . . . . 0.0 110.999 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -160.32 125.84 3.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.124 0.487 . . . . 0.0 110.475 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 3.3 m -107.98 125.9 52.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.07 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 17.2 t0 -90.35 110.75 42.96 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 27.5 Cg_endo -62.28 -21.71 73.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.414 2.742 . . . . 0.0 112.306 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.485 ' HE ' ' HB3' ' A' ' 44' ' ' ARG . 26.5 ttp180 -66.06 -30.87 71.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.688 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.653 HG12 HG11 ' A' ' 24' ' ' VAL . 50.9 mt -89.53 126.5 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.935 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -110.65 -42.98 3.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.7 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -156.37 145.41 20.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.274 0.559 . . . . 0.0 112.0 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.67 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.24 131.54 10.64 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.488 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.99 121.69 55.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.057 0.456 . . . . 0.0 111.023 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 76.7 m -97.92 137.95 20.95 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.7 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.6 Cg_exo -76.83 -143.79 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.884 2.39 . . . . 0.0 112.445 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.2 mt 63.92 41.75 6.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.778 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.269 0 CA-C-O 117.331 -1.319 . . . . 0.0 108.658 179.611 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 121.423 0.63 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -151.68 60.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.859 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.2 pt -64.62 140.64 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.336 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 52.2 t -87.15 69.11 10.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.554 0.693 . . . . 0.0 110.268 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.9 p -120.49 -164.15 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.86 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -175.04 161.09 2.86 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.4 m -60.06 -35.31 74.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.49 -23.55 64.59 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.198 0.523 . . . . 0.0 110.938 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.41 -109.56 0.36 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.177 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.92 -136.45 50.83 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.186 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.5 m -152.17 127.53 9.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 42.0 tptt -60.07 133.11 55.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.783 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.08 -26.16 23.88 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.893 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.451 ' HB2' ' HE1' ' A' ' 16' ' ' TYR . 33.9 m -88.05 129.76 35.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.125 0.488 . . . . 0.0 110.458 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -90.3 114.92 27.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.047 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.703 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.1 m-85 -96.2 128.68 43.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.855 0.36 . . . . 0.0 110.359 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.995 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 0.6 OUTLIER -148.91 178.27 8.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.028 0.442 . . . . 0.0 111.502 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.1 p -78.72 174.7 11.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.887 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -68.6 -35.6 77.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.27 -36.59 84.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.041 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.32 -18.84 4.13 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.238 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.3 m -58.56 115.35 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.059 0.457 . . . . 0.0 111.262 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.995 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 23.8 t80 -65.04 118.14 8.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.569 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG23 ' HA ' ' A' ' 17' ' ' PHE . 87.8 t -84.81 -58.91 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.353 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 26.0 p -178.26 151.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.775 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.2 147.06 28.25 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.19 124.41 29.95 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.746 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -128.4 65.49 1.4 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.58 43.18 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.627 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -70.02 130.02 90.24 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.148 178.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 4.4 Cg_exo -81.99 39.05 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.399 2.733 . . . . 0.0 112.973 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.461 ' HG3' HH11 ' A' ' 32' ' ' ARG . 17.2 mmt85 -131.22 -46.7 1.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.479 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 18.0 p30 -62.86 136.19 96.34 Favored Pre-proline 0 C--O 1.237 0.445 0 CA-C-O 121.201 0.524 . . . . 0.0 110.624 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 32.0 Cg_exo -60.22 139.22 86.0 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.609 2.873 . . . . 0.0 113.736 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -132.95 128.62 36.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.098 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.7 -37.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.256 0.347 . . . . 0.0 110.823 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -59.0 136.28 87.7 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.989 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 16.7 Cg_exo -68.38 59.29 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.716 2.944 . . . . 0.0 113.122 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.546 ' HD2' ' OD2' ' A' ' 42' ' ' ASP . 12.6 tpp180 -94.99 43.94 1.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.933 0.873 . . . . 0.0 109.704 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -90.65 139.58 30.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.797 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 65.3 m 60.49 52.62 4.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.672 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.546 ' OD2' ' HD2' ' A' ' 39' ' ' ARG . 8.4 t0 -58.5 113.23 6.21 Favored Pre-proline 0 N--CA 1.464 0.269 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.39 -30.61 91.83 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.575 2.85 . . . . 0.0 113.915 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.522 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 34.5 ptt180 -70.64 -26.25 63.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.375 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.9 mt -89.13 111.31 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.977 0.417 . . . . 0.0 110.761 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.91 -49.99 6.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.245 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.468 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 14.8 p90 -161.77 147.49 13.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.253 0.549 . . . . 0.0 111.678 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.703 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.38 129.4 9.56 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.296 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.11 124.8 52.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.025 0.44 . . . . 0.0 111.194 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.4 m -100.13 139.33 20.64 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.98 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.07 126.77 17.85 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.588 2.192 . . . . 0.0 112.103 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.0 tp -88.74 138.1 31.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.378 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.832 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.1 t0 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.604 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -64.97 144.93 56.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.205 0.526 . . . . 0.0 111.311 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 pt -68.06 135.01 29.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.238 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 41.8 t -87.66 57.87 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.692 0.758 . . . . 0.0 110.254 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 9' ' ' ALA . 34.1 p -124.5 -143.35 0.31 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.765 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.754 ' HA ' HD12 ' A' ' 45' ' ' ILE . 0.4 OUTLIER -177.46 -171.15 0.31 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.474 ' C ' ' HG2' ' A' ' 28' ' ' GLU . 4.3 m -60.33 -41.86 94.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.589 0.233 . . . . 0.0 110.453 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.571 ' N ' ' HG2' ' A' ' 28' ' ' GLU . . . -60.11 -44.47 94.83 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.715 0.293 . . . . 0.0 111.584 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' A' ' 5' ' ' THR . . . -82.52 21.75 0.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.099 0.476 . . . . 0.0 110.521 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -91.46 131.45 10.79 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.188 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.631 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 5.3 m -69.22 148.96 49.1 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.647 0.26 . . . . 0.0 110.591 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -58.34 131.89 52.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.439 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.76 -11.03 54.98 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.13 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 61.3 m -89.52 128.83 36.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.422 0.629 . . . . 0.0 110.624 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 15.2 mmtp -98.81 121.34 40.63 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.715 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.603 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.5 m-85 -92.05 125.76 36.87 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.768 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.26 162.84 16.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.734 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.416 ' HB2' ' H ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -78.51 -154.14 0.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.997 178.353 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.416 ' H ' ' HB2' ' A' ' 18' ' ' SER . 14.4 p-10 -82.76 -42.15 18.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.681 0.276 . . . . 0.0 110.488 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -64.41 -41.26 96.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.665 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.96 -0.04 4.38 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -68.27 134.5 50.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 110.754 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.9 t80 -68.78 111.88 5.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.614 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.466 HG13 ' HD2' ' A' ' 44' ' ' ARG . 94.7 t -83.26 -57.11 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.778 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.9 p -175.53 158.28 2.22 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.981 0.42 . . . . 0.0 111.923 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 38.0 tt0 -92.44 173.21 7.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -69.91 108.48 2.49 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.572 -0.823 . . . . 0.0 114.062 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.571 ' HG2' ' N ' ' A' ' 8' ' ' ALA . 21.8 pt-20 -89.16 36.43 0.82 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.201 1.0 . . . . 0.0 108.392 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 3.5 p -78.08 56.24 1.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.359 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -63.46 128.97 93.28 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.532 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 33' ' ' ASN . 73.9 Cg_endo -75.63 -136.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.784 2.323 . . . . 0.0 111.237 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' H ' ' HB2' ' A' ' 31' ' ' PRO . 38.2 mtp85 73.21 -31.96 0.23 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.388 0.675 . . . . 0.0 111.122 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.494 ' H ' ' C ' ' A' ' 31' ' ' PRO . 5.8 p30 -169.37 141.7 2.06 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.055 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 14.0 Cg_exo -70.35 71.8 1.79 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.602 2.868 . . . . 0.0 113.004 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 33' ' ' ASN . 35.5 mtmm -68.23 112.81 5.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.728 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.6 122.07 28.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.321 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.72 114.43 50.06 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.898 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.42 46.51 2.23 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.838 2.359 . . . . 0.0 112.254 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.87 52.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.216 0.531 . . . . 0.0 111.322 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.9 p30 -69.99 161.48 29.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.399 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 65.62 48.6 1.94 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.365 0.416 . . . . 0.0 110.436 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.666 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 4.4 t0 -60.5 113.59 7.94 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 12.1 Cg_endo -56.58 -33.72 93.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.646 2.898 . . . . 0.0 114.313 -177.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.666 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 23.2 ptt180 -71.07 -27.01 63.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.789 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 6' ' ' ASN . 67.7 mt -91.72 127.31 44.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 111.703 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.08 -45.34 3.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.55 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -152.5 145.82 24.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.209 0.528 . . . . 0.0 111.616 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -111.84 129.19 8.97 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.31 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.1 mm -110.69 125.05 67.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 19.2 m -87.68 -51.69 0.41 Allowed Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.646 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 2.8 Cg_exo -75.74 61.64 6.27 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.373 2.049 . . . . 0.0 112.469 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.9 tt -154.83 116.55 4.13 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 O-C-N 124.078 0.861 . . . . 0.0 111.397 179.817 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 110.432 -0.211 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.762 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 61.6 mtt85 54.27 60.52 3.52 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.863 0.727 . . . . 0.0 111.931 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 pt -57.28 147.44 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.323 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 43.6 t -85.33 75.24 10.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.758 0.79 . . . . 0.0 109.937 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.3 p -140.9 -163.94 1.64 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.205 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.957 ' HA ' HD12 ' A' ' 45' ' ' ILE . 15.4 p30 -173.24 -158.62 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 m -69.71 -54.5 13.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.267 0.485 . . . . 0.0 110.467 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -65.91 -44.03 86.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.307 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.82 -4.65 47.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.089 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.26 141.04 23.59 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.053 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 31' ' ' PRO . 72.7 m -68.26 127.19 32.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.727 0.298 . . . . 0.0 110.497 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.721 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 82.2 tttt -57.66 131.31 49.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.907 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.27 -29.59 12.17 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.532 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.5 m -88.42 128.44 35.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.124 0.488 . . . . 0.0 109.943 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.632 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 10.9 mtpp -90.67 114.42 26.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.364 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.723 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.5 m-85 -86.37 126.01 34.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.302 0.572 . . . . 0.0 111.637 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.632 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 14.4 m-85 -119.89 163.07 18.09 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.653 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.7 t -84.32 169.22 14.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -69.1 -32.25 71.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 0.0 110.127 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -66.27 -33.94 76.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.591 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.73 -23.9 3.72 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.195 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -60.97 133.18 55.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.095 0.474 . . . . 0.0 112.097 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -73.49 122.86 22.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.454 HG11 ' CG1' ' A' ' 45' ' ' ILE . 48.9 t -86.93 -65.13 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.403 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.0 p -175.69 152.29 1.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.577 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -85.71 145.72 27.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -66.37 144.41 45.86 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.659 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 8' ' ' ALA . 14.2 pt-20 -117.32 -18.12 9.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.567 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 82.5 p -78.56 139.9 38.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.372 0.606 . . . . 0.0 112.445 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.408 ' OD2' ' HB2' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -63.52 138.14 97.28 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.606 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.562 ' HB3' HG23 ' A' ' 11' ' ' THR . 90.5 Cg_endo -82.36 29.49 0.54 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.663 2.242 . . . . 0.0 113.68 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.7 mmp_? -129.04 29.07 5.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.926 0.393 . . . . 0.0 110.348 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -154.07 146.4 17.34 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.77 143.75 46.79 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.829 2.353 . . . . 0.0 111.631 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -70.19 140.76 52.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.719 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -43.64 -51.27 7.11 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -166.96 125.53 1.05 Allowed Pre-proline 0 C--N 1.328 -0.342 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.571 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 3.0 Cg_exo -75.61 63.21 6.48 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.538 2.825 . . . . 0.0 111.665 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -148.76 -23.11 0.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.011 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -86.37 48.78 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.49 0.662 . . . . 0.0 110.101 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m -67.34 125.52 26.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.058 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 66.0 t0 -78.32 116.98 63.41 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.18 -24.77 75.43 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.334 2.689 . . . . 0.0 113.97 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.489 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 28.6 ptt-85 -93.78 -1.53 54.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.413 -0.515 . . . . 0.0 112.326 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.957 HD12 ' HA ' ' A' ' 6' ' ' ASN . 15.7 mt -102.79 124.02 56.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.984 0.421 . . . . 0.0 110.7 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -108.67 -46.13 3.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.29 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -153.25 147.48 25.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.262 0.553 . . . . 0.0 112.431 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.66 125.68 7.53 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.6 mm -89.74 113.61 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.826 0.346 . . . . 0.0 110.785 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.0 m -95.72 134.14 24.53 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.065 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.69 131.92 25.57 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.496 2.131 . . . . 0.0 112.32 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.6 tp -83.78 137.35 33.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.826 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.3 t70 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.8 ptt85 -162.26 108.05 1.25 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.23 0.538 . . . . 0.0 110.34 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 pt -65.04 145.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.766 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -87.24 78.76 8.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.481 0.658 . . . . 0.0 109.676 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.2 p -138.35 -168.32 2.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.854 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.758 ' HA ' HD12 ' A' ' 45' ' ' ILE . 17.7 p30 -168.9 -179.53 3.73 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -55.99 -46.01 78.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.37 -49.28 17.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.67 60.47 6.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.515 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.53 -143.16 5.03 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.097 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 m -132.19 131.13 41.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.59 ' HG2' ' OE1' ' A' ' 28' ' ' GLU . 29.8 mtpp -56.96 130.09 44.47 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.45 0.469 . . . . 0.0 111.379 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.31 -21.24 25.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.384 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.7 m -88.21 128.98 35.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.285 0.564 . . . . 0.0 110.208 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 46.1 mttm -96.25 123.67 39.96 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.298 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.646 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 11.6 m-85 -92.39 127.46 37.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.204 0.526 . . . . 0.0 111.31 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 12.2 m-85 -118.38 164.61 14.98 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.4 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.9 m -77.29 -158.98 0.12 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.797 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -84.58 -40.38 17.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.776 0.322 . . . . 0.0 110.311 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -65.35 -43.81 89.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.529 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.92 -3.79 2.31 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -65.43 130.13 42.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 110.989 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.1 t80 -72.87 115.71 12.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.732 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.435 HG11 HG13 ' A' ' 45' ' ' ILE . 38.5 t -82.67 -62.43 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 28.7 p -175.21 150.31 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.698 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 23.0 tt0 -83.12 141.23 32.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.562 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.66 132.97 12.07 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.697 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.59 ' OE1' ' HG2' ' A' ' 12' ' ' LYS . 4.5 tp10 -141.09 69.99 1.34 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.961 0.886 . . . . 0.0 109.741 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -85.39 43.56 1.03 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.692 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.578 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.5 t70 -64.47 -51.42 60.08 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.707 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 32.6 Cg_exo -61.55 133.91 48.26 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.741 1.627 . . . . 0.0 111.743 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -81.75 36.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.347 0.594 . . . . 0.0 109.903 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.5 p30 -167.32 63.09 0.66 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.85 132.49 52.27 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.785 2.323 . . . . 0.0 111.634 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -107.97 115.99 31.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.04 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -174.34 176.49 2.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.576 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.27 137.93 95.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 123.058 0.224 . . . . 0.0 110.482 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.62 125.32 15.28 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.355 2.036 . . . . 0.0 112.283 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.0 tpp85 60.56 44.97 11.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -96.04 135.96 37.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.935 0.398 . . . . 0.0 110.096 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.9 m -115.55 123.28 48.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -71.91 115.75 41.31 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.39 -22.36 74.34 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.168 2.578 . . . . 0.0 112.84 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -82.73 -27.51 31.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.758 HD12 ' HA ' ' A' ' 6' ' ' ASN . 68.1 mt -87.86 124.92 41.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.399 0.619 . . . . 0.0 112.332 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.07 -46.78 3.07 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.573 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -149.75 142.93 25.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.346 0.593 . . . . 0.0 111.91 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -103.01 132.3 10.96 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.746 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.1 mm -101.05 122.6 53.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.83 0.348 . . . . 0.0 110.542 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 83.2 m -105.15 124.39 36.68 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.201 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.59 135.66 18.3 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.69 2.26 . . . . 0.0 112.237 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.72 HD23 ' H ' ' A' ' 52' ' ' LEU . 2.3 pt? -80.1 140.68 36.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.328 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.99 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -168.16 121.97 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 45' ' ' ILE . 9.7 pt -65.42 129.67 29.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 110.693 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.01 62.49 6.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.493 0.663 . . . . 0.0 109.406 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -128.73 -154.43 0.64 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.991 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.569 ' HA ' HD12 ' A' ' 45' ' ' ILE . 15.6 p30 -176.84 -166.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 m -61.39 -53.91 50.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.32 0.388 . . . . 0.0 111.083 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.463 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . . . -61.69 -40.57 95.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 0.0 111.007 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.12 57.44 4.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.61 141.5 7.12 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.212 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -61.51 135.69 57.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.479 0.18 . . . . 0.0 110.723 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER -57.89 -32.33 67.6 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.515 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.1 27.16 3.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.074 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.6 m -147.51 132.02 17.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 59.2 mttp -105.67 126.87 52.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.698 ' HD2' HD13 ' A' ' 45' ' ' ILE . 3.1 m-30 -82.99 124.48 30.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.144 0.497 . . . . 0.0 111.249 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -121.47 161.32 22.45 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.799 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.5 t -87.38 163.86 16.54 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.417 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 15.8 p-10 -66.58 -33.04 74.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.662 0.268 . . . . 0.0 110.54 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.49 -31.12 72.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.502 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.28 -21.72 4.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.305 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 m -63.84 133.34 53.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.238 0.542 . . . . 0.0 112.335 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 19.2 t80 -74.56 122.02 22.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.508 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.8 t -86.72 -62.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.396 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.5 p -174.8 150.95 1.34 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.208 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.578 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 37.1 tt0 -80.38 149.64 30.13 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.42 137.99 40.44 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.251 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 8' ' ' ALA . 16.3 pt-20 -137.21 61.05 1.63 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.787 0.803 . . . . 0.0 110.099 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.15 65.66 3.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.89 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.474 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.7 t70 -58.33 128.93 83.15 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.998 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 2.3 Cg_endo -81.77 -147.83 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.072 2.515 . . . . 0.0 111.158 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 70.88 -30.75 0.21 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.399 0.68 . . . . 0.0 112.098 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 31' ' ' PRO . 10.6 p30 -132.12 133.26 23.68 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 121.202 0.525 . . . . 0.0 110.772 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 20.2 Cg_exo -66.81 137.6 45.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.369 2.713 . . . . 0.0 112.956 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -95.04 130.83 41.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.465 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -155.04 148.37 25.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.969 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.407 ' N ' ' HD3' ' A' ' 38' ' ' PRO . . . 56.92 64.73 4.31 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.943 0.777 . . . . 0.0 112.045 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 37' ' ' ALA . 9.5 Cg_exo -72.19 52.62 1.92 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.319 2.679 . . . . 0.0 112.337 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -76.61 49.45 0.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.311 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -153.8 43.99 0.58 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.608 0.718 . . . . 0.0 109.857 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.3 m -65.07 131.99 48.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.498 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.449 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 65.6 t0 -91.46 112.21 53.06 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.919 0.39 . . . . 0.0 110.298 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 29.6 Cg_endo -63.46 -22.89 71.28 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.122 2.548 . . . . 0.0 112.546 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -67.86 -21.95 65.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.782 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.698 HD13 ' HD2' ' A' ' 16' ' ' TYR . 67.3 mt -87.3 133.82 29.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.189 0.518 . . . . 0.0 111.432 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.17 -41.72 2.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.466 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 19' ' ' ASP . 4.5 p90 -155.24 149.18 25.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.051 0.453 . . . . 0.0 111.857 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -106.84 126.66 8.54 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.2 mm -92.27 117.39 35.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.859 0.361 . . . . 0.0 110.612 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.608 ' H ' ' HD2' ' A' ' 51' ' ' PRO . 76.8 m -99.68 -46.19 0.22 Allowed Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.173 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' ' H ' ' A' ' 50' ' ' CYS . 52.1 Cg_endo -68.53 73.36 0.89 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.2 1.933 . . . . 0.0 113.025 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 57.2 tp 74.05 116.29 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.747 0.819 . . . . 0.0 111.476 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.447 ' O ' ' HD2' ' A' ' 15' ' ' LYS . . . . . . . . 0 C--O 1.244 0.776 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.17 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.627 0.251 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.05 138.03 1.65 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.099 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 pt -64.49 133.9 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.3 0.571 . . . . 0.0 111.933 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t -89.79 69.1 7.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.984 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -135.17 -169.73 2.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.802 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.846 ' HA ' HD12 ' A' ' 45' ' ' ILE . 16.9 p30 -165.15 -173.86 3.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 m -59.68 -48.93 79.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.57 -48.95 23.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.11 0.481 . . . . 0.0 110.462 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.87 63.04 7.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.737 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.23 -135.21 2.83 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.734 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.5 m -161.0 125.58 3.56 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 12.8 ttmm -60.91 133.48 56.14 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.178 0.514 . . . . 0.0 109.944 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.19 -39.58 2.55 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 40.0 m -92.49 125.69 37.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.77 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -96.23 125.18 40.56 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 53.2 m-85 -91.78 126.06 36.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.162 0.506 . . . . 0.0 111.52 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -117.56 163.92 15.7 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.838 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -76.21 -155.21 0.05 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.966 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -91.19 -40.24 11.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.824 0.345 . . . . 0.0 110.129 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.17 -41.83 96.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.772 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.61 -13.55 2.7 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.748 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -60.84 132.0 52.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.285 0.564 . . . . 0.0 111.542 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.593 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.0 t80 -74.0 120.89 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.718 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.0 t -88.3 -62.68 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.308 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.3 p -171.8 149.59 2.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 0.0 111.116 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.77 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 23.1 tt0 -85.38 151.88 23.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -59.83 122.26 29.41 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.467 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -105.27 58.69 0.68 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.577 0.703 . . . . 0.0 110.088 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 p -156.03 141.19 17.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.429 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 10.0 t70 -63.0 134.1 95.67 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.19 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 18.8 Cg_exo -68.36 41.35 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.982 3.122 . . . . 0.0 114.176 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -71.06 -32.83 69.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.416 . . . . 0.0 110.405 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -173.2 149.77 1.79 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.648 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.89 128.61 26.02 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.363 2.042 . . . . 0.0 111.148 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -89.61 140.51 29.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -161.75 145.0 12.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.39 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.47 149.5 21.48 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.095 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.86 116.13 2.91 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.751 2.301 . . . . 0.0 113.248 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 59.37 33.29 22.35 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.642 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 35.4 p-10 -93.11 26.02 3.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.746 0.784 . . . . 0.0 110.236 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.42 120.52 17.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.07 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 10.0 t70 -78.61 121.3 83.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.24 -27.87 68.47 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.24 2.626 . . . . 0.0 113.524 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 -30.24 26.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.634 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 6' ' ' ASN . 84.6 mt -88.72 123.98 41.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.11 -44.69 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.551 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -146.58 145.34 30.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.445 . . . . 0.0 111.427 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -116.04 136.13 12.68 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.785 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.1 mm -101.52 119.6 49.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 85.9 m -88.22 -41.32 0.48 Allowed Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 50' ' ' CYS . 9.9 Cg_endo -51.79 148.92 20.84 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 121.907 1.738 . . . . 0.0 112.052 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -46.38 124.19 5.53 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.696 0.623 . . . . 0.0 112.217 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.827 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.532 179.905 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 49.2 t0 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 59.21 54.83 4.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.528 0.731 . . . . 0.0 110.518 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -60.11 138.62 20.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.429 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.6 t -86.03 84.93 7.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.8 p -138.48 -168.05 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.832 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -165.6 159.9 17.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.6 m -57.15 -38.1 73.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.68 95.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.983 0.42 . . . . 0.0 110.931 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.86 -96.89 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.062 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.91 -131.82 47.95 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.674 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.3 m -155.02 115.56 3.88 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 18.4 tptm -61.15 121.59 12.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.52 -33.88 4.91 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.422 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 86.3 m -95.56 131.93 41.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.107 0.48 . . . . 0.0 110.159 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 0.8 OUTLIER -92.03 122.11 34.23 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.376 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.795 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.4 m-85 -87.04 131.73 34.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.759 0.314 . . . . 0.0 110.743 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -125.41 163.93 21.54 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.767 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.473 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 44.2 m -85.78 -179.99 6.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.119 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -69.5 -37.36 77.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.64 0.257 . . . . 0.0 111.434 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 43.9 p-10 -66.24 -40.41 90.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.14 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.67 -9.64 3.99 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -62.88 132.53 52.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.111 0.481 . . . . 0.0 111.155 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 15' ' ' LYS . 20.6 t80 -71.94 120.15 17.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.696 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.965 HG11 HG12 ' A' ' 45' ' ' ILE . 82.9 t -83.7 -68.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 27.2 p 177.72 158.39 0.42 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -91.7 146.56 23.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -75.23 119.0 5.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.434 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -89.62 50.59 1.93 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 117.452 0.626 . . . . 0.0 111.99 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 40.94 1.03 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.771 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.67 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 1.6 t70 -65.62 -58.31 12.01 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.15 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 9.8 Cg_endo -90.73 -148.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.883 2.389 . . . . 0.0 111.685 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -117.91 41.82 2.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.366 0.603 . . . . 0.0 110.637 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.565 ' OD1' ' HD3' ' A' ' 34' ' ' PRO . 10.1 p-10 -79.56 -40.91 1.47 Allowed Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.565 ' HD3' ' OD1' ' A' ' 33' ' ' ASN . 2.8 Cg_exo -75.83 146.88 30.26 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.074 1.849 . . . . 0.0 112.718 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.497 ' HD2' ' C ' ' A' ' 34' ' ' PRO . 13.4 mptt -124.99 133.95 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.61 -134.22 0.48 Allowed 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.761 0.663 . . . . 0.0 110.471 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.575 ' H ' ' HD2' ' A' ' 38' ' ' PRO . . . -166.81 -52.38 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.575 ' HD2' ' H ' ' A' ' 37' ' ' ALA . 74.4 Cg_endo -74.06 45.02 1.08 Allowed 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.226 1.951 . . . . 0.0 113.336 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -83.64 -40.28 19.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.621 0.724 . . . . 0.0 109.485 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -174.2 135.38 0.46 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.904 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.2 m -123.21 137.17 54.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.824 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 8.0 t0 -86.7 120.18 71.68 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.091 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.11 -24.27 78.97 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.351 2.701 . . . . 0.0 112.55 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.481 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 21.1 ttp180 -68.13 -19.47 64.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.263 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.965 HG12 HG11 ' A' ' 24' ' ' VAL . 57.5 mt -85.94 129.27 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.923 0.392 . . . . 0.0 110.875 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.02 -51.2 2.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.459 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -155.97 144.95 20.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.237 0.542 . . . . 0.0 112.082 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.795 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -104.24 128.3 9.42 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.5 mm -122.58 129.0 75.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 117.183 0.492 . . . . 0.0 112.069 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.3 m -89.57 113.47 56.8 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 177.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 72.5 Cg_endo -81.06 163.53 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.648 2.232 . . . . 0.0 111.793 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.3 mt -85.25 38.6 0.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.403 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 C--O 1.254 1.302 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.144 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 2' ' ' ARG . 12.4 p-10 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 121.578 0.704 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 1' ' ' ASP . 19.6 mmt85 -121.5 131.96 54.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.939 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -79.11 129.94 36.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.759 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.39 62.34 5.99 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 17.2 p -128.84 -151.95 0.5 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.868 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 21.4 p30 -163.83 -176.79 4.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.764 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.3 m -56.94 -44.39 82.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.151 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 -50.5 72.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.016 0.436 . . . . 0.0 110.61 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.53 37.48 0.64 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.596 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -97.26 -27.37 9.34 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.772 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 10' ' ' GLY . 31.5 m 76.41 126.36 0.04 OUTLIER 'General case' 0 C--O 1.237 0.426 0 C-N-CA 122.878 0.471 . . . . 0.0 111.055 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.596 ' HD2' ' O ' ' A' ' 27' ' ' GLY . 25.2 mmmt -54.85 133.35 47.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.42 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.71 -42.93 1.79 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.727 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.3 m -87.68 136.65 32.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.208 0.527 . . . . 0.0 110.579 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 59.4 mttp -112.02 127.44 55.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.536 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.799 ' HD2' HD13 ' A' ' 45' ' ' ILE . 5.3 m-30 -82.51 129.03 34.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -125.88 160.29 30.31 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.812 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.427 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 39.3 m -83.96 178.87 7.7 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -76.37 -33.28 58.92 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.022 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.5 p-10 -65.87 -39.54 90.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.378 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.27 -14.46 3.49 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.987 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.5 m -62.52 134.06 55.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.272 0.558 . . . . 0.0 111.787 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.543 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 20.0 t80 -75.44 120.78 21.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.196 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 45' ' ' ILE . 57.7 t -84.46 -63.35 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.722 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.2 p -176.61 147.09 0.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.999 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 36.4 tt0 -79.19 150.56 31.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.596 ' O ' ' HD2' ' A' ' 12' ' ' LYS . . . -63.64 122.91 27.73 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.047 -1.073 . . . . 0.0 111.084 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 4.6 tp10 -109.39 63.08 0.6 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.291 0.567 . . . . 0.0 110.278 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.7 p -79.52 112.64 16.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.421 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -69.47 130.37 90.77 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.079 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.26 42.13 1.08 Allowed 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.793 2.329 . . . . 0.0 113.335 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -135.22 52.26 2.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.715 0.293 . . . . 0.0 111.061 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 38.28 69.7 1.45 Allowed Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -70.63 65.97 2.3 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.189 2.593 . . . . 0.0 112.296 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -70.48 137.68 50.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.446 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.67 35.11 7.16 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.867 0.729 . . . . 0.0 111.196 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.0 145.58 96.48 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.796 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.79 114.98 2.14 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.626 2.217 . . . . 0.0 112.009 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.5 ptt-85 -92.59 41.56 1.08 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.263 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.54 115.76 19.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 5' ' ' THR . 7.9 m -77.6 126.85 31.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.761 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.733 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 12.1 t0 -90.42 123.74 64.66 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 47.9 Cg_exo -58.15 -30.65 91.19 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 123.556 2.838 . . . . 0.0 114.273 -178.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.733 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 15.5 ptt180 -74.87 -14.62 60.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.799 HD13 ' HD2' ' A' ' 16' ' ' TYR . 75.8 mt -88.17 128.88 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.977 0.418 . . . . 0.0 111.231 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.22 -52.91 2.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.818 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -153.7 150.19 28.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.08 0.467 . . . . 0.0 111.576 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.9 131.62 10.63 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.704 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -105.86 119.31 54.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.781 0.324 . . . . 0.0 110.414 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 35.5 m -104.56 127.29 29.29 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.516 ' HB2' ' H ' ' A' ' 52' ' ' LEU . 1.1 Cg_endo -84.08 -134.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.469 2.779 . . . . 0.0 112.05 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.81 ' H ' HD23 ' A' ' 52' ' ' LEU . 2.1 pt? -90.61 33.26 0.92 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.182 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.44 ' O ' ' HD2' ' A' ' 51' ' ' PRO . . . . . . . . 0 C--O 1.253 1.238 0 CA-C-O 117.311 -1.328 . . . . 0.0 108.767 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.874 ' HG3' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -60.67 127.68 32.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.862 0.363 . . . . 0.0 110.707 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -66.88 142.25 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.221 0.534 . . . . 0.0 111.723 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.7 t -87.44 84.0 7.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.493 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 p -140.74 -166.57 2.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.751 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.504 ' HA ' HD12 ' A' ' 45' ' ' ILE . 21.6 p30 -171.99 165.63 6.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -50.18 -47.05 54.67 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.77 92.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.978 0.418 . . . . 0.0 112.008 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.443 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . . . -75.92 -37.34 58.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.847 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.33 144.29 36.79 Favored Glycine 0 N--CA 1.453 -0.219 0 O-C-N 123.847 0.717 . . . . 0.0 114.01 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -77.42 136.37 38.39 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.747 0.419 . . . . 0.0 111.339 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HB2' ' HE3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -58.03 147.57 29.04 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.257 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.67 -35.14 4.17 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 77.6 m -89.05 125.49 35.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 72.6 mttt -106.0 119.28 38.78 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.6 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.663 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 6.1 m-85 -87.89 132.2 34.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.671 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -120.86 157.97 28.63 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.481 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.0 t -86.26 161.84 18.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.573 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -65.38 -29.98 70.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.432 0.158 . . . . 0.0 111.387 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.35 -33.89 75.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.973 0.416 . . . . 0.0 110.001 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.69 -14.75 5.51 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.259 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -69.53 130.69 43.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.143 0.497 . . . . 0.0 111.576 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.506 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 23.1 t80 -68.83 129.78 40.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.82 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 18.3 t -90.74 -69.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.468 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.0 p -178.84 157.44 0.9 Allowed 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.371 0.419 . . . . 0.0 111.154 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 69.8 tt0 -88.42 157.52 18.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.88 115.06 7.52 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.497 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -89.42 27.78 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.802 0.334 . . . . 0.0 111.55 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 p -90.99 21.42 4.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.563 0.697 . . . . 0.0 110.737 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.532 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.0 t0 -86.86 -51.99 0.43 Allowed Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.109 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 10.5 Cg_exo -71.26 22.0 0.23 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.29 1.994 . . . . 0.0 112.482 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 30' ' ' ASP . 58.2 mmt-85 52.54 51.18 16.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.042 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 8.5 p30 -64.38 134.92 96.14 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 15.2 Cg_exo -69.08 119.87 6.81 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.821 2.347 . . . . 0.0 111.773 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' NZ ' ' HA ' ' A' ' 9' ' ' ALA . 4.7 mmmm -83.24 96.93 8.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.409 0.623 . . . . 0.0 110.629 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.41 -40.11 9.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.161 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . . . -124.12 59.17 17.61 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.96 58.69 6.62 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.349 2.032 . . . . 0.0 110.869 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.523 ' NH1' ' HA ' ' A' ' 37' ' ' ALA . 7.2 ptp85 -155.34 53.0 0.61 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.542 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -149.2 144.61 26.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.662 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.8 m -111.88 121.07 44.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.946 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.582 ' OD2' ' HB2' ' A' ' 44' ' ' ARG . 9.9 t70 -83.81 120.02 74.45 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.05 -23.29 72.73 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.236 2.624 . . . . 0.0 112.782 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 42.7 mtp85 -71.8 -32.0 67.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.639 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 6' ' ' ASN . 43.6 mt -86.85 120.59 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.566 0.698 . . . . 0.0 112.222 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.874 ' HA ' ' HG3' ' A' ' 2' ' ' ARG . . . -106.74 -48.45 3.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.415 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -150.53 143.13 24.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.061 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -103.97 122.82 7.53 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.695 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.683 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.2 mm -101.43 128.19 54.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 35.8 m -106.41 89.0 3.64 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.743 0.306 . . . . 0.0 110.281 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.683 ' HD3' ' O ' ' A' ' 49' ' ' ILE . 19.2 Cg_endo -92.27 154.27 3.12 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.321 2.68 . . . . 0.0 112.155 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.51 37.64 0.64 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.85 0.357 . . . . 0.0 110.232 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.442 -0.799 . . . . 0.0 108.917 -179.866 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.747 0.308 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.617 ' HG2' ' HA ' ' A' ' 46' ' ' ALA . 7.5 tmm_? -152.66 102.5 2.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 3' ' ' ILE . 5.0 pt -60.13 138.23 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.286 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.5 t -88.31 69.59 9.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.547 0.689 . . . . 0.0 109.715 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.9 p -133.78 153.71 51.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.276 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.565 ' OD1' ' HA ' ' A' ' 39' ' ' ARG . 17.5 p-10 -131.1 160.32 35.05 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -48.66 -46.55 40.31 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.98 -38.33 88.16 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.401 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -114.94 56.91 0.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.809 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.77 -148.77 0.5 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.115 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 78.5 m -155.3 124.53 6.28 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.565 -0.374 . . . . 0.0 111.258 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 56.97 -88.73 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 O-C-N 124.052 0.845 . . . . 0.0 111.341 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.56 41.55 0.18 Allowed Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 108.811 -1.715 . . . . 0.0 108.811 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.1 m -88.09 133.9 33.88 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.657 -0.771 . . . . 0.0 110.52 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 42.2 mttp -83.03 115.9 22.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.175 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 92.0 m-85 -84.03 128.56 34.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.88 0.372 . . . . 0.0 111.11 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -122.47 158.72 29.15 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.344 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.498 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 50.0 m -84.65 176.28 8.68 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -68.07 -35.6 78.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.628 0.252 . . . . 0.0 110.896 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.1 p-10 -65.36 -40.03 93.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.787 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.7 -16.88 3.99 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.201 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.7 m -64.49 134.1 53.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.165 0.507 . . . . 0.0 111.503 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -69.88 123.58 21.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.445 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.656 HG13 ' HD2' ' A' ' 44' ' ' ARG . 21.6 t -84.25 -65.18 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.877 0.37 . . . . 0.0 111.141 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 p -175.33 154.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.624 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.8 tt0 -85.08 144.93 27.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.57 102.63 0.57 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.944 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.21 61.87 5.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.136 0.97 . . . . 0.0 109.139 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 p -92.75 36.83 1.01 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.457 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 45.1 t0 -92.4 124.96 57.84 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.538 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 43.9 Cg_endo -68.31 54.7 0.75 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.261 2.641 . . . . 0.0 114.374 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.405 ' HD3' ' OD2' ' A' ' 30' ' ' ASP . 14.8 mmm180 -69.59 -43.52 72.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -167.5 153.97 7.66 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.284 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.31 123.51 13.27 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.18 1.92 . . . . 0.0 111.928 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.97 128.16 33.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.419 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.0 -30.73 61.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.022 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.92 121.03 81.48 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.08 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.22 153.44 74.56 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.006 2.47 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.565 ' HA ' ' OD1' ' A' ' 6' ' ' ASN . 14.0 ttm180 -77.45 56.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.571 0.7 . . . . 0.0 110.421 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.5 p30 -71.19 154.82 41.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.111 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.9 m -66.17 93.89 0.23 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 9.6 t0 -62.94 117.84 36.53 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.177 0.513 . . . . 0.0 110.919 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 26.0 Cg_exo -62.68 -25.54 75.16 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 123.276 2.651 . . . . 0.0 112.907 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.656 ' HD2' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -82.26 -26.16 33.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.519 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.442 ' CG1' HG11 ' A' ' 24' ' ' VAL . 54.5 mt -88.4 125.3 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.617 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . . . -109.47 -51.52 2.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.564 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -149.08 147.5 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.81 127.39 8.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.318 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.3 mm -91.56 112.24 25.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.9 m -89.68 128.91 48.74 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.531 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.76 46.06 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.82 2.347 . . . . 0.0 112.363 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.2 tp -171.11 133.28 0.86 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.858 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.918 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 C--O 1.234 0.264 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -74.86 170.27 16.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 179.447 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 pt -57.81 128.93 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.472 0.653 . . . . 0.0 112.093 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.9 t -88.03 71.3 9.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.257 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 19.8 p -137.16 -158.66 0.88 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.478 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.555 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 18.2 p30 -171.21 -177.17 2.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -60.85 -43.79 97.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.01 66.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.039 0.447 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.95 44.52 1.2 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.981 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.88 142.22 14.45 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.927 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.0 m -58.38 122.36 13.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.577 0.227 . . . . 0.0 110.969 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -59.76 136.73 58.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.668 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.86 -29.7 10.14 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.222 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.7 m -89.46 130.01 35.87 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -99.86 122.08 42.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.978 179.396 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.789 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.0 m-85 -81.23 128.09 33.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.137 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.652 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 5.7 m-85 -118.57 162.09 18.95 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.674 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.447 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 12.4 t -80.3 -170.26 2.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.245 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -74.21 -44.33 53.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.722 0.296 . . . . 0.0 110.961 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 18' ' ' SER . 42.9 p-10 -62.01 -42.59 99.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.682 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.4 -1.89 3.06 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -69.64 131.14 44.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.008 0.433 . . . . 0.0 110.842 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -69.45 119.73 14.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.774 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG11 HG12 ' A' ' 45' ' ' ILE . 90.3 t -86.75 -63.95 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.346 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.0 p -174.67 148.48 1.14 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.771 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 14.7 tt0 -82.44 142.51 31.86 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -80.02 145.76 27.4 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.234 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -145.09 67.62 1.24 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-O 122.163 0.982 . . . . 0.0 110.129 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 p -78.76 132.07 36.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.895 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.483 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.2 t70 -63.38 137.2 97.01 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 10.4 Cg_exo -71.3 33.0 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.267 2.645 . . . . 0.0 112.884 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 31' ' ' PRO . 28.4 mmm180 -140.29 -36.39 0.49 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.088 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -171.65 151.88 3.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.043 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.53 128.31 23.2 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 121.94 1.76 . . . . 0.0 111.052 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -62.8 135.91 57.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 66.9 -120.16 0.26 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.948 0.78 . . . . 0.0 110.235 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -164.44 140.97 5.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 7.6 Cg_exo -73.04 46.83 1.17 Allowed 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.097 2.532 . . . . 0.0 112.127 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -110.51 -40.5 4.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.033 0.444 . . . . 0.0 110.105 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -82.11 56.48 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.605 0.717 . . . . 0.0 109.712 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' THR . 12.4 m -61.56 124.31 20.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.07 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.737 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 12.0 t0 -79.27 124.44 84.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.01 -32.13 94.5 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.349 2.699 . . . . 0.0 113.715 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.737 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 16.8 ptt180 -74.27 -10.24 59.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 6' ' ' ASN . 55.5 mt -88.34 106.94 17.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -97.55 -45.99 6.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.292 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -156.79 142.99 18.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.211 0.529 . . . . 0.0 112.254 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -97.44 128.9 9.71 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.652 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.82 120.13 43.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.2 m -102.02 107.94 54.55 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.26 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -87.64 51.73 2.16 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.453 2.769 . . . . 0.0 112.215 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' H ' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -81.53 146.57 30.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.64 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 48.7 t0 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 2' ' ' ARG . 20.6 mmm180 59.53 50.66 7.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.711 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.5 pt -64.16 129.72 28.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.375 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 8.9 t -88.88 52.8 2.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.478 0.656 . . . . 0.0 110.8 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.409 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 13.7 p -112.28 -144.1 0.39 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.19 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.409 ' H ' ' HB ' ' A' ' 5' ' ' THR . 25.4 p30 -169.91 171.24 7.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.9 m -51.32 -48.22 62.43 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.535 0.522 . . . . 0.0 112.293 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.717 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . . . -58.02 -49.09 78.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.983 0.421 . . . . 0.0 111.0 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.34 31.49 0.51 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.266 0.555 . . . . 0.0 110.822 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.588 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -88.27 -19.32 53.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.925 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m 74.72 118.09 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.095 0.558 . . . . 0.0 110.502 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -53.27 127.85 26.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.544 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.0 -38.09 3.5 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.868 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 70.6 m -90.82 131.7 36.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.222 0.534 . . . . 0.0 109.602 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 17.0 mtmm -104.54 127.94 52.39 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.136 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.588 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 4.7 m-30 -82.68 121.27 26.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.78 0.324 . . . . 0.0 110.303 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -108.3 158.17 17.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.326 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.603 ' OG ' ' HD3' ' A' ' 44' ' ' ARG . 6.0 t -82.64 -158.05 0.25 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.091 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -84.25 -46.53 11.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.166 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -63.98 -37.9 89.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.278 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.07 -6.22 5.07 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.5 m -66.61 132.65 48.64 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.176 0.512 . . . . 0.0 111.151 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.2 t80 -68.5 120.53 14.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.198 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.61 -60.14 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.534 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 16.8 p -171.33 140.12 1.4 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.792 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 29.8 tt0 -81.45 160.23 24.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.95 112.7 2.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.363 -0.446 . . . . 0.0 113.307 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 8' ' ' ALA . 79.4 tt0 -88.79 52.4 2.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.639 0.733 . . . . 0.0 110.138 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 92.0 p -105.28 53.87 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.103 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 8.7 t70 -140.42 131.19 13.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 32.4 Cg_exo -58.59 159.68 19.54 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.041 2.494 . . . . 0.0 112.889 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 48.0 mtm180 78.87 33.34 0.25 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.562 0.745 . . . . 0.0 110.276 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 11.8 p-10 -116.86 148.03 41.25 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.049 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 11.5 Cg_exo -70.08 117.24 4.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.371 2.047 . . . . 0.0 110.651 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -59.89 111.81 1.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 111.093 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.76 -128.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.539 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 69.44 153.85 0.14 Allowed Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 123.737 0.648 . . . . 0.0 111.784 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.72 147.25 88.92 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.786 2.324 . . . . 0.0 111.868 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -64.62 -57.4 9.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 111.225 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -174.82 155.25 2.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.363 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 7.8 m 59.81 42.59 16.39 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.662 0.601 . . . . 0.0 111.817 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.71 124.02 77.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.017 0.437 . . . . 0.0 110.224 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.08 -30.61 90.84 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.474 2.783 . . . . 0.0 113.839 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.603 ' HD3' ' OG ' ' A' ' 18' ' ' SER . 10.9 tpp180 -82.39 -24.0 34.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.037 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.586 HD13 ' HD2' ' A' ' 16' ' ' TYR . 75.9 mt -87.69 123.14 40.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.211 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.29 -58.18 2.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.764 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -140.58 139.85 35.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.329 0.585 . . . . 0.0 111.707 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.28 135.92 12.43 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.974 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.0 mm -120.15 127.01 75.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.868 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 57.9 m -85.61 -50.12 0.53 Allowed Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.053 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 6.2 Cg_exo -73.67 -145.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.811 1.674 . . . . 0.0 111.838 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.4 tp 61.71 38.68 14.95 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.355 0.598 . . . . 0.0 110.4 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.86 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.647 179.761 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--O 1.235 0.331 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -136.24 118.49 15.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.848 0.356 . . . . 0.0 110.412 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 46' ' ' ALA . 13.1 pt -63.67 150.7 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.878 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.0 t -86.49 77.32 9.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.573 0.702 . . . . 0.0 109.661 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 p -141.51 -173.28 3.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.815 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.894 ' HA ' HD12 ' A' ' 45' ' ' ILE . 19.4 p30 -171.69 -172.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.7 m -60.27 -45.1 94.48 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -76.76 -39.87 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.26 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.06 -30.78 69.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.88 140.01 37.49 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.381 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.9 m -67.85 135.75 53.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.759 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 5.9 tmtm? -59.27 126.1 26.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.476 ' N ' ' HD3' ' A' ' 12' ' ' LYS . . . 112.71 -28.62 8.8 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 29.8 m -87.85 128.28 35.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.086 0.469 . . . . 0.0 110.283 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.623 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 31.2 mmtt -93.21 119.33 32.27 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.602 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 15.1 m-85 -95.53 128.28 42.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.254 0.549 . . . . 0.0 111.596 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.623 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 8.6 m-85 -120.8 162.02 20.5 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.495 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.476 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 69.3 m -83.28 176.99 8.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.548 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -72.43 -29.8 64.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.564 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 44.1 p-10 -69.08 -38.37 78.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.968 0.413 . . . . 0.0 110.742 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.22 -13.25 4.35 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 m -66.69 134.38 52.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.095 0.474 . . . . 0.0 111.537 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.0 123.75 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.947 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.448 HG11 HG12 ' A' ' 45' ' ' ILE . 53.6 t -86.29 -65.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 111.243 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.0 p -176.56 152.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.664 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -84.88 139.27 31.99 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -67.35 144.58 44.56 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.144 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.759 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 7.6 tt0 -146.26 46.07 1.23 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.682 0.753 . . . . 0.0 110.399 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 95.1 p -79.13 133.83 36.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.395 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.81 129.66 94.48 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 123.481 0.488 . . . . 0.0 110.272 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -90.0 39.35 0.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.186 2.591 . . . . 0.0 113.132 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -127.81 -47.24 1.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.026 0.441 . . . . 0.0 110.006 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 5.7 p30 -81.08 143.88 53.69 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.387 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 20.1 Cg_exo -65.63 106.26 0.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.403 2.069 . . . . 0.0 111.223 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -62.91 107.61 1.03 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.364 0.602 . . . . 0.0 111.192 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.38 -50.8 0.17 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.46 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -63.97 -53.49 48.33 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.306 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 2.8 Cg_exo -75.65 71.47 5.39 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.297 1.998 . . . . 0.0 111.191 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -139.62 36.4 2.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.354 0.597 . . . . 0.0 110.419 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -83.54 135.55 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.7 m -70.89 123.82 22.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.387 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 66.8 t0 -97.49 110.81 56.44 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 13.0 Cg_exo -69.98 43.98 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.747 2.965 . . . . 0.0 112.28 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HE ' ' HB3' ' A' ' 44' ' ' ARG . 27.5 ttp180 -144.37 -33.21 0.4 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.748 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.894 HD12 ' HA ' ' A' ' 6' ' ' ASN . 39.1 mt -88.82 134.59 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.796 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -111.15 -44.53 3.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.021 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -151.47 150.43 30.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.608 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -122.84 127.89 6.87 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.918 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.1 mm -98.09 119.78 46.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 74.1 m -88.09 -46.67 0.46 Allowed Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 8.6 Cg_exo . . . . . 0 C--N 1.358 1.077 0 C-N-CA 122.332 2.021 . . . . 0.0 112.297 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 121.489 0.662 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.875 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -71.45 140.75 50.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.809 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 46' ' ' ALA . 12.5 pt -60.74 135.91 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.351 0.596 . . . . 0.0 111.822 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.3 t -88.99 60.77 5.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.597 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.449 ' HG1' ' HE2' ' A' ' 16' ' ' TYR . 24.0 p -123.62 -148.54 0.4 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.949 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.668 ' HA ' HD12 ' A' ' 45' ' ' ILE . 2.8 p-10 -170.09 176.76 4.51 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 m -51.09 -45.97 61.65 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.483 0.489 . . . . 0.0 111.8 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.64 82.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.844 0.354 . . . . 0.0 111.297 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.1 56.45 2.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.106 0.479 . . . . 0.0 110.767 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.09 133.79 3.52 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -59.45 136.71 58.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.268 0.227 . . . . 0.0 111.426 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 14' ' ' CYS . 17.7 tppt? -56.19 -36.49 68.44 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 110.604 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.85 27.39 1.95 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.129 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.727 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 59.1 m -147.32 138.23 23.63 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.638 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 29.0 mttt -114.78 127.48 55.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.836 0.35 . . . . 0.0 110.216 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.532 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 3.3 m-85 -81.22 129.45 34.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.02 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.455 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 26.0 m-85 -123.11 158.99 29.47 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.407 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.544 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 50.9 m -86.32 164.82 16.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.34 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.406 ' CG ' HH21 ' A' ' 2' ' ' ARG . 1.0 OUTLIER -68.98 -25.44 64.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.914 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.544 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 3.5 p-10 -70.84 -34.46 71.7 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.78 -17.21 5.25 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.439 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.496 HG22 HH22 ' A' ' 44' ' ' ARG . 83.1 m -71.68 135.13 46.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.231 0.538 . . . . 0.0 111.912 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.638 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 26.9 t80 -65.69 130.63 43.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.675 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.547 HG11 ' CG1' ' A' ' 45' ' ' ILE . 46.2 t -90.96 -68.34 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 p -169.03 159.02 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.178 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -80.34 162.7 24.39 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.05 98.19 0.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.513 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -90.11 51.27 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.932 0.396 . . . . 0.0 110.952 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -80.16 47.14 0.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.155 0.503 . . . . 0.0 111.635 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 38.7 t70 -74.09 135.44 76.75 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.927 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 57.2 Cg_endo -71.29 45.31 0.63 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.922 2.414 . . . . 0.0 113.938 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -134.46 34.19 3.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 34' ' ' PRO . 14.8 p30 39.19 58.19 6.08 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 33' ' ' ASN . 12.8 Cg_exo -69.33 87.7 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.619 2.212 . . . . 0.0 112.261 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 12.8 mmmt -63.74 134.8 55.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.997 0.903 . . . . 0.0 113.221 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 6' ' ' ASN . . . -161.08 -172.56 3.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.74 -1.573 . . . . 0.0 107.295 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.77 149.17 0.12 Allowed Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.922 0.764 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HB2' ' H ' ' A' ' 39' ' ' ARG . 64.8 Cg_endo -72.54 -141.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.896 2.397 . . . . 0.0 112.866 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.445 ' H ' ' HB2' ' A' ' 38' ' ' PRO . 13.8 tpt180 -61.01 -40.8 94.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.379 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -176.22 144.31 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.631 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 m 62.54 116.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 O-C-N 124.03 0.831 . . . . 0.0 111.971 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.682 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . 9.3 t70 -71.37 122.16 86.33 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 64.3 Cg_exo -53.05 -32.67 59.56 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.643 2.896 . . . . 0.0 114.762 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.496 HH22 HG22 ' A' ' 22' ' ' THR . 5.7 ptm180 -104.61 -3.21 24.07 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.682 ' HB ' ' HB3' ' A' ' 42' ' ' ASP . 23.4 mt -89.0 132.65 33.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.007 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.875 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -125.02 -49.51 1.72 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.134 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -154.65 148.65 25.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 0.0 111.9 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.54 125.4 7.8 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.615 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.0 mm -101.82 120.33 51.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.727 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 39.0 m -89.87 110.79 42.3 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.606 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 5.8 Cg_exo . . . . . 0 C--N 1.345 0.347 0 C-N-CA 123.4 2.733 . . . . 0.0 111.904 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.84 0.353 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -140.05 123.88 17.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 46' ' ' ALA . 13.7 pt -60.54 139.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.26 0.552 . . . . 0.0 111.68 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 40.4 t -85.93 83.93 7.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.517 0.675 . . . . 0.0 109.211 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -139.86 -159.39 0.95 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.989 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.511 ' HA ' HD12 ' A' ' 45' ' ' ILE . 4.4 p-10 -170.47 171.96 6.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.6 m -51.87 -40.85 61.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.59 -46.0 81.05 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 110.915 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.88 40.53 0.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.179 0.514 . . . . 0.0 110.659 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.479 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -110.51 129.49 9.34 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.854 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.443 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 10.7 m -63.69 131.87 49.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.543 0.211 . . . . 0.0 110.646 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -57.91 132.29 52.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.362 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.47 -26.2 16.96 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.218 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 38.1 m -88.26 129.56 35.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 50.6 mttm -99.23 120.74 40.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.949 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.737 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.5 m-85 -88.57 127.13 35.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.042 0.449 . . . . 0.0 110.984 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.521 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 26.9 m-85 -120.69 161.06 22.05 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.86 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -83.89 165.27 18.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.97 -34.07 76.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.466 0.175 . . . . 0.0 111.005 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.08 -37.59 84.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.83 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.33 -23.68 2.84 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.053 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 m -59.8 136.92 58.15 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.8 t80 -74.12 123.87 25.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.947 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.598 HG11 ' CG1' ' A' ' 45' ' ' ILE . 13.9 t -85.76 -64.5 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.609 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 p -178.31 157.68 1.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.699 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.456 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 4.6 tt0 -86.26 -159.99 0.52 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.463 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.456 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -83.14 89.57 1.52 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.457 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -88.18 39.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.365 0.603 . . . . 0.0 110.596 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 p -85.45 56.41 3.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.162 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.2 t70 -126.38 135.87 27.81 Favored Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.357 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 23.3 Cg_exo -65.03 -179.12 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.879 2.386 . . . . 0.0 112.439 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.9 mtm-85 78.84 -32.11 0.15 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.972 0.909 . . . . 0.0 110.705 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -141.41 54.57 4.36 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.409 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 56.2 Cg_endo -70.04 137.54 34.88 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.79 1.66 . . . . 0.0 110.946 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 34' ' ' PRO . 67.9 mmtt -126.4 127.06 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.77 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.16 136.57 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.167 0.917 . . . . 0.0 111.888 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -69.92 136.96 87.41 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.154 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 7.8 Cg_exo -72.11 68.71 3.23 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.318 2.679 . . . . 0.0 111.933 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.1 ttp85 -155.38 -42.29 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.075 0.465 . . . . 0.0 110.606 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.18 121.52 28.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.216 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 2.3 m -69.86 128.34 36.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.739 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.429 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 67.2 t0 -79.6 114.97 50.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 19.6 Cg_endo -61.05 -17.25 50.81 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.041 2.494 . . . . 0.0 112.483 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.1 mtp-105 -73.09 -35.38 66.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.598 ' CG1' HG11 ' A' ' 24' ' ' VAL . 43.4 mt -88.48 134.37 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.422 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -118.12 -47.98 2.56 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.986 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -154.14 145.72 23.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.209 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.13 128.4 8.84 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.553 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.6 mm -93.82 121.01 44.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 94.6 m -97.77 152.61 38.21 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.992 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo . . . . . 0 N--CA 1.463 -0.313 0 C-N-CA 122.404 2.069 . . . . 0.0 111.525 179.926 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 2' ' ' ARG . 1.2 p30 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.402 0.62 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 1' ' ' ASP . 13.0 mtt-85 -151.96 131.74 13.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.085 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -76.06 141.29 15.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.801 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 47.6 t -87.23 59.62 5.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.717 0.77 . . . . 0.0 109.532 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 p -135.28 125.9 27.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.431 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.441 ' HA ' HD12 ' A' ' 45' ' ' ILE . 3.4 p-10 -90.28 176.52 6.71 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.0 m -51.2 -44.74 61.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.971 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . . . -61.05 -47.53 85.97 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.15 67.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.998 0.427 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.34 138.13 48.42 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.539 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -67.71 124.42 23.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.689 0.281 . . . . 0.0 110.936 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -60.02 131.3 50.42 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.449 ' O ' ' HE2' ' A' ' 15' ' ' LYS . . . 112.35 -33.91 5.44 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.8 m -88.63 131.47 34.96 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.514 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -97.93 119.05 35.86 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.747 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 3.9 m-85 -89.62 125.07 35.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.157 0.503 . . . . 0.0 110.872 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.98 163.55 15.42 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.95 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.4 t -86.49 168.56 13.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.921 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -66.8 -32.77 74.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.83 0.348 . . . . 0.0 110.336 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.53 -32.56 73.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.647 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.23 -23.75 4.29 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.191 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.8 m -62.92 135.45 57.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.141 0.496 . . . . 0.0 111.992 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.3 t80 -71.17 124.29 24.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.787 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.584 HG11 HG12 ' A' ' 45' ' ' ILE . 46.8 t -87.91 -64.96 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.515 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 p -172.89 153.95 2.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 111.58 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.99 157.61 17.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.334 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.78 130.02 45.71 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.429 -0.415 . . . . 0.0 113.849 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.971 ' HB3' ' HA ' ' A' ' 8' ' ' ALA . 6.6 tt0 -96.82 0.26 49.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.145 0.498 . . . . 0.0 110.734 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.3 p -77.75 -168.92 1.34 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.48 . . . . 0.0 111.632 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.517 ' HB3' HD21 ' A' ' 33' ' ' ASN . 38.7 t0 -163.86 124.31 1.4 Allowed Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 17.3 Cg_exo -68.7 38.25 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.175 2.583 . . . . 0.0 113.983 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HE ' ' CG ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -147.12 17.8 1.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.517 HD21 ' HB3' ' A' ' 30' ' ' ASP . 8.3 p30 -165.21 142.03 4.76 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.033 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.54 57.88 5.66 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.805 2.337 . . . . 0.0 113.861 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -80.25 105.84 11.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.946 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -163.97 29.45 0.08 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.52 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.719 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -74.78 -56.64 2.13 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.849 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.719 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 8.2 Cg_exo -71.33 134.35 24.55 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.894 1.729 . . . . 0.0 110.82 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -157.09 48.87 0.44 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.233 0.539 . . . . 0.0 110.9 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -80.39 138.56 36.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.018 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 38.6 m -75.78 70.68 2.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.384 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.592 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 33.2 t70 -66.14 115.57 24.76 Favored Pre-proline 0 C--N 1.332 -0.179 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.39 -24.83 78.87 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.302 2.668 . . . . 0.0 112.979 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.592 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 19.7 ttm105 -66.8 -33.53 75.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.628 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.584 HG12 HG11 ' A' ' 24' ' ' VAL . 62.5 mt -88.2 108.98 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.084 0.469 . . . . 0.0 110.053 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.07 -48.17 5.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.497 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -153.39 145.13 23.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.12 128.18 8.89 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.34 119.45 47.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.764 0.316 . . . . 0.0 110.964 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.5 m -98.0 122.16 55.32 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo . . . . . 0 N--CA 1.465 -0.174 0 C-N-CA 123.082 2.521 . . . . 0.0 112.687 -179.552 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.477 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . 44.5 t0 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.602 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -169.31 62.88 0.05 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 46' ' ' ALA . 6.9 pt -55.3 142.88 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.934 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 t -87.22 66.86 9.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.553 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.7 p -133.91 -149.41 0.36 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.723 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.798 ' HA ' HD12 ' A' ' 45' ' ' ILE . 24.4 p30 -174.12 -159.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.8 m -66.25 -63.73 1.01 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.064 0.227 . . . . 0.0 111.135 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.961 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . . . -57.5 -38.39 74.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.029 0.443 . . . . 0.0 112.081 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.88 -19.43 60.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.082 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.94 147.9 31.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.681 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.441 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 20.2 m -63.39 124.19 20.64 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.585 0.231 . . . . 0.0 111.359 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -57.4 132.1 52.08 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.531 ' N ' ' HD2' ' A' ' 12' ' ' LYS . . . 106.6 -36.37 4.44 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.729 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 76.2 m -88.35 132.98 34.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.675 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.857 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 25.0 mmtp -82.92 111.33 18.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.74 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.698 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 6.1 m-85 -86.97 124.15 32.85 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.233 0.54 . . . . 0.0 109.894 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.968 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -147.49 178.5 8.39 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.395 0.617 . . . . 0.0 111.834 -178.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.532 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 14.7 m -76.14 168.49 19.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.543 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -66.89 -35.35 79.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.1 p-10 -63.49 -41.4 98.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.999 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.7 -11.92 2.92 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.074 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.7 m -62.61 111.04 1.9 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.86 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.968 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 25.1 t80 -68.08 122.72 18.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.113 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.631 HG23 ' HA ' ' A' ' 17' ' ' PHE . 45.8 t -91.55 -61.84 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.549 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.9 p -174.58 152.69 1.71 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.96 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.857 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 10.2 tt0 -80.06 158.29 26.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -65.09 133.92 36.79 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.029 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.961 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 45.2 mt-10 -105.71 16.13 25.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.694 0.247 . . . . 0.0 111.629 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.626 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 26.5 p -80.3 46.78 0.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.402 0.62 . . . . 0.0 110.823 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.408 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 12.3 t0 -66.15 -50.77 49.05 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.518 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 4.2 Cg_exo -76.23 27.05 0.41 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.236 1.957 . . . . 0.0 112.657 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 52.28 40.89 29.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.308 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.626 ' OD1' ' HA ' ' A' ' 29' ' ' SER . 8.8 p-10 -74.49 132.76 78.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.402 . . . . 0.0 110.739 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.33 67.67 3.5 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.144 2.563 . . . . 0.0 112.023 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 68.31 -134.08 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.048 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.15 -144.27 0.11 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.568 0.223 . . . . 0.0 110.998 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.06 138.11 94.78 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.483 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.12 45.7 1.42 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.847 2.365 . . . . 0.0 112.604 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -174.17 47.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.249 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.96 41.53 1.54 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.331 0.586 . . . . 0.0 111.367 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.1 m -80.93 124.21 28.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.356 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.515 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 33.4 t70 -75.02 114.82 38.75 Favored Pre-proline 0 C--O 1.239 0.531 0 O-C-N 123.233 0.333 . . . . 0.0 110.387 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.41 46.93 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.298 2.665 . . . . 0.0 111.896 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.515 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 13.9 ttp180 -154.94 -23.53 0.12 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.907 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 6' ' ' ASN . 63.3 mt -85.64 120.89 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.029 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -95.61 -51.9 4.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.449 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.477 ' HD2' ' HB3' ' A' ' 1' ' ' ASP . 13.7 p90 -159.92 154.25 23.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.034 0.445 . . . . 0.0 111.59 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.08 131.56 10.51 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.902 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.4 mm -122.02 132.93 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.756 0.312 . . . . 0.0 111.18 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.4 m -88.49 -54.21 0.34 Allowed Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 C--N 1.353 0.795 0 C-N-CA 121.768 1.646 . . . . 0.0 113.4 -179.185 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.654 0.74 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.406 ' NE ' ' HA ' ' A' ' 46' ' ' ALA . 39.1 ttt180 -73.9 124.49 26.25 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.938 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -65.32 124.84 21.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.452 0.644 . . . . 0.0 111.771 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 t -93.42 51.17 1.57 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.592 0.71 . . . . 0.0 109.724 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.424 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 9.1 p -110.04 -145.47 0.4 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.356 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.519 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 16.1 p30 -173.16 176.92 2.84 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.8 m -53.19 -47.77 68.61 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.514 ' HB1' ' HG2' ' A' ' 31' ' ' PRO . . . -68.72 -44.54 73.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.226 0.536 . . . . 0.0 110.44 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.18 49.16 1.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.285 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA2' ' OH ' ' A' ' 16' ' ' TYR . . . -104.2 -141.1 10.89 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.125 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.75 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 87.2 m -157.4 131.58 8.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HD3' ' H ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -55.19 131.54 45.53 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.306 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.87 21.6 71.02 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.524 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 57.9 m -137.63 127.61 25.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 25.9 mtmm -107.26 131.54 54.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.102 0.477 . . . . 0.0 111.763 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.719 ' HD2' HD13 ' A' ' 45' ' ' ILE . 6.4 m-30 -85.24 126.85 34.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.369 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -121.63 155.95 34.01 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.451 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.502 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 19.9 m -78.4 175.68 10.06 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.071 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.44 -38.14 86.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.207 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 43.1 p-10 -66.52 -40.24 89.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.948 0.404 . . . . 0.0 111.069 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.15 -7.97 3.78 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.5 m -65.33 134.35 53.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.13 0.49 . . . . 0.0 111.477 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -73.35 122.08 21.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.619 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.56 -63.02 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.72 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 p -174.5 147.67 1.13 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.373 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 19.2 tt0 -77.78 151.8 33.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.75 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -68.3 94.57 0.33 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.683 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 13.3 tp10 -88.82 69.89 8.65 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 11.4 p -77.51 41.92 0.34 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.528 -1.214 . . . . 0.0 113.266 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.511 ' H ' ' HD2' ' A' ' 31' ' ' PRO . 22.6 t70 -89.7 -51.26 0.36 Allowed Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 119.421 -0.323 . . . . 0.0 111.011 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.514 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 42.9 Cg_endo -67.7 58.66 0.79 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 122.87 2.38 . . . . 0.0 112.497 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -65.64 -26.99 68.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.871 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -73.09 135.87 79.73 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.822 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -45.4 128.94 10.58 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 123.581 2.854 . . . . 0.0 114.248 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 35.9 mmtm -149.09 158.13 43.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.493 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.05 -24.94 58.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.66 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -61.93 -54.34 51.56 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 11.9 Cg_exo -70.51 122.22 8.71 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.918 1.745 . . . . 0.0 111.597 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -114.15 -124.64 0.28 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -171.04 152.85 3.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.048 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.7 m 56.32 52.99 9.32 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.759 0.662 . . . . 0.0 111.907 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 37.0 t70 -66.3 127.92 93.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 9.9 Cg_endo -51.87 -36.15 62.29 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.764 2.976 . . . . 0.0 114.605 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.09 -23.87 35.52 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.888 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.719 HD13 ' HD2' ' A' ' 16' ' ' TYR . 91.8 mt -87.36 127.62 40.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.232 0.539 . . . . 0.0 111.927 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . . . -120.91 -50.61 2.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.858 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -149.75 148.35 29.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.979 0.418 . . . . 0.0 111.802 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.94 134.03 11.92 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.5 mm -112.89 129.16 69.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.646 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 39.2 m -101.96 -55.63 0.12 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.253 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 74.2 Cg_endo . . . . . 0 C--N 1.355 0.884 0 C-N-CA 121.651 1.567 . . . . 0.0 112.701 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 2' ' ' ARG . 4.2 p-10 . . . . . 0 C--O 1.233 0.193 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.92 ' HD2' ' HA ' ' A' ' 46' ' ' ALA . 26.8 ptt-85 47.7 -164.42 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.192 0.932 . . . . 0.0 112.664 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -82.54 120.8 34.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.122 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.2 t -89.11 58.36 4.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.547 0.689 . . . . 0.0 109.994 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 23.5 p -117.29 -152.03 0.49 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.742 ' HA ' HD12 ' A' ' 45' ' ' ILE . 14.6 p30 -175.45 172.26 2.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 59.2 m -58.05 -43.09 86.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.02 -44.17 82.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 111.579 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.06 26.08 6.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.591 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.19 129.11 11.24 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.707 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 m -67.22 124.4 23.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.737 0.303 . . . . 0.0 110.785 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.915 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 54.3 mtmt -55.96 136.06 52.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.415 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.89 -30.96 7.33 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.922 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 39.7 m -88.98 125.03 34.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.0 110.642 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.677 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 2.2 tppt? -85.86 119.42 26.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.205 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.485 ' HD2' HG21 ' A' ' 45' ' ' ILE . 2.4 m-85 -89.41 124.73 34.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.272 0.558 . . . . 0.0 111.423 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 87.4 m-85 -122.56 158.18 30.47 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.088 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 p -78.11 -161.51 0.27 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.13 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -44.97 47.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.55 0.214 . . . . 0.0 111.253 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -63.36 -39.81 95.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.601 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.61 0.9 5.24 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -67.47 135.98 53.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.033 0.444 . . . . 0.0 111.033 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -67.26 112.52 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.925 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.596 HG11 HG12 ' A' ' 45' ' ' ILE . 83.6 t -87.83 -55.72 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.28 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.411 ' SG ' HG12 ' A' ' 24' ' ' VAL . 7.7 p -174.38 -170.18 0.5 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.946 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.818 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 13.9 tt0 -134.27 -158.81 0.91 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.742 0.305 . . . . 0.0 110.645 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.818 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -79.78 85.78 1.27 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.251 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -88.26 15.39 7.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.87 0.367 . . . . 0.0 110.985 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 p -79.67 55.31 1.98 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.915 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 24.4 t0 -173.94 -57.73 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 7.3 Cg_exo -72.86 65.68 4.02 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.421 2.081 . . . . 0.0 112.657 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 64.07 55.01 1.59 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -48.63 134.61 13.55 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.106 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.82 178.55 3.89 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.681 2.254 . . . . 0.0 110.678 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.716 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -92.95 129.95 38.7 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.213 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 73.7 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.727 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -67.24 -48.91 46.4 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.313 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 11.7 Cg_exo -70.97 66.28 2.49 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.648 2.232 . . . . 0.0 111.859 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -68.65 -34.49 75.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.82 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -80.34 45.49 0.76 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.425 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.9 m 67.37 118.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.413 0.685 . . . . 0.0 110.933 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.567 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 10.5 t70 -58.06 111.67 3.84 Favored Pre-proline 0 C--O 1.24 0.566 0 CA-C-O 120.75 0.31 . . . . 0.0 111.0 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.8 52.1 2.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.653 2.902 . . . . 0.0 112.042 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.567 ' HB3' ' OD1' ' A' ' 42' ' ' ASP . 12.8 ttp180 -166.27 -34.31 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.313 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.742 HD12 ' HA ' ' A' ' 6' ' ' ASN . 62.7 mt -89.39 129.76 39.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.2 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.92 ' HA ' ' HD2' ' A' ' 2' ' ' ARG . . . -115.16 -44.19 3.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -152.77 152.89 32.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 112.009 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.4 128.69 7.26 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.937 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mm -97.24 116.06 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 49.9 m -89.19 -52.03 0.36 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.672 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 60.5 Cg_endo . . . . . 0 C--N 1.354 0.84 0 C-N-CA 121.56 1.507 . . . . 0.0 112.365 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 13.0 mtm105 62.76 58.25 1.61 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.549 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.3 pt -58.08 150.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.518 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 40.9 t -85.2 78.69 9.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.6 0.714 . . . . 0.0 109.575 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.2 p -138.71 -156.62 0.7 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.04 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.562 ' HA ' HD12 ' A' ' 45' ' ' ILE . 17.1 p30 -178.3 178.59 0.87 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 m -54.12 -55.45 27.54 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.806 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . . . -62.2 -35.76 79.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.81 -30.17 62.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.882 0.373 . . . . 0.0 111.366 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.93 147.13 48.81 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.206 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.453 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 23.1 m -69.31 128.29 36.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.562 0.22 . . . . 0.0 111.122 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 43.8 mtmt -57.05 136.22 56.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.344 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.75 -32.27 7.42 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.658 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.5 m -87.91 134.27 33.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.974 0.416 . . . . 0.0 109.958 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.52 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 38.3 mmtt -93.1 122.47 35.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.488 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.67 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.3 m-85 -95.17 129.73 42.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.966 0.412 . . . . 0.0 110.823 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 38.3 m-85 -121.04 165.22 15.61 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.885 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.2 m -79.1 -156.65 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.748 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -84.75 -42.17 15.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.746 0.308 . . . . 0.0 110.622 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -63.98 -42.46 97.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.633 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.89 -5.25 3.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.1 m -64.34 131.2 46.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.005 0.431 . . . . 0.0 110.779 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.9 t80 -70.3 117.74 12.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.942 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.653 HG11 HG12 ' A' ' 45' ' ' ILE . 86.0 t -81.66 -63.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.986 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.455 ' SG ' HG12 ' A' ' 24' ' ' VAL . 16.6 p -178.1 167.79 1.99 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.502 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -95.57 156.25 16.4 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -68.81 133.39 27.12 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.874 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.806 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 29.9 mt-10 -116.09 32.78 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.977 0.418 . . . . 0.0 110.243 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 11' ' ' THR . 14.5 p -78.41 55.0 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 0.0 111.76 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.577 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 13.0 t0 -68.12 -56.79 10.3 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.006 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 1.2 Cg_endo -82.21 12.89 2.69 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.264 1.976 . . . . 0.0 111.254 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 60.66 33.66 20.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.549 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -169.85 137.14 1.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.18 0.514 . . . . 0.0 110.964 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.32 60.14 7.24 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.803 2.335 . . . . 0.0 111.501 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.635 ' NZ ' ' HB2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER 67.76 116.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.499 -178.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 57.57 -135.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.812 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -96.79 134.57 22.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.52 0.2 . . . . 0.0 110.684 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 22.6 Cg_exo -64.22 130.84 28.26 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.717 2.278 . . . . 0.0 111.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -164.04 45.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.887 0.375 . . . . 0.0 110.999 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -160.32 125.84 3.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.124 0.487 . . . . 0.0 110.475 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 3.3 m -107.98 125.9 52.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.07 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 17.2 t0 -90.35 110.75 42.96 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 27.5 Cg_endo -62.28 -21.71 73.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.414 2.742 . . . . 0.0 112.306 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.485 ' HE ' ' HB3' ' A' ' 44' ' ' ARG . 26.5 ttp180 -66.06 -30.87 71.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.688 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.653 HG12 HG11 ' A' ' 24' ' ' VAL . 50.9 mt -89.53 126.5 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.935 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -110.65 -42.98 3.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.7 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -156.37 145.41 20.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.274 0.559 . . . . 0.0 112.0 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.67 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.24 131.54 10.64 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.488 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.99 121.69 55.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.057 0.456 . . . . 0.0 111.023 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 76.7 m -97.92 137.95 20.95 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.7 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.6 Cg_exo . . . . . 0 CA--C 1.53 0.317 0 C-N-CA 122.884 2.39 . . . . 0.0 112.445 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 121.423 0.63 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -151.68 60.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.859 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.2 pt -64.62 140.64 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.336 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 52.2 t -87.15 69.11 10.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.554 0.693 . . . . 0.0 110.268 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.9 p -120.49 -164.15 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.86 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -175.04 161.09 2.86 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.4 m -60.06 -35.31 74.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.49 -23.55 64.59 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.198 0.523 . . . . 0.0 110.938 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.41 -109.56 0.36 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.177 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.92 -136.45 50.83 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.186 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.5 m -152.17 127.53 9.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 42.0 tptt -60.07 133.11 55.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.783 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.08 -26.16 23.88 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.893 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.451 ' HB2' ' HE1' ' A' ' 16' ' ' TYR . 33.9 m -88.05 129.76 35.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.125 0.488 . . . . 0.0 110.458 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -90.3 114.92 27.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.047 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.703 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.1 m-85 -96.2 128.68 43.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.855 0.36 . . . . 0.0 110.359 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.995 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 0.6 OUTLIER -148.91 178.27 8.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.028 0.442 . . . . 0.0 111.502 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.1 p -78.72 174.7 11.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.887 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -68.6 -35.6 77.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.27 -36.59 84.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.041 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.32 -18.84 4.13 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.238 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.3 m -58.56 115.35 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.059 0.457 . . . . 0.0 111.262 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.995 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 23.8 t80 -65.04 118.14 8.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.569 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.535 HG23 ' HA ' ' A' ' 17' ' ' PHE . 87.8 t -84.81 -58.91 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.353 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 26.0 p -178.26 151.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.775 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.2 147.06 28.25 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.19 124.41 29.95 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.746 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -128.4 65.49 1.4 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.58 43.18 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.627 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -70.02 130.02 90.24 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.148 178.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 4.4 Cg_exo -81.99 39.05 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.399 2.733 . . . . 0.0 112.973 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.461 ' HG3' HH11 ' A' ' 32' ' ' ARG . 17.2 mmt85 -131.22 -46.7 1.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.479 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 18.0 p30 -62.86 136.19 96.34 Favored Pre-proline 0 C--O 1.237 0.445 0 CA-C-O 121.201 0.524 . . . . 0.0 110.624 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 32.0 Cg_exo -60.22 139.22 86.0 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.609 2.873 . . . . 0.0 113.736 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -132.95 128.62 36.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.098 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.7 -37.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.256 0.347 . . . . 0.0 110.823 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -59.0 136.28 87.7 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.989 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 16.7 Cg_exo -68.38 59.29 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.716 2.944 . . . . 0.0 113.122 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.546 ' HD2' ' OD2' ' A' ' 42' ' ' ASP . 12.6 tpp180 -94.99 43.94 1.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.933 0.873 . . . . 0.0 109.704 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -90.65 139.58 30.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.797 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 65.3 m 60.49 52.62 4.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.672 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.546 ' OD2' ' HD2' ' A' ' 39' ' ' ARG . 8.4 t0 -58.5 113.23 6.21 Favored Pre-proline 0 N--CA 1.464 0.269 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.39 -30.61 91.83 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.575 2.85 . . . . 0.0 113.915 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.522 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 34.5 ptt180 -70.64 -26.25 63.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.375 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.9 mt -89.13 111.31 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.977 0.417 . . . . 0.0 110.761 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.91 -49.99 6.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.245 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.468 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 14.8 p90 -161.77 147.49 13.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.253 0.549 . . . . 0.0 111.678 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.703 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.38 129.4 9.56 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.296 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.11 124.8 52.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.025 0.44 . . . . 0.0 111.194 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.4 m -100.13 139.33 20.64 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.98 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--N 1.342 0.194 0 C-N-CA 122.588 2.192 . . . . 0.0 112.103 -179.854 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.1 t0 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.604 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -64.97 144.93 56.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.205 0.526 . . . . 0.0 111.311 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 pt -68.06 135.01 29.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.238 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 41.8 t -87.66 57.87 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.692 0.758 . . . . 0.0 110.254 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 9' ' ' ALA . 34.1 p -124.5 -143.35 0.31 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.765 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.754 ' HA ' HD12 ' A' ' 45' ' ' ILE . 9.4 p-10 -177.46 -171.15 0.31 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.474 ' C ' ' HG2' ' A' ' 28' ' ' GLU . 4.3 m -60.33 -41.86 94.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.589 0.233 . . . . 0.0 110.453 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.594 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -60.11 -44.47 94.83 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.715 0.293 . . . . 0.0 111.584 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' A' ' 5' ' ' THR . . . -82.52 21.75 0.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.099 0.476 . . . . 0.0 110.521 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -91.46 131.45 10.79 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.188 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.631 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 5.3 m -69.22 148.96 49.1 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.647 0.26 . . . . 0.0 110.591 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -58.34 131.89 52.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.439 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.76 -11.03 54.98 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.13 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 61.3 m -89.52 128.83 36.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.422 0.629 . . . . 0.0 110.624 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 15.2 mmtp -98.81 121.34 40.63 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.715 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.603 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.5 m-85 -92.05 125.76 36.87 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.768 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.26 162.84 16.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.734 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.416 ' HB2' ' H ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -78.51 -154.14 0.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.997 178.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.416 ' H ' ' HB2' ' A' ' 18' ' ' SER . 14.4 p-10 -82.76 -42.15 18.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.681 0.276 . . . . 0.0 110.488 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -64.41 -41.26 96.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.665 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.96 -0.04 4.38 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -68.27 134.5 50.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 110.754 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.9 t80 -68.78 111.88 5.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.614 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.466 HG13 ' HD2' ' A' ' 44' ' ' ARG . 94.7 t -83.26 -57.11 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.778 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.9 p -175.53 158.28 2.22 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.981 0.42 . . . . 0.0 111.923 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 38.0 tt0 -92.44 173.21 7.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -69.91 108.48 2.49 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.572 -0.823 . . . . 0.0 114.062 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.571 ' HG2' ' N ' ' A' ' 8' ' ' ALA . 21.8 pt-20 -89.16 36.43 0.82 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.201 1.0 . . . . 0.0 108.392 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 3.5 p -78.08 56.24 1.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.359 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -63.46 128.97 93.28 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.532 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 33' ' ' ASN . 73.9 Cg_endo -75.63 -136.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.784 2.323 . . . . 0.0 111.237 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.437 ' H ' ' HB2' ' A' ' 31' ' ' PRO . 38.2 mtp85 73.21 -31.96 0.23 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.388 0.675 . . . . 0.0 111.122 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.494 ' H ' ' C ' ' A' ' 31' ' ' PRO . 5.8 p30 -169.37 141.7 2.06 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.055 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 14.0 Cg_exo -70.35 71.8 1.79 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.602 2.868 . . . . 0.0 113.004 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 33' ' ' ASN . 35.5 mtmm -68.23 112.81 5.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.728 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.6 122.07 28.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.321 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.72 114.43 50.06 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.898 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.42 46.51 2.23 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.838 2.359 . . . . 0.0 112.254 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.87 52.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.216 0.531 . . . . 0.0 111.322 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.99 161.48 29.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.399 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 65.62 48.6 1.94 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.365 0.416 . . . . 0.0 110.436 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.666 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 4.4 t0 -60.5 113.59 7.94 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 12.1 Cg_endo -56.58 -33.72 93.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.646 2.898 . . . . 0.0 114.313 -177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.666 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 23.2 ptt180 -71.07 -27.01 63.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.789 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 6' ' ' ASN . 67.7 mt -91.72 127.31 44.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 111.703 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.08 -45.34 3.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.55 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -152.5 145.82 24.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.209 0.528 . . . . 0.0 111.616 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -111.84 129.19 8.97 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.31 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.1 mm -110.69 125.05 67.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 19.2 m -87.68 -51.69 0.41 Allowed Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.646 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 2.8 Cg_exo . . . . . 0 C--N 1.353 0.791 0 C-N-CA 122.373 2.049 . . . . 0.0 112.469 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 110.432 -0.211 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.762 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 61.6 mtt85 54.27 60.52 3.52 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.863 0.727 . . . . 0.0 111.931 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 pt -57.28 147.44 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.323 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 43.6 t -85.33 75.24 10.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.758 0.79 . . . . 0.0 109.937 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.3 p -140.9 -163.94 1.64 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.205 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.957 ' HA ' HD12 ' A' ' 45' ' ' ILE . 15.4 p30 -173.24 -158.62 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 m -69.71 -54.5 13.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.267 0.485 . . . . 0.0 110.467 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -65.91 -44.03 86.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.307 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.82 -4.65 47.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.089 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.26 141.04 23.59 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.053 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 31' ' ' PRO . 72.7 m -68.26 127.19 32.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.727 0.298 . . . . 0.0 110.497 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.721 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 82.2 tttt -57.66 131.31 49.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.907 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.27 -29.59 12.17 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.532 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.5 m -88.42 128.44 35.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.124 0.488 . . . . 0.0 109.943 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.632 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 10.9 mtpp -90.67 114.42 26.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.364 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.723 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.5 m-85 -86.37 126.01 34.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.302 0.572 . . . . 0.0 111.637 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.632 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 14.4 m-85 -119.89 163.07 18.09 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.653 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.7 t -84.32 169.22 14.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -69.1 -32.25 71.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 0.0 110.127 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -66.27 -33.94 76.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.591 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.73 -23.9 3.72 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.195 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -60.97 133.18 55.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.095 0.474 . . . . 0.0 112.097 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -73.49 122.86 22.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.454 HG11 ' CG1' ' A' ' 45' ' ' ILE . 48.9 t -86.93 -65.13 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.403 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.0 p -175.69 152.29 1.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.577 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -85.71 145.72 27.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -66.37 144.41 45.86 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.659 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 8' ' ' ALA . 14.2 pt-20 -117.32 -18.12 9.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.567 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 82.5 p -78.56 139.9 38.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.372 0.606 . . . . 0.0 112.445 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.408 ' OD2' ' HB2' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -63.52 138.14 97.28 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.606 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.562 ' HB3' HG23 ' A' ' 11' ' ' THR . 90.5 Cg_endo -82.36 29.49 0.54 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.663 2.242 . . . . 0.0 113.68 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.7 mmp_? -129.04 29.07 5.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.926 0.393 . . . . 0.0 110.348 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -154.07 146.4 17.34 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.77 143.75 46.79 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.829 2.353 . . . . 0.0 111.631 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -70.19 140.76 52.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.719 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -43.64 -51.27 7.11 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -166.96 125.53 1.05 Allowed Pre-proline 0 C--N 1.328 -0.342 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.571 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 3.0 Cg_exo -75.61 63.21 6.48 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.538 2.825 . . . . 0.0 111.665 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -148.76 -23.11 0.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.011 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -86.37 48.78 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.49 0.662 . . . . 0.0 110.101 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m -67.34 125.52 26.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.058 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 66.0 t0 -78.32 116.98 63.41 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.18 -24.77 75.43 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.334 2.689 . . . . 0.0 113.97 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.489 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 28.6 ptt-85 -93.78 -1.53 54.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.413 -0.515 . . . . 0.0 112.326 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.957 HD12 ' HA ' ' A' ' 6' ' ' ASN . 15.7 mt -102.79 124.02 56.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.984 0.421 . . . . 0.0 110.7 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -108.67 -46.13 3.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.29 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -153.25 147.48 25.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.262 0.553 . . . . 0.0 112.431 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.66 125.68 7.53 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.6 mm -89.74 113.61 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.826 0.346 . . . . 0.0 110.785 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.0 m -95.72 134.14 24.53 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.065 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo . . . . . 0 C--O 1.231 0.167 0 C-N-CA 122.496 2.131 . . . . 0.0 112.32 -179.843 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.3 t70 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.8 ptt85 -162.26 108.05 1.25 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.23 0.538 . . . . 0.0 110.34 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 pt -65.04 145.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.766 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -87.24 78.76 8.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.481 0.658 . . . . 0.0 109.676 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.2 p -138.35 -168.32 2.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.854 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.758 ' HA ' HD12 ' A' ' 45' ' ' ILE . 17.7 p30 -168.9 -179.53 3.73 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -55.99 -46.01 78.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.37 -49.28 17.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.67 60.47 6.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.515 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.53 -143.16 5.03 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.097 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 m -132.19 131.13 41.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.59 ' HG2' ' OE1' ' A' ' 28' ' ' GLU . 29.8 mtpp -56.96 130.09 44.47 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.45 0.469 . . . . 0.0 111.379 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.31 -21.24 25.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.384 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.7 m -88.21 128.98 35.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.285 0.564 . . . . 0.0 110.208 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 46.1 mttm -96.25 123.67 39.96 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.298 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.646 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 11.6 m-85 -92.39 127.46 37.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.204 0.526 . . . . 0.0 111.31 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 12.2 m-85 -118.38 164.61 14.98 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.4 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.9 m -77.29 -158.98 0.12 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.797 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -84.58 -40.38 17.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.776 0.322 . . . . 0.0 110.311 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -65.35 -43.81 89.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.529 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.92 -3.79 2.31 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -65.43 130.13 42.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 110.989 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.1 t80 -72.87 115.71 12.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.732 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.435 HG11 HG13 ' A' ' 45' ' ' ILE . 38.5 t -82.67 -62.43 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 28.7 p -175.21 150.31 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.698 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 23.0 tt0 -83.12 141.23 32.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.562 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.66 132.97 12.07 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.697 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.59 ' OE1' ' HG2' ' A' ' 12' ' ' LYS . 4.5 tp10 -141.09 69.99 1.34 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.961 0.886 . . . . 0.0 109.741 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -85.39 43.56 1.03 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.692 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.578 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.5 t70 -64.47 -51.42 60.08 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.707 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 32.6 Cg_exo -61.55 133.91 48.26 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.741 1.627 . . . . 0.0 111.743 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -81.75 36.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.347 0.594 . . . . 0.0 109.903 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.5 p30 -167.32 63.09 0.66 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.85 132.49 52.27 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.785 2.323 . . . . 0.0 111.634 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -107.97 115.99 31.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.04 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -174.34 176.49 2.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.576 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.27 137.93 95.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 123.058 0.224 . . . . 0.0 110.482 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.62 125.32 15.28 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.355 2.036 . . . . 0.0 112.283 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.0 tpp85 60.56 44.97 11.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -96.04 135.96 37.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.935 0.398 . . . . 0.0 110.096 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.9 m -115.55 123.28 48.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -71.91 115.75 41.31 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.39 -22.36 74.34 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.168 2.578 . . . . 0.0 112.84 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -82.73 -27.51 31.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.758 HD12 ' HA ' ' A' ' 6' ' ' ASN . 68.1 mt -87.86 124.92 41.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.399 0.619 . . . . 0.0 112.332 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.07 -46.78 3.07 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.573 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -149.75 142.93 25.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.346 0.593 . . . . 0.0 111.91 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -103.01 132.3 10.96 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.746 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.1 mm -101.05 122.6 53.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.83 0.348 . . . . 0.0 110.542 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 83.2 m -105.15 124.39 36.68 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.201 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 N--CA 1.462 -0.37 0 C-N-CA 122.69 2.26 . . . . 0.0 112.237 -179.92 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -168.16 121.97 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 45' ' ' ILE . 9.7 pt -65.42 129.67 29.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 110.693 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.01 62.49 6.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.493 0.663 . . . . 0.0 109.406 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -128.73 -154.43 0.64 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.991 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.569 ' HA ' HD12 ' A' ' 45' ' ' ILE . 15.6 p30 -176.84 -166.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 m -61.39 -53.91 50.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.32 0.388 . . . . 0.0 111.083 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.463 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . . . -61.69 -40.57 95.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 0.0 111.007 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.12 57.44 4.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.61 141.5 7.12 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.212 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -61.51 135.69 57.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.479 0.18 . . . . 0.0 110.723 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER -57.89 -32.33 67.6 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.515 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.1 27.16 3.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.074 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.6 m -147.51 132.02 17.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 59.2 mttp -105.67 126.87 52.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.698 ' HD2' HD13 ' A' ' 45' ' ' ILE . 3.1 m-30 -82.99 124.48 30.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.144 0.497 . . . . 0.0 111.249 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -121.47 161.32 22.45 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.799 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.5 t -87.38 163.86 16.54 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.417 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 15.8 p-10 -66.58 -33.04 74.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.662 0.268 . . . . 0.0 110.54 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.49 -31.12 72.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.502 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.28 -21.72 4.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.305 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 m -63.84 133.34 53.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.238 0.542 . . . . 0.0 112.335 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 19.2 t80 -74.56 122.02 22.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.508 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.8 t -86.72 -62.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.396 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.5 p -174.8 150.95 1.34 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.208 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.578 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 37.1 tt0 -80.38 149.64 30.13 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.42 137.99 40.44 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.251 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 8' ' ' ALA . 16.3 pt-20 -137.21 61.05 1.63 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.787 0.803 . . . . 0.0 110.099 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.15 65.66 3.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.89 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.474 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.7 t70 -58.33 128.93 83.15 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.998 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 2.3 Cg_endo -81.77 -147.83 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.072 2.515 . . . . 0.0 111.158 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 70.88 -30.75 0.21 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.399 0.68 . . . . 0.0 112.098 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 31' ' ' PRO . 10.6 p30 -132.12 133.26 23.68 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 121.202 0.525 . . . . 0.0 110.772 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 20.2 Cg_exo -66.81 137.6 45.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.369 2.713 . . . . 0.0 112.956 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -95.04 130.83 41.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.465 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -155.04 148.37 25.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.969 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.407 ' N ' ' HD3' ' A' ' 38' ' ' PRO . . . 56.92 64.73 4.31 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.943 0.777 . . . . 0.0 112.045 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 37' ' ' ALA . 9.5 Cg_exo -72.19 52.62 1.92 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.319 2.679 . . . . 0.0 112.337 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -76.61 49.45 0.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.311 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -153.8 43.99 0.58 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.608 0.718 . . . . 0.0 109.857 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.3 m -65.07 131.99 48.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.498 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.449 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 65.6 t0 -91.46 112.21 53.06 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.919 0.39 . . . . 0.0 110.298 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 29.6 Cg_endo -63.46 -22.89 71.28 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.122 2.548 . . . . 0.0 112.546 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -67.86 -21.95 65.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.782 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.698 HD13 ' HD2' ' A' ' 16' ' ' TYR . 67.3 mt -87.3 133.82 29.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.189 0.518 . . . . 0.0 111.432 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.17 -41.72 2.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.466 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 19' ' ' ASP . 4.5 p90 -155.24 149.18 25.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.051 0.453 . . . . 0.0 111.857 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -106.84 126.66 8.54 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.2 mm -92.27 117.39 35.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.859 0.361 . . . . 0.0 110.612 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.608 ' H ' ' HD2' ' A' ' 51' ' ' PRO . 76.8 m -99.68 -46.19 0.22 Allowed Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.173 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' ' H ' ' A' ' 50' ' ' CYS . 52.1 Cg_endo . . . . . 0 C--N 1.363 1.296 0 C-N-CA 122.2 1.933 . . . . 0.0 113.025 -179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.627 0.251 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.05 138.03 1.65 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.099 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 pt -64.49 133.9 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.3 0.571 . . . . 0.0 111.933 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t -89.79 69.1 7.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.984 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -135.17 -169.73 2.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.802 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.846 ' HA ' HD12 ' A' ' 45' ' ' ILE . 16.9 p30 -165.15 -173.86 3.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 m -59.68 -48.93 79.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.57 -48.95 23.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.11 0.481 . . . . 0.0 110.462 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.87 63.04 7.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.737 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.23 -135.21 2.83 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.734 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.5 m -161.0 125.58 3.56 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 12.8 ttmm -60.91 133.48 56.14 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.178 0.514 . . . . 0.0 109.944 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.19 -39.58 2.55 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 40.0 m -92.49 125.69 37.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.77 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -96.23 125.18 40.56 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.454 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 53.2 m-85 -91.78 126.06 36.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.162 0.506 . . . . 0.0 111.52 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -117.56 163.92 15.7 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.838 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -76.21 -155.21 0.05 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.966 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -91.19 -40.24 11.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.824 0.345 . . . . 0.0 110.129 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.17 -41.83 96.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.772 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.61 -13.55 2.7 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.748 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -60.84 132.0 52.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.285 0.564 . . . . 0.0 111.542 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.593 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.0 t80 -74.0 120.89 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.718 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.0 t -88.3 -62.68 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.308 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.3 p -171.8 149.59 2.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 0.0 111.116 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.77 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 23.1 tt0 -85.38 151.88 23.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -59.83 122.26 29.41 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.467 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -105.27 58.69 0.68 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.577 0.703 . . . . 0.0 110.088 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 p -156.03 141.19 17.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.429 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 10.0 t70 -63.0 134.1 95.67 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.19 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 18.8 Cg_exo -68.36 41.35 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.982 3.122 . . . . 0.0 114.176 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -71.06 -32.83 69.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.416 . . . . 0.0 110.405 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -173.2 149.77 1.79 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.648 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.89 128.61 26.02 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.363 2.042 . . . . 0.0 111.148 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -89.61 140.51 29.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -161.75 145.0 12.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.39 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.47 149.5 21.48 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.095 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.86 116.13 2.91 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.751 2.301 . . . . 0.0 113.248 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 59.37 33.29 22.35 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.642 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.11 26.02 3.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.746 0.784 . . . . 0.0 110.236 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.42 120.52 17.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.07 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 10.0 t70 -78.61 121.3 83.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.24 -27.87 68.47 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.24 2.626 . . . . 0.0 113.524 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 -30.24 26.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.634 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 6' ' ' ASN . 84.6 mt -88.72 123.98 41.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.11 -44.69 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.551 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -146.58 145.34 30.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.445 . . . . 0.0 111.427 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -116.04 136.13 12.68 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.785 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.1 mm -101.52 119.6 49.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 85.9 m -88.22 -41.32 0.48 Allowed Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 50' ' ' CYS . 9.9 Cg_endo . . . . . 0 C--N 1.362 1.274 0 C-N-CA 121.907 1.738 . . . . 0.0 112.052 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 49.2 t0 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 59.21 54.83 4.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.528 0.731 . . . . 0.0 110.518 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -60.11 138.62 20.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.429 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.6 t -86.03 84.93 7.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.8 p -138.48 -168.05 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.832 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -165.6 159.9 17.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.6 m -57.15 -38.1 73.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.68 95.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.983 0.42 . . . . 0.0 110.931 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.86 -96.89 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.062 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.91 -131.82 47.95 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.674 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.3 m -155.02 115.56 3.88 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 18.4 tptm -61.15 121.59 12.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.52 -33.88 4.91 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.422 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 86.3 m -95.56 131.93 41.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.107 0.48 . . . . 0.0 110.159 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 0.8 OUTLIER -92.03 122.11 34.23 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.795 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.4 m-85 -87.04 131.73 34.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.759 0.314 . . . . 0.0 110.743 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -125.41 163.93 21.54 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.767 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.473 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 44.2 m -85.78 -179.99 6.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.119 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -69.5 -37.36 77.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.64 0.257 . . . . 0.0 111.434 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 43.9 p-10 -66.24 -40.41 90.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.14 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.67 -9.64 3.99 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -62.88 132.53 52.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.111 0.481 . . . . 0.0 111.155 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 15' ' ' LYS . 20.6 t80 -71.94 120.15 17.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.696 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.965 HG11 HG12 ' A' ' 45' ' ' ILE . 82.9 t -83.7 -68.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 27.2 p 177.72 158.39 0.42 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -91.7 146.56 23.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -75.23 119.0 5.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.434 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -89.62 50.59 1.93 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 117.452 0.626 . . . . 0.0 111.99 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 40.94 1.03 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.771 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.67 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 1.6 t70 -65.62 -58.31 12.01 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.15 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 9.8 Cg_endo -90.73 -148.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.883 2.389 . . . . 0.0 111.685 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -117.91 41.82 2.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.366 0.603 . . . . 0.0 110.637 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.565 ' OD1' ' HD3' ' A' ' 34' ' ' PRO . 10.1 p-10 -79.56 -40.91 1.47 Allowed Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.565 ' HD3' ' OD1' ' A' ' 33' ' ' ASN . 2.8 Cg_exo -75.83 146.88 30.26 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.074 1.849 . . . . 0.0 112.718 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.497 ' HD2' ' C ' ' A' ' 34' ' ' PRO . 13.4 mptt -124.99 133.95 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.61 -134.22 0.48 Allowed 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.761 0.663 . . . . 0.0 110.471 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.575 ' H ' ' HD2' ' A' ' 38' ' ' PRO . . . -166.81 -52.38 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.575 ' HD2' ' H ' ' A' ' 37' ' ' ALA . 74.4 Cg_endo -74.06 45.02 1.08 Allowed 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.226 1.951 . . . . 0.0 113.336 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -83.64 -40.28 19.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.621 0.724 . . . . 0.0 109.485 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -174.2 135.38 0.46 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.904 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.2 m -123.21 137.17 54.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.824 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 8.0 t0 -86.7 120.18 71.68 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.091 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.11 -24.27 78.97 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.351 2.701 . . . . 0.0 112.55 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.481 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 21.1 ttp180 -68.13 -19.47 64.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.263 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.965 HG12 HG11 ' A' ' 24' ' ' VAL . 57.5 mt -85.94 129.27 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.923 0.392 . . . . 0.0 110.875 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.02 -51.2 2.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.459 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -155.97 144.95 20.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.237 0.542 . . . . 0.0 112.082 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.795 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -104.24 128.3 9.42 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.5 mm -122.58 129.0 75.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 117.183 0.492 . . . . 0.0 112.069 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.3 m -89.57 113.47 56.8 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 177.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.456 -0.679 0 C-N-CA 122.648 2.232 . . . . 0.0 111.793 179.866 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 2' ' ' ARG . 12.4 p-10 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 121.578 0.704 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 1' ' ' ASP . 19.6 mmt85 -121.5 131.96 54.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.939 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -79.11 129.94 36.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.759 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.39 62.34 5.99 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 17.2 p -128.84 -151.95 0.5 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.868 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 21.4 p30 -163.83 -176.79 4.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.764 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.3 m -56.94 -44.39 82.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.151 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 -50.5 72.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.016 0.436 . . . . 0.0 110.61 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.53 37.48 0.64 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.596 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -97.26 -27.37 9.34 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.772 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 10' ' ' GLY . 31.5 m 76.41 126.36 0.04 OUTLIER 'General case' 0 C--O 1.237 0.426 0 C-N-CA 122.878 0.471 . . . . 0.0 111.055 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.596 ' HD2' ' O ' ' A' ' 27' ' ' GLY . 25.2 mmmt -54.85 133.35 47.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.42 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.71 -42.93 1.79 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.727 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.3 m -87.68 136.65 32.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.208 0.527 . . . . 0.0 110.579 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 59.4 mttp -112.02 127.44 55.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.536 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.799 ' HD2' HD13 ' A' ' 45' ' ' ILE . 5.3 m-30 -82.51 129.03 34.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -125.88 160.29 30.31 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.812 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.427 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 39.3 m -83.96 178.87 7.7 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -76.37 -33.28 58.92 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.022 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.5 p-10 -65.87 -39.54 90.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.378 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.27 -14.46 3.49 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.987 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.5 m -62.52 134.06 55.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.272 0.558 . . . . 0.0 111.787 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.543 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 20.0 t80 -75.44 120.78 21.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.196 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 45' ' ' ILE . 57.7 t -84.46 -63.35 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.722 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.2 p -176.61 147.09 0.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.999 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 36.4 tt0 -79.19 150.56 31.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.596 ' O ' ' HD2' ' A' ' 12' ' ' LYS . . . -63.64 122.91 27.73 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.047 -1.073 . . . . 0.0 111.084 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 4.6 tp10 -109.39 63.08 0.6 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.291 0.567 . . . . 0.0 110.278 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.7 p -79.52 112.64 16.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.421 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -69.47 130.37 90.77 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.079 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.26 42.13 1.08 Allowed 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.793 2.329 . . . . 0.0 113.335 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -135.22 52.26 2.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.715 0.293 . . . . 0.0 111.061 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 38.28 69.7 1.45 Allowed Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -70.63 65.97 2.3 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.189 2.593 . . . . 0.0 112.296 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -70.48 137.68 50.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.446 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.67 35.11 7.16 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.867 0.729 . . . . 0.0 111.196 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.0 145.58 96.48 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.796 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.79 114.98 2.14 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.626 2.217 . . . . 0.0 112.009 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.5 ptt-85 -92.59 41.56 1.08 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.263 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.54 115.76 19.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 5' ' ' THR . 7.9 m -77.6 126.85 31.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.761 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.733 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 12.1 t0 -90.42 123.74 64.66 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 47.9 Cg_exo -58.15 -30.65 91.19 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 123.556 2.838 . . . . 0.0 114.273 -178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.733 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 15.5 ptt180 -74.87 -14.62 60.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.799 HD13 ' HD2' ' A' ' 16' ' ' TYR . 75.8 mt -88.17 128.88 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.977 0.418 . . . . 0.0 111.231 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.22 -52.91 2.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.818 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -153.7 150.19 28.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.08 0.467 . . . . 0.0 111.576 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.9 131.62 10.63 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.704 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -105.86 119.31 54.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.781 0.324 . . . . 0.0 110.414 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 35.5 m -104.56 127.29 29.29 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 1.1 Cg_endo . . . . . 0 N--CA 1.457 -0.652 0 C-N-CA 123.469 2.779 . . . . 0.0 112.05 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.874 ' HG3' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -60.67 127.68 32.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.862 0.363 . . . . 0.0 110.707 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -66.88 142.25 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.221 0.534 . . . . 0.0 111.723 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.7 t -87.44 84.0 7.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.493 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 p -140.74 -166.57 2.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.751 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.504 ' HA ' HD12 ' A' ' 45' ' ' ILE . 21.6 p30 -171.99 165.63 6.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -50.18 -47.05 54.67 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.77 92.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.978 0.418 . . . . 0.0 112.008 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.443 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . . . -75.92 -37.34 58.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.847 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.33 144.29 36.79 Favored Glycine 0 N--CA 1.453 -0.219 0 O-C-N 123.847 0.717 . . . . 0.0 114.01 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -77.42 136.37 38.39 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.747 0.419 . . . . 0.0 111.339 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HB2' ' HE3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -58.03 147.57 29.04 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.67 -35.14 4.17 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 77.6 m -89.05 125.49 35.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 72.6 mttt -106.0 119.28 38.78 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.6 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.663 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 6.1 m-85 -87.89 132.2 34.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.671 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -120.86 157.97 28.63 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.481 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.0 t -86.26 161.84 18.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.573 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -65.38 -29.98 70.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.432 0.158 . . . . 0.0 111.387 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.35 -33.89 75.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.973 0.416 . . . . 0.0 110.001 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.69 -14.75 5.51 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.259 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -69.53 130.69 43.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.143 0.497 . . . . 0.0 111.576 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.506 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 23.1 t80 -68.83 129.78 40.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.82 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 18.3 t -90.74 -69.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.468 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.0 p -178.84 157.44 0.9 Allowed 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.371 0.419 . . . . 0.0 111.154 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 69.8 tt0 -88.42 157.52 18.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.88 115.06 7.52 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.497 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -89.42 27.78 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.802 0.334 . . . . 0.0 111.55 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 p -90.99 21.42 4.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.563 0.697 . . . . 0.0 110.737 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.532 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.0 t0 -86.86 -51.99 0.43 Allowed Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.109 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 10.5 Cg_exo -71.26 22.0 0.23 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.29 1.994 . . . . 0.0 112.482 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 30' ' ' ASP . 58.2 mmt-85 52.54 51.18 16.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.042 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 8.5 p30 -64.38 134.92 96.14 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 15.2 Cg_exo -69.08 119.87 6.81 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.821 2.347 . . . . 0.0 111.773 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' NZ ' ' HA ' ' A' ' 9' ' ' ALA . 4.7 mmmm -83.24 96.93 8.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.409 0.623 . . . . 0.0 110.629 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.41 -40.11 9.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.161 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . . . -124.12 59.17 17.61 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.96 58.69 6.62 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.349 2.032 . . . . 0.0 110.869 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.523 ' NH1' ' HA ' ' A' ' 37' ' ' ALA . 7.2 ptp85 -155.34 53.0 0.61 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.542 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -149.2 144.61 26.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.662 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.8 m -111.88 121.07 44.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.946 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.582 ' OD2' ' HB2' ' A' ' 44' ' ' ARG . 9.9 t70 -83.81 120.02 74.45 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.05 -23.29 72.73 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.236 2.624 . . . . 0.0 112.782 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 42.7 mtp85 -71.8 -32.0 67.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.639 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 6' ' ' ASN . 43.6 mt -86.85 120.59 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.566 0.698 . . . . 0.0 112.222 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.874 ' HA ' ' HG3' ' A' ' 2' ' ' ARG . . . -106.74 -48.45 3.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.415 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -150.53 143.13 24.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.061 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -103.97 122.82 7.53 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.695 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.683 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.2 mm -101.43 128.19 54.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 35.8 m -106.41 89.0 3.64 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.743 0.306 . . . . 0.0 110.281 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.683 ' HD3' ' O ' ' A' ' 49' ' ' ILE . 19.2 Cg_endo . . . . . 0 N--CA 1.45 -1.039 0 C-N-CA 123.321 2.68 . . . . 0.0 112.155 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.747 0.308 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.617 ' HG2' ' HA ' ' A' ' 46' ' ' ALA . 7.5 tmm_? -152.66 102.5 2.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 3' ' ' ILE . 5.0 pt -60.13 138.23 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.286 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.5 t -88.31 69.59 9.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.547 0.689 . . . . 0.0 109.715 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.9 p -133.78 153.71 51.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.276 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.565 ' OD1' ' HA ' ' A' ' 39' ' ' ARG . 17.5 p-10 -131.1 160.32 35.05 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -48.66 -46.55 40.31 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.98 -38.33 88.16 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.401 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -114.94 56.91 0.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.809 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.77 -148.77 0.5 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.115 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 78.5 m -155.3 124.53 6.28 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.565 -0.374 . . . . 0.0 111.258 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 56.97 -88.73 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 O-C-N 124.052 0.845 . . . . 0.0 111.341 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.56 41.55 0.18 Allowed Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 108.811 -1.715 . . . . 0.0 108.811 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.1 m -88.09 133.9 33.88 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.657 -0.771 . . . . 0.0 110.52 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 42.2 mttp -83.03 115.9 22.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.175 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 92.0 m-85 -84.03 128.56 34.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.88 0.372 . . . . 0.0 111.11 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -122.47 158.72 29.15 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.344 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.498 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 50.0 m -84.65 176.28 8.68 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -68.07 -35.6 78.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.628 0.252 . . . . 0.0 110.896 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.1 p-10 -65.36 -40.03 93.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.787 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.7 -16.88 3.99 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.201 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.7 m -64.49 134.1 53.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.165 0.507 . . . . 0.0 111.503 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -69.88 123.58 21.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.445 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.656 HG13 ' HD2' ' A' ' 44' ' ' ARG . 21.6 t -84.25 -65.18 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.877 0.37 . . . . 0.0 111.141 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 p -175.33 154.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.624 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.8 tt0 -85.08 144.93 27.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.57 102.63 0.57 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.944 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.21 61.87 5.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.136 0.97 . . . . 0.0 109.139 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 p -92.75 36.83 1.01 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.457 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 45.1 t0 -92.4 124.96 57.84 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.538 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 43.9 Cg_endo -68.31 54.7 0.75 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.261 2.641 . . . . 0.0 114.374 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.405 ' HD3' ' OD2' ' A' ' 30' ' ' ASP . 14.8 mmm180 -69.59 -43.52 72.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -167.5 153.97 7.66 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.284 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.31 123.51 13.27 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.18 1.92 . . . . 0.0 111.928 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.97 128.16 33.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.419 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.0 -30.73 61.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.022 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.92 121.03 81.48 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.08 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.22 153.44 74.56 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.006 2.47 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.565 ' HA ' ' OD1' ' A' ' 6' ' ' ASN . 14.0 ttm180 -77.45 56.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.571 0.7 . . . . 0.0 110.421 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.19 154.82 41.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.111 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.9 m -66.17 93.89 0.23 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 9.6 t0 -62.94 117.84 36.53 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.177 0.513 . . . . 0.0 110.919 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 26.0 Cg_exo -62.68 -25.54 75.16 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 123.276 2.651 . . . . 0.0 112.907 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.656 ' HD2' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -82.26 -26.16 33.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.519 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.442 ' CG1' HG11 ' A' ' 24' ' ' VAL . 54.5 mt -88.4 125.3 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.617 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . . . -109.47 -51.52 2.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.564 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -149.08 147.5 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.81 127.39 8.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.318 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.3 mm -91.56 112.24 25.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.9 m -89.68 128.91 48.74 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.531 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo . . . . . 0 CA--C 1.53 0.28 0 C-N-CA 122.82 2.347 . . . . 0.0 112.363 179.95 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 C--O 1.234 0.264 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -74.86 170.27 16.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 pt -57.81 128.93 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.472 0.653 . . . . 0.0 112.093 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.9 t -88.03 71.3 9.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.257 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 19.8 p -137.16 -158.66 0.88 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.478 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.555 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 18.2 p30 -171.21 -177.17 2.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -60.85 -43.79 97.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.01 66.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.039 0.447 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.95 44.52 1.2 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.981 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.88 142.22 14.45 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.927 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.0 m -58.38 122.36 13.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.577 0.227 . . . . 0.0 110.969 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -59.76 136.73 58.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.668 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.86 -29.7 10.14 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.222 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.7 m -89.46 130.01 35.87 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -99.86 122.08 42.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.978 179.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.789 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.0 m-85 -81.23 128.09 33.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.137 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.652 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 5.7 m-85 -118.57 162.09 18.95 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.674 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.447 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 12.4 t -80.3 -170.26 2.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.245 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -74.21 -44.33 53.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.722 0.296 . . . . 0.0 110.961 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 18' ' ' SER . 42.9 p-10 -62.01 -42.59 99.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.682 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.4 -1.89 3.06 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -69.64 131.14 44.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.008 0.433 . . . . 0.0 110.842 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -69.45 119.73 14.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.774 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.535 HG11 HG12 ' A' ' 45' ' ' ILE . 90.3 t -86.75 -63.95 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.346 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.0 p -174.67 148.48 1.14 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.771 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 14.7 tt0 -82.44 142.51 31.86 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -80.02 145.76 27.4 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.234 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -145.09 67.62 1.24 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-O 122.163 0.982 . . . . 0.0 110.129 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 p -78.76 132.07 36.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.895 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.483 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.2 t70 -63.38 137.2 97.01 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 10.4 Cg_exo -71.3 33.0 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.267 2.645 . . . . 0.0 112.884 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 31' ' ' PRO . 28.4 mmm180 -140.29 -36.39 0.49 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.088 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -171.65 151.88 3.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.043 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.53 128.31 23.2 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 121.94 1.76 . . . . 0.0 111.052 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -62.8 135.91 57.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 66.9 -120.16 0.26 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.948 0.78 . . . . 0.0 110.235 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -164.44 140.97 5.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 7.6 Cg_exo -73.04 46.83 1.17 Allowed 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.097 2.532 . . . . 0.0 112.127 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -110.51 -40.5 4.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.033 0.444 . . . . 0.0 110.105 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -82.11 56.48 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.605 0.717 . . . . 0.0 109.712 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' THR . 12.4 m -61.56 124.31 20.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.07 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.737 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 12.0 t0 -79.27 124.44 84.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.01 -32.13 94.5 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.349 2.699 . . . . 0.0 113.715 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.737 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 16.8 ptt180 -74.27 -10.24 59.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 6' ' ' ASN . 55.5 mt -88.34 106.94 17.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -97.55 -45.99 6.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.292 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -156.79 142.99 18.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.211 0.529 . . . . 0.0 112.254 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -97.44 128.9 9.71 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.652 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.82 120.13 43.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.2 m -102.02 107.94 54.55 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.26 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 N--CA 1.458 -0.608 0 C-N-CA 123.453 2.769 . . . . 0.0 112.215 -179.841 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 48.7 t0 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 2' ' ' ARG . 20.6 mmm180 59.53 50.66 7.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.711 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.5 pt -64.16 129.72 28.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.375 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 8.9 t -88.88 52.8 2.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.478 0.656 . . . . 0.0 110.8 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.409 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 13.7 p -112.28 -144.1 0.39 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.19 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.409 ' H ' ' HB ' ' A' ' 5' ' ' THR . 25.4 p30 -169.91 171.24 7.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.9 m -51.32 -48.22 62.43 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.535 0.522 . . . . 0.0 112.293 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.717 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . . . -58.02 -49.09 78.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.983 0.421 . . . . 0.0 111.0 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.34 31.49 0.51 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.266 0.555 . . . . 0.0 110.822 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.588 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -88.27 -19.32 53.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.925 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m 74.72 118.09 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.095 0.558 . . . . 0.0 110.502 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -53.27 127.85 26.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.544 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.0 -38.09 3.5 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.868 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 70.6 m -90.82 131.7 36.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.222 0.534 . . . . 0.0 109.602 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 17.0 mtmm -104.54 127.94 52.39 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.136 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.588 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 4.7 m-30 -82.68 121.27 26.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.78 0.324 . . . . 0.0 110.303 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -108.3 158.17 17.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.326 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.603 ' OG ' ' HD3' ' A' ' 44' ' ' ARG . 6.0 t -82.64 -158.05 0.25 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.091 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -84.25 -46.53 11.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.166 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -63.98 -37.9 89.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.278 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.07 -6.22 5.07 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.5 m -66.61 132.65 48.64 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.176 0.512 . . . . 0.0 111.151 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.2 t80 -68.5 120.53 14.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.198 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.61 -60.14 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.534 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 16.8 p -171.33 140.12 1.4 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.792 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 29.8 tt0 -81.45 160.23 24.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.95 112.7 2.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.363 -0.446 . . . . 0.0 113.307 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 8' ' ' ALA . 79.4 tt0 -88.79 52.4 2.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.639 0.733 . . . . 0.0 110.138 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 92.0 p -105.28 53.87 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.103 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 8.7 t70 -140.42 131.19 13.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 32.4 Cg_exo -58.59 159.68 19.54 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.041 2.494 . . . . 0.0 112.889 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 48.0 mtm180 78.87 33.34 0.25 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.562 0.745 . . . . 0.0 110.276 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 11.8 p-10 -116.86 148.03 41.25 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.049 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 11.5 Cg_exo -70.08 117.24 4.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.371 2.047 . . . . 0.0 110.651 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -59.89 111.81 1.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 111.093 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.76 -128.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.539 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 69.44 153.85 0.14 Allowed Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 123.737 0.648 . . . . 0.0 111.784 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.72 147.25 88.92 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.786 2.324 . . . . 0.0 111.868 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -64.62 -57.4 9.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 111.225 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -174.82 155.25 2.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.363 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 7.8 m 59.81 42.59 16.39 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.662 0.601 . . . . 0.0 111.817 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.71 124.02 77.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.017 0.437 . . . . 0.0 110.224 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.08 -30.61 90.84 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.474 2.783 . . . . 0.0 113.839 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.603 ' HD3' ' OG ' ' A' ' 18' ' ' SER . 10.9 tpp180 -82.39 -24.0 34.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.037 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.586 HD13 ' HD2' ' A' ' 16' ' ' TYR . 75.9 mt -87.69 123.14 40.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.211 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.29 -58.18 2.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.764 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -140.58 139.85 35.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.329 0.585 . . . . 0.0 111.707 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.28 135.92 12.43 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.974 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.0 mm -120.15 127.01 75.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.868 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 57.9 m -85.61 -50.12 0.53 Allowed Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.053 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 6.2 Cg_exo . . . . . 0 C--N 1.354 0.817 0 C-N-CA 121.811 1.674 . . . . 0.0 111.838 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 28.8 t70 . . . . . 0 C--O 1.235 0.331 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -136.24 118.49 15.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.848 0.356 . . . . 0.0 110.412 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 46' ' ' ALA . 13.1 pt -63.67 150.7 9.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.878 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.0 t -86.49 77.32 9.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.573 0.702 . . . . 0.0 109.661 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 42.2 p -141.51 -173.28 3.72 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.815 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.894 ' HA ' HD12 ' A' ' 45' ' ' ILE . 19.4 p30 -171.69 -172.43 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 12.7 m -60.27 -45.1 94.48 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -76.76 -39.87 50.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.914 0.388 . . . . 0.0 111.26 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.06 -30.78 69.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.949 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.88 140.01 37.49 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.609 -0.723 . . . . 0.0 113.381 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 89.9 m -67.85 135.75 53.03 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.759 ' HG2' ' HA ' ' A' ' 28' ' ' GLU . 5.9 tmtm? -59.27 126.1 26.3 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.476 ' N ' ' HD3' ' A' ' 12' ' ' LYS . . . 112.71 -28.62 8.8 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 29.8 m -87.85 128.28 35.34 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.086 0.469 . . . . 0.0 110.283 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.623 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 31.2 mmtt -93.21 119.33 32.27 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.602 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 15.1 m-85 -95.53 128.28 42.26 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.254 0.549 . . . . 0.0 111.596 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.623 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 8.6 m-85 -120.8 162.02 20.5 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.495 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.476 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 69.3 m -83.28 176.99 8.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.548 177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -72.43 -29.8 64.03 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.564 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 44.1 p-10 -69.08 -38.37 78.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.968 0.413 . . . . 0.0 110.742 179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.22 -13.25 4.35 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.549 -0.62 . . . . 0.0 111.549 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 m -66.69 134.38 52.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.095 0.474 . . . . 0.0 111.537 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -75.0 123.75 25.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.947 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.448 HG11 HG12 ' A' ' 45' ' ' ILE . 53.6 t -86.29 -65.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 120.804 0.335 . . . . 0.0 111.243 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.0 p -176.56 152.81 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.664 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -84.88 139.27 31.99 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.726 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -67.35 144.58 44.56 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.144 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.759 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 7.6 tt0 -146.26 46.07 1.23 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.682 0.753 . . . . 0.0 110.399 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 95.1 p -79.13 133.83 36.74 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.395 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.81 129.66 94.48 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 123.481 0.488 . . . . 0.0 110.272 178.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -90.0 39.35 0.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 123.186 2.591 . . . . 0.0 113.132 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -127.81 -47.24 1.39 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.026 0.441 . . . . 0.0 110.006 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 5.7 p30 -81.08 143.88 53.69 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.387 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 20.1 Cg_exo -65.63 106.26 0.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.357 0 C-N-CA 122.403 2.069 . . . . 0.0 111.223 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -62.91 107.61 1.03 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.364 0.602 . . . . 0.0 111.192 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -148.38 -50.8 0.17 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.46 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.65 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -63.97 -53.49 48.33 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.306 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 2.8 Cg_exo -75.65 71.47 5.39 Favored 'Trans proline' 0 C--N 1.356 0.924 0 C-N-CA 122.297 1.998 . . . . 0.0 111.191 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -139.62 36.4 2.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.354 0.597 . . . . 0.0 110.419 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -83.54 135.55 34.59 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.391 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.7 m -70.89 123.82 22.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.387 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 66.8 t0 -97.49 110.81 56.44 Favored Pre-proline 0 C--O 1.239 0.502 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 13.0 Cg_exo -69.98 43.98 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.747 2.965 . . . . 0.0 112.28 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HE ' ' HB3' ' A' ' 44' ' ' ARG . 27.5 ttp180 -144.37 -33.21 0.4 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.748 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.894 HD12 ' HA ' ' A' ' 6' ' ' ASN . 39.1 mt -88.82 134.59 27.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.796 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -111.15 -44.53 3.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.021 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.5 p90 -151.47 150.43 30.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 111.608 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.602 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -122.84 127.89 6.87 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.918 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.1 mm -98.09 119.78 46.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.607 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 74.1 m -88.09 -46.67 0.46 Allowed Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 8.6 Cg_exo -72.7 59.06 3.34 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 122.332 2.021 . . . . 0.0 112.297 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -156.65 132.65 9.7 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.137 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.975 -179.353 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 121.489 0.662 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.875 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -71.45 140.75 50.16 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.809 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 46' ' ' ALA . 12.5 pt -60.74 135.91 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.351 0.596 . . . . 0.0 111.822 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.3 t -88.99 60.77 5.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.597 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.449 ' HG1' ' HE2' ' A' ' 16' ' ' TYR . 24.0 p -123.62 -148.54 0.4 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.949 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.668 ' HA ' HD12 ' A' ' 45' ' ' ILE . 2.8 p-10 -170.09 176.76 4.51 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 m -51.09 -45.97 61.65 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.483 0.489 . . . . 0.0 111.8 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.24 -46.64 82.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.844 0.354 . . . . 0.0 111.297 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.1 56.45 2.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.106 0.479 . . . . 0.0 110.767 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.09 133.79 3.52 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -59.45 136.71 58.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 122.268 0.227 . . . . 0.0 111.426 -179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 14' ' ' CYS . 17.7 tppt? -56.19 -36.49 68.44 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.839 0.352 . . . . 0.0 110.604 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.85 27.39 1.95 Allowed Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.129 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.727 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 59.1 m -147.32 138.23 23.63 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.638 ' HB3' ' HE1' ' A' ' 23' ' ' PHE . 29.0 mttt -114.78 127.48 55.76 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.836 0.35 . . . . 0.0 110.216 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.532 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 3.3 m-85 -81.22 129.45 34.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.02 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.455 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 26.0 m-85 -123.11 158.99 29.47 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-N 115.274 -0.876 . . . . 0.0 110.407 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.544 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 50.9 m -86.32 164.82 16.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.34 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.406 ' CG ' HH21 ' A' ' 2' ' ' ARG . 1.0 OUTLIER -68.98 -25.44 64.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.914 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.544 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 3.5 p-10 -70.84 -34.46 71.7 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.78 -17.21 5.25 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.439 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.496 HG22 HH22 ' A' ' 44' ' ' ARG . 83.1 m -71.68 135.13 46.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.231 0.538 . . . . 0.0 111.912 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.638 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 26.9 t80 -65.69 130.63 43.98 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.675 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.547 HG11 ' CG1' ' A' ' 45' ' ' ILE . 46.2 t -90.96 -68.34 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 p -169.03 159.02 8.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.178 -177.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -80.34 162.7 24.39 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.05 98.19 0.55 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.513 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -90.11 51.27 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.932 0.396 . . . . 0.0 110.952 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -80.16 47.14 0.87 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.155 0.503 . . . . 0.0 111.635 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 38.7 t70 -74.09 135.44 76.75 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.844 -0.617 . . . . 0.0 109.927 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 57.2 Cg_endo -71.29 45.31 0.63 Allowed 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.922 2.414 . . . . 0.0 113.938 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -134.46 34.19 3.25 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.344 -0.243 . . . . 0.0 110.344 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 34' ' ' PRO . 14.8 p30 39.19 58.19 6.08 Favored Pre-proline 0 N--CA 1.478 0.964 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 33' ' ' ASN . 12.8 Cg_exo -69.33 87.7 0.5 Allowed 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.619 2.212 . . . . 0.0 112.261 179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 35' ' ' LYS . 12.8 mmmt -63.74 134.8 55.97 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.997 0.903 . . . . 0.0 113.221 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.41 ' HB3' HD22 ' A' ' 6' ' ' ASN . . . -161.08 -172.56 3.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.74 -1.573 . . . . 0.0 107.295 178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 67.77 149.17 0.12 Allowed Pre-proline 0 N--CA 1.468 0.426 0 O-C-N 123.922 0.764 . . . . 0.0 111.676 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HB2' ' H ' ' A' ' 39' ' ' ARG . 64.8 Cg_endo -72.54 -141.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.896 2.397 . . . . 0.0 112.866 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.445 ' H ' ' HB2' ' A' ' 38' ' ' PRO . 13.8 tpt180 -61.01 -40.8 94.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.379 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.4 p30 -176.22 144.31 0.56 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.631 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 27.3 m 62.54 116.2 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 O-C-N 124.03 0.831 . . . . 0.0 111.971 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.682 ' HB3' ' HB ' ' A' ' 45' ' ' ILE . 9.3 t70 -71.37 122.16 86.33 Favored Pre-proline 0 C--O 1.235 0.328 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 64.3 Cg_exo -53.05 -32.67 59.56 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.643 2.896 . . . . 0.0 114.762 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.496 HH22 HG22 ' A' ' 22' ' ' THR . 5.7 ptm180 -104.61 -3.21 24.07 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.682 ' HB ' ' HB3' ' A' ' 42' ' ' ASP . 23.4 mt -89.0 132.65 33.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 119.996 -0.682 . . . . 0.0 111.007 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.875 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -125.02 -49.51 1.72 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.57 -0.452 . . . . 0.0 112.134 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.4 p90 -154.65 148.65 25.74 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.979 0.419 . . . . 0.0 111.9 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.54 125.4 7.8 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.615 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.0 mm -101.82 120.33 51.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.727 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 39.0 m -89.87 110.79 42.3 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.606 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 5.8 Cg_exo -78.19 55.26 5.28 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.4 2.733 . . . . 0.0 111.904 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.0 mt -100.51 38.51 1.5 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.474 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 CA-C-O 117.458 -1.258 . . . . 0.0 109.092 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 . . . . . 0 CA--C 1.529 0.144 0 CA-C-O 120.84 0.353 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -140.05 123.88 17.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 46' ' ' ALA . 13.7 pt -60.54 139.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.26 0.552 . . . . 0.0 111.68 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 40.4 t -85.93 83.93 7.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.517 0.675 . . . . 0.0 109.211 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -139.86 -159.39 0.95 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.989 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.511 ' HA ' HD12 ' A' ' 45' ' ' ILE . 4.4 p-10 -170.47 171.96 6.24 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.6 m -51.87 -40.85 61.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.59 -46.0 81.05 Favored 'General case' 0 C--O 1.226 -0.163 0 CA-C-O 120.749 0.309 . . . . 0.0 110.915 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.88 40.53 0.69 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.179 0.514 . . . . 0.0 110.659 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.479 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -110.51 129.49 9.34 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.854 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.443 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 10.7 m -63.69 131.87 49.27 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.543 0.211 . . . . 0.0 110.646 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -57.91 132.29 52.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.362 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.47 -26.2 16.96 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.218 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.443 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 38.1 m -88.26 129.56 35.33 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.521 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 50.6 mttm -99.23 120.74 40.02 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.949 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.737 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.5 m-85 -88.57 127.13 35.54 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.042 0.449 . . . . 0.0 110.984 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.521 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 26.9 m-85 -120.69 161.06 22.05 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.86 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.4 m -83.89 165.27 18.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.97 -34.07 76.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.466 0.175 . . . . 0.0 111.005 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.08 -37.59 84.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.83 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 139.33 -23.68 2.84 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.647 -0.787 . . . . 0.0 113.053 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 m -59.8 136.92 58.15 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.8 t80 -74.12 123.87 25.24 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.947 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.598 HG11 ' CG1' ' A' ' 45' ' ' ILE . 13.9 t -85.76 -64.5 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.609 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 p -178.31 157.68 1.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.699 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.456 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 4.6 tt0 -86.26 -159.99 0.52 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.463 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.456 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -83.14 89.57 1.52 Allowed Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.457 -179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -88.18 39.17 0.89 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.365 0.603 . . . . 0.0 110.596 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.9 p -85.45 56.41 3.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.162 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.2 t70 -126.38 135.87 27.81 Favored Pre-proline 0 C--N 1.32 -0.703 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.357 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 23.3 Cg_exo -65.03 -179.12 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.879 2.386 . . . . 0.0 112.439 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.9 mtm-85 78.84 -32.11 0.15 Allowed 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.972 0.909 . . . . 0.0 110.705 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -141.41 54.57 4.36 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 56.2 Cg_endo -70.04 137.54 34.88 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 121.79 1.66 . . . . 0.0 110.946 178.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' HD3' ' O ' ' A' ' 34' ' ' PRO . 67.9 mmtt -126.4 127.06 44.87 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.77 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 70.16 136.57 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.167 0.917 . . . . 0.0 111.888 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.461 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -69.92 136.96 87.41 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.154 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 7.8 Cg_exo -72.11 68.71 3.23 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.318 2.679 . . . . 0.0 111.933 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 56.1 ttp85 -155.38 -42.29 0.08 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.075 0.465 . . . . 0.0 110.606 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -85.18 121.52 28.06 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.216 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 2.3 m -69.86 128.34 36.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.739 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.429 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 67.2 t0 -79.6 114.97 50.08 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 19.6 Cg_endo -61.05 -17.25 50.81 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.041 2.494 . . . . 0.0 112.483 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.1 mtp-105 -73.09 -35.38 66.62 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.598 ' CG1' HG11 ' A' ' 24' ' ' VAL . 43.4 mt -88.48 134.37 28.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' O ' HG12 ' A' ' 3' ' ' ILE . . . -118.12 -47.98 2.56 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.986 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -154.14 145.72 23.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.209 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.737 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.13 128.4 8.84 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.553 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.6 mm -93.82 121.01 44.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 94.6 m -97.77 152.61 38.21 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.992 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -65.01 96.81 0.27 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.404 2.069 . . . . 0.0 111.525 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.9 mt 66.23 42.51 3.07 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.634 -178.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.235 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.878 179.634 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 2' ' ' ARG . 1.2 p30 . . . . . 0 C--O 1.233 0.208 0 CA-C-O 121.402 0.62 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 1' ' ' ASP . 13.0 mtt-85 -151.96 131.74 13.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.085 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.6 pt -76.06 141.29 15.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.801 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 47.6 t -87.23 59.62 5.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.717 0.77 . . . . 0.0 109.532 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.6 p -135.28 125.9 27.02 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.431 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.441 ' HA ' HD12 ' A' ' 45' ' ' ILE . 3.4 p-10 -90.28 176.52 6.71 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.0 m -51.2 -44.74 61.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 111.871 0.322 . . . . 0.0 111.871 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.971 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . . . -61.05 -47.53 85.97 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.95 -30.15 67.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.998 0.427 . . . . 0.0 110.687 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.34 138.13 48.42 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.539 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.6 m -67.71 124.42 23.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.689 0.281 . . . . 0.0 110.936 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -60.02 131.3 50.42 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.449 ' O ' ' HE2' ' A' ' 15' ' ' LYS . . . 112.35 -33.91 5.44 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 40.8 m -88.63 131.47 34.96 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.514 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 0.0 OUTLIER -97.93 119.05 35.86 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.747 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 3.9 m-85 -89.62 125.07 35.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.157 0.503 . . . . 0.0 110.872 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -114.98 163.55 15.42 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.95 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 37.4 t -86.49 168.56 13.62 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.921 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -66.8 -32.77 74.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.83 0.348 . . . . 0.0 110.336 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -67.53 -32.56 73.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.647 179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 131.23 -23.75 4.29 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.583 -0.818 . . . . 0.0 113.191 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.8 m -62.92 135.45 57.31 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.141 0.496 . . . . 0.0 111.992 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.3 t80 -71.17 124.29 24.12 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.787 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.584 HG11 HG12 ' A' ' 45' ' ' ILE . 46.8 t -87.91 -64.96 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.515 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.8 p -172.89 153.95 2.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.077 0.465 . . . . 0.0 111.58 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -90.99 157.61 17.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.334 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.78 130.02 45.71 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 121.429 -0.415 . . . . 0.0 113.849 -178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.971 ' HB3' ' HA ' ' A' ' 8' ' ' ALA . 6.6 tt0 -96.82 0.26 49.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.145 0.498 . . . . 0.0 110.734 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.3 p -77.75 -168.92 1.34 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.48 . . . . 0.0 111.632 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.517 ' HB3' HD21 ' A' ' 33' ' ' ASN . 38.7 t0 -163.86 124.31 1.4 Allowed Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 17.3 Cg_exo -68.7 38.25 0.21 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.175 2.583 . . . . 0.0 113.983 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HE ' ' CG ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -147.12 17.8 1.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.517 HD21 ' HB3' ' A' ' 30' ' ' ASP . 8.3 p30 -165.21 142.03 4.76 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.033 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.54 57.88 5.66 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.805 2.337 . . . . 0.0 113.861 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -80.25 105.84 11.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.296 -0.411 . . . . 0.0 109.946 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -163.97 29.45 0.08 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.52 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.719 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -74.78 -56.64 2.13 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.849 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.719 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 8.2 Cg_exo -71.33 134.35 24.55 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.894 1.729 . . . . 0.0 110.82 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -157.09 48.87 0.44 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.233 0.539 . . . . 0.0 110.9 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -80.39 138.56 36.67 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.018 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 38.6 m -75.78 70.68 2.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.384 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.592 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 33.2 t70 -66.14 115.57 24.76 Favored Pre-proline 0 C--N 1.332 -0.179 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.39 -24.83 78.87 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.302 2.668 . . . . 0.0 112.979 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.592 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 19.7 ttm105 -66.8 -33.53 75.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.628 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.584 HG12 HG11 ' A' ' 24' ' ' VAL . 62.5 mt -88.2 108.98 19.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.084 0.469 . . . . 0.0 110.053 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.07 -48.17 5.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.497 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -153.39 145.13 23.45 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.747 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.12 128.18 8.89 Favored Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.439 -0.665 . . . . 0.0 111.439 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.3 mm -99.34 119.45 47.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.764 0.316 . . . . 0.0 110.964 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 59.5 m -98.0 122.16 55.32 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.74 54.32 5.14 Favored 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 123.082 2.521 . . . . 0.0 112.687 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 52' ' ' LEU . 4.0 mm? 62.51 44.79 6.76 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.383 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.111 -1.423 . . . . 0.0 108.471 179.68 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.477 ' HB3' ' HD2' ' A' ' 47' ' ' TYR . 44.5 t0 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.602 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -169.31 62.88 0.05 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.462 HG12 ' O ' ' A' ' 46' ' ' ALA . 6.9 pt -55.3 142.88 8.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.934 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 t -87.22 66.86 9.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.553 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.7 p -133.91 -149.41 0.36 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.723 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.798 ' HA ' HD12 ' A' ' 45' ' ' ILE . 24.4 p30 -174.12 -159.43 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.8 m -66.25 -63.73 1.01 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 123.064 0.227 . . . . 0.0 111.135 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.961 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . . . -57.5 -38.39 74.53 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.029 0.443 . . . . 0.0 112.081 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.88 -19.43 60.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.082 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.94 147.9 31.1 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.291 -0.48 . . . . 0.0 112.681 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.441 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 20.2 m -63.39 124.19 20.64 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.585 0.231 . . . . 0.0 111.359 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.4 OUTLIER -57.4 132.1 52.08 Favored 'General case' 0 N--CA 1.462 0.148 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.531 ' N ' ' HD2' ' A' ' 12' ' ' LYS . . . 106.6 -36.37 4.44 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.729 -179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 76.2 m -88.35 132.98 34.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.675 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.857 ' HD3' ' HG3' ' A' ' 26' ' ' GLU . 25.0 mmtp -82.92 111.33 18.7 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.74 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.698 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 6.1 m-85 -86.97 124.15 32.85 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.233 0.54 . . . . 0.0 109.894 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.968 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 0.4 OUTLIER -147.49 178.5 8.39 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.395 0.617 . . . . 0.0 111.834 -178.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.532 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 14.7 m -76.14 168.49 19.95 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.543 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -66.89 -35.35 79.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.532 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.1 p-10 -63.49 -41.4 98.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.999 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.7 -11.92 2.92 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.074 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.7 m -62.61 111.04 1.9 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.86 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.968 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 25.1 t80 -68.08 122.72 18.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.113 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.631 HG23 ' HA ' ' A' ' 17' ' ' PHE . 45.8 t -91.55 -61.84 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.549 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.9 p -174.58 152.69 1.71 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.96 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.857 ' HG3' ' HD3' ' A' ' 15' ' ' LYS . 10.2 tt0 -80.06 158.29 26.5 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -65.09 133.92 36.79 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.029 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.961 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 45.2 mt-10 -105.71 16.13 25.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.694 0.247 . . . . 0.0 111.629 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.626 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 26.5 p -80.3 46.78 0.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.402 0.62 . . . . 0.0 110.823 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.408 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 12.3 t0 -66.15 -50.77 49.05 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.518 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 4.2 Cg_exo -76.23 27.05 0.41 Allowed 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.236 1.957 . . . . 0.0 112.657 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 52.28 40.89 29.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.308 178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.626 ' OD1' ' HA ' ' A' ' 29' ' ' SER . 8.8 p-10 -74.49 132.76 78.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.943 0.402 . . . . 0.0 110.739 179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.33 67.67 3.5 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.144 2.563 . . . . 0.0 112.023 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 68.31 -134.08 0.1 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.048 -178.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -160.15 -144.27 0.11 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.568 0.223 . . . . 0.0 110.998 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.06 138.11 94.78 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.483 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.12 45.7 1.42 Allowed 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.847 2.365 . . . . 0.0 112.604 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -174.17 47.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.249 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.96 41.53 1.54 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.331 0.586 . . . . 0.0 111.367 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 57.1 m -80.93 124.21 28.94 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.356 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.515 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 33.4 t70 -75.02 114.82 38.75 Favored Pre-proline 0 C--O 1.239 0.531 0 O-C-N 123.233 0.333 . . . . 0.0 110.387 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -74.41 46.93 1.49 Allowed 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.298 2.665 . . . . 0.0 111.896 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.515 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 13.9 ttp180 -154.94 -23.53 0.12 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.907 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.798 HD12 ' HA ' ' A' ' 6' ' ' ASN . 63.3 mt -85.64 120.89 36.5 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.245 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.029 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -95.61 -51.9 4.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.449 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.477 ' HD2' ' HB3' ' A' ' 1' ' ' ASP . 13.7 p90 -159.92 154.25 23.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.034 0.445 . . . . 0.0 111.59 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.08 131.56 10.51 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.103 -0.57 . . . . 0.0 111.902 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.4 mm -122.02 132.93 69.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 120.756 0.312 . . . . 0.0 111.18 -179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.4 m -88.49 -54.21 0.34 Allowed Pre-proline 0 CA--C 1.538 0.507 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.34 139.1 18.31 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.768 1.646 . . . . 0.0 113.4 -179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 98.8 mt 62.97 45.98 5.08 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.87 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 15' ' ' LYS . . . . . . . . 0 C--O 1.251 1.132 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.0 p-10 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 121.654 0.74 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.406 ' NE ' ' HA ' ' A' ' 46' ' ' ALA . 39.1 ttt180 -73.9 124.49 26.25 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.938 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -65.32 124.84 21.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.452 0.644 . . . . 0.0 111.771 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 35.5 t -93.42 51.17 1.57 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.592 0.71 . . . . 0.0 109.724 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.424 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 9.1 p -110.04 -145.47 0.4 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.356 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.519 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 16.1 p30 -173.16 176.92 2.84 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.8 m -53.19 -47.77 68.61 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.514 ' HB1' ' HG2' ' A' ' 31' ' ' PRO . . . -68.72 -44.54 73.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.226 0.536 . . . . 0.0 110.44 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.18 49.16 1.49 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.285 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' HA2' ' OH ' ' A' ' 16' ' ' TYR . . . -104.2 -141.1 10.89 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.125 -179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.75 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 87.2 m -157.4 131.58 8.32 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.551 ' HD3' ' H ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -55.19 131.54 45.53 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.306 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.87 21.6 71.02 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.524 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 57.9 m -137.63 127.61 25.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 25.9 mtmm -107.26 131.54 54.08 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.102 0.477 . . . . 0.0 111.763 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.719 ' HD2' HD13 ' A' ' 45' ' ' ILE . 6.4 m-30 -85.24 126.85 34.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.369 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -121.63 155.95 34.01 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.451 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.502 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 19.9 m -78.4 175.68 10.06 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.071 179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -66.44 -38.14 86.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.207 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 43.1 p-10 -66.52 -40.24 89.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.948 0.404 . . . . 0.0 111.069 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.15 -7.97 3.78 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.647 -0.581 . . . . 0.0 111.647 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.5 m -65.33 134.35 53.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.13 0.49 . . . . 0.0 111.477 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -73.35 122.08 21.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.619 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 19.6 t -90.56 -63.02 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.72 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.4 p -174.5 147.67 1.13 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.66 -0.246 . . . . 0.0 111.373 -178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 19.2 tt0 -77.78 151.8 33.86 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.75 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -68.3 94.57 0.33 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.683 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.452 ' O ' ' HD2' ' A' ' 31' ' ' PRO . 13.3 tp10 -88.82 69.89 8.65 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 11.4 p -77.51 41.92 0.34 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.528 -1.214 . . . . 0.0 113.266 -176.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.511 ' H ' ' HD2' ' A' ' 31' ' ' PRO . 22.6 t70 -89.7 -51.26 0.36 Allowed Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 119.421 -0.323 . . . . 0.0 111.011 177.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.514 ' HG2' ' HB1' ' A' ' 8' ' ' ALA . 42.9 Cg_endo -67.7 58.66 0.79 Allowed 'Trans proline' 0 C--N 1.363 1.294 0 C-N-CA 122.87 2.38 . . . . 0.0 112.497 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.4 mtm180 -65.64 -26.99 68.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.871 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -73.09 135.87 79.73 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.822 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -45.4 128.94 10.58 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 123.581 2.854 . . . . 0.0 114.248 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.438 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 35.9 mmtm -149.09 158.13 43.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.493 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.05 -24.94 58.35 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.66 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -61.93 -54.34 51.56 Favored Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.66 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 11.9 Cg_exo -70.51 122.22 8.71 Favored 'Trans proline' 0 C--N 1.355 0.878 0 C-N-CA 121.918 1.745 . . . . 0.0 111.597 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.1 ptt-85 -114.15 -124.64 0.28 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -171.04 152.85 3.6 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.048 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.7 m 56.32 52.99 9.32 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 123.759 0.662 . . . . 0.0 111.907 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.418 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 37.0 t70 -66.3 127.92 93.54 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 9.9 Cg_endo -51.87 -36.15 62.29 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.764 2.976 . . . . 0.0 114.605 -178.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.09 -23.87 35.52 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.888 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.719 HD13 ' HD2' ' A' ' 16' ' ' TYR . 91.8 mt -87.36 127.62 40.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.232 0.539 . . . . 0.0 111.927 -178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.406 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . . . -120.91 -50.61 2.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.858 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -149.75 148.35 29.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.979 0.418 . . . . 0.0 111.802 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.94 134.03 11.92 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.5 mm -112.89 129.16 69.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.646 ' HB2' ' HD3' ' A' ' 51' ' ' PRO . 39.2 m -101.96 -55.63 0.12 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.253 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.646 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 74.2 Cg_endo -78.71 135.16 12.65 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.651 1.567 . . . . 0.0 112.701 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.8 mp 62.87 46.28 5.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.331 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.332 179.504 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.579 ' O ' ' HG2' ' A' ' 2' ' ' ARG . 4.2 p-10 . . . . . 0 C--O 1.233 0.193 0 N-CA-C 110.521 -0.178 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.92 ' HD2' ' HA ' ' A' ' 46' ' ' ALA . 26.8 ptt-85 47.7 -164.42 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.192 0.932 . . . . 0.0 112.664 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -82.54 120.8 34.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.122 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.2 t -89.11 58.36 4.48 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.547 0.689 . . . . 0.0 109.994 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.423 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 23.5 p -117.29 -152.03 0.49 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.831 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.742 ' HA ' HD12 ' A' ' 45' ' ' ILE . 14.6 p30 -175.45 172.26 2.69 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 59.2 m -58.05 -43.09 86.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.02 -44.17 82.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.995 0.426 . . . . 0.0 111.579 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -100.06 26.08 6.78 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.591 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -74.19 129.11 11.24 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.901 -0.666 . . . . 0.0 111.707 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 m -67.22 124.4 23.0 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.737 0.303 . . . . 0.0 110.785 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.915 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 54.3 mtmt -55.96 136.06 52.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.415 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.89 -30.96 7.33 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.922 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 39.7 m -88.98 125.03 34.8 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.0 110.642 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.82 ' HE2' ' HB1' ' A' ' 53' ' ' ALA . 2.2 tppt? -85.86 119.42 26.16 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.205 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.485 ' HD2' HG21 ' A' ' 45' ' ' ILE . 2.4 m-85 -89.41 124.73 34.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.272 0.558 . . . . 0.0 111.423 -179.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.554 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 87.4 m-85 -122.56 158.18 30.47 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.088 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.3 p -78.11 -161.51 0.27 Allowed 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.13 178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -44.97 47.02 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.55 0.214 . . . . 0.0 111.253 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p-10 -63.36 -39.81 95.55 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.601 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.61 0.9 5.24 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -67.47 135.98 53.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.033 0.444 . . . . 0.0 111.033 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 28.0 t80 -67.26 112.52 4.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.925 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.596 HG11 HG12 ' A' ' 45' ' ' ILE . 83.6 t -87.83 -55.72 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.28 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.411 ' SG ' HG12 ' A' ' 24' ' ' VAL . 7.7 p -174.38 -170.18 0.5 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.946 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.818 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 13.9 tt0 -134.27 -158.81 0.91 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 120.742 0.305 . . . . 0.0 110.645 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.818 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -79.78 85.78 1.27 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 116.211 -0.45 . . . . 0.0 112.251 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -88.26 15.39 7.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.87 0.367 . . . . 0.0 110.985 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.3 p -79.67 55.31 1.98 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.915 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 24.4 t0 -173.94 -57.73 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 7.3 Cg_exo -72.86 65.68 4.02 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.421 2.081 . . . . 0.0 112.657 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 64.07 55.01 1.59 Allowed 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -48.63 134.61 13.55 Favored Pre-proline 0 C--O 1.243 0.749 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.106 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.82 178.55 3.89 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.681 2.254 . . . . 0.0 110.678 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.716 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -92.95 129.95 38.7 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.213 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.99 73.7 0.89 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.727 -177.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB3' ' HD3' ' A' ' 38' ' ' PRO . . . -67.24 -48.91 46.4 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.313 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 37' ' ' ALA . 11.7 Cg_exo -70.97 66.28 2.49 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.648 2.232 . . . . 0.0 111.859 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 20.6 tpp180 -68.65 -34.49 75.8 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.82 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -80.34 45.49 0.76 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.425 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 8.9 m 67.37 118.51 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.413 0.685 . . . . 0.0 110.933 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.567 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 10.5 t70 -58.06 111.67 3.84 Favored Pre-proline 0 C--O 1.24 0.566 0 CA-C-O 120.75 0.31 . . . . 0.0 111.0 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.8 52.1 2.06 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.653 2.902 . . . . 0.0 112.042 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.567 ' HB3' ' OD1' ' A' ' 42' ' ' ASP . 12.8 ttp180 -166.27 -34.31 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.313 -178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.742 HD12 ' HA ' ' A' ' 6' ' ' ASN . 62.7 mt -89.39 129.76 39.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.2 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.92 ' HA ' ' HD2' ' A' ' 2' ' ' ARG . . . -115.16 -44.19 3.03 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -152.77 152.89 32.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.159 0.504 . . . . 0.0 112.009 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -122.4 128.69 7.26 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.937 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.9 mm -97.24 116.06 38.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 49.9 m -89.19 -52.03 0.36 Allowed Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.672 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 60.5 Cg_endo -73.65 138.32 26.4 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.56 1.507 . . . . 0.0 112.365 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 63.92 60.39 1.03 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.563 0.539 . . . . 0.0 111.046 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.82 ' HB1' ' HE2' ' A' ' 15' ' ' LYS . . . . . . . . 0 C--O 1.251 1.141 0 CA-C-O 118.698 -0.668 . . . . 0.0 109.626 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 17.0 p-10 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 13.0 mtm105 62.76 58.25 1.61 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.549 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.3 pt -58.08 150.21 4.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.518 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.546 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 40.9 t -85.2 78.69 9.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.6 0.714 . . . . 0.0 109.575 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 39.2 p -138.71 -156.62 0.7 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.04 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.562 ' HA ' HD12 ' A' ' 45' ' ' ILE . 17.1 p30 -178.3 178.59 0.87 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.1 m -54.12 -55.45 27.54 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -178.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.806 ' HA ' ' HB2' ' A' ' 28' ' ' GLU . . . -62.2 -35.76 79.84 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.81 -30.17 62.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.882 0.373 . . . . 0.0 111.366 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.93 147.13 48.81 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.783 -0.644 . . . . 0.0 113.206 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.453 ' HA ' ' OG ' ' A' ' 29' ' ' SER . 23.1 m -69.31 128.29 36.05 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.562 0.22 . . . . 0.0 111.122 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 43.8 mtmt -57.05 136.22 56.33 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.344 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.75 -32.27 7.42 Favored Glycine 0 N--CA 1.444 -0.815 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.658 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.5 m -87.91 134.27 33.74 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.974 0.416 . . . . 0.0 109.958 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.52 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 38.3 mmtt -93.1 122.47 35.5 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.488 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.67 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.3 m-85 -95.17 129.73 42.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.966 0.412 . . . . 0.0 110.823 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.5 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 38.3 m-85 -121.04 165.22 15.61 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.885 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 57.2 m -79.1 -156.65 0.11 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.748 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -84.75 -42.17 15.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.746 0.308 . . . . 0.0 110.622 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -63.98 -42.46 97.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.633 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.89 -5.25 3.05 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.1 m -64.34 131.2 46.57 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.005 0.431 . . . . 0.0 110.779 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.52 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.9 t80 -70.3 117.74 12.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.942 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.653 HG11 HG12 ' A' ' 45' ' ' ILE . 86.0 t -81.66 -63.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.986 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.455 ' SG ' HG12 ' A' ' 24' ' ' VAL . 16.6 p -178.1 167.79 1.99 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.502 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -95.57 156.25 16.4 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -68.81 133.39 27.12 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.874 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.806 ' HB2' ' HA ' ' A' ' 8' ' ' ALA . 29.9 mt-10 -116.09 32.78 5.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.977 0.418 . . . . 0.0 110.243 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.453 ' OG ' ' HA ' ' A' ' 11' ' ' THR . 14.5 p -78.41 55.0 1.51 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.363 . . . . 0.0 111.76 -179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.577 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 13.0 t0 -68.12 -56.79 10.3 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.006 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 1.2 Cg_endo -82.21 12.89 2.69 Favored 'Trans proline' 0 C--N 1.358 1.059 0 C-N-CA 122.264 1.976 . . . . 0.0 111.254 178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 60.66 33.66 20.24 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.156 -1.384 . . . . 0.0 112.549 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -169.85 137.14 1.4 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.18 0.514 . . . . 0.0 110.964 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -82.32 60.14 7.24 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.803 2.335 . . . . 0.0 111.501 179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.635 ' NZ ' ' HB2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER 67.76 116.52 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.499 -178.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 57.57 -135.3 1.09 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.812 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -96.79 134.57 22.94 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.52 0.2 . . . . 0.0 110.684 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 22.6 Cg_exo -64.22 130.84 28.26 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.717 2.278 . . . . 0.0 111.695 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -164.04 45.46 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.887 0.375 . . . . 0.0 110.999 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -160.32 125.84 3.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.124 0.487 . . . . 0.0 110.475 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.546 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 3.3 m -107.98 125.9 52.07 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.07 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.416 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 17.2 t0 -90.35 110.75 42.96 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 27.5 Cg_endo -62.28 -21.71 73.03 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.414 2.742 . . . . 0.0 112.306 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.485 ' HE ' ' HB3' ' A' ' 44' ' ' ARG . 26.5 ttp180 -66.06 -30.87 71.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.688 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.653 HG12 HG11 ' A' ' 24' ' ' VAL . 50.9 mt -89.53 126.5 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.991 0.424 . . . . 0.0 110.935 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -110.65 -42.98 3.92 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.7 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -156.37 145.41 20.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.274 0.559 . . . . 0.0 112.0 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.67 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.24 131.54 10.64 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.488 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.4 mm -103.99 121.69 55.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.057 0.456 . . . . 0.0 111.023 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 76.7 m -97.92 137.95 20.95 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.7 179.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.6 Cg_exo -76.83 -143.79 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.884 2.39 . . . . 0.0 112.445 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.2 mt 63.92 41.75 6.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.778 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.269 0 CA-C-O 117.331 -1.319 . . . . 0.0 108.658 179.611 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.2 p30 . . . . . 0 CA--C 1.523 -0.083 0 CA-C-O 121.423 0.63 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -151.68 60.55 0.87 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.859 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.2 pt -64.62 140.64 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.336 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 52.2 t -87.15 69.11 10.1 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.554 0.693 . . . . 0.0 110.268 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.9 p -120.49 -164.15 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.86 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -175.04 161.09 2.86 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.4 m -60.06 -35.31 74.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.49 -23.55 64.59 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.198 0.523 . . . . 0.0 110.938 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -115.41 -109.56 0.36 Allowed 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.177 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.92 -136.45 50.83 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.186 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.5 m -152.17 127.53 9.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 42.0 tptt -60.07 133.11 55.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.826 0.346 . . . . 0.0 110.783 -178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.08 -26.16 23.88 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.893 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.451 ' HB2' ' HE1' ' A' ' 16' ' ' TYR . 33.9 m -88.05 129.76 35.19 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.125 0.488 . . . . 0.0 110.458 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -90.3 114.92 27.07 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.047 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.703 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.1 m-85 -96.2 128.68 43.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.855 0.36 . . . . 0.0 110.359 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.995 ' HB3' ' HA ' ' A' ' 23' ' ' PHE . 0.6 OUTLIER -148.91 178.27 8.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.028 0.442 . . . . 0.0 111.502 179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 13.1 p -78.72 174.7 11.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.887 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -68.6 -35.6 77.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.361 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -64.27 -36.59 84.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.041 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 134.32 -18.84 4.13 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.238 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.3 m -58.56 115.35 2.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.059 0.457 . . . . 0.0 111.262 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.995 ' HA ' ' HB3' ' A' ' 17' ' ' PHE . 23.8 t80 -65.04 118.14 8.7 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.569 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG23 ' HA ' ' A' ' 17' ' ' PHE . 87.8 t -84.81 -58.91 3.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.353 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 26.0 p -178.26 151.36 0.63 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.775 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -83.2 147.06 28.25 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.19 124.41 29.95 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.238 -0.982 . . . . 0.0 111.746 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -128.4 65.49 1.4 Allowed 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.58 43.18 0.39 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.627 -179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 0.1 OUTLIER -70.02 130.02 90.24 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.148 178.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 4.4 Cg_exo -81.99 39.05 0.8 Allowed 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.399 2.733 . . . . 0.0 112.973 -179.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.461 ' HG3' HH11 ' A' ' 32' ' ' ARG . 17.2 mmt85 -131.22 -46.7 1.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.479 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 18.0 p30 -62.86 136.19 96.34 Favored Pre-proline 0 C--O 1.237 0.445 0 CA-C-O 121.201 0.524 . . . . 0.0 110.624 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 32.0 Cg_exo -60.22 139.22 86.0 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.609 2.873 . . . . 0.0 113.736 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -132.95 128.62 36.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.098 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -168.7 -37.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.256 0.347 . . . . 0.0 110.823 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.502 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -59.0 136.28 87.7 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.989 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 16.7 Cg_exo -68.38 59.29 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.716 2.944 . . . . 0.0 113.122 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.546 ' HD2' ' OD2' ' A' ' 42' ' ' ASP . 12.6 tpp180 -94.99 43.94 1.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.933 0.873 . . . . 0.0 109.704 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -90.65 139.58 30.58 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.797 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.746 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 65.3 m 60.49 52.62 4.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.672 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.546 ' OD2' ' HD2' ' A' ' 39' ' ' ARG . 8.4 t0 -58.5 113.23 6.21 Favored Pre-proline 0 N--CA 1.464 0.269 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -58.39 -30.61 91.83 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.575 2.85 . . . . 0.0 113.915 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.522 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 34.5 ptt180 -70.64 -26.25 63.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.375 -179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 59.9 mt -89.13 111.31 22.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.977 0.417 . . . . 0.0 110.761 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.91 -49.99 6.29 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.245 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.468 ' HE1' ' HE1' ' A' ' 17' ' ' PHE . 14.8 p90 -161.77 147.49 13.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.253 0.549 . . . . 0.0 111.678 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.703 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.38 129.4 9.56 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.296 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.11 124.8 52.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.025 0.44 . . . . 0.0 111.194 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.4 m -100.13 139.33 20.64 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.98 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.07 126.77 17.85 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.588 2.192 . . . . 0.0 112.103 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 50.0 tp -88.74 138.1 31.73 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.378 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.832 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.1 t0 . . . . . 0 C--O 1.235 0.299 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.604 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -64.97 144.93 56.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.205 0.526 . . . . 0.0 111.311 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 pt -68.06 135.01 29.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.238 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 41.8 t -87.66 57.87 4.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.692 0.758 . . . . 0.0 110.254 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.63 ' HB ' ' HB3' ' A' ' 9' ' ' ALA . 34.1 p -124.5 -143.35 0.31 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.765 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.754 ' HA ' HD12 ' A' ' 45' ' ' ILE . 9.4 p-10 -177.46 -171.15 0.31 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.474 ' C ' ' HG2' ' A' ' 28' ' ' GLU . 4.3 m -60.33 -41.86 94.43 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.589 0.233 . . . . 0.0 110.453 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.594 ' H ' ' ND2' ' A' ' 6' ' ' ASN . . . -60.11 -44.47 94.83 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.715 0.293 . . . . 0.0 111.584 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.63 ' HB3' ' HB ' ' A' ' 5' ' ' THR . . . -82.52 21.75 0.94 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.099 0.476 . . . . 0.0 110.521 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.549 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -91.46 131.45 10.79 Favored Glycine 0 N--CA 1.442 -0.96 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.188 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.631 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 5.3 m -69.22 148.96 49.1 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.647 0.26 . . . . 0.0 110.591 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -58.34 131.89 52.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.439 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.76 -11.03 54.98 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.89 -0.671 . . . . 0.0 113.13 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 61.3 m -89.52 128.83 36.04 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.422 0.629 . . . . 0.0 110.624 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 15.2 mmtp -98.81 121.34 40.63 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.049 -0.978 . . . . 0.0 108.715 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.603 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.5 m-85 -92.05 125.76 36.87 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.768 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.26 162.84 16.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.734 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.416 ' HB2' ' H ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -78.51 -154.14 0.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.997 178.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.416 ' H ' ' HB2' ' A' ' 18' ' ' SER . 14.4 p-10 -82.76 -42.15 18.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.681 0.276 . . . . 0.0 110.488 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -64.41 -41.26 96.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.665 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 132.96 -0.04 4.38 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -68.27 134.5 50.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.948 0.404 . . . . 0.0 110.754 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.532 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.9 t80 -68.78 111.88 5.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.614 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.466 HG13 ' HD2' ' A' ' 44' ' ' ARG . 94.7 t -83.26 -57.11 4.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.778 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.9 p -175.53 158.28 2.22 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-O 120.981 0.42 . . . . 0.0 111.923 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.473 ' HG2' ' H ' ' A' ' 27' ' ' GLY . 38.0 tt0 -92.44 173.21 7.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.473 ' H ' ' HG2' ' A' ' 26' ' ' GLU . . . -69.91 108.48 2.49 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.572 -0.823 . . . . 0.0 114.062 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.571 ' HG2' ' N ' ' A' ' 8' ' ' ALA . 21.8 pt-20 -89.16 36.43 0.82 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 122.201 1.0 . . . . 0.0 108.392 177.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 3.5 p -78.08 56.24 1.6 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.7 -1.136 . . . . 0.0 112.359 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -63.46 128.97 93.28 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.532 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 33' ' ' ASN . 73.9 Cg_endo -75.63 -136.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.784 2.323 . . . . 0.0 111.237 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' H ' ' HB2' ' A' ' 31' ' ' PRO . 38.2 mtp85 73.21 -31.96 0.23 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.388 0.675 . . . . 0.0 111.122 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.494 ' H ' ' C ' ' A' ' 31' ' ' PRO . 5.8 p30 -169.37 141.7 2.06 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.055 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 14.0 Cg_exo -70.35 71.8 1.79 Allowed 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 123.602 2.868 . . . . 0.0 113.004 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 33' ' ' ASN . 35.5 mtmm -68.23 112.81 5.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.728 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.6 122.07 28.52 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.321 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -81.72 114.43 50.06 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.898 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.42 46.51 2.23 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.838 2.359 . . . . 0.0 112.254 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.87 52.93 0.29 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.216 0.531 . . . . 0.0 111.322 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -69.99 161.48 29.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.399 178.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m 65.62 48.6 1.94 Allowed 'General case' 0 N--CA 1.465 0.289 0 O-C-N 123.365 0.416 . . . . 0.0 110.436 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.666 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 4.4 t0 -60.5 113.59 7.94 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.468 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 12.1 Cg_endo -56.58 -33.72 93.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.646 2.898 . . . . 0.0 114.313 -177.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.666 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 23.2 ptt180 -71.07 -27.01 63.32 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.789 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.754 HD12 ' HA ' ' A' ' 6' ' ' ASN . 67.7 mt -91.72 127.31 44.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.102 0.477 . . . . 0.0 111.703 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.08 -45.34 3.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.55 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -152.5 145.82 24.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.209 0.528 . . . . 0.0 111.616 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.603 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -111.84 129.19 8.97 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.31 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.1 mm -110.69 125.05 67.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 19.2 m -87.68 -51.69 0.41 Allowed Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 121.061 -0.256 . . . . 0.0 111.646 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 2.8 Cg_exo -75.74 61.64 6.27 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.373 2.049 . . . . 0.0 112.469 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 5.9 tt -154.83 116.55 4.13 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.921 0 O-C-N 124.078 0.861 . . . . 0.0 111.397 179.817 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 26.1 t0 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 110.432 -0.211 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.762 ' HA ' ' HA ' ' A' ' 46' ' ' ALA . 61.6 mtt85 54.27 60.52 3.52 Favored 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.863 0.727 . . . . 0.0 111.931 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.1 pt -57.28 147.44 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.323 179.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.553 ' HA ' ' HB3' ' A' ' 41' ' ' CYS . 43.6 t -85.33 75.24 10.27 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.758 0.79 . . . . 0.0 109.937 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 32.3 p -140.9 -163.94 1.64 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.205 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.957 ' HA ' HD12 ' A' ' 45' ' ' ILE . 15.4 p30 -173.24 -158.62 0.1 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.3 m -69.71 -54.5 13.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.267 0.485 . . . . 0.0 110.467 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . -65.91 -44.03 86.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.307 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.82 -4.65 47.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.089 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.26 141.04 23.59 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.053 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.562 HG23 ' HB3' ' A' ' 31' ' ' PRO . 72.7 m -68.26 127.19 32.02 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.727 0.298 . . . . 0.0 110.497 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.721 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 82.2 tttt -57.66 131.31 49.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.907 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 102.27 -29.59 12.17 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.532 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.5 m -88.42 128.44 35.52 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.124 0.488 . . . . 0.0 109.943 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.632 ' HB2' ' HE1' ' A' ' 17' ' ' PHE . 10.9 mtpp -90.67 114.42 26.71 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.364 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.723 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 5.5 m-85 -86.37 126.01 34.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.302 0.572 . . . . 0.0 111.637 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.632 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 14.4 m-85 -119.89 163.07 18.09 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.653 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 35.7 t -84.32 169.22 14.89 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -69.1 -32.25 71.54 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 0.0 110.127 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -66.27 -33.94 76.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.591 179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.73 -23.9 3.72 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.195 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.1 m -60.97 133.18 55.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.095 0.474 . . . . 0.0 112.097 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -73.49 122.86 22.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.935 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.454 HG11 ' CG1' ' A' ' 45' ' ' ILE . 48.9 t -86.93 -65.13 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.403 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 24.0 p -175.69 152.29 1.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.577 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -85.71 145.72 27.15 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.721 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -66.37 144.41 45.86 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.659 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 8' ' ' ALA . 14.2 pt-20 -117.32 -18.12 9.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.567 ' HB3' ' O ' ' A' ' 8' ' ' ALA . 82.5 p -78.56 139.9 38.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.372 0.606 . . . . 0.0 112.445 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.408 ' OD2' ' HB2' ' A' ' 32' ' ' ARG . 0.6 OUTLIER -63.52 138.14 97.28 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.606 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.562 ' HB3' HG23 ' A' ' 11' ' ' THR . 90.5 Cg_endo -82.36 29.49 0.54 Allowed 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.663 2.242 . . . . 0.0 113.68 -179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.7 mmp_? -129.04 29.07 5.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.926 0.393 . . . . 0.0 110.348 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.7 p30 -154.07 146.4 17.34 Favored Pre-proline 0 C--O 1.238 0.448 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.2 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.77 143.75 46.79 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.829 2.353 . . . . 0.0 111.631 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -70.19 140.76 52.58 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.719 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -43.64 -51.27 7.11 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -166.96 125.53 1.05 Allowed Pre-proline 0 C--N 1.328 -0.342 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.571 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 3.0 Cg_exo -75.61 63.21 6.48 Favored 'Trans proline' 0 N--CA 1.463 -0.276 0 C-N-CA 123.538 2.825 . . . . 0.0 111.665 179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -148.76 -23.11 0.31 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.011 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -86.37 48.78 1.68 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.49 0.662 . . . . 0.0 110.101 179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m -67.34 125.52 26.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.206 -0.907 . . . . 0.0 111.058 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 66.0 t0 -78.32 116.98 63.41 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.18 -24.77 75.43 Favored 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.334 2.689 . . . . 0.0 113.97 -178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.489 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 28.6 ptt-85 -93.78 -1.53 54.89 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.413 -0.515 . . . . 0.0 112.326 -178.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.957 HD12 ' HA ' ' A' ' 6' ' ' ASN . 15.7 mt -102.79 124.02 56.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.984 0.421 . . . . 0.0 110.7 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 2' ' ' ARG . . . -108.67 -46.13 3.71 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.29 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.7 p90 -153.25 147.48 25.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.262 0.553 . . . . 0.0 112.431 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.723 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -110.66 125.68 7.53 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.6 mm -89.74 113.61 26.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.826 0.346 . . . . 0.0 110.785 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.0 m -95.72 134.14 24.53 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.065 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.69 131.92 25.57 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.496 2.131 . . . . 0.0 112.32 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.6 tp -83.78 137.35 33.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.29 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 179.826 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 25.3 t70 . . . . . 0 C--O 1.234 0.239 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 31.8 ptt85 -162.26 108.05 1.25 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.23 0.538 . . . . 0.0 110.34 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.6 pt -65.04 145.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.766 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 53.5 t -87.24 78.76 8.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.481 0.658 . . . . 0.0 109.676 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.2 p -138.35 -168.32 2.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.854 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.758 ' HA ' HD12 ' A' ' 45' ' ' ILE . 17.7 p30 -168.9 -179.53 3.73 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -55.99 -46.01 78.84 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -177.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.37 -49.28 17.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.831 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -85.67 60.47 6.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.515 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.53 -143.16 5.03 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.097 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.8 m -132.19 131.13 41.9 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.59 ' HG2' ' OE1' ' A' ' 28' ' ' GLU . 29.8 mtpp -56.96 130.09 44.47 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 123.45 0.469 . . . . 0.0 111.379 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.31 -21.24 25.92 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.384 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 63.7 m -88.21 128.98 35.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.285 0.564 . . . . 0.0 110.208 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 46.1 mttm -96.25 123.67 39.96 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.298 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.646 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 11.6 m-85 -92.39 127.46 37.88 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.204 0.526 . . . . 0.0 111.31 -178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 12.2 m-85 -118.38 164.61 14.98 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.4 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.9 m -77.29 -158.98 0.12 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.797 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -84.58 -40.38 17.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.776 0.322 . . . . 0.0 110.311 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.3 p-10 -65.35 -43.81 89.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.529 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.92 -3.79 2.31 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.1 m -65.43 130.13 42.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.058 0.456 . . . . 0.0 110.989 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.1 t80 -72.87 115.71 12.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.732 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.435 HG11 HG13 ' A' ' 45' ' ' ILE . 38.5 t -82.67 -62.43 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.894 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 28.7 p -175.21 150.31 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.698 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 23.0 tt0 -83.12 141.23 32.13 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.562 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.66 132.97 12.07 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.697 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.59 ' OE1' ' HG2' ' A' ' 12' ' ' LYS . 4.5 tp10 -141.09 69.99 1.34 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.961 0.886 . . . . 0.0 109.741 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -85.39 43.56 1.03 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.692 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.578 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.5 t70 -64.47 -51.42 60.08 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.707 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 32.6 Cg_exo -61.55 133.91 48.26 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 121.741 1.627 . . . . 0.0 111.743 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.4 mmt85 -81.75 36.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.347 0.594 . . . . 0.0 109.903 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.5 p30 -167.32 63.09 0.66 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.85 132.49 52.27 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.785 2.323 . . . . 0.0 111.634 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.8 mttm -107.97 115.99 31.15 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.04 -178.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -174.34 176.49 2.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.576 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.27 137.93 95.75 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 123.058 0.224 . . . . 0.0 110.482 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -63.62 125.32 15.28 Favored 'Trans proline' 0 N--CA 1.465 -0.206 0 C-N-CA 122.355 2.036 . . . . 0.0 112.283 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.0 tpp85 60.56 44.97 11.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -96.04 135.96 37.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.935 0.398 . . . . 0.0 110.096 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.9 m -115.55 123.28 48.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -71.91 115.75 41.31 Favored Pre-proline 0 C--N 1.328 -0.347 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -61.39 -22.36 74.34 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 123.168 2.578 . . . . 0.0 112.84 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.1 mtm180 -82.73 -27.51 31.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.175 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.758 HD12 ' HA ' ' A' ' 6' ' ' ASN . 68.1 mt -87.86 124.92 41.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.399 0.619 . . . . 0.0 112.332 -177.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -113.07 -46.78 3.07 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.573 178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -149.75 142.93 25.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.346 0.593 . . . . 0.0 111.91 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.646 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -103.01 132.3 10.96 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.746 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.1 mm -101.05 122.6 53.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 120.83 0.348 . . . . 0.0 110.542 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 83.2 m -105.15 124.39 36.68 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.201 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -75.59 135.66 18.3 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.69 2.26 . . . . 0.0 112.237 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.72 HD23 ' H ' ' A' ' 52' ' ' LEU . 2.3 pt? -80.1 140.68 36.34 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.328 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.99 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.787 0.327 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -168.16 121.97 0.91 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 45' ' ' ILE . 9.7 pt -65.42 129.67 29.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.119 0.485 . . . . 0.0 110.693 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.7 t -88.01 62.49 6.87 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.493 0.663 . . . . 0.0 109.406 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 p -128.73 -154.43 0.64 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.47 -0.787 . . . . 0.0 109.991 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.569 ' HA ' HD12 ' A' ' 45' ' ' ILE . 15.6 p30 -176.84 -166.75 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.7 m -61.39 -53.91 50.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 123.32 0.388 . . . . 0.0 111.083 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.463 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . . . -61.69 -40.57 95.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.156 0.503 . . . . 0.0 111.007 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.12 57.44 4.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.388 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.61 141.5 7.12 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.212 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -61.51 135.69 57.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.479 0.18 . . . . 0.0 110.723 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.6 OUTLIER -57.89 -32.33 67.6 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.515 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.1 27.16 3.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.074 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.6 m -147.51 132.02 17.7 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.578 ' HG2' ' HG3' ' A' ' 26' ' ' GLU . 59.2 mttp -105.67 126.87 52.65 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.698 ' HD2' HD13 ' A' ' 45' ' ' ILE . 3.1 m-30 -82.99 124.48 30.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.144 0.497 . . . . 0.0 111.249 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -121.47 161.32 22.45 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.799 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.5 t -87.38 163.86 16.54 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.417 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 15.8 p-10 -66.58 -33.04 74.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.662 0.268 . . . . 0.0 110.54 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -65.49 -31.12 72.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.502 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.28 -21.72 4.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.305 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.5 m -63.84 133.34 53.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.238 0.542 . . . . 0.0 112.335 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 19.2 t80 -74.56 122.02 22.47 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.508 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.8 t -86.72 -62.26 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.396 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.5 p -174.8 150.95 1.34 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.94 0.4 . . . . 0.0 111.208 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.578 ' HG3' ' HG2' ' A' ' 15' ' ' LYS . 37.1 tt0 -80.38 149.64 30.13 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.42 137.99 40.44 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.251 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 8' ' ' ALA . 16.3 pt-20 -137.21 61.05 1.63 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.787 0.803 . . . . 0.0 110.099 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.15 65.66 3.57 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.89 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.474 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.7 t70 -58.33 128.93 83.15 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.998 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 2.3 Cg_endo -81.77 -147.83 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.072 2.515 . . . . 0.0 111.158 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 58.2 mtp85 70.88 -30.75 0.21 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.399 0.68 . . . . 0.0 112.098 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.456 ' H ' ' C ' ' A' ' 31' ' ' PRO . 10.6 p30 -132.12 133.26 23.68 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 121.202 0.525 . . . . 0.0 110.772 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 20.2 Cg_exo -66.81 137.6 45.88 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.369 2.713 . . . . 0.0 112.956 -178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -95.04 130.83 41.57 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.465 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -155.04 148.37 25.03 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.969 -179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.407 ' N ' ' HD3' ' A' ' 38' ' ' PRO . . . 56.92 64.73 4.31 Favored Pre-proline 0 CA--C 1.531 0.242 0 O-C-N 123.943 0.777 . . . . 0.0 112.045 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 37' ' ' ALA . 9.5 Cg_exo -72.19 52.62 1.92 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.319 2.679 . . . . 0.0 112.337 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -76.61 49.45 0.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.311 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -153.8 43.99 0.58 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.608 0.718 . . . . 0.0 109.857 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.3 m -65.07 131.99 48.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.498 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.449 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 65.6 t0 -91.46 112.21 53.06 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-O 120.919 0.39 . . . . 0.0 110.298 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 42' ' ' ASP . 29.6 Cg_endo -63.46 -22.89 71.28 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.122 2.548 . . . . 0.0 112.546 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 79.7 mtm180 -67.86 -21.95 65.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.782 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.698 HD13 ' HD2' ' A' ' 16' ' ' TYR . 67.3 mt -87.3 133.82 29.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.189 0.518 . . . . 0.0 111.432 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.17 -41.72 2.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.466 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.417 ' CE2' ' HA ' ' A' ' 19' ' ' ASP . 4.5 p90 -155.24 149.18 25.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.051 0.453 . . . . 0.0 111.857 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -106.84 126.66 8.54 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 179.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.2 mm -92.27 117.39 35.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 120.859 0.361 . . . . 0.0 110.612 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.608 ' H ' ' HD2' ' A' ' 51' ' ' PRO . 76.8 m -99.68 -46.19 0.22 Allowed Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.173 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HD2' ' H ' ' A' ' 50' ' ' CYS . 52.1 Cg_endo -68.53 73.36 0.89 Allowed 'Trans proline' 0 C--N 1.363 1.296 0 C-N-CA 122.2 1.933 . . . . 0.0 113.025 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 57.2 tp 74.05 116.29 0.06 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.747 0.819 . . . . 0.0 111.476 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.447 ' O ' ' HD2' ' A' ' 15' ' ' LYS . . . . . . . . 0 C--O 1.244 0.776 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.17 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.1 p30 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.627 0.251 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.05 138.03 1.65 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.099 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 pt -64.49 133.9 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 121.3 0.571 . . . . 0.0 111.933 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.8 t -89.79 69.1 7.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.984 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 p -135.17 -169.73 2.43 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.802 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.846 ' HA ' HD12 ' A' ' 45' ' ' ILE . 16.9 p30 -165.15 -173.86 3.04 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.9 m -59.68 -48.93 79.71 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -74.57 -48.95 23.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.11 0.481 . . . . 0.0 110.462 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.87 63.04 7.32 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.737 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.23 -135.21 2.83 Favored Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.734 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 51.5 m -161.0 125.58 3.56 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 12.8 ttmm -60.91 133.48 56.14 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.178 0.514 . . . . 0.0 109.944 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.19 -39.58 2.55 Favored Glycine 0 N--CA 1.438 -1.222 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 40.0 m -92.49 125.69 37.25 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.77 ' HG3' ' HG3' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -96.23 125.18 40.56 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 53.2 m-85 -91.78 126.06 36.73 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.162 0.506 . . . . 0.0 111.52 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -117.56 163.92 15.7 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.838 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.1 m -76.21 -155.21 0.05 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.966 178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -91.19 -40.24 11.67 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.824 0.345 . . . . 0.0 110.129 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -64.17 -41.83 96.97 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.772 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.61 -13.55 2.7 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.748 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 m -60.84 132.0 52.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.285 0.564 . . . . 0.0 111.542 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.593 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.0 t80 -74.0 120.89 20.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.718 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 34.0 t -88.3 -62.68 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.308 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.3 p -171.8 149.59 2.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.856 0.36 . . . . 0.0 111.116 -178.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.77 ' HG3' ' HG3' ' A' ' 15' ' ' LYS . 23.1 tt0 -85.38 151.88 23.67 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -59.83 122.26 29.41 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.041 -1.076 . . . . 0.0 111.467 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -105.27 58.69 0.68 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.577 0.703 . . . . 0.0 110.088 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 p -156.03 141.19 17.43 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.429 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 10.0 t70 -63.0 134.1 95.67 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.19 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 18.8 Cg_exo -68.36 41.35 0.24 Allowed 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.982 3.122 . . . . 0.0 114.176 -179.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -71.06 -32.83 69.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.416 . . . . 0.0 110.405 179.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -173.2 149.77 1.79 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.648 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -60.89 128.61 26.02 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.363 2.042 . . . . 0.0 111.148 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -89.61 140.51 29.48 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.727 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -161.75 145.0 12.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.39 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.47 149.5 21.48 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.095 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.86 116.13 2.91 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.751 2.301 . . . . 0.0 113.248 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 59.37 33.29 22.35 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.162 -0.927 . . . . 0.0 112.642 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.11 26.02 3.03 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.746 0.784 . . . . 0.0 110.236 178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.42 120.52 17.12 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.07 -178.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 10.0 t70 -78.61 121.3 83.45 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.24 -27.87 68.47 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 123.24 2.626 . . . . 0.0 113.524 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.08 -30.24 26.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.634 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.846 HD12 ' HA ' ' A' ' 6' ' ' ASN . 84.6 mt -88.72 123.98 41.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.11 -44.69 3.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.551 179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -146.58 145.34 30.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.445 . . . . 0.0 111.427 179.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -116.04 136.13 12.68 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.785 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 51.1 mm -101.52 119.6 49.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 85.9 m -88.22 -41.32 0.48 Allowed Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 113.294 0.849 . . . . 0.0 113.294 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' A' ' 50' ' ' CYS . 9.9 Cg_endo -51.79 148.92 20.84 Favored 'Trans proline' 0 C--N 1.362 1.274 0 C-N-CA 121.907 1.738 . . . . 0.0 112.052 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -46.38 124.19 5.53 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 123.696 0.623 . . . . 0.0 112.217 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.827 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.532 179.905 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 49.2 t0 . . . . . 0 C--O 1.234 0.259 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 59.21 54.83 4.62 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.528 0.731 . . . . 0.0 110.518 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -60.11 138.62 20.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.429 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.6 t -86.03 84.93 7.39 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.8 p -138.48 -168.05 2.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.832 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 p30 -165.6 159.9 17.02 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 18.6 m -57.15 -38.1 73.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.07 -43.68 95.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.983 0.42 . . . . 0.0 110.931 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.86 -96.89 0.13 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.062 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.91 -131.82 47.95 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.674 179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.3 m -155.02 115.56 3.88 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 18.4 tptm -61.15 121.59 12.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.52 -33.88 4.91 Favored Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.422 -178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 86.3 m -95.56 131.93 41.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.107 0.48 . . . . 0.0 110.159 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HG3' ' CE1' ' A' ' 23' ' ' PHE . 0.8 OUTLIER -92.03 122.11 34.23 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 178.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.795 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.4 m-85 -87.04 131.73 34.02 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.759 0.314 . . . . 0.0 110.743 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -125.41 163.93 21.54 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.767 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.473 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 44.2 m -85.78 -179.99 6.94 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.119 177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -69.5 -37.36 77.15 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.64 0.257 . . . . 0.0 111.434 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 43.9 p-10 -66.24 -40.41 90.22 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.14 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.67 -9.64 3.99 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -62.88 132.53 52.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.111 0.481 . . . . 0.0 111.155 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 15' ' ' LYS . 20.6 t80 -71.94 120.15 17.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.696 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.965 HG11 HG12 ' A' ' 45' ' ' ILE . 82.9 t -83.7 -68.48 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.978 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 27.2 p 177.72 158.39 0.42 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -91.7 146.56 23.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -75.23 119.0 5.74 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.434 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -89.62 50.59 1.93 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 117.452 0.626 . . . . 0.0 111.99 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.52 40.94 1.03 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.771 178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.67 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 1.6 t70 -65.62 -58.31 12.01 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.15 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 9.8 Cg_endo -90.73 -148.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.883 2.389 . . . . 0.0 111.685 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 31' ' ' PRO . 0.3 OUTLIER -117.91 41.82 2.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.366 0.603 . . . . 0.0 110.637 179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.565 ' OD1' ' HD3' ' A' ' 34' ' ' PRO . 10.1 p-10 -79.56 -40.91 1.47 Allowed Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.565 ' HD3' ' OD1' ' A' ' 33' ' ' ASN . 2.8 Cg_exo -75.83 146.88 30.26 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.074 1.849 . . . . 0.0 112.718 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.497 ' HD2' ' C ' ' A' ' 34' ' ' PRO . 13.4 mptt -124.99 133.95 52.79 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 62.61 -134.22 0.48 Allowed 'General case' 0 C--N 1.331 -0.207 0 O-C-N 123.761 0.663 . . . . 0.0 110.471 -178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.575 ' H ' ' HD2' ' A' ' 38' ' ' PRO . . . -166.81 -52.38 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.575 ' HD2' ' H ' ' A' ' 37' ' ' ALA . 74.4 Cg_endo -74.06 45.02 1.08 Allowed 'Trans proline' 0 C--N 1.359 1.093 0 C-N-CA 122.226 1.951 . . . . 0.0 113.336 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 59.8 ttt-85 -83.64 -40.28 19.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.621 0.724 . . . . 0.0 109.485 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -174.2 135.38 0.46 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.525 -1.216 . . . . 0.0 108.904 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 39.2 m -123.21 137.17 54.95 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.824 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.481 ' OD2' ' HB3' ' A' ' 44' ' ' ARG . 8.0 t0 -86.7 120.18 71.68 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.091 179.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.11 -24.27 78.97 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.351 2.701 . . . . 0.0 112.55 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.481 ' HB3' ' OD2' ' A' ' 42' ' ' ASP . 21.1 ttp180 -68.13 -19.47 64.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.263 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.965 HG12 HG11 ' A' ' 24' ' ' VAL . 57.5 mt -85.94 129.27 38.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.923 0.392 . . . . 0.0 110.875 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.02 -51.2 2.88 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.459 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -155.97 144.95 20.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.237 0.542 . . . . 0.0 112.082 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.795 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -104.24 128.3 9.42 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.494 -1.043 . . . . 0.0 110.494 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 40.5 mm -122.58 129.0 75.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 117.183 0.492 . . . . 0.0 112.069 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 1.3 m -89.57 113.47 56.8 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 177.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.445 ' HG2' ' O ' ' A' ' 53' ' ' ALA . 72.5 Cg_endo -81.06 163.53 20.2 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.648 2.232 . . . . 0.0 111.793 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 86.3 mt -85.25 38.6 0.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.403 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 51' ' ' PRO . . . . . . . . 0 C--O 1.254 1.302 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.144 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.4 ' O ' ' HD3' ' A' ' 2' ' ' ARG . 12.4 p-10 . . . . . 0 CA--C 1.518 -0.266 0 CA-C-O 121.578 0.704 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 1' ' ' ASP . 19.6 mmt85 -121.5 131.96 54.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.939 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -79.11 129.94 36.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.759 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.6 t -89.39 62.34 5.99 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 17.2 p -128.84 -151.95 0.5 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.868 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.454 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 21.4 p30 -163.83 -176.79 4.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.764 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 34.3 m -56.94 -44.39 82.46 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.226 -0.443 . . . . 0.0 112.151 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.43 -50.5 72.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.016 0.436 . . . . 0.0 110.61 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.53 37.48 0.64 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.596 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.49 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -97.26 -27.37 9.34 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.772 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 10' ' ' GLY . 31.5 m 76.41 126.36 0.04 OUTLIER 'General case' 0 C--O 1.237 0.426 0 C-N-CA 122.878 0.471 . . . . 0.0 111.055 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.596 ' HD2' ' O ' ' A' ' 27' ' ' GLY . 25.2 mmmt -54.85 133.35 47.74 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.42 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.71 -42.93 1.79 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.656 -0.783 . . . . 0.0 111.727 -179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.3 m -87.68 136.65 32.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.208 0.527 . . . . 0.0 110.579 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.615 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 59.4 mttp -112.02 127.44 55.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.536 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.799 ' HD2' HD13 ' A' ' 45' ' ' ILE . 5.3 m-30 -82.51 129.03 34.83 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -125.88 160.29 30.31 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.812 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.427 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 39.3 m -83.96 178.87 7.7 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -76.37 -33.28 58.92 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.022 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.5 p-10 -65.87 -39.54 90.8 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.378 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 138.27 -14.46 3.49 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.987 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.5 m -62.52 134.06 55.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.272 0.558 . . . . 0.0 111.787 -179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.543 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 20.0 t80 -75.44 120.78 21.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.196 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.646 HG11 HG12 ' A' ' 45' ' ' ILE . 57.7 t -84.46 -63.35 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.722 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.2 p -176.61 147.09 0.62 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.999 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.615 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 36.4 tt0 -79.19 150.56 31.62 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 178.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.596 ' O ' ' HD2' ' A' ' 12' ' ' LYS . . . -63.64 122.91 27.73 Favored Glycine 0 N--CA 1.442 -0.951 0 C-N-CA 120.047 -1.073 . . . . 0.0 111.084 179.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 28' ' ' GLU . 4.6 tp10 -109.39 63.08 0.6 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.291 0.567 . . . . 0.0 110.278 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.7 p -79.52 112.64 16.97 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.421 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -69.47 130.37 90.77 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.079 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.26 42.13 1.08 Allowed 'Trans proline' 0 CA--C 1.532 0.423 0 C-N-CA 122.793 2.329 . . . . 0.0 113.335 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -135.22 52.26 2.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.715 0.293 . . . . 0.0 111.061 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 38.28 69.7 1.45 Allowed Pre-proline 0 N--CA 1.475 0.807 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -70.63 65.97 2.3 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.189 2.593 . . . . 0.0 112.296 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -70.48 137.68 50.48 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.446 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 65.67 35.11 7.16 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.867 0.729 . . . . 0.0 111.196 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.0 145.58 96.48 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.796 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.79 114.98 2.14 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.626 2.217 . . . . 0.0 112.009 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 25.5 ptt-85 -92.59 41.56 1.08 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.263 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -79.54 115.76 19.35 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.713 -0.476 . . . . 0.0 109.713 179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 5' ' ' THR . 7.9 m -77.6 126.85 31.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.761 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.733 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 12.1 t0 -90.42 123.74 64.66 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 47.9 Cg_exo -58.15 -30.65 91.19 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 123.556 2.838 . . . . 0.0 114.273 -178.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.733 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 15.5 ptt180 -74.87 -14.62 60.69 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.799 HD13 ' HD2' ' A' ' 16' ' ' TYR . 75.8 mt -88.17 128.88 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.977 0.418 . . . . 0.0 111.231 -179.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.22 -52.91 2.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.818 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -153.7 150.19 28.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.08 0.467 . . . . 0.0 111.576 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.9 131.62 10.63 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.704 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.9 mm -105.86 119.31 54.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.781 0.324 . . . . 0.0 110.414 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 35.5 m -104.56 127.29 29.29 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.516 ' HB2' ' H ' ' A' ' 52' ' ' LEU . 1.1 Cg_endo -84.08 -134.47 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.469 2.779 . . . . 0.0 112.05 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.81 ' H ' HD23 ' A' ' 52' ' ' LEU . 2.1 pt? -90.61 33.26 0.92 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.182 179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.44 ' O ' ' HD2' ' A' ' 51' ' ' PRO . . . . . . . . 0 C--O 1.253 1.238 0 CA-C-O 117.311 -1.328 . . . . 0.0 108.767 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.6 t0 . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.874 ' HG3' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -60.67 127.68 32.88 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.862 0.363 . . . . 0.0 110.707 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -66.88 142.25 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.221 0.534 . . . . 0.0 111.723 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.7 t -87.44 84.0 7.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.493 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.4 p -140.74 -166.57 2.17 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.751 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.504 ' HA ' HD12 ' A' ' 45' ' ' ILE . 21.6 p30 -171.99 165.63 6.28 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.5 m -50.18 -47.05 54.67 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.77 92.29 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.978 0.418 . . . . 0.0 112.008 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.443 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . . . -75.92 -37.34 58.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.847 -179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.33 144.29 36.79 Favored Glycine 0 N--CA 1.453 -0.219 0 O-C-N 123.847 0.717 . . . . 0.0 114.01 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -77.42 136.37 38.39 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.747 0.419 . . . . 0.0 111.339 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HB2' ' HE3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -58.03 147.57 29.04 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.67 -35.14 4.17 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.33 -1.108 . . . . 0.0 110.33 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 77.6 m -89.05 125.49 35.03 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 72.6 mttt -106.0 119.28 38.78 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.6 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.663 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 6.1 m-85 -87.89 132.2 34.29 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.671 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -120.86 157.97 28.63 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.481 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 28.0 t -86.26 161.84 18.58 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.573 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -65.38 -29.98 70.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.432 0.158 . . . . 0.0 111.387 -179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.35 -33.89 75.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.973 0.416 . . . . 0.0 110.001 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 130.69 -14.75 5.51 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.259 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.5 m -69.53 130.69 43.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.143 0.497 . . . . 0.0 111.576 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.506 ' HE1' ' HB3' ' A' ' 15' ' ' LYS . 23.1 t80 -68.83 129.78 40.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.82 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.556 ' HA ' ' NH2' ' A' ' 44' ' ' ARG . 18.3 t -90.74 -69.43 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.468 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.0 p -178.84 157.44 0.9 Allowed 'General case' 0 C--O 1.233 0.217 0 O-C-N 123.371 0.419 . . . . 0.0 111.154 -178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 69.8 tt0 -88.42 157.52 18.66 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.88 115.06 7.52 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.497 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -89.42 27.78 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.802 0.334 . . . . 0.0 111.55 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 p -90.99 21.42 4.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.563 0.697 . . . . 0.0 110.737 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.532 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.0 t0 -86.86 -51.99 0.43 Allowed Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.109 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 10.5 Cg_exo -71.26 22.0 0.23 Allowed 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.29 1.994 . . . . 0.0 112.482 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.501 ' H ' ' C ' ' A' ' 30' ' ' ASP . 58.2 mmt-85 52.54 51.18 16.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.042 178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 8.5 p30 -64.38 134.92 96.14 Favored Pre-proline 0 C--O 1.236 0.391 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 15.2 Cg_exo -69.08 119.87 6.81 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.821 2.347 . . . . 0.0 111.773 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' NZ ' ' HA ' ' A' ' 9' ' ' ALA . 4.7 mmmm -83.24 96.93 8.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.409 0.623 . . . . 0.0 110.629 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -95.41 -40.11 9.66 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.161 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HA ' ' NH1' ' A' ' 39' ' ' ARG . . . -124.12 59.17 17.61 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -77.96 58.69 6.62 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.349 2.032 . . . . 0.0 110.869 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.523 ' NH1' ' HA ' ' A' ' 37' ' ' ALA . 7.2 ptp85 -155.34 53.0 0.61 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.542 -178.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -149.2 144.61 26.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.662 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 2.8 m -111.88 121.07 44.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.946 -178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.582 ' OD2' ' HB2' ' A' ' 44' ' ' ARG . 9.9 t70 -83.81 120.02 74.45 Favored Pre-proline 0 C--N 1.33 -0.276 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.05 -23.29 72.73 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.236 2.624 . . . . 0.0 112.782 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HB2' ' OD2' ' A' ' 42' ' ' ASP . 42.7 mtp85 -71.8 -32.0 67.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.639 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 6' ' ' ASN . 43.6 mt -86.85 120.59 36.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.566 0.698 . . . . 0.0 112.222 -178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.874 ' HA ' ' HG3' ' A' ' 2' ' ' ARG . . . -106.74 -48.45 3.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.415 179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -150.53 143.13 24.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.061 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -103.97 122.82 7.53 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.695 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.683 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 46.2 mm -101.43 128.19 54.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 35.8 m -106.41 89.0 3.64 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.743 0.306 . . . . 0.0 110.281 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.683 ' HD3' ' O ' ' A' ' 49' ' ' ILE . 19.2 Cg_endo -92.27 154.27 3.12 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.321 2.68 . . . . 0.0 112.155 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 93.4 mt -84.51 37.64 0.64 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.85 0.357 . . . . 0.0 110.232 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-N 115.442 -0.799 . . . . 0.0 108.917 -179.866 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.747 0.308 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.617 ' HG2' ' HA ' ' A' ' 46' ' ' ALA . 7.5 tmm_? -152.66 102.5 2.71 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.411 HG12 ' H ' ' A' ' 3' ' ' ILE . 5.0 pt -60.13 138.23 21.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.286 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.5 t -88.31 69.59 9.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.547 0.689 . . . . 0.0 109.715 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.9 p -133.78 153.71 51.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.355 -0.838 . . . . 0.0 110.276 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.565 ' OD1' ' HA ' ' A' ' 39' ' ' ARG . 17.5 p-10 -131.1 160.32 35.05 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -48.66 -46.55 40.31 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.98 -38.33 88.16 Favored 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.401 ' HB3' ' OD1' ' A' ' 6' ' ' ASN . . . -114.94 56.91 0.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.809 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -70.77 -148.77 0.5 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.115 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 78.5 m -155.3 124.53 6.28 Favored 'General case' 0 C--O 1.237 0.418 0 O-C-N 122.565 -0.374 . . . . 0.0 111.258 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm 56.97 -88.73 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 O-C-N 124.052 0.845 . . . . 0.0 111.341 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -171.56 41.55 0.18 Allowed Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 108.811 -1.715 . . . . 0.0 108.811 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.1 m -88.09 133.9 33.88 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.657 -0.771 . . . . 0.0 110.52 -178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 42.2 mttp -83.03 115.9 22.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.175 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 92.0 m-85 -84.03 128.56 34.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.88 0.372 . . . . 0.0 111.11 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -122.47 158.72 29.15 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.344 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.498 ' HB2' ' OD1' ' A' ' 20' ' ' ASP . 50.0 m -84.65 176.28 8.68 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -68.07 -35.6 78.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.628 0.252 . . . . 0.0 110.896 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.498 ' OD1' ' HB2' ' A' ' 18' ' ' SER . 5.1 p-10 -65.36 -40.03 93.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.787 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 135.7 -16.88 3.99 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.201 -179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.7 m -64.49 134.1 53.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.165 0.507 . . . . 0.0 111.503 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -69.88 123.58 21.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.445 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.656 HG13 ' HD2' ' A' ' 44' ' ' ARG . 21.6 t -84.25 -65.18 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.877 0.37 . . . . 0.0 111.141 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 p -175.33 154.02 1.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.624 -178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 15.8 tt0 -85.08 144.93 27.93 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.57 102.63 0.57 Allowed Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.944 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -89.21 61.87 5.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 122.136 0.97 . . . . 0.0 109.139 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 p -92.75 36.83 1.01 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.457 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.538 ' OD1' ' HD2' ' A' ' 31' ' ' PRO . 45.1 t0 -92.4 124.96 57.84 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.538 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 43.9 Cg_endo -68.31 54.7 0.75 Allowed 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.261 2.641 . . . . 0.0 114.374 -178.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.405 ' HD3' ' OD2' ' A' ' 30' ' ' ASP . 14.8 mmm180 -69.59 -43.52 72.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -167.5 153.97 7.66 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.284 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.31 123.51 13.27 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.18 1.92 . . . . 0.0 111.928 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.97 128.16 33.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.419 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.0 -30.73 61.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.022 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.92 121.03 81.48 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.08 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.22 153.44 74.56 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.006 2.47 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.565 ' HA ' ' OD1' ' A' ' 6' ' ' ASN . 14.0 ttm180 -77.45 56.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.571 0.7 . . . . 0.0 110.421 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.19 154.82 41.39 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.111 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 29.9 m -66.17 93.89 0.23 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.418 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 9.6 t0 -62.94 117.84 36.53 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.177 0.513 . . . . 0.0 110.919 -178.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 26.0 Cg_exo -62.68 -25.54 75.16 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 123.276 2.651 . . . . 0.0 112.907 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.656 ' HD2' HG13 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -82.26 -26.16 33.43 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.519 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.442 ' CG1' HG11 ' A' ' 24' ' ' VAL . 54.5 mt -88.4 125.3 41.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.767 0.318 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.617 ' HA ' ' HG2' ' A' ' 2' ' ' ARG . . . -109.47 -51.52 2.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.858 0.361 . . . . 0.0 110.564 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -149.08 147.5 28.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.149 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.616 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -109.81 127.39 8.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.318 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.3 mm -91.56 112.24 25.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.9 m -89.68 128.91 48.74 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.531 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.76 46.06 2.06 Favored 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.82 2.347 . . . . 0.0 112.363 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.2 tp -171.11 133.28 0.86 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.858 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.918 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 50.4 t0 . . . . . 0 C--O 1.234 0.264 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.542 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -74.86 170.27 16.27 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 179.447 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.3 pt -57.81 128.93 19.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.472 0.653 . . . . 0.0 112.093 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.9 t -88.03 71.3 9.37 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.257 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 19.8 p -137.16 -158.66 0.88 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.478 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.555 ' HA ' ' CD1' ' A' ' 45' ' ' ILE . 18.2 p30 -171.21 -177.17 2.08 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -60.85 -43.79 97.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -50.01 66.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.039 0.447 . . . . 0.0 110.898 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.95 44.52 1.2 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.981 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -122.88 142.22 14.45 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.927 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.0 m -58.38 122.36 13.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.577 0.227 . . . . 0.0 110.969 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.1 OUTLIER -59.76 136.73 58.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.668 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.86 -29.7 10.14 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.222 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.7 m -89.46 130.01 35.87 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.661 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -99.86 122.08 42.28 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.978 179.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.789 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 2.0 m-85 -81.23 128.09 33.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.137 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.652 ' HE1' ' HG3' ' A' ' 15' ' ' LYS . 5.7 m-85 -118.57 162.09 18.95 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.674 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.447 ' HB3' ' OD1' ' A' ' 20' ' ' ASP . 12.4 t -80.3 -170.26 2.46 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.245 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.2 p-10 -74.21 -44.33 53.65 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.722 0.296 . . . . 0.0 110.961 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 18' ' ' SER . 42.9 p-10 -62.01 -42.59 99.32 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.682 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 137.4 -1.89 3.06 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -69.64 131.14 44.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.008 0.433 . . . . 0.0 110.842 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -69.45 119.73 14.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.774 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.535 HG11 HG12 ' A' ' 45' ' ' ILE . 90.3 t -86.75 -63.95 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.346 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.0 p -174.67 148.48 1.14 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.771 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 14.7 tt0 -82.44 142.51 31.86 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.684 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -80.02 145.76 27.4 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.234 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -145.09 67.62 1.24 Allowed 'General case' 0 C--O 1.238 0.455 0 CA-C-O 122.163 0.982 . . . . 0.0 110.129 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.7 p -78.76 132.07 36.79 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.895 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.483 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 2.2 t70 -63.38 137.2 97.01 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.719 -178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.556 ' O ' ' HD2' ' A' ' 32' ' ' ARG . 10.4 Cg_exo -71.3 33.0 0.24 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.267 2.645 . . . . 0.0 112.884 -179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.556 ' HD2' ' O ' ' A' ' 31' ' ' PRO . 28.4 mmm180 -140.29 -36.39 0.49 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.088 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -171.65 151.88 3.0 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.043 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.53 128.31 23.2 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 121.94 1.76 . . . . 0.0 111.052 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -62.8 135.91 57.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.597 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . 66.9 -120.16 0.26 Allowed 'General case' 0 C--N 1.332 -0.166 0 O-C-N 123.948 0.78 . . . . 0.0 110.235 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . . . -164.44 140.97 5.08 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 110.232 -0.285 . . . . 0.0 110.232 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 37' ' ' ALA . 7.6 Cg_exo -73.04 46.83 1.17 Allowed 'Trans proline' 0 CA--C 1.53 0.319 0 C-N-CA 123.097 2.532 . . . . 0.0 112.127 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -110.51 -40.5 4.6 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.033 0.444 . . . . 0.0 110.105 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -82.11 56.48 3.18 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.605 0.717 . . . . 0.0 109.712 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 5' ' ' THR . 12.4 m -61.56 124.31 20.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.07 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.737 ' OD1' ' HG2' ' A' ' 44' ' ' ARG . 12.0 t0 -79.27 124.44 84.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.01 -32.13 94.5 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.349 2.699 . . . . 0.0 113.715 -178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.737 ' HG2' ' OD1' ' A' ' 42' ' ' ASP . 16.8 ptt180 -74.27 -10.24 59.4 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.657 0.243 . . . . 0.0 111.657 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 6' ' ' ASN . 55.5 mt -88.34 106.94 17.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.525 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -97.55 -45.99 6.2 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.292 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -156.79 142.99 18.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.211 0.529 . . . . 0.0 112.254 -179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.789 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -97.44 128.9 9.71 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.652 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.3 mm -94.82 120.13 43.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.764 0.316 . . . . 0.0 110.665 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.2 m -102.02 107.94 54.55 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.26 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -87.64 51.73 2.16 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.453 2.769 . . . . 0.0 112.215 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' H ' ' CD1' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -81.53 146.57 30.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.64 -179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.992 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.93 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 48.7 t0 . . . . . 0 C--O 1.234 0.27 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.416 ' HD2' ' HA ' ' A' ' 2' ' ' ARG . 20.6 mmm180 59.53 50.66 7.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.711 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.5 pt -64.16 129.72 28.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.375 178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 41' ' ' CYS . 8.9 t -88.88 52.8 2.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.478 0.656 . . . . 0.0 110.8 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.409 ' HB ' ' H ' ' A' ' 6' ' ' ASN . 13.7 p -112.28 -144.1 0.39 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.19 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.409 ' H ' ' HB ' ' A' ' 5' ' ' THR . 25.4 p30 -169.91 171.24 7.27 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 77.9 m -51.32 -48.22 62.43 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.535 0.522 . . . . 0.0 112.293 -179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.717 ' HA ' ' HB3' ' A' ' 28' ' ' GLU . . . -58.02 -49.09 78.04 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.983 0.421 . . . . 0.0 111.0 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.34 31.49 0.51 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.266 0.555 . . . . 0.0 110.822 178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.588 ' HA2' ' CZ ' ' A' ' 16' ' ' TYR . . . -88.27 -19.32 53.18 Favored Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.925 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.3 m 74.72 118.09 0.05 Allowed 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.095 0.558 . . . . 0.0 110.502 -179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -53.27 127.85 26.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.544 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.0 -38.09 3.5 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.868 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 70.6 m -90.82 131.7 36.31 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.222 0.534 . . . . 0.0 109.602 178.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 17.0 mtmm -104.54 127.94 52.39 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.136 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.588 ' CZ ' ' HA2' ' A' ' 10' ' ' GLY . 4.7 m-30 -82.68 121.27 26.64 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.78 0.324 . . . . 0.0 110.303 178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -108.3 158.17 17.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.326 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.603 ' OG ' ' HD3' ' A' ' 44' ' ' ARG . 6.0 t -82.64 -158.05 0.25 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.091 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -84.25 -46.53 11.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.166 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.2 p-10 -63.98 -37.9 89.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.278 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 133.07 -6.22 5.07 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 85.5 m -66.61 132.65 48.64 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.176 0.512 . . . . 0.0 111.151 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.407 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.2 t80 -68.5 120.53 14.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.198 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.2 t -89.61 -60.14 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.534 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 16.8 p -171.33 140.12 1.4 Allowed 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.792 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.68 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 29.8 tt0 -81.45 160.23 24.05 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.95 112.7 2.34 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.363 -0.446 . . . . 0.0 113.307 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.717 ' HB3' ' HA ' ' A' ' 8' ' ' ALA . 79.4 tt0 -88.79 52.4 2.41 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.639 0.733 . . . . 0.0 110.138 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 92.0 p -105.28 53.87 0.71 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.103 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 8.7 t70 -140.42 131.19 13.87 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 32.4 Cg_exo -58.59 159.68 19.54 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 123.041 2.494 . . . . 0.0 112.889 -179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 31' ' ' PRO . 48.0 mtm180 78.87 33.34 0.25 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.562 0.745 . . . . 0.0 110.276 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 11.8 p-10 -116.86 148.03 41.25 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.049 179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 11.5 Cg_exo -70.08 117.24 4.99 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.371 2.047 . . . . 0.0 110.651 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -59.89 111.81 1.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.822 0.344 . . . . 0.0 111.093 -179.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -165.76 -128.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.539 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 69.44 153.85 0.14 Allowed Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 123.737 0.648 . . . . 0.0 111.784 179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.72 147.25 88.92 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.786 2.324 . . . . 0.0 111.868 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -64.62 -57.4 9.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.874 0.369 . . . . 0.0 111.225 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -174.82 155.25 2.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.363 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 7.8 m 59.81 42.59 16.39 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 123.662 0.601 . . . . 0.0 111.817 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -60.71 124.02 77.2 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.017 0.437 . . . . 0.0 110.224 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -58.08 -30.61 90.84 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.474 2.783 . . . . 0.0 113.839 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.603 ' HD3' ' OG ' ' A' ' 18' ' ' SER . 10.9 tpp180 -82.39 -24.0 34.66 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.714 -0.221 . . . . 0.0 111.037 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.586 HD13 ' HD2' ' A' ' 16' ' ' TYR . 75.9 mt -87.69 123.14 40.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.211 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -118.29 -58.18 2.01 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.764 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -140.58 139.85 35.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.329 0.585 . . . . 0.0 111.707 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -98.28 135.92 12.43 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.974 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 50.0 mm -120.15 127.01 75.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.868 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 57.9 m -85.61 -50.12 0.53 Allowed Pre-proline 0 C--N 1.32 -0.693 0 C-N-CA 120.595 -0.442 . . . . 0.0 112.053 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 50' ' ' CYS . 6.2 Cg_exo -73.67 -145.1 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 121.811 1.674 . . . . 0.0 111.838 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 25.4 tp 61.71 38.68 14.95 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.355 0.598 . . . . 0.0 110.4 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.86 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.647 179.761 . . . . . . . . 0 0 . 1 stop_ save_